FY 2021 Annual Report

USF Research & Innovation State-of-the-Art 120,000 square foot Mixed Use Innovation Faci l i ty opened

March 2022

USF Research & Innovation University of South Florida

3702 Spectrum Blvd, Suite 165 Tampa, Florida 33612-9445

Phone: 813-974-5570 Fax: 813-974-4962

Email: [email protected]

This document is also available on the USF Office of Research Web site at www.research.usf.edu

1

UNIVERSITY OF SOUTH FLORIDA R E S E A R C H & I N N O VAT I O N

REPORT OF RESEARCH

ACTIVITIES

F I S C A L Y E A R 2 0 2 1

S E C T I O N 1 C O N T A C T S

2

3

CONTACT INFORMATION

USF Research & Innovation

Office of the Vice President

Fiscal Year 2021

Wilson Thomas, Sylvia [email protected] (813) 974-7988 Interim Vice President for Research, Innovation & Knowledge Enterprise

Anderson, Keith Assistant Vice President Research & Innovation

[email protected] (813) 974-6329

Mullings, Cerise [email protected] (813) 974-7136 Director of Operations McLaughlin, Mark Assistant Director Lowry, Judy Senior Director Outreach & Engagement

[email protected] [email protected]

(813) 974-8124 (813) 974-3181

Sponsored Research

Kern, Eric Director, Sponsored Research

[email protected] (813) 974-6001

4

mailto:[email protected]

Research Integrity and Compliance Ramage, Jason [email protected] (813) 974-2302 Director Research Integrity & Compliance

Moulvi, Farah [email protected] (813) 974-0954 Institutional Biosafety Officer & IACUC Program Manager

Allen, Eric [email protected] (813) 974-5452 Associate Director Research Integrity & Compliance Ruff, Bryan Chief Export Control Officer

[email protected]

(813) 974-0554

Weaver, Adam [email protected] (813) 974-1194 Radiation Safety Manager

5

Comparative Medicine

Engelman, Robert [email protected] (813) 745-4361 Associate Vice President Professor of Pediatrics Perez, Marta [email protected] (813) 974-3836 Assistant Director

Technology Transfer Tyrpak, Michele [email protected] (813) 974-3732 Director Technology Engagement & Commercialization

USF Research Foundation, Inc. Wilson Thomas, Sylvia [email protected] (813) 974-7988

President & CEO Gamble, Patricia [email protected] (813) 974-6171 CFO & Director Madden, Allison [email protected] (813) 974-5095 Director, USFRF Operations

6



REPORT OF RESEARCH

ACTIVITIES

F I S C A L Y E A R 2 0 2 1

S E C T I O N 2 R E S E A R C H F U N D I N G

7

8

USF Research and Innovation Annual Report FY2021Section 2.4 Research Funding Research Funding By Source

1. FederalDHHS (Non-NIH)

Admin For Children and Families 749,920Administration for Community Living 631,433Ctrs for Disease Control and Prevention 1,083,065Ctrs for Medicare and Medicaid Svcs 2,333,924Health Resources and Srvcs Admin 2,549,890Natl Inst for Occupational Safety & Hlth 1,628,849Substance Abuse & Mental Health 325,750US Food and Drug Administration 420,657

DHHS (Non-NIH) Total 9,723,488

NASANASA Goddard 38,727NASA Jet Propulsion Laboratory 357,087National Aeronautics & Space Admin 1,916,010

NASA Total 2,311,824

National Institutes of HealthNational Cancer Institute 39,001,917National Eye Institute 12,450,193National Human Genome Research Institute 74,750National Institute of Mental Health 320,999National Institute of Neurological Disor 1,534,025National Institute of Nursing Research 157,892National Institute on Aging 13,407,215National Institute on Drug Abuse 1,166,508National Institutes of Health 23,395,929Natl Ctr Complementary & Integrative Hea 277,695Natl Heart Lung and Blood Inst 12,423,410Natl Inst of Allergy and Infectious 11,857,700Natl Insti Alcohol Abuse and Alcoholism 339,634Natl Insti of Biomedical Imaging 432,358Natl Insti of Child Health 609,996Natl Insti of Dental and Craniof 991,453Natl Insti of Diabetes (NIDDK) 63,689,702Natl Insti of Environmental Health 286,854Natl Insti of Gen Medical Science 6,492,390Natl Insti on Deafness and Other Comm D 2,315,013

National Institutes of Health Total 191,225,633

National Science FoundationNational Science Foundation 15,723,627

National Science Foundation Total 15,723,627

9


Other Federal AgenciesEnvironmental Protection Agency 393,063National Endowment for the Arts 25,000National Endowment for the Humanities 30,510Natl Historical Publications 125,000Peace Corps 23,964

Other Federal Agencies Total 597,537

U.S. Dept. of CommerceNational Institute of Standards and Tech 30,000Natl Oceanic & Atmospheric Admin 1,956,847

U.S. Dept. of Commerce Total 1,986,847

U.S. Dept. of DefenseAir Force Office of Scientific Research 456,696Asian Office of Aerospace Research and D 139,628Department of the Air Force 64,036Department of the Army 85,166National Security Agency 69,926Office of Naval Research 414,020US Army Medical Research & Material Comm 8,401,164US Special Operations Command 2,625,604

U.S. Dept. of Defense Total 12,256,240

U.S. Dept. of EducationUS Department of Education 7,395,941

U.S. Dept. of Education Total 7,395,941

U.S. Dept. of EnergyArgonne National Laboratory 240,639National Renewable Energy Laboratory 164,450US Department of Energy 1,136,498

U.S. Dept. of Energy Total 1,541,587

U.S. Dept. of JusticeNational Institute of Justice 547,581US Department of Justice 204,677

U.S. Dept. of Justice Total 752,258

U.S. Dept. of LaborOccupational Safety & Health Admin 2,711,500

U.S. Dept. of Labor Total 2,711,500

U.S. Dept. of the InteriorBureau of Ocean Energy Mgt, Reg and Enf 49,845Bureau of Reclamation 51,482

10


National Park Service 4,680US Fish & Wildlife Service 15,748US Geological Survey 1,476,415

U.S. Dept. of the Interior Total 1,598,169

U.S. Dept. of TransportationDepartment of Transportation 2,468,106Federal Transit Administration 107,672

U.S. Dept. of Transportation Total 2,575,778

U.S. Dept. of TreasuryUS Department of Treasury 983,632

U.S. Dept. of Treasury Total 983,632

U.S. Dept. of Veterans AffairsCorporal Michael J. Crescenz Medical Cen 82,917Department of Veterans Affairs 331,904James A. Haley Veteran's Hospital 1,712,467

U.S. Dept. of Veterans Affairs Total 2,127,288

U.S. Dept. of StateDepartment of State 20,000

U.S. Dept. of State Total 20,000

1. Federal Direct Total 253,531,348

2. State/LocalLocal FL Government

13th Judicial Court Hillsborough Co 104,764Arts Council of Hillsborough County 12,500Children's Board of Hillsborough County 1,653,681City of Clearwater Florida 55,938City of Kissimmee 2,950City of St Petersburg Florida 163,995City of Tampa 596,265City of Tampa Housing Authority 149,610Environmental Protection Commission 50,000FL Dept of Environmental Protection 10,000FL Metro Planning Org Advisory Council 140,000Flagler County Board 93,050Florida MPOAC 37,500Greater Hernando County Chamber of Comme 15,450Highlands County Board of County Commiss 11,330Hills Co Board of Co Commissioners 73,309Hillsborough Co City Co Planning Comm 32,250

11


Hillsborough County 597,102Hillsborough County Anti-Drug Alliance 14,000Hillsborough County Board of 32,878Hillsborough County Health Department 8,700Hillsborough County Metropolitan Plannin 13,750Hillsborough County Public Schools 298,594Juvenile Welfare Board of Pinellas Co 310,246Lake County Water Authority 25,000Orange County Florida 67,040Pinellas County Commission (17,245)Pinellas County Dept of Human Services 264,232Pinellas County Florida 240,722Polk County Florida 95,250Sarasota County Government 287,620Seminole County Florida 67,000St Lucie County 59,400Tampa Bay Estuary Program 128,908Tampa Bay Regional Transportation Author 25,000Tampa Hills Co Expressway Auth 38,726Tampa Hillsborough County Expressway Aut 1,088,000The School Board of Hillsborough County 20,000

Local FL Government Total 6,867,515

State FL GovernmentChildren's Board of Hillsborough County 745,166Fish and Wildlife Research Institute 127,304FL Department Environmental Protection 603,773Florida A&M University 195,910Florida Agency for Health Care Admin 15,886Florida Atlantic University 50,978Florida Department of Agriculture 219,182Florida Department of Education 24,241,281Florida Department of Elder Affairs 84,724Florida Department of Health 25,192,691Florida Department of Law Enforcement 116,206Florida Department of State 300,847Florida Department of Transportation 10,350,769Florida Dept of Children and Families 2,940,819Florida Division of Cultural Affairs 43,068Florida Division of Emergency Management 641,856Florida Division of Workers Compensation 235,000Florida Fish and Wildlife Conservation 759,859Florida Gulf Coast University 136,280Florida Institute for Child Welfare 63,265Florida International University 66,895Florida Office of Attorney General 206,877

12


Florida Office of Early Learning 4,802,344Florida State University 230,718Johnnie B Byrd Sr Alzheimers Research Ct 116,969St. Petersburg College 44,219The Florida Dept of Veterans Affairs 200,000Univ of South Florida 259,062University of Central Florida 371,155University of Central Florida - FSEC 83,040University of Florida 2,546,211University of West Florida 4,370,257USF Research Foundation 192,832

State FL Government Total 80,555,443

2. State/Local Direct Total 87,422,958

3. Private PartnershipsPrivate- Corporate (For Profit)

Abbott Cardiovascular Systems, Inc. 36,322Abbott Laboratories 77,479AbbVie Inc. 1,536,279Ablative Solutions 7,214ACADIA Pharmaceuticals, Inc. 24,980Acell, Inc. 0Acerta Pharma BV 14,608Achilles Therapeutics 42,676Actelion Clinical Research, Inc. 3,000Actuate Therapeutics 71,113Adaptimmune 190,596Addex Pharmaceuticals SA 28,700Advanced Accelerator 138,423Advanced Tech & Testing Labs, Inc. 60,000Advicenne Pharma 25,773Aeglea Biotherapeutics 2,600Agendia, Inc. 1,040Aileron Therapeutics 39,821Aimmune Therapeutics, Inc. 110,492Alexion Pharmaceuticlas, Inc. 355,717Allergan, Inc. 206,851Allogene Therapeutics 1,177,223Allon Therapeutics, Inc. 16,500Alnylam, Inc - Discovery Study Team 23,321Alzamend Neuro, Inc. 350,000AMAG Pharmaceuticals, Inc. (8,847)Amazon 46,966Amgen 511,222

13


Amicus Therapeutics, Inc. 42,211Amphivena 92,140AnaptysBio Inc. 21,000AngioDynamics 42,300AOBiome, LLC. (500)Apellis Pharmaceuticals, Inc. 124,669Apollomics Inc. 117,402Aprea AB 1,294,663Arena Pharmaceuticals, Inc. 93,682Argenx BVBA 82,131Ariad Pharmaceuticals, Inc. 35,596Ariosa Diagnostics, Inc (5,680)Arizona Health Care Cost Containment Sys 46,063Array BioPharma 43,853Arvinas, Inc. 844,910Asana BioSciences 9,060Astellas Pharma US, Inc. 7,096Astex Pharmaceuticals 18,754AstraZeneca Ltd 1,478,785ATARA BIOTHERAPEUTICS, INC. 1,835,373Avanir Pharmaceuticals, Inc 34,976Avelas Biosciences, Inc. 5,925Avita Medical Americas, LLC 8,500Axogen, Inc 69,820Bavarian Nordic 47,272Baxalta US, Inc. 82,945Bayer Healthcare Pharmaceuticals 730,735BerGenBio 500Beta Bionics 1,119,735BioAtla, LLC 806,149BioCryst Pharmaceuticals, Inc. 34,447Biogen 982,441Biohaven Pharmaceuticals, Icn 479,712BioMarin Pharmaceutical Inc. 213,549Bioniz Therapeutics 5,532Biosense Webster, Inc. 8,140BioXcel Therapeutics 470,388Bluebird Bio Inc 766,771Bluebird Bio, Inc. 455,834Blueprint Medicines 34,715Boehringer Ingelheim Pharm., Inc. 258,317Boston Scientific Corporation 96,970Brain Sentinel, Inc. (888)Brigham and Women's Hospital 446,975Bristol-Myers Squibb Company 3,118,278Bristol-Myers Squibb Pharmaceuticals (9,250)

14


Buena Fe (9,000)Calithera Biosciences, Inc. 76,638Carrick Therapeutics� 43,146CARsgen Therapeutics Corp 348,878Celator Pharmaceuticals 1,646Celgene Corporation 2,778,711Cellectis S.A 68,299Celyad 139,199Center on Budget and Policy Priorities 7,000Centinel Spine, LLC 15,994Cerapedics, Inc. 13,853Cerecor Inc. (28,105)Certainty Therapeutics, Inc. 245,198Children's Hospital of Boston 44,850Citrus Health Network, Inc. 151,569Clinigen Group 181,658Clovis Oncology 207,585Cognosetta, Inc. 16,000Constellation Pharmaceuticals 94,637Cook Biotech Inc. 5,206Corbus Pharmaceuticals Inc. 65,858Corelink 85,890Corin Group 7,565Corporation for Public Broadcasting 520,667Corporation to Develop Communities Tampa 123,731Corrona, LLC 8,495Criterium, Inc. 11,965CSL Behring 77,080Cue Biopharma, Inc. 405,955Curis, Inc. 19,883CVRx, Inc. 10,438CYNAPSUS Therapeutics Inc (293)CytoKinetics, Inc 26,800Daiichi Sankyo Pharma Development (DSI) 172,712Debiopharm SA 66,093Deciphera Pharmaceuticals 328,845Delcath Systems, Inc 85,050DePuy Orthopaedics, Inc. 10,761Dexcom, Inc. 7,519Dia Cardio Ltd (7,800)DJO Global 532,514DNAtrix, Inc 216,857Dyax Corp 21,238Eisai Company Ltd 896,475Eisai Inc. 307,049Elevation Oncology, Inc 20,569

15


Eli Lilly Research Laboratories 86,696Elicio Therapeutics 651,078Elucent Medical 26,113Emalex Biosciences, Inc. 11,200EMD Serono, Inc 136,856Endectra LLC 195,000Endo Pharmaceuticals, Inc. 102,520Endocyte, Inc. 121,987EndoStim, Inc (77,033)Endotronix, Inc. 29,742ENSCO, Inc. 119,998Enterin, Inc. 6,864Environmental Science Associates 45,000EpicentRx, Inc. 11,250Epizyme, Inc. 15,834Equillium, Inc. 45,042Eram Scientific Solutions 397,566ERMI 15,785Evidera 3,000Exelixis, Inc. 383,553Extremity Medical, LLC 3,311Fintech 14,545FKD Therapies Oy 8,432Food allergy Research & Education, Inc. 262,500Ford Motor Company 10,800Forty Seven, Inc. 1,586,776Freedom Metal Finishing, Inc. 100,000Functional Neuromodulation, Ltd 203,474G1 Therapeutics 35,239Geisinger Clinic, Henry Hood Center 36,238Genentech 1,204,365GenMab A/S 94,401Genzyme Corporation 10,738Geron Corporation 10,842Gilead Sciences, Inc. 465,862GlaxoSmithKline 120,578Glenmark Pharmaceuticals S.A. 3,346Global ETS, LLC 150,000Global Kinetics Corporation 12,550Global Science & Technology, Inc. 115,948Google 36,000Green Cross Corporation 10,000GW Pharmaceuticals 144,292H3 Biomedicine, Inc. 7,262Halozyme Therapeutics 100,000Harris Corporation 192,500

16


HealthMyne 73,961Helix Biopharma Corp 191,219Hemophilia of Georgia 31,900Hoffmann-La Roche Inc 1,210,674Horizon Pharma 149,500Houston Methodist Research Institute 122,527Humacyte, Inc 60,730HUYA Bioscience 661,556Hyperion Therapeutics, Inc. 1,412I.R.I.S. Servier 29,574Ignyta, Inc. 18,708Imaging Endpoints 144,299Immunocore, Ltd. 9,870Immunomedics, Inc 380,486Impax Laboratories, Inc. 116,850Inc. Research, LLC 335,374Incyte Corporation 1,290,780Infant Bacterial Therapeutics 28,632Infinity Pharmaceuticals, Inc 810,884Infuseon Therapeutics, Inc. 21,939Inovio Pharmaceuticals 24,818Inspire Medical Systems, Inc 27,755Intellia Therapeutics 535,920Intelligent Automation, Inc. 172,053Intrexon T1D Partners LLC 1,145Ionis Pharmaceuticals 72,554Iovance Biotherapeutics, Inc 1,559,714IQVIA 448,355IrriMax Corporation 31,080IRX Therapeutics, Inc. 244,469ITM Solucin GmbH 83,479Jabil Circuit, Inc. 655,250Janssen Biotech, Inc. 23,000Janssen Pharmaceutica Inc 1,069,466Jazz Pharmaceuticals, Inc. 104,884Johnson, Mirmiran & Thompson, Inc. 51,600Kadmon Corporation, LLC 71,408Kaleido Biosciences, Inc. 60,467KaloBios Pharmaceuticals 16,460Kartos Therapeutics, Inc. 29,583Karyopharm Therapeutics Inc. 136,121Kite Pharma Inc. 4,914,935Kura Oncology 177,489Kyowa Pharmaceutical, Inc. 16,916LDA Consulting 3,300Leadiant Biosciences, Inc. 27,015

17


Leidos Biomedical Research, Inc. 67,524Leidos, Inc 108,774Lexicon Pharmaceuticals, Inc. 360,586Lixte Biotechnology Holdings, Inc 34,580Lumicell 70,717MacroGenics, Inc. 19,488Mallinckrodt Medical 8,505MannKind Corporation 2,227Marker Therapeutics 60,293MedImmune LLC 14,850Mediti Pharma Inc. (2,403)MediWound Ltd 11,424MedPacto, Inc 250Medtronic, Inc. 532,089Mega Nano Biotech 229,500MEI Pharma 9,854Memgen 168,934Merck & Company 2,363,589Merck Sharp & Dohme Research Corp 8,216Mersana Therapeutics, Inc. 269,900Merz Pharmaceuticals, LLC 27,000Millenium Pharmaceuticals 69,884miRagen Therapeutics, Inc. 8,487Mirati Therapeutics 32,442Mitsubishi Pharma Corporation 31,440Modelithics, Inc. 177,500Molekule, Inc. 534,478Momenta Pharmaceuticals, Inc. 21,000Montana Molecular 144,747Morehouse School of Medicine 766,099Morphogenesis 93,481Morphotek 27,829Mote Marine Laboratory 21,807Multi Vir 41,287Myovant Sciences Inc. (7,086)Myst Therapeutics 3,193,234Natural Immunogenics Corp. 70,000Nektar Therapeutics 195,900NeoImmuneTech, Inc. 834,347NeuroDerm Ltd. 269NeuroPace, Inc. 14,475Neurovascular Diagnostics, Inc. 12,500New England Research Institutes, Inc 9,500NewLink Genetics Corporation 36,392NorthShore University Health System 180,560Northwest BioTherapeutics, Inc. 6,399

18


Novartis Pharmaceutical Corporation 1,712,057Novo Nordisk Pharmaceuticals Inc 4,757,647NuVasive, Inc. 14,925Nuvelution TS Pharma, Inc. 88ObsEva S.A. (5,600)Octapharma AG 54,520Omega Orthopaedics 125,000On Target Laboratories, LLC 4,671Oncologie, Inc. 413,481OncoMed Pharmaceuticals 9,742Oncorus, Inc. 185,709Oncosec Medical, Inc 252,224Oncosynergy, Inc. 99,512ONY Inc. 6,580Onyx Pharmaceuticals 28,271OptoXense Inc 186,001Orbus Therapeutics, Inc. 44,681Organogenesis 7,500Orion Corporation 12,492Orthofix 27,193Otsuka America Pharmaceutical 22,870Ovid Therapeutics, Inc. 9,077Oxford BioTherapeutics 98,424Pacira Pharmaceuticals, Inc 37,406Paradigm Diagnostics, Inc. (4,000)Param Bhakti Healthcare and Research Ser 50,000Pelvalon (11,298)Penumbra 16,128Pfizer 582,061Pfizer Inc US Pharmaceuticals Group (3,318)Pharma Two B Ltd. 59,431Phoenix Molecular Designs 32,972Polaris Group 83,790PolyMaterials App, LLC 325,328Precigen 978,762PrECOG, LLC 6,318PreludeDX 17,690Prescient Therapeutics Limited 66,136Pressio 51,034Prexton Therapeutics (1,000)Prilenia Therapeutics Development Ltd. 29,428PRIME Education, Inc. 48,874Prometheus Laboratories, Inc. 69,360ProMetic BioTherapeutics (4,557)Provention Bio, Inc. 35,909Ra Pharmaceuticals, Inc. 223,193

19


Radius Pharmaceuticals, Inc. 217,210Reata Pharmaceuticals, Inc. 88,546Regeneron Pharmeceuticals, Inc. 4,401,390Relay Therapeutics, Inc. 102,111Rensselaer Polytechnic Institute 112,125Replimune, Inc 183,709Research Foundation for Mental Hygiene 53,174Respivant Sciences, Inc. (2,361)Retrophin, Inc. 21,289Retrotope, Inc 140,411Revance Therapeutic, Inc. 34,517Revolution Medicines 1,112,127Rhodes & Brito Architects 25,907RTI International 268,343Sagene Pharmaceuticals, Inc (35,028)Salarius Pharmaceuticals 51,382Sanofi Pharmaceuticals 458,920Sanofi-Aventis U.S., Inc. 36,403Santen Incorporated 37,797Seattle Children's Hospital Research Ins 18,898Seattle Genetics, Inc. 450,168Senhwa Biosciences, Inc 94,272SetPoint Medical, Inc. 35,850SGN Nanopharma, Inc. 300,000Shire Pharmaceutical Development, Inc. 115,684SK Life Science, Inc. 42,311Smith & Nephew, Inc 31,360Soc for Industrial & Organizational Psyc 10,000Solidia Technologies, Inc. 150,000Soligenix 3,490Sonova AG 264,409Spectrum Pharmaceuticals 495,809SprainGo, LLC 371,210Stemedix Inc. 72,250Stereology Resource Center, Inc. 169,462Stryker Corporation 10,000Sunovion Pharmaceuticals (2,025)SunPharma 2,000Supernus Pharmaceuticals, Inc 10,080Syntrix Pharmaceuticals 911,411T2C- Energy, LLC 450,000Takeda Pharmaceuticals USA, Inc. 120,710Tandem Diabetes Care 45,682TapImmune 16,341Terumo Medical Corporation 16,823Tesaro, Inc. 459,532

20


Tesla 400TEVA Pharmaceutical USA (4,000)TG Therapeutics, Inc. 726,804The Cleveland Clinic Foundation 186,452The Emmes Company 82,350The Healthy Aging Company (THAC) 50,000The Villages Health System, LLC. 52,500Therapure Biopharma, Inc. 40,631Theravance Inc 2,000TiGenix 143,727Tmunity 73,654Tolerion, Inc. 18,510Tolero Pharmaceuticals 294,625TRACON Pharmaceuticals, Inc. 116,034TransGenex Nanobiotech, Inc. 225,000TransMedics 11,560Transtek International Group (TIG) LLC 129,880Trillium Therapeutics Inc. 46,702Turning Point Therapeutics 127,662UCB Biosciences, Inc (12,795)UCB Pharma, Inc. 147,562UCB, Inc. (8,385)Ultragenyx Pharmaceuticals Inc. 12,896uniQure Biosciences, Inc. 28,695United Health Group 554,408United Therapeutics Corporation 109,762Varian Medical Systems, Inc. 267,760Vascular Therapies, Inc 13,268Vedanta Biosciences 162,183Veracyte 17,040Vertex Pharmaceuticals 56,304W. L. Gore & Associates 28,614WindMIL Therapeutics 89,387Winter Innovation, LLC 41,056Xcenda, LLC 96,058Xcovery 81,515Xencor, Inc. 11,579Xenon Pharmaceuticals Inc. 13,233Zimmer Biomet 53,502Zoll Services LLC 8,400Zymeworks, Inc. 440,257

Private- Corporate (For Profit) Total 91,675,159

Private- FoundationAdelson (Miriam & Sheldon) Medical Res F 450,319American Psychological Foundation 18,438

21


AO Trauma North America 6,662ASES Foundation 19,800Bill and Melinda Gates Foundation 666,668Breast Cancer Research Foundation 9,908Casey (Annie E) Foundation 100,000CHDI Foundation, Inc. 79,335Cisco Systems Inc 99,998Community Foundation of Tampa Bay 10,084Cystic Fibrosis Foundation 225,327Eli Lilly and Company Foundation 337,635Evans Fdtn. 166,667Florida Blue Fdtn 253,361Florida Breast Cancer Foundation 172,756Florida Education Foundation 15,000Foundation for a Healthy St. Pete 176,293Foundation for Orthopedic Trauma 10,394Foundation for Physical Therapy Research 15,176Gateway for Cancer Research 44,192Genentech Ctr for Clincial Research 526,361GlaxoSmithKline 21,580Gulf Coast Community Foundation of Venic 30,000Helios Education Foundation 596,445Helmsley Trust 461,154Henry Jackson Foundation for the Advance 11,428Jackson (Henry M) Foundation 218,854Juvenile Diabetes Research Foundation 527,491Lymphoma Research Foundation of America 5,458Melanoma Research Foundation 58,470Michael J Fox Found for Parkinson's Rsch 35,938Mike Slive Foundation 50,000Movember Foundation 62,500National Ataxia Foundation 65,553National Marine Sanctuary Foundation 6,000National Parkinson Foundation 60,000National Pediatric Cancer Foundation 671,734NSABP Foundation 66,633Osteogenesis Imperfecta Foundation 29,000Prostate Cancer Foundation 573,896REAM Foundation 200,000Rita Allen Foundation 100,000Rust Family Foundation 6,000Simons Foundation 16,800Spencer Foundation 48,121Tampa Community Foundation 351,537Tampa VA Research & Education Foundation 241,264The Arnold P. Gold Foundation 2,400

22


The Cleveland Clinic Foundation (20,168)The HOPE Foundation 12,500The Retirement Research Foundation 97,390The Salah Foundation 469,647University of South Florida Foundation 17,663,889V Foundation for Cancer Research 386,325Weil Foundation 20,000

Private- Foundation Total 26,552,213

Private- Government (Non-FL)Cuyahoga County Division of Children and 30,000Gorgas Memorial Institute for Health Stu 25,500Metro Nashville Public Schools 54,121Nevada Dept of Child and Family Services 20,000Ntnl Action Cncl for Minorities in Engin 150,000The Norwegian Centre for Violence and Tr 2,690

Private- Government (Non-FL) Total 282,311

Private- OtherRadiation Therapy Oncology Group (RTOG) 3,174

Private- Other Total 3,174

Private- Private (Not For Profit)Abbott Diagnostics Scarborough Inc. 22,638ABIOMED, Inc. 10,000ADMA Biologics 163,710Aerin Medical Inc 60,761ALISE Assoc Library and Info Sciences Ed 10,000ALK-Abello A/S 9,700All Children's Hospital 7,026All Children's Research Institute 104,965Alliance For Clinical Trials In Oncology 195,356Alpha Omega Alpha Honor Medical Society 2,000Alzheimer's Association 138,333Amer Assoc of State Highway & Transport 20,000American Association of Nurse Practition 5,000American Association of Obstetricians & 75,000American Association of Retired Persons 179,119American Cancer Society 942,592American Chemical Society 109,297American College of OBGYN 9,000American Educational Research Associatio 4,000American Federation for Aging Research 59,728American Heart Association 525,153American Lung Association 100,000American Medical Association (AMA) 22,625

23


American Orthotic Prosthetic Assoc 14,117American Psychiatric Nurses Association 5,000American Public Health Association 500American Society of Hematology 56,000American Society of Nephrology 200,000Angion Biomedica Corp. 17,500Annexon Biosciences, Inc. 27,000APTA Academy of Pediatric Physical Thera 26,172ARCTOS Technology Solutions, LLC 136,000Armata Pharmaceuticals, Inc. 36,381ARS Pharmaceuticals, Inc. 225,567Association for Institutional Research 50,000AvaWatz 125,000Aylstock Witkin Kreis & Overholtz, PLLC 31,548Becton, Dickinson and Company 163,148Bellerophon 35,775Big Ten Cancer Research Consortium 9,264Biogen IDEC Inc 19,320Blade Therapeutics, Inc. 17,918Blood & Marrow Transplant CT Network 231,838Blue Cross and Blue Shield of FL, Inc. 29,297Boston Children's Hospital 14,953Bukwang Pharmaceutical Co., Ltd. 3,500Cadent Therapeutics, Inc. 23,000Cancer Immunotherapy Trials Network (CIT 23,300Caribbean Community Climate Change Cente 40,000Caris MPI, Inc. 18,000Cary Institute of Ecosystem Studies 33,778Cedars-Sinai Medical Center 324,987Center for Transportation, Equity, Decis 121Centogene AG 104,260CENTRO DE VACUNACl6N E INVESTIGACl6N S.A 12,506Cerapedics, Inc. 29,588Cerevance Beta, Inc. 28,519Cerevel Therapeutics, LLC 99,764Champions for Children, Inc 187,500Chan Mas & Scholars of the Uni Oxford 108,866Charlotte Harbor Nat'l Estuary Program 75,585Children¿s Hospital of Wisconsin Foundat 4,000Childrens Home Society of Florida 399,763Children's Home Society of North Carolin 9,000Children's Services Council Martin Count 275,000Cincinnati Children's Hospital 27,367Circle of Hope Cancer Research Inc. 10,000City of Hope 131,067Clear Creek Bio, Inc. 95,469

24


Cobblestone Milk Cooperative, Inc. 6,502Code Virginia 28,862COPE NOTES LLC 9,000Craig Hospital 44,982Critical Path Institute 92,018CryoLife, Inc. 21,569CTR for Occupational RSCH & Development 100,000CVS Health Foundation 3,000Dana-Farber Cancer Institute 385,346Defensewerx 217,940Doolittle Institute 665,422Dot Laboratories, Inc. 10,000Drug Abuse Comprehensive Office, Inc. 78,600Drug Free Charlotte 8,000Eckerd Youth Alternatives, Inc. 1,107,836ECOG 313,301Educational Development Center 99,754EdVision Corp. 71,452Edwards Lifesciences, LLC 8,600Endo Pharmaceuticals, Inc. 61,500Endpoint Outcomes 31,268Engineering Resources Group, Inc. 9,000Equillium, Inc. 31,500EuroQol Research Foundation 72,959Family First 31,000Family Support Services of North Florida 167,776Fast Pathway Inc. 9,950Feeding America 75,000Feeding Tampa Bay 125,006FibroGen, Inc. 10,000FL Assoc of Healthy Start Coalitions 87,680Florida Department of State 160,233Florida Education Fund, Inc. 315,926Florida Health Justice Project 11,000Florida Healthy Kids Corporation 45,878Florida High Tech Corridor 154,956Florida Humanities Council 5,000Florida Makes, Inc. 5,134Florida Policy Institute 70,000Florida Strawberry Rsch and Educa Fdn 45,397FORCE 62,078Fred Hutchinson Cancer Research Center 2,145,737Freedom Metal Finishing, Inc. 50,000Freeline Therapeutics 21,912Frequency Therapeutics, Inc. 164,700Fulcrum Therapeutics, Inc. 127,117

25


Galecto Biotech AB 30,031Galera Therapeutics, Inc. 20,472Gentuity, LLC 20,982Georgetown University Medical Center 36,590Global Coalition for Adaptive Research 54,073Greater Tampa Marine Advisory Council 20,000H. Lee Moffitt Cancer Center 5,871,002HealthPartners Regions Cancer Care and F 40,058Heart Rhythm Society (7,500)Helen of Troy 233,763Hikma Pharmaceuticals USA Inc 10,000Hill-Rom Company, Inc. 40,900Homology Medicines, Inc., 30,000Hope Pharmaceuticals 21,750Huntington's Disease Society of America 31,500Huntsman Cancer Institute 106,220ImmunoGen, Inc. 27,775Inari Medical 12,550Inc Rsch Institutions for Seismology 13,199INNATE PHARMA 61,490Institute for Clinical Research, Inc. 86,500Integrative Research Laboratories Sweden 22,500International Association of Med Sci Edu 2,500International Catacomb Society 15,000International Myeloma Foundation (IMF) 118,494International Network for Strategic Init 46,438International Solar Energy Society 56,140InVivo Therapeutics Corporation 21,500IVERIC bio, Inc. 22,800Janssen Research & Development, LLC 78,633Jayne Koskinas & Ted Giovanis Foundation 5,744Kaiser Permanente Center for Health RSCH 79,301Kaligia Biosciences 412,176Kentucky Cabinet for Health and Family S 55,586Kidney Cancer Association (KCA) 75,000Kiniksa Pharmaceuticals Corp. (7,000)Knopp Biosciences LLC (7,000)Kuwait Fdn for the Advancement of Scienc 11,070L3HARRIS TECHNOLOGIES, INC 95,000Leukemia and Lymphoma Society 60,803Ludwig Institute for Cancer Research 140,620MacLean Engineering & Applied Technologi 8,821Manchester Waterway Civic Association, I 23,681Massachusetts Dept. of Public Health 180,088Massachusetts General Hospital 100,654May Institute 289,284

26


Mayo Clinic 44,000MD Anderson Cancer Center 205,772Melanoma Research Alliance 75,000Meridian Behavioral Healthcare, Inc. 25,000Miro Health (18,000)MIVI Neuroscience, Inc., 25,225MOHAWK VALLEY COMMUNITY COLLEGE 240,868Mote Marine 146,673Nanobase, Incorporated 10,000Nat Radiation Gynecologic Cooperative Gr 7,000National Academy of Sciences 145,031National Comprehensive Cancer Network (N 74,306National Empowerment Center, Inc. (NEC) 5,040National Geographic Society 29,360National Marrow Donor Program 155,373National Safety Council 21,281NC Medical Research, Inc. 28,275Negotiation and Team Resources 2,500Neuraly Inc. 113,465New Life Village 42,000New Mexico Cancer Care Alliance (NMCCA) 1,000NGM Biopharmaceuticals, INC. 19,000Northern CA Institute for Research & Edu (41,916)Notitia Biotechnologies Company 15,500NRG Oncology 113,511Nyxoah Inc. 22,000Ocala Royal Dames 50,000Ocean Conservancy 5,000Ocean State Research Institute 1,751ORCA 5,000Organization Teratology Information Spec 46,000Organon LLC 67,319Otonomy, Inc. 136,279Pan American Health Organization 21,324Pancreatic Cancer Action Network 2,414Patient Centered Outcomes Research Insti 917,424PCCTC (Prostate Cancer Clinical Trial Co 10,000Phi Alpha Theta 152,000Phycological Society of America 2,400Pinellas Community Foundation 178,004Pinellas County Economic Development 50,000PPD Investigator Services, LLC 159,821Prader-Willi Syndrome Association 25,000Proteus Fund 20,000Provepharm, Inc. 133,500Psi Chi 4,500

27


PTC Therapeutics, Inc. 99,519Pulse Infoframe US, LLC 1,000QuantumLeap Heathcare Collaborative 160,403REACH UP, Inc. 82,236Relypsa, Inc. 16,600Research America 1,000Roadify 10,000Romark, L.C. 38,580SafeHeal SAS 27,300Samus Therapeutics, Inc. 10,000Sanford Burnham Medical Research Inst 456,892Selah Freedom, Inc. 15,672Shock Society 40,000Sigma Xi 986Siteman Cancer Center 33,491Southeast Coastal Ocean Observing Region 579,373Southwest Oncology Group 227,858Spruce Biosciences, Inc. 57,550Stand Up To Cancer 128,690Stemedix Inc. 30,230Sutro Biopharma, Inc. 29,375Tampa General Hospital 75,777The Carter Center 167,208The Children's Hosp. of San Antonio Foun 15,000The Concord Consortium 103,035The Healthy Aging Company 25,000The Jackson Laboratory 20,153The Koerner Family Foundation 20,000The Kresge Foundation 50,000The National Academy of Inventors, Inc. 150,000The School District of Philadelphia 48,561The Scripps Research Institute 136,703The Skilled Center 71,981The Stephen Group, LLC 35,000The University of Texas Health Science C 15,419Tourette's Syndrome Association 10,000Transtek International Group (TIG) LLC 120,001Tres Cantos Open Lab Foundation 334,210Turning Points for Children 55,067UCB BIOPHARMA SRL 46,700Universidad Catolica Boliviana San Pablo 12,372University Health Network 223,009University Medical Service Associates 60,584,951Vasculitis Foundation 21,500Viela Bio 20,000Virginia Polytechnic Institute and State 62,536

28


WEC projects Ltd 95,419Women & Infants Hospital of Rhode Island (7,900)WorkSafe New Zealand 5,270WSP USA Inc. 160,955Xtend Villages, LLC. 20,000

Private- Private (Not For Profit) Total 90,592,000

Private- University (Non-FL)Arizona State University 220,000Baylor College of Medicine 1,696,637Benaroya Research Inst at Virginia Mason 585,150Carnegie Mellon University (700)Case Western Reserve University 132,236Columbia University 48,239Cornell University 1,064,237Duke University 244,989Emory University 152,110George Washington University 19,511Georgetown University 125,140Georgia Institute of Technology 131,141Harvard University 600Icahn School of Medicine at Mount Sinai 56,467Indiana University 118,882Johns Hopkins University 178,514Medical College of Wisconsin 301,519Michigan State University 284,653Montana State University 231,898New York University 21,484North Dakota State University 5,000Northeastern University 269,428Northwestern University 248,443Nova Southeastern University 67,387Oak Ridge Associated Universities 5,000Ohio State University 287,131Oklahoma State University 144,201Oregon Health & Science University 89,002Oregon State University 44,998Pennsylvania State University 23,694Ponce School of Medicine & Health Scienc 53,142Queen's University 10,727Rochester Institute of Technology 42,752Rutgers University 388,947Temple University 21,324Texas A&M University 197,169Tulane University 600

29


University of Alabama 168,106University of Alabama, Birmingham 110,654University of Alaska Fairbanks 33,500University of Alberta International Inst 176,221University of Arizona 317,937University of California 8,451University of California Los Angeles 138,073University of California, Berkeley 87,414University of California, Riverside 342,275University of California, San Diego 253,125University of California, San Francisco 81,257University of Chicago 127,462University of Cincinnati 90,695University of Colorado 26,365University of Colorado Denver 14,836University of Hawaii 45,227University of Houston 30,375University of Illinois, Chicago 40,425University of Kansas 34,993University of Kentucky 391,019University of Louisville Research Founda 29,120University of Maryland 249,367University of Massachusetts 391,887University of Miami 272,727University of Michigan 40,811University of Nebraska 61,954University of New Mexico 29,069University of North Carolina,Chapel Hill 373,606University of Oklahoma 62,494University of Oregon 759,852University of Pennsylvania 624,006University of Puerto Rico 38,500University of Rhode Island 63,032University of Rochester 108,334University of Rwanda 215,424University of South Carolina 351,152University of Southern California 699,727University of Tennessee 79,332University of Texas 123,968University of Texas Southwestern Med Ctr 187,492University of Texas, Arlington 387,283University of Texas, El Paso 18,551University of Texas, San Antonio 8,514University of Utah 239,158University of Washington 84,246University of Wisconsin - Madison 98,085

30


Vanderbilt University 370,073Virginia Commonwealth University 663,625Wake Forest University 232,026Washington State University 146,488Washington University, St. Louis 239,826West Virginia University 6,819Yale University 207,007

Private- University (Non-FL) Total 17,493,615

Private- ForeignAPIS Assay Technologies - UK 455,788Bold Therapeutics - Canada 70,621European Commission 15,709Leo Foundation - Netherlands 3,271Microba Pty Ltd - Australia 19,266

Private- Foreign Total 564,655

3. Private Partnerships Direct Total 227,163,126

Grand Total 568,117,432

31

Contract and Grant DataFiscal Year 2021

Sylvia Wilson Thomas, PhDInterim Vice President for Research & Innovation

President & CEO of the USF Research Foundation, Inc.University of South Florida

1 32

2

Source: Total research funding amounts include Project and Non-Project data from USF and all affiliates.

$0

$50

$100

$150

$200

$250

$300

$350

$400

$450

$500

FY2012 FY2013 FY2014 FY2015 FY2016 FY2017 FY2018 FY2019 FY2020 FY2021Federal $166 $151 $149 $166 $194 $198 $184 $225 $219 $254Total $411 $414 $428 $441 $459 $475 $489 $525 $535 $568Federal % 40% 37% 35% 38% 42% 42% 38% 43% 41% 45%

USF Research & Innovation10 Year Research Funding History

Millions

33

College/Area 5-Year ComparisonResearch Funding

3

College/Institution FY2017 FY2018 FY2019 FY2020 FY2021College of Arts and Sciences 22,151,195 23,471,553 19,733,579 20,276,062 27,266,563College of Behavioral and Community Sciences 24,140,587 29,438,269 30,975,976 29,769,017 31,444,211College of Education 15,274,086 16,506,903 18,473,577 17,676,295 22,841,975College of Engineering 45,088,515 45,637,646 43,419,291 39,965,622 38,988,715College of Marine Science 18,396,178 12,815,156 14,970,574 11,210,763 11,324,812College of The Arts 851,708 1,035,937 1,000,760 1,141,129 928,382Muma College of Business 3,600,338 2,858,912 3,110,980 3,382,283 4,673,216Patel College of Global Sustainability 166,000 586,363 813,713 380,627 21,807USF Health-College of Nursing 3,119,991 4,685,303 3,340,520 3,087,168 2,168,252USF Health-College of Public Health 25,785,913 23,021,031 20,288,216 17,132,226 21,129,003USF Health-Morsani College of Medicine 288,574,820 302,802,190 340,395,970 357,380,611 386,570,669USF Health-Taneja College of Pharmacy 1,749,626 2,489,526 2,055,723 1,016,503 2,233,393USF Other Areas 19,862,325 17,146,583 19,227,695 12,584,619 18,526,433USF Sarasota-Manatee 454,197 1,375,750 493,903 146,876USF St. Petersburg 5,947,584 5,616,594 7,088,775 20,239,234Grand Total 475,163,063 489,487,717 525,389,253 535,389,034 568,117,432

34

Recovery of Facilities & Administrative Costs (Indirect Costs)Five Year Summary by College/Area

4

College/Area FY2017 FY2018 FY2019 FY2020 FY2021College of Arts and Sciences 4,314,008 4,818,411 4,658,816 4,404,817 4,452,532 College of Behavioral and Community Sciences 3,299,973 3,384,182 3,500,558 3,459,945 3,715,460 College of Education 1,174,037 1,569,857 1,576,280 1,730,662 1,847,821 College of Engineering 5,327,002 5,932,159 5,388,606 5,469,540 5,761,887 College of Marine Science 2,286,236 2,408,606 2,620,094 2,262,787 1,664,435 College of The Arts 25,417 104,697 39,606 65,336 43,857 Genshaft Honors College 0 1,022 3,903 18,586 841 Muma College of Business 179,934 180,102 213,871 239,725 278,684 Patel College of Global Sustainability 24,343 49,726 108,553 167,776 135,301 USF Health-College of Nursing 573,041 678,115 660,038 716,107 716,701 USF Health-College of Public Health 2,938,867 2,700,513 2,623,020 2,719,935 2,909,740 USF Health-Morsani College of Medicine 19,731,557 21,968,428 21,911,799 19,739,583 21,405,324 USF Health-Taneja College of Pharmacy 197,257 282,911 289,342 118,306 302,026 USF Other Areas 563,102 484,508 472,456 421,426 413,011 Total Indirect Costs 40,634,776 44,563,235 44,066,940 41,534,530 43,647,620

Prior years results restated to "One USF" format for comparative results

35

Funding by Project Type USF and Affiliates – FY2021

5

Research Training Other Total$260.2 $95.6 $212.3 $568.1

1. Research$260,176,501 46%

2. Training Activities

$95,658,420 17%

3. Other Sponsored

Activity$212,282,511

37%

36

Research Funding by Funding TypeUSF and Affiliates – FY2021

6

Federal State Private Total$253.5 $87.4 $227.2 $568.1

Federal Direct$253,531,348

45%Private Partnerships

$227,163,126 40%

State/Local$87,422,958

15%

37

Research Funding by Source of FundsUSF and Affiliates – FY2021

7

Federal Direct Federal Flow Thru FL State & Local Gov't Private Partnerships Total$253.5 $78.4 $41.2 $195.0 $568.1

Federal Direct

$253,531,348 45%

Federal Flow Through

$78,353,196 14%FL State and Local

Government$41,216,085 7%

Private Partnerships, $195,016,803

34%

38

Total Funding by Original Funding SourceFive Year Summary

8

Funding Source FY2017 FY2018 FY2019 FY2020 FY2021

FederalFederal Direct 197,810,618 184,471,149 225,144,697 218,898,462 253,531,348

Federal Total 197,810,618 184,471,149 225,144,697 218,898,462 253,531,348

Non FederalFederal Flow Through 68,415,290 78,021,236 79,851,390 79,569,723 78,353,196 FL State and Local Government 37,637,286 33,385,028 36,987,508 42,031,649 41,216,085 Private Partnerships 171,299,870 193,610,303 183,405,658 194,889,200 195,016,803

Non Federal Total 277,352,445 305,016,568 300,244,557 316,490,572 314,586,084

Grand Total 475,163,063 489,487,717 525,389,253 535,389,034 568,117,432

39

Federal Direct Funding by Agency5-year Comparison

9

Federal Agency FY2017 FY2018 FY2019 FY2020 FY2021DHHS (Non-NIH) 13,810,228 12,602,130 8,895,834 7,551,795 9,723,488 NASA 3,515,974 2,613,031 2,533,485 2,674,421 2,311,824 National Institutes of Health 134,228,832 126,409,190 167,597,306 158,652,474 191,225,633 National Science Foundation 15,434,757 16,085,263 13,889,348 13,912,531 15,723,627 Other Federal Agencies 825,124 60,060 427,347 206,870 597,537 U.S. Dept. of Agriculture 512,261 529,400 288,339 U.S. Dept. of Commerce 967,706 790,613 375,520 791,674 1,986,847 U.S. Dept. of Defense 6,911,891 8,140,103 6,875,942 10,357,901 12,256,240 U.S. Dept. of Education 3,946,978 5,385,237 7,097,257 5,276,529 7,395,941 U.S. Dept. of Energy 2,019,389 456,965 1,238,454 3,240,395 1,541,587 U.S. Dept. of Homeland Security 316,375 U.S. Dept. of Justice 210,256 50,000 498,077 535,693 752,258 U.S. Dept. of Labor 2,456,500 2,401,375 2,411,300 2,413,528 2,711,500 U.S. Dept. of State 20,000 U.S. Dept. of the Interior 1,639,859 1,714,027 1,698,812 1,540,922 1,598,169 U.S. Dept. of Transportation 3,409,692 1,397,581 4,395,344 3,627,775 2,575,778 U.S. Dept. of Treasury 670,855 410,884 623,024 983,632 U.S. Dept. of Veterans Affairs 6,933,940 5,836,175 6,511,447 7,492,930 2,127,288 Grand Total 197,810,618 184,471,149 225,144,697 218,898,462 253,531,348

40

Primary Sources of Federal Direct FundingUSF and Affiliates – FY2021

10

0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200

U.S. Dept. of State

U.S. Dept. of Justice

U.S. Dept. of Treasury

Other Federal Agencies

U.S. Dept. of Energy

U.S. Dept. of the Interior

U.S. Dept. of Commerce

U.S. Dept. of Veterans Affairs

NASA

U.S. Dept. of Transportation

U.S. Dept. of Labor

U.S. Dept. of Education

DHHS (Non-NIH)

U.S. Dept. of Defense

National Science Foundation

National Institutes of Health

0

1

1

1

2

2

2

2

2

3

3

7

9

12

16

191

Millions

41

Total Federal Direct Funding 5 year Comparison by College/Area

11

College/Institution FY2017 FY2018 FY2019 FY2020 FY2021College of Arts and Sciences 14,907,955 16,713,678 13,162,459 12,893,455 19,203,241 College of Behavioral and Community Sciences 4,058,924 6,531,456 6,832,580 6,871,197 10,919,772 College of Education 2,527,874 1,522,704 2,322,957 1,342,237 2,532,283 College of Engineering 13,842,955 13,191,985 15,079,658 18,935,038 16,580,638 College of Marine Science 6,681,894 5,962,305 6,300,960 6,374,636 8,565,523 College of The Arts 40,000 35,000 41,800 Muma College of Business 135,140 (496) 89,417 USF Health-College of Nursing 2,861,591 4,509,385 2,726,523 2,752,153 1,887,118 USF Health-College of Public Health 18,506,197 17,490,691 14,605,812 12,633,926 14,608,269 USF Health-Morsani College of Medicine 127,460,422 114,598,547 159,288,825 153,454,639 175,285,424 USF Health-Taneja College of Pharmacy 843,420 1,289,202 1,178,004 460,201 1,695,453 USF Other Areas 4,747,166 1,519,432 2,468,527 1,877,899 2,211,828 USF Sarasota-Manatee 45,197 USF St. Petersburg 1,151,884 1,142,260 1,178,393 1,178,663 Grand Total 197,810,618 184,471,149 225,144,697 218,898,462 253,531,348

42

NIH Federal Direct Funding by College/Area

12

College/Institution FY2017 FY2018 FY2019 FY2020 FY2021College of Arts and Sciences 6,344,349 8,229,025 4,569,589 5,157,807 11,286,278

College of Behavioral and Community Sciences 1,767,935 1,776,287 1,360,382 2,595,830 5,422,474

College of Engineering 2,343,342 3,756,018 4,213,373 4,620,290 2,282,556

USF Health-College of Nursing 984,164 2,706,898 1,625,764 2,084,885 1,728,453

USF Health-College of Public Health 4,882,773 4,820,506 5,810,498 4,394,233 4,825,570

USF Health-Morsani College of Medicine 116,592,477 103,318,908 148,251,516 138,625,419 164,034,849

USF Health-Taneja College of Pharmacy 714,621 1,198,448 1,178,004 460,201 1,645,453

USF St. Petersburg 599,172 603,100 588,180 713,809

Grand Total 134,228,832 126,409,190 167,597,306 158,652,474 191,225,633

43

NSF Federal Direct Funding by College/Area

13

College/Institution FY2017 FY2018 FY2019 FY2020 FY2021College of Arts and Sciences 5,347,346 5,837,810 4,721,976 4,335,155 5,198,406

College of Education 1,012,680 824,099 689,696 97,829 139,822

College of Engineering 6,045,562 6,665,013 5,007,013 6,540,480 7,108,497

College of Marine Science 1,707,990 1,935,043 2,432,150 1,783,061 2,428,933

Muma College of Business 105,140 89,417

USF Health-College of Nursing 50,000 50,000

USF Health-College of Public Health 257,526

USF Health-Morsani College of Medicine 82,708 231,528 376,755 365,059

USF Health-Taneja College of Pharmacy 50,000

USF Other Areas 1,038,134 773,298 506,000 349,980 175,384

USF Sarasota-Manatee 45,197

USF St. Petersburg 300,986 339,854 Grand Total 15,434,757 16,085,263 13,889,348 13,912,531 15,723,627

44

14

2017 2018 2019 2020 2021Federal Direct $197,810,618 $184,471,149 $225,144,697 $218,898,462 $253,531,348Federal Flow Through $68,415,290 $78,021,236 $79,851,390 $79,569,723 $78,353,196FL State and Local Government $37,637,286 $33,385,028 $36,987,508 $42,031,649 $41,216,085Private Partnerships $171,299,870 $193,610,303 $183,405,658 $194,889,200 $195,016,803

$171 $194 $183 $195 $195

$38 $33 $37 $42 $41

$68 $78 $80 $80 $78

$198 $184 $225 $219 $254

$-

$100

$200

$300

$400

$500

$600

Mill

ions

45

15

2017 2018 2019 2020 2021Other Federal Agencies $34,336,800 $29,374,566 $34,762,208 $38,781,662 $37,490,033National Science Foundation $15,434,757 $16,085,263 $13,889,348 $13,912,531 $15,723,627National Institutes of Health $134,228,832 $126,409,190 $167,597,306 $158,652,474 $191,225,633DHHS (Non-NIH) $13,810,228 $12,602,130 $8,895,834 $7,551,795 $9,092,055

$14 $13 $9 $8 $9

$134 $126 $168 $159

$191

$15 $16

$14 $14

$16

$34 $29

$35 $39

$37

$-

$50

$100

$150

$200

$250

$300

Mill

ions Federal Direct Funding

46

16


$4 $3 $3 $3 $3

$1 $1 $1 $3 $2 $2 $2 $2 $2 $3

$15 $17 $13 $13

$19

$-

$5

$10

$15

$20

$25

$30

Mill

ions

47

17

2017 2018 2019 2020 2021Other Federal Agencies $2,480,260 $1,910,844 $3,134,894 $3,400,493 $1,968,636National Science Foundation $5,347,346 $5,837,810 $4,721,976 $4,335,155 $5,198,406National Institutes of Health $6,344,349 $8,229,025 $4,569,589 $5,157,807 $11,286,278DHHS (Non-NIH) $736,000 $736,000 $736,000 $749,920

$1 $1 $1 $1

$6 $8

$5 $5

$11

$5

$6

$5 $4

$5 $2

$2

$3 $3

$2

$-

$5

$10

$15

$20

$25

Mill


48

18


$2 $2 $2 $2 $3 $5 $5 $5 $5 $5

$14 $16 $17 $15

$13

$4

$7 $7

$7 $11

$-

$5

$10

$15

$20

$25

$30

$35

Mill

ions

49

19

2017 2018 2019 2020 2021Other Federal Agencies $1,743,989 $4,208,169 $4,226,948 $2,880,616 $4,747,298National Institutes of Health $1,767,935 $1,776,287 $1,360,382 $2,595,830 $5,422,474DHHS (Non-NIH) $547,000 $547,000 $1,245,250 $1,394,751 $750,000

$1 $1 $1 $1 $1

$2 $2 $1

$3 $5 $2

$4 $4 $3

$5

$-

$2

$4

$6

$8

$10

$12

Mill


50

20

2017 2018 2019 2020 2021Federal Direct $2,527,874 $1,522,704 $2,322,957 $1,342,237 $2,532,283Federal Flow Through $11,366,596 $13,802,054 $15,752,704 $15,662,749 $14,067,363FL State and Local Government $401,927 $372,072 $5,544,971Private Partnerships $977,689 $810,074 $397,916 $671,309 $697,358

$1 $1 $0 $1 $1 $0 $0

$6

$11 $14 $16 $16

$14 $3 $2

$2 $1

$3

$-

$5

$10

$15

$20

$25

Mill

ions

51

21

2017 2018 2019 2020 2021Other Federal Agencies $1,515,194 $698,605 $1,519,642 $1,130,789 $2,267,461National Science Foundation $1,012,680 $824,099 $689,696 $97,829 $139,822DHHS (Non-NIH) $113,619 $113,619 $125,000

$0 $0 $0

$1 $1 $1

$0 $0

$2

$1

$2

$1

$2

$-

$1

$1

$2

$2

$3

$3

Mill


52

22


$6 $8 $5 $5 $5

$7 $5 $7 $7 $6

$18 $19 $17

$8 $11

$14 $13 $15

$19 $17

$-

$5

$10

$15

$20

$25

$30

$35

$40

$45

$50

Mill

ions

53

23

2017 2018 2019 2020 2021Other Federal Agencies $5,454,051 $2,770,954 $5,859,272 $7,774,268 $7,189,585National Science Foundation $6,045,562 $6,665,013 $5,007,013 $6,540,480 $7,108,497National Institutes of Health $2,343,342 $3,756,018 $4,213,373 $4,620,290 $2,282,556

$2 $4 $4 $5

$2

$6

$7 $5 $7

$7

$5 $3 $6

$8

$7

$-

$2

$4

$6

$8

$10

$12

$14

$16

$18

$20

Mill


54

24

2017 2018 2019 2020 2021Federal Direct $6,681,894 $5,962,305 $6,300,960 $6,374,636 $8,565,523Federal Flow Through $2,125,009 $2,193,016 $3,376,251 $2,053,027 $1,683,242FL State and Local Government $163,051 $120,307 $138,453 $1,689,115 $810,325Private Partnerships $9,426,224 $4,539,528 $5,154,910 $1,093,985 $265,722

$9

$5 $5

$1 $0

$0

$0 $0

$2 $1

$2

$2 $3

$2

$2

$7

$6

$6

$6 $9

$-

$2

$4

$6

$8

$10

$12

$14

$16

$18

$20

Mill

ions

55

25

2017 2018 2019 2020 2021Other Federal Agencies $4,973,904 $4,027,262 $3,868,810 $4,591,575 $6,136,590National Science Foundation $1,707,990 $1,935,043 $2,432,150 $1,783,061 $2,428,933

$2 $2 $2

$2 $2

$5 $4

$4 $5

$6

$-

$1

$2

$3

$4

$5

$6

$7

$8

$9

Mill


56

26

2017 2018 2019 2020 2021Federal Direct $40,000 $35,000 $41,800FL State and Local Government $239,366 $247,793 $213,635 $205,527 $315,196Private Partnerships $572,342 $788,144 $787,125 $900,602 $571,386

$1

$1 $1 $1

$1

$0

$0 $0

$0

$0

$0

$0

$0

$-

$0

$0

$1

$1

$1

$1

Mill

ions

57

27

2017 2018 2019 2020 2021Federal Direct $135,140 ($496) $89,417Federal Flow Through $1,315,552 $1,096,375 $1,387,186 $1,939,748 $2,845,221FL State and Local Government $726,691 $726,692 $762,180 $38,295 $782,593Private Partnerships $1,422,955 $1,036,341 $961,614 $1,314,822 $1,045,402

$1 $1 $1

$1 $1

$1 $1 $1 $0 $1

$1

$1 $1 $2

$3 $0

$0

$-

$1

$1

$2

$2

$3

$3

$4

$4

$5

$5

Mill

ions

58

28

2017 2018 2019 2020 2021Federal Flow Through $486,355 $558,712 $307,802FL State and Local Government $250,001Private Partnerships $166,000 $100,008 $5,000 $72,825 $21,807

$0 $0

$0 $0 $0

$0

$0

$1

$0

$-

$0

$0

$0

$0

$1

$1

$1

$1

$1

Mill

ions

59

29

College of Arts & Sciences College of Behavioral and Community Sciences

College of Education College of Engineering

College of Marine ScienceCollege of The Arts

Muma College of Business Patel College of Global Sustainability


$24 $21 $17 $15 $13

$15 $12 $15 $17 $21

$49 $55 $57 $46 $45

$42 $44 $44 $47

$58

$-

$20

$40

$60

$80

$100

$120

$140

$160

Mill

ions

60

30


$130 $154 $147 $168 $167

$17 $17 $18

$18 $19 $14

$16 $16 $19 $26

$127 $115

$159 $153

$175

$-

$50

$100

$150

$200

$250

$300

$350

$400

$450

Mill

ions

61

31

2017 2018 2019 2020 2021Other Federal Agencies $10,183,307 $11,216,060 $10,808,820 $14,202,465 $10,264,860National Science Foundation $82,708 $231,528 $376,755 $365,059National Institutes of Health $116,592,477 $103,318,908 $148,251,516 $138,625,419 $164,034,849DHHS (Non-NIH) $601,930 $63,580 $(3,040) $250,000 $620,657

$1 $0 $0 $1

$117 $103

$148 $139 $164

$0

$0 $0

$0

$10 $11

$11 $14

$10

$-

$20

$40

$60

$80

$100

$120

$140

$160

$180

$200

Mill


62

32

2017 2018 2019 2020 2021Federal Direct $2,861,591 $4,509,385 $2,726,523 $2,752,153 $1,887,118Federal Flow Through $212,672 $164,758 $477,485 $262,870 $189,424Private Partnerships $45,728 $11,160 $136,512 $72,145 $91,710

$0 $0 $0 $0 $0 $0 $0 $0

$0 $0

$3

$5

$3 $3

$2

$-

$1

$1

$2

$2

$3

$3

$4

$4

$5

$5

Mill

ions

63

33

2017 2018 2019 2020 2021Federal Direct $843,420 $1,289,202 $1,178,004 $460,201 $1,695,453Federal Flow Through $29,380 $86,866FL State and Local Government $21,876 $145,452 $133,250 $50,739 $78,125Private Partnerships $854,950 $968,006 $744,469 $505,563 $459,815

$1 $1 $1

$1 $0

$0 $0

$0

$0 $0

$0

$0 $1

$1

$1

$0

$2

$-

$1

$1

$2

$2

$3

$3

Mill

ions

64

34

2017 2018 2019 2020 2021Federal Direct $18,506,197 $17,490,691 $14,605,812 $12,633,926 $14,608,269Federal Flow Through $2,522,413 $3,739,721 $3,733,001 $2,174,456 $4,515,347FL State and Local Government $978,282 $432,834 $616,043 $999,708 $964,945Private Partnerships $3,779,021 $1,357,786 $1,333,361 $1,324,136 $1,040,442

$4 $1 $1 $1 $1

$1

$0 $1 $1 $1

$3 $4 $4 $2 $5

$19 $17

$15 $13

$15

$-

$5

$10

$15

$20

$25

$30

Mill

ions

65

35

2017 2018 2019 2020 2021Other Federal Agencies $2,801,545 $2,485,572 $2,805,040 $2,509,017 $2,754,443National Science Foundation $257,526National Institutes of Health $4,882,773 $4,820,506 $5,810,498 $4,394,233 $4,825,570DHHS (Non-NIH) $10,821,878 $10,184,612 $5,990,274 $5,730,676 $6,770,730

$11 $10

$6 $6 $7

$5 $5

$6 $4

$5

$0

$3 $2

$3

$3

$3

$-

$2

$4

$6

$8

$10

$12

$14

$16

$18

$20

Mill


66

36

Morsani College of MedicineCollege of Nursing

Taneja College of PharmacyCollege of Public Health


$134 $157 $149 $169 $168

$18 $18 $19

$19 $20 $17

$20 $21 $21 $30

$150 $138 $178

$169 $193

$-

$50

$100

$150

$200

$250

$300

$350

$400

$450

Mill

ions

67

37



Federal Direct Federal Flow Thru FL State & Local Gov't Private Partnerships Total$193.5 $30.3 $19.9 $168.4 $412.1

Federal Direct

$193,476,264 47%

Federal Flow Through

$30,287,218 7%

FL State and Local Government$19,949,625 5%

Private Partnerships, $168,388,210

41%

68

38



Federal Direct State/Local Private Partnerships Grand Total$193.5 $29.3 $189.4 $412.1

Federal Direct$193,476,264

47%Private

Partnerships$189,352,919 46%

State/Local$29,272,134 7%

69

USF Research and Innovation Annual Report FY2021 Section 2.2 Centers and Institutes

Centers and Institutes FY2017 FY2018 FY2019 FY2020 FY2021Area Health Education Center 2,854,393 2,787,653 3,086,132 3,081,854 3,106,722 Center for Analytics and Creativity 29,226 175,000 8,820 16,113 Center for Digital Heritage Geospatial Information 65,868 Center for Drug Discovery and Innovation 485,666 189,631 Center for Entrepreneurship 91,980 47,068 38,627 56,235 55,917 Center for Health Outcomes Research 489,878 230,742 317,904 305,202 Center for Hearing & Speech Research 2,148,920 2,238,034 2,049,660 1,894,036 23,609 Center for Holocene Studies 227,601 Center for Improvement in Teaching & Research STEM 120,796 750,691 511,722 443,851 450,582 Center for Leadership in Public Health Practice 30,000 30,000 Center for Migrant Education 892,212 897,368 Center for Research, Evaluation, Assessment and Measurement 1,340,087 1,884,310 1,391,794 1,181,792 2,799,865 Center for Urban Transportation Research 22,106,389 19,782,627 21,162,054 14,963,360 14,787,988 CFS RIghtpath Research Center 976,645 1,585,306 524,623 750,902 Clean Energy Research Center 337,525 40,000 30,000 105,000 56,140 Coalition for Science Literacy 822,476 677,690 531,674 383,024 COPH OSHA Education Center 2,658,100 2,663,528 2,946,500 David Anchin Center 2,998,444 1,604,948 752,214 869,903 445,426 Diabetes Center 472,532 340,433 125,438 118,482 105,474 Florida Center for Community Design & Research 166,950 320,542 289,442 421,249 301,628 Florida Center for Cybersecurity 760,349 4,000 4,000 977,564 Florida Health Information Center 1,345,945 1,455,290 1,278,616 1,462,702 1,561,650 Florida Institute of Government 182,875 115,281 170,375 179,025 319,028 Florida Institute of Oceanography 757,977 50,000 410,884 1,208,466 983,632 Florida Prevention Research Center 734,000 753,084 780,132 264,211 799,164 Global Health Center 2,297,639 3,818,916 5,742,622 4,504,476 5,412,987 Gus A. Stavros Center 85,104 81,933 84,798 93,000 Health Informatics Institute 63,711,158 48,869,096 69,398,137 47,459,641 79,926,287 Heart Institute 59,362 1,989,980 Humanities Institute 5,000 5,000 Infant Family Mental Health Center 39,995 97,095 39,995 39,995 116,000 Institute for School Reform 8,390,815 12,766,568 15,274,777 14,608,891 10,898,305 Institute of Applied Engineering 924,816 2,907,580 Lawton & Rhea Chiles Center 7,163,640 6,859,849 2,660,620 3,168,687 4,496,730 Nanomaterials and Nanomanufacturing Research Center 112,993 41,130 44,951 24,550 Neuroscience Center for Aging 1,325,769 932,631 2,538,423 1,562,705 660,437 Patel Center for Global Understanding 166,000 586,363 563,712 380,627 21,807 Small Business Development Center 1,762,936 1,838,067 2,004,520 1,993,493 3,429,093 Suncoast Gerontology Center 1,272,705 1,834,444 1,177,718 722,450 570,565 USF Alzheimer's Institute 562,023 386,300 153,868 371,275 353,664 Total 125,137,184 112,541,063 136,867,034 107,211,439 142,248,463

70

Research & Innovation Schedule of Interdiciplinary Awards Annual Report FY2021Primary PI College |------------------------------------------------------------ Collaborating College/Area -------------- ------------------------- ----------- ------------- ----------- --------------|

Row Labels

Academic Affairs

College of Arts and Sciences

College of Business Admin

College of Education

College of Engineering

College of Marine Science

College of Medicine

College of Nursing

College of Public Health

Florida Mental Health Institute

Honors College

Office of Research

Student Affairs

Grand Total

College of Arts and SciencesDixon,Timothy HughNational Science Foundation

Lembke,Chad E;Malservisi,Rocco

Measuring Sea Floor Motion: New Technology for Continental Margin Geodesy 244,268 244,268Lewis,DavidNational Science Foundation

Rains,Mark C;Ergas,Sarina;Prevost,Luanna;Lane,Tonisha BrandyGraduate Student Scholarships to Advance Community Engaged Solutions to the Grand Challenge of Managing Nitrogen 199,304 199,304

Ma,ShengqianBureau of Reclamation

Zhang,QiongEfficient Nutrient Recovery from Urine to Prevent Downstream Water Treatment Costs and Resell of Valuable Commodities 150,000 150,000

Rohrer,Douglas MUS Department of Education

Dedrick,Robert FAn Efficacy Study of Interleaved Mathematics Practice 496,958 496,958Skvoretz JR.,John VOffice of Naval Research

Iamnitchi,Adriana IoanaExploring Majority Illusion and Pluralistic Ignorance Within the Context of Eastern European Social Media 197,622 197,622

College of Arts and Sciences Total 696,262 347,622 244,268 1,288,152College of Behavioral and Community SciencesBlair,Kwang-Sun ChoUS Department of Education

Crosland,Kimberly;Castillo,Jose M;Cividini-Motta,CatiaProject EBAS: Enhancing Behavior Analytic Services for Children with Severe Emotional and Behavioral disorders 209,640 209,640

McPherson,Marie AndreFlorida Department of Health

Murphy,Tanya KPediatric Telepsychiatry Services Throughout Florida 192,800 192,800

College of Behavioral and Community Sciences Total 209,640 192,800 402,440College of EducationFeldman,AllanNational Science Foundation

Meisels,Gerhard G;Herman,Benjamin C;Sears,Ruthmae;Davis,Jeni R;Prevost,Luanna

Robert Noyce USF Scholarship Program for Science Majors 172,385 172,385 344,770College of Education Total 172,385 172,385 344,770

College of EngineeringChellappan,SriramNational Science Foundation

71


Row Labels

Academic Affairs






College of Medicine

College of Nursing



Honors College

Office of Research

Student Affairs

Grand Total

Fisk,Nathan WSaTC: CORE: Small: A Privacy Preserving Meta-Data Analysis Framework For Cyber Abuse Research Foundations, Tools and Algorithms 177,762 177,762

Ergas,SarinaNational Science Foundation

Scott,Kathleen M;Zhang,QiongA Novel Algal-Bacterial Shortcut Nitrogen Removal Process for Wastewater Treatment 110,463 110,463

Gaines,Jonathan ElliotNational Science Foundation

Vomvoridi,Eugenia;Lane,Tonisha BrandyEngineering Youth Experience for Promoting Relationships, Identity Development, and Empowerment 148,526 148,526

Iamnitchi,Adriana IoanaAir Force Office of Scientific Research

Hall,Lawrence O;Skvoretz JR.,John VModeling Information Diffusion Processes with Deep Learning Algorithms 545,490 545,490National Science FoundationSkvoretz JR.,John VBIGDATA:IA:F: Structural Anoymization Techniques for large, Labeled and Dynamic Social Graphs

225,527225,527

Reed,Kyle BrandonNational Science FoundationSalomon,Kristen L;Crane,Nathan B;Guldiken,RasimCHS: Small: Investigation of Dynamic Thermal Perception over Large Skin Areas

182,447182,447

Sarkar,SudeepNational Science Foundation

Fountain,Michael W;Sanberg,Paul R;Conrad,DavidI-Corps Site at Unversity of South Florida: Catalyzing Research Translation

59,93859,938

Sanberg,Paul R;McDevitt,Valerie L.;Zayas-Castro,Jose L;Mullarkey,Matthew Timothy;Berman,Richard Angel;Conrad,David

Type II: I-Corps Site at University of South Florida-Tampa 80,000 80,000Trotz,Maya Ayanna

National Science FoundationZarger,Rebecca K;Mihelcic,James;Zhang,Qiong

Collaborative Research: NRT-INFEWS: Systems Training for Research ON Geography-based Coastal Food Energy Water Systems (STRONG-CFEWS)

518,546518,546

Tu,YichengNational Science Foundation

Sarkar,Sudeep;Ligatti,Jarred A;Pandit,Sagar Avinash;Ghosh,SwaroopII New: A Research Platform for Heterogeneous, Massive Parallel Computing

140,002140,002

Yilmaz,Yasin

72


Row Labels

Academic Affairs






College of Medicine

College of Nursing



Honors College

Office of Research

Student Affairs

Grand Total

National Science FoundationHafen,Mark R;Bush,Alan Christen

SCC-Planning: Agent-Based Scenario Planning for a Smart & Connected Community Against Sea Level Rise in Tampa Bay

49,244 49,24498,488

Zhang,QiongNational Science Foundation

Wells,Eric C;Zhang,Yu;Lu,Qing;Li,Mingyang;Ou,Xinming;Mohebbi,Shima

CRISP Type II: Integrative Decision Making Framework to Enhance the Resiliency of Interdependent Critical Infrastructures

477,227477,227

College of Engineering Total 2,199,702 326,288 49,244 49,244 139,938 2,764,416College of Marine ScienceBreitbart,Mya ENational Science Foundation

Harwood,Valerie J

Coastal SEES: Collaborative Research: Integration of Human Behavior and Perception into a Risk Based Microbial Water Quality Management Approach

301,257301,257

College of Marine Science Total 301,257 301,257College of NursingHyer,KathrynHealth Resources and Srvcs Admin

Hyer,Kathryn;Roetzheim,Richard G;Sneed,Kevin BGeriatrics Workforce Enhancement Program 780,837 780,837Wang,Hsiao-LanNational Science Foundation

Katkoori,SrinivasI-Corps: Use of eHealth to Personalize Exergame Prescriptions 50,000 50,000

College of Nursing Total 50,000 780,837 830,837College of Public HealthKip,Kevin ENational Institute on Aging

Buck,Harleah GrahamAccelerated Resolution Therapy for Treatment of Complicated Grief in Senior Adults 224,250 224,250

Wolfson,JayHealth Resources and Srvcs Admin

Rodriguez,Carina ARyan White HIV/AIDS Program Part D Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) 1,461,802 1,461,802

College of Public Health Total 1,461,802 224,250 1,686,052College of The ArtsSabia,Taryn ECity of Tampa

Arias,MauricioCity of Tampa Baffle Box Evaluation Study Phase II 48,900 48,900Hills Co Board of Co Commissioners

73


Row Labels

Academic Affairs






College of Medicine

College of Nursing



Honors College

Office of Research

Student Affairs

Grand Total

Bourgeois,Marie;Bohn JR.,Herman JosephHillsborough County Perils of Flood Act Matrix of Impacts Initiative 48,048 48,048

College of The Arts Total 48,900 48,048 96,948Morsani College of MedicineCurrier,Glenn WBayCare Behavioral Health, Inc.

Boaz,Timothy LStatement of Work # 1 190,000 190,000Guerra,LucyThe Arnold P. Gold Foundation

Kumar,AmbujThe USF Geriatric Loneliness Project - Effects of a pilot volunteer - based lunch program on feelings of loneliness in elders 1,000 1,000

Morsani College of Medicine Total 1,000 190,000 191,000Office of Research & InnovationLowry,Judith HeckThe National Academy of Inventors, Inc.

Sticht,Michelle M;Limayem,Moez;Maradei,Lauren Hunt;Bishop,Robert Harold;Pandolfo,Autumn

National Academy of Inventors 50,000 50,000 50,000 150,000

Office of Research & Innovation Total 50,000 50,000 50,000 150,000USF St. PetersburgSmoak II,Joseph MUS Department of Agriculture

Rosenheim,Brad E

Organic Carbon Biomass, Burial, and Biogeochemistry in Blue Carbon Ecosystems Along the South Florida Coast: Climate Change and Anthropogenic Influences

529,400529,400

USF St. Petersburg Total 529,400 529,400Grand Total 172,385 2,673,344 50,000 1,232,190 496,522 822,912 2,435,439 224,250 49,048 190,000 49,244 139,938 50,000 8,585,272

74


REPORT OF RESEARCH

ACTIVITIES

F I S C A L Y E A R 2 0 2 1

S E C T I O N 3 D E T A I L E D F U N D I N G B Y R E S E A R C H E R

75

76

Section 3 - Detailed Funding by College, Department, PI and COPI FY 2021COLLEGE/INSTITUTION DEPARTMENT_NAME PI_COPI Type SPONSOR_NAME TITLE Funded Amount

College of Arts and Sciences Anthropology PI: Deubel,Tara F Spon National Science FoundationIRES Track 1: US-Morocco Collaborative Research for Socially and Environmentally Sustainable Women's Argan Oil Production 58,715

College of Arts and Sciences AnthropologyPI: Gray,Heewon Lee , Co-PI(s): Crocker,Theresa T Spon Feeding Tampa Bay Humana Bold Gold Pregnancy Pilot Program 22,055

College of Arts and Sciences Anthropology PI: Himmelgreen,David A Spon Feeding America Feeding America: Home Delivery Pilot Project 75,000

College of Arts and Sciences Anthropology PI: Himmelgreen,David A Spon James A. Haley Veteran's HospitalGainesville/Tampa CIN13-409 Professional Development and Supplemental Funds - Agritherapy Project 15,000

College of Arts and Sciences Anthropology PI: Jackson,Antoinette T Spon National Park ServiceCESU SOFL-Cultural Landscape Report and Cultural Landscape Inventory for Carter Compound at Jimmy Carter National Historic Site 4,680

College of Arts and Sciences Anthropology PI: Pluckhahn,Thomas John Spon National Science FoundationDoctoral Dissertation Improvement Grant: Geoarchaeology of Estuarine Seascapes 22,249

College of Arts and Sciences Anthropology PI: Pluckhahn,Thomas John Spon Pinellas County Florida Archaeological Services: Historic Resources Survey of the Flood Hazard Area 5,000 College of Arts and Sciences Anthropology PI: Pluckhahn,Thomas John Spon University of Florida GPR Survey; Bethlehem Methodist Episcopal Cemetery 3,125

College of Arts and Sciences AnthropologyPI: Pluckhahn,Thomas John , Co-PI(s): Bird,Elizabeth Spon University of West Florida Tampa Center of the Florida Public Archaeology Network 304,237

College of Arts and Sciences AnthropologyPI: Romero-Daza,Nancy Y , Co-PI(s): Himmelgreen,David A Spon Feeding Tampa Bay Food Pharmacy Program 102,951

College of Arts and Sciences Anthropology PI: Wallman,Diane E Spon Florida Humanities Council Monuments, Markers, and Memory 2021 Symposium Series 5,000

College of Arts and Sciences Anthropology PI: Wallman,Diane E Spon Rust Family Foundation

A Diachronic View of the Impacts of Interactions between Indigenous West Africans and Europeans during the Trans-Atlantic Trade. A Biocultural Analysis from Elmina, Ghana 6,000

College of Arts and Sciences Anthropology PI: Wells,Eric C Spon Corporation to Develpment Communities of Environmental Workforce Development and Job Training 123,731

College of Arts and Sciences Anthropology PI: Wells,Eric C Spon FL Department Environmental ProtectionSocial and Economic Impacts of Federal Grant-Supported Rehabilitation and Redevelopment Activities Conducted at Brownfield Sites in Florida: Phase IV 4,000

College of Arts and Sciences Anthropology Total 751,743

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Arendash,Gary W Spon National Institutes of HealthDisaggregation of Toxic Protein Oligomers in Brain with Electromagnetic Treatment 1,100,000

College of Arts and Sciences Cellular, Molecular & Micro-BiologyPI: Burkhardt,Brant , Co-PI(s): Gardner,Alycia Marie Spon National Institutes of Health

Determining the Role of Dendritic Cells and Spatial Localization in Anti-Tumor Immunity 34,530

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Chalfant,Charles Edward Conv University of South Florida Foundation Richard & Patricia Wood Chair Natural Sciences 60,000

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Chalfant,Charles Edward Spon Natl Insti of Diabetes (NIDDK) iPLA2beta-mediated alternative splicing and #-cell death in type 1 diabetes 521,245

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Chalfant,Charles Edward Spon Natl Insti of Gen Medical ScienceRESUB: The role and mechanistic regulation of cPLA2alpha in eicosanoid biosynthesis and wound healing 450,475

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Chalfant,Charles Edward Spon Virginia Commonwealth UniversityThe Roles of Ceramide and its Derivatives in A. Phagocytophilum Pathogenesis 486,373

College of Arts and Sciences Cellular, Molecular & Micro-BiologyPI: Chalfant,Charles Edward , Co-PI(s): Park,Margaret A. Spon Natl Insti of Gen Medical Science The role of ceramide kinase in mitophagy 336,375

College of Arts and Sciences Cellular, Molecular & Micro-BiologyPI: Chalfant,Charles Edward , Co-PI(s): Park,Margaret A. Spon Virginia Commonwealth University

The Utilization of Photonics Technology to Rapidly Detect Bioactive Lipids Associated with Preeclampsia Development 68,800

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Cooke,Marcus S Spon Engineering Resources Group, Inc.AHTP-comet: development of an automated, high throughput comet assay system 9,000

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Cooke,Marcus S Spon Natl Insti of Environmental HealthUrinary DNA Adductomics for the Assessment of Exposure to Cancer Risk Factors 286,854

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Daughdrill,Gary W Spon H. Lee Moffitt Cancer Center Discovery of p53 inhibitors for reducing toxicity of chemotherapy 30,864 College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Daughdrill,Gary W Spon Natl Insti of Gen Medical Science Regulation of transcriptional activation by protein disorder 330,442

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Do Nascimento Nunes,Maria Cecilia Spon Florida Strawberry Rsch and Educa Fdn

Biochemical characterization and postharvest performance of the first Florida white-fruited strawberry FL 16.78-109 and the newest breeding selections FL 17.14-250 and FL 17. 15-86 45,397

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Dungrawala,Huzefa Spon Natl Insti of Gen Medical Science Molecular Mechanisms of replication stress response 711,154 College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Eswara,Prahathees J Spon Natl Insti of Gen Medical Science Division site determination in Gram-positive bacteria 459,306 College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Lockwood,Charles J Conv H. Lee Moffitt Cancer Center CMMB Moffitt Support 968,272

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Schmidt,Kristina Spon Natl Insti of Gen Medical ScienceRole of the Pif1-gamily DNA helicase Rrm3 In regulating DNA synthesis during replication stress 296,745

College of Arts and Sciences Cellular, Molecular & Micro-BiologyPI: Schmidt,Kristina , Co-PI(s): Varma,Sameer Spon Natl Insti of Gen Medical Science

Novel function of the Bloom's syndrome DNA helicase BLM in replication initiation and elongation 349,866

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Shaw,Lindsey Neil Spon Natl Inst of Allergy and InfectiousDissecting the Influence of a C-Terminal Processing Protease on S. aureus Pathogenesis 373,750

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Shaw,Lindsey Neil Spon Natl Inst of Allergy and Infectious The Role and Regulation of Extracellular Proteases in Staphylococcus aureus 429,644

College of Arts and Sciences Cellular, Molecular & Micro-BiologyPI: Stevens JR.,Stanley M , Co-PI(s): Bickford,Paula C;Burkhardt,Brant Spon National Institutes of Health

The role of histone demethylase Kdm5B in ethanol-induced microglial activation 1,000,533

77


College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Te Strake,Diane Spon Florida Fish and Wildlife ConservationNon-native vascular plant species in the Atlas of Florida Plants website database 31,000

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Te Strake,Diane Spon Hillsborough County Board of Blackwater Creek Floristic Survey 2,550

College of Arts and Sciences Cellular, Molecular & Micro-Biology PI: Westerheide,Sandra Spon Natl Insti of Gen Medical ScienceThe Role of UBR5 in the PRC1-mediated transcriptional repression at damaged chromatin 263,482

College of Arts and Sciences Cellular, Molecular & Micro-Biology Total 8,646,658 College of Arts and Sciences Center Improve Teaching & Research STEM PI: Lewis,Jennifer E Spon National Science Foundation NSF Program Director Position Assignment Agreement 204,666

College of Arts and Sciences Center Improve Teaching & Research STEMPI: Prevost,Luanna , Co-PI(s): Skvoretz JR.,John V Spon National Science Foundation

Collaborative Research: Mapping Change in Higher Education- social Networks and STEM Reforms 186,125

College of Arts and Sciences Center Improve Teaching & Research STEM PI: Raker,Jeffrey R Spon National Science FoundationCollaborative Research: Improving Inorganic Chemistry Education Through A Community-Developed Student-Centered Curriculum 59,791

College of Arts and Sciences Center Improve Teaching & Research STEM Total 450,582 College of Arts and Sciences Chemistry PI: Acevedo Duncan,Mildred E Conv University of South Florida Foundation Cancer Cell Biology and Biochemistry Research Fund 133,865 College of Arts and Sciences Chemistry PI: Acevedo Duncan,Mildred E Conv University of South Florida Foundation Prostate Cancer Cell Research 168,196 College of Arts and Sciences Chemistry PI: Baker,Billy J Spon National Institutes of Health Natural Product Derived Inhibitors of ESKAPE Pathogens 655,589 College of Arts and Sciences Chemistry PI: Baker,Billy J Spon Natl Ctr Complementary & Integrative Hea Bioprospecting the Fungal Metabolome for Anti-Fungal Natural Products 216,740

College of Arts and Sciences Chemistry PI: Baker,Billy J Spon Natl Inst of Allergy and InfectiousInduction of Antiprotozoal Secondary Metabolites from Endophytic Fungi Using Epigenetic Modifiers 150,988

College of Arts and Sciences Chemistry PI: Baker,Billy J Spon SprainGo, LLCAnalysis of SprainGo Pine Rosin to Identify Additional Active Compounds & Develop New Delivery Mechanisms 329,780

College of Arts and Sciences Chemistry PI: Cai,Jianfeng Spon National Institute on AgingGamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation 358,175

College of Arts and Sciences Chemistry PI: Cai,Jianfeng Spon National Institutes of Health Alpha-AA Peptides as a Novel Class of Antimicrobial Biomaterials 300,000

College of Arts and Sciences Chemistry PI: Cai,Jianfeng Spon National Institutes of HealthGamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation 250,000

College of Arts and Sciences Chemistry PI: Cai,Jianfeng Spon University of OklahomaBlocking tumor progression in therapy-responsive RET aberration-associated cancer 26,296

College of Arts and Sciences Chemistry PI: Cai,Jianfeng Spon Virginia Commonwealth University Targeting Mutant KRAS for Cancer Therapy 78,552 College of Arts and Sciences Chemistry PI: Cai,Jianfeng , Co-PI(s): Cao,Chuanhai Spon Natl Inst of Allergy and Infectious Antimicrobial Agents Derived from AApeptide Biomaterials 373,750

College of Arts and Sciences ChemistryPI: Cai,Jianfeng , Co-PI(s): Eswara,Prahathees J Spon Natl Insti of Gen Medical Science

Self-Assembly of 2D Metallo-Supramolecules as a Novel Class of Antimicrobial Biomaterials via Forming Transmembrane Channels 282,405

College of Arts and Sciences Chemistry PI: Cai,Jianfeng , Co-PI(s): Sun,Xingmin Spon Natl Inst of Allergy and Infectious Novel polymer biomaterials combating C. difficile infection 373,750

College of Arts and Sciences Chemistry PI: Evans-Nguyen,Theresa Spon University of Central FloridaSampling Preparation for Organic Mass Spectrometry-Applications for the Identification of Chiral Excess 25,000

College of Arts and Sciences Chemistry PI: Guida,Wayne C Conv University of South Florida Foundation Computer Aided Drug Discovery Fund 12,066

College of Arts and Sciences ChemistryPI: Guida,Wayne C , Co-PI(s): Brooks,Wesley H Spon Natl Inst of Allergy and Infectious

Development of Antagonists Targeting STING in Systemic Lupus Erythematosus (SLE) 155,628

College of Arts and Sciences ChemistryPI: Leahy,James Williams , Co-PI(s): Merkler,David J. Spon Natl Insti of Gen Medical Science

Tools and Methods for the Elucidation of Fatty Acid Amide Cell Signaling Pathways 213,999

College of Arts and Sciences Chemistry PI: Ma,Shengqian , Co-PI(s): Zhang,Qiong Spon Bureau of ReclamationEfficient Nutrient Recovery from Urine to Prevent Downstream Water Treatment Costs and Resell of Valuable Commodities (176)

College of Arts and Sciences Chemistry PI: Raker,Jeffrey R Spon National Science FoundationCollaborative Research: Impacting Assessment Practices of Postsecondary Faculty Teaching Gateway Chemistry Courses 91,843

College of Arts and Sciences Chemistry PI: Shi,Xiaodong M Spon Natl Insti of Gen Medical Science Achieving Challenging Coupling With Gold Redox Catalysts 313,950

College of Arts and Sciences Chemistry PI: Woodcock III,Henry Lee Spon Natl Insti of Gen Medical ScienceDesign and application of robust and efficient QM/MM free energy simulation methods for biomolecular systems. 284,873

College of Arts and Sciences Chemistry Total 4,795,269 College of Arts and Sciences Communication PI: Kruzel,Marleah Dean Spon FORCE Expanding XRAYS ThRough Alliances: Project EXTRA 62,078

College of Arts and Sciences Communication Total 62,078

College of Arts and Sciences Economics PI: Munkin,Murat Khairzhanuly Spon EuroQol Research Foundation Fast-Track Proposal: Scale, Rate, and Premium {SCRAP} in Health Valuation 29,940 College of Arts and Sciences Economics PI: Munkin,Murat Khairzhanuly Spon EuroQol Research Foundation Preference heterogeneity in health valuation 43,019

College of Arts and Sciences Economics Total 72,959 College of Arts and Sciences English PI: Eisenberg,Eric M Conv University of South Florida Foundation De Bartolo Endowed Chair in the Liberal Arts 80,000

College of Arts and Sciences English Total 80,000 College of Arts and Sciences Florida Institute of Government PI: Crist,Angela Severino Spon City of Clearwater Florida Clearwater Strategic Planning Process 55,938 College of Arts and Sciences Florida Institute of Government PI: Crist,Angela Severino Spon Florida State University 2020-2021 FIOG Affiliate Office 85,000 College of Arts and Sciences Florida Institute of Government PI: Crist,Angela Severino Spon Sarasota County Government 2020 Sarasota Citizen Opinion Survey 89,045 College of Arts and Sciences Florida Institute of Government PI: Crist,Angela Severino Spon Sarasota County Government 2021 Sarasota County Citizen Opinion Survey 89,045

College of Arts and Sciences Florida Institute of Government Total 319,028

College of Arts and Sciences GeosciencesPI: Braunmiller,Jochen , Co-PI(s): Thompson,Glenn Spon University of Alaska Fairbanks

Improving Small Event Characterization and Determination of Moment Tensor Uncertainties with Application to Iran 33,500

78


College of Arts and Sciences GeosciencesPI: Braunmiller,Jochen , Co-PI(s): Wetmore,Paul H Spon US Geological Survey

Space-time evolution of the early 2020 Stanley, Idaho Mw6.5 earthquake aftershock sequence ¿ Complex faulting and faultinteraction at the northern end of the Basin and Range Province? 34,760

College of Arts and Sciences Geosciences PI: Charbonnier,Sylvain J Spon National Science FoundationCAREER: Developing a Consensual Validation and Benchmarking Procedure for Pyroclastic Density Current (PDC) Hazard Models 66,720

College of Arts and Sciences GeosciencesPI: Collins,Jennifer Mary , Co-PI(s): Dunn,Elizabeth A Spon National Science Foundation RAPID: Hurricane Evacuations in the Age of COVID-19 78,821

College of Arts and Sciences GeosciencesPI: Connor,Charles B , Co-PI(s): Rodgers,Melanie J;Charbonnier,Sylvain J Spon The Concord Consortium CynerG: Integrating Computational and Geoscience Thinking 103,035

College of Arts and Sciences Geosciences PI: Dixon,Timothy Hugh Spon NASA GoddardOptimization of digital Elevation models and topography analysis: Implications for volcanic hazard asessments 38,727

College of Arts and Sciences Geosciences PI: Dixon,Timothy Hugh Spon National Science FoundationGEODETIC OBSERVATIONS IN THE NORTHERN COSTA RICA SUBDUCTION ZONE 200,036

College of Arts and Sciences GeosciencesPI: Dixon,Timothy Hugh , Co-PI(s): Lembke,Chad E;Malservisi,Rocco Spon National Science Foundation

Continental Shelf Geodesy: Continued Development of a Low Cost Sea Floor Geodetic System Based on GPS 416,315

College of Arts and Sciences GeosciencesPI: Germa,Aurelie M , Co-PI(s): Charbonnier,Sylvain J Spon US Geological Survey High precision potassium determination for modernization of K/Ar dating 24,488

College of Arts and Sciences Geosciences PI: Gulley,Jason Daniel Spon University of Texas, El PasoEfficient Surrogate Modeling for Sustainable Management of Complex Seawater Intrusion-Impacted Aquifers 18,551

College of Arts and Sciences Geosciences PI: Herbert,Gregory S Spon Florida Fish and Wildlife Conservation Filling Data Gaps For Florida Marine Gastropods 58,691 College of Arts and Sciences Geosciences PI: Kruse,Sarah E Spon Inc Rsch Institutions for Seismology Urban Geophysics Course Development 13,199

College of Arts and Sciences GeosciencesPI: Kruse,Sarah E , Co-PI(s): Connor,Charles B;Connor,Laura M Spon University of Maryland

Geophysical Exploration Of the Dynamics and Evolution of the Solar System (GEODES) 127,992

College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon City of Kissimmee City of Kissimmee WIN Data Management 2,950 College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon City of Tampa Tampa Tree Map 2021 2,800 College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon FL Department Environmental Protection SEACAR Data Discovery Interface and Atlas 2020-21 388,383

College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon Florida Fish and Wildlife ConservationFlorida Species and Habitat MonitoringPrograms Catalog (Terra-CAT) 29,949

College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon Kuwait Fdn for the Advancement of Scienc

Study on Relationships Between Metal Air Pollution, Vegetation Cover, and Environmental Equity in Tampa Using Spanish Moss as aBio-indicator 11,070

College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon Orange County Florida Orange County Water Atlas 2019-23 67,040 College of Arts and Sciences Geosciences PI: Landry,Shawn M Spon Pinellas County Commission Pinellas Water Atlas website component services (17,245) College of Arts and Sciences Geosciences PI: Landry,Shawn M , Co-PI(s): Allyn,Jan Spon FL Department Environmental Protection Water-CAT 2020-21 36,000 College of Arts and Sciences Geosciences PI: Landry,Shawn M , Co-PI(s): Allyn,Jan Spon Hillsborough County Hillsborough County Water Atlas FY2020-21 27,000 College of Arts and Sciences Geosciences PI: Landry,Shawn M , Co-PI(s): Allyn,Jan Spon Lake County Water Authority Lake County Water Atlas 2020-21 25,000 College of Arts and Sciences Geosciences PI: Landry,Shawn M , Co-PI(s): Allyn,Jan Spon Sarasota County Government Sarasota County Water Atlas 2020-2025 109,530 College of Arts and Sciences Geosciences PI: Landry,Shawn M , Co-PI(s): Allyn,Jan Spon Seminole County Florida Seminole County Water Atlas 2020-2025 67,000 College of Arts and Sciences Geosciences PI: Landry,Shawn M , Co-PI(s): Allyn,Jan Spon Tampa Bay Estuary Program Tampa Bay Regional Water Atlas 2020-21 61,530

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Eilers,David T Spon Environmental Science Associates

Lakeland Bathymetry, Stage Volume and Submerged Aquatic VegetationSurvey 45,000

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Eilers,David T Spon Hillsborough County Hillsborough County Aquatic System Assessment Survey 2020-21 42,770

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Eilers,David T Spon Pinellas County Florida Lake Seminole Bathymetry and SAV Survey 4,300

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Eilers,David T;Allyn,Jan Spon Charlotte Harbor Nat'l Estuary Program Charlotte Harbor NEP Water Atlas 2020-21 75,585

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Eilers,David T;Allyn,Jan Spon Polk County Florida Polk County Water Atlas 2020-2021 95,250

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Scolaro,Jason A Spon Hillsborough County Hillsborough County Support Services: 2020-21 SWIS and CSITS 43,885

College of Arts and Sciences GeosciencesPI: Landry,Shawn M , Co-PI(s): Zarger,Rebecca K Spon City of Tampa City of Tampa 2021 Urban Forest Analysis 235,250

College of Arts and Sciences Geosciences PI: Onac,Petroniu Bogdan Spon National Science FoundationExploring the paleoenvironmental data archived in ice deposits from lava tubes ¿ before its imminent loss to ice melting 109,817

College of Arts and Sciences Geosciences PI: Pasek,Matthew A Spon Georgia Institute of Technology Center for Chemical Innovation: Center for Chemical Evolution 23,439 College of Arts and Sciences Geosciences PI: Pasek,Matthew A Spon NASA Jet Propulsion Laboratory Phosphorus Redox Chemistry on Icy and Rocky Planets 61,770

College of Arts and Sciences Geosciences PI: Pasek,Matthew A Spon National Aeronautics & Space Admin Phosphorylation on Water Worlds as a Consequence of Phosphite Oxidation 137,757

College of Arts and Sciences Geosciences PI: Pasek,Matthew A Spon National Science FoundationRAPID: Phosphorus Molecular Biogeochemistry during a Rapidly Changing Nutrient Load in Tampa Bay, FL 71,507

College of Arts and Sciences Geosciences PI: Qiang,Yi Spon National Science Foundation

CoPe EAGER: Collaborative Research: A GeoAI Data-Fusion Framework for Real-Time Assessment of Flood Damage andTransportation Resilience by Integrating Complex Sensor Datasets 25,560

79


College of Arts and Sciences Geosciences PI: Qiang,Yi Spon National Science Foundation Cross-Scale Spatiotemporal Modeling Using an Integrated Data Framework 232,440

College of Arts and Sciences GeosciencesPI: Rains,Kai C , Co-PI(s): Landry,Shawn M;Rains,Mark C Spon St Lucie County WETLAND VULNERABILITY AND RESILIENCY STUDY, PHASE III 28,516

College of Arts and Sciences Geosciences PI: Rains,Mark C Spon FL Department Environmental Protection

MEMORANDUM OF AGREEMENT BETWEEN FLORIDA DEPARTMENT OF ENVIRONMENTAL PROTECTION AND UNIVERSITY OF SOUTHFLORIDA BOARD OF TRUSTEES DEP AGREEMENT NO. 202101 175,390

College of Arts and Sciences Geosciences PI: Rains,Mark C Spon Florida Gulf Coast University Academic Affiliation Agreement with USF and FGCU (Taylor Lee Hancock ) 17,479

College of Arts and Sciences Geosciences PI: Rains,Mark C Spon Florida Gulf Coast UniversityMonitoring, predicting and controlling harmful algal blooms by buoy ultrasonic technology in a range of lakes in southwest Florida 41,182

College of Arts and Sciences Geosciences PI: Rains,Mark C , Co-PI(s): Rains,Kai C Spon Natl Oceanic & Atmospheric Admin Groundwater Vulnerability in coupled human-natural systems 56,000

College of Arts and Sciences Geosciences PI: Ryan,Jeffrey G Spon Columbia UniversityUS Science Support Program Office associated with the International Ocean Discovery Program (61)

College of Arts and Sciences Geosciences PI: Thompson,Glenn Spon National Aeronautics & Space Admin

Science and Heliophysics Antenna Array for Radar and Communications (SHAARC): Scientific Research, Studies, and Analysis for Solar Radio Burst Instrumentation 97,173

College of Arts and Sciences Geosciences

PI: Thompson,Glenn , Co-PI(s): McNutt,Stephen Russell;Braunmiller,Jochen Spon WorkSafe New Zealand

Assess the response of GNS Science to volcanic unrest at White Island, New Zealand in 2019 5,270

College of Arts and Sciences Geosciences PI: Van Beynen,Philip E Spon National Science Foundation

REU Site Proposal: Water sustainability in the urban environment: Improving the sustainable use of water through Interdisciplinary research undergraduate research, water, sustainability, faculty mentoring 139,028

College of Arts and Sciences Geosciences PI: Wang,Ping Spon Bureau of Ocean Energy Mgt, Reg and Enf Influences of Storm Surge on the Depth of Closure 49,845 College of Arts and Sciences Geosciences PI: Wang,Ping Spon FL Dept of Environmental Protection Bathymetric Survey for the 77-Acre Piney Point Pond 10,000

College of Arts and Sciences Geosciences PI: Wang,Ping Spon Pinellas County FloridaCauses and Mitigation of Sedimentation along the Northern Side of Johns Pass Channel 35,000

College of Arts and Sciences Geosciences PI: Wang,Ping Spon Pinellas County Florida Numerical Modeling of Circulation Pattern within the Fort De Soto Park Bay 39,375

College of Arts and Sciences Geosciences PI: Wang,Ping Spon Pinellas County FloridaPhysical monitoring of the Sand key, Treasure Island, and Long key Beach Nourishment Projects 84,594

College of Arts and Sciences Geosciences PI: Wang,Ping Spon US Fish & Wildlife ServiceInvestigating Beach Changes Associated with Post-Nourishment Profile Equilibration on Turtle Nesting 15,748

College of Arts and Sciences GeosciencesPI: Wetmore,Paul H , Co-PI(s): Dixon,Timothy Hugh Spon US Geological Survey

Collaborative Research with University of South Florida and University of Cincinnati: Determining Slip Rates for Camp Rock Fault (Eastern California Shear Zone) Using Terrestrial Cosmogenic Nuclide Dating (152)

College of Arts and Sciences Geosciences Total 4,024,559

College of Arts and Sciences History PI: Tanasi,Davide Spon International Catacomb Society The Digital afterlife of the Catacombs of Abbatija tad-Dejr at Rabat (Malta) 15,000 College of Arts and Sciences History PI: Tunstall Werner,Wendy Marie Spon Phi Alpha Theta Phi Alpha Theta National History Honor Society 152,000

College of Arts and Sciences History Total 167,000

College of Arts and Sciences Integrative Biology PI: Bell,Susan S Spon National Academy of SciencesUsing Past Seagrass Restoration Projects to Inform Research and Improve the Monitoring of Future Restoration Efforts 58,097

College of Arts and Sciences Integrative BiologyPI: Carney,Ryan Marc , Co-PI(s): Chellappan,Sriram Spon National Science Foundation

SCH: INT: Surveillance and Control of Mosquito-Borne Diseases through Automated Species Identification and Spatiotemporal Modeling 206,588

College of Arts and Sciences Integrative Biology PI: Gemmell,Bradford James Spon National Science FoundationCollaborative Research: Quantifying the Trophic Roles of Epipelagic Ctenophores 194,138

College of Arts and Sciences Integrative Biology PI: Gemmell,Bradford James Spon University of OregonPropulsive Advantages of Coordinating Multiple Jets by Colonial Marine Organisms 13,000

College of Arts and Sciences Integrative Biology PI: Harwood,Valerie J Spon Hillsborough CountyMicrobial Source Tracking for Selected Waterbodies within Hillsborough County 75,000

College of Arts and Sciences Integrative Biology PI: Harwood,Valerie J Spon University of WashingtonGut microbiome, enteric infections and child growth across a rural urban gradient 84,246

College of Arts and Sciences Integrative Biology PI: Harwood,Valerie J Spon Virginia Polytechnic Institute and State

Standardizing Methods with QA/QC Standards for Investigating the Occurrence and Removal of Antibiotic Resistant Bacteria/Antibiotic Resistance Genes (ARB/ARGs) in Surface Water, Wastewater, and Recycled Water 62,536

College of Arts and Sciences Integrative BiologyPI: Harwood,Valerie J , Co-PI(s): Lewis,David Spon Environmental Protection Commission

New Methods to Enhance Fecal Source Detection in Water Bodies by Microbial Source Tracking Project 50,000

College of Arts and Sciences Integrative Biology PI: Kramer,Andrew M Spon Cary Institute of Ecosystem StudiesPreventing Emergence and Spillover of Bat Pathogens in High-Risk Global Hot-Spots 33,778

College of Arts and Sciences Integrative Biology PI: Kramer,Andrew M Spon National Science Foundation RAPID Collaborative Proposal: SPATIAL DYNAMICS OF COVID-19 124,654

80


College of Arts and Sciences Integrative Biology

PI: Lewis,David , Co-PI(s): Rains,Mark C;Ergas,Sarina;Prevost,Luanna;Lane,Tonisha Brandy Spon National Science Foundation

Graduate Student Scholarships to Advance Community Engaged Solutions to the Grand Challenge of Managing Nitrogen 199,304

College of Arts and Sciences Integrative Biology PI: Margres,Mark J Spon National Geographic SocietyVenomous archipelagos: Integrating adaptability and island biogeography theory to assess persistence in the Anthropocene 29,360

College of Arts and Sciences Integrative Biology PI: Margres,Mark J Spon Washington State University BEE: Eco-evolutionary dynamics of disease-induced apex predator declines 106,124

College of Arts and Sciences Integrative Biology PI: Martin II,Lynn Bloxom Spon National Science FoundationCollaborative Research: Constraints of Biomass on Innate Immunity Across Terrestrial Mammals 55,038

College of Arts and Sciences Integrative Biology PI: Parkinson,John Everett Spon National Science Foundation

COLLABORATIVE RESEARCH: Investigating the genomic basis of key performance traits to quantify the evolutionary potential of coral populations under climate change 83,883

College of Arts and Sciences Integrative Biology PI: Parkinson,John Everett Spon Phycological Society of AmericaEpigenetic regulation of transcript variants involved in the heat stress response of coral symbionts (family Symbiodiniaceae) 2,400

College of Arts and Sciences Integrative Biology PI: Prevost,Luanna Spon Educational Development CenterIncreasing the Impact and Reach of the Amgen Biotech Experience Program: 2020-2023 99,754

College of Arts and Sciences Integrative Biology PI: Richards,Christina L Spon Florida Fish and Wildlife ConservationPopulation Dynamics of the Giant Caribbean Sea Anemone (Condylactis Gigantea) in Florida and Across the Caribbean (1,069)

College of Arts and Sciences Integrative Biology PI: Scott,Kathleen M Spon National Science FoundationEnigmatic Carboxysomes from the Marine and Hypersaline Chemolithoautotrophic Bacteria fo Genus Thiomicrospira 114,440

College of Arts and Sciences Integrative Biology Total 1,591,271

College of Arts and Sciences Mathematics & Statistics PI: Biasse,Jean-Francois Spon National Science FoundationCAREER: Algebraic Methods for the Computation of Approximate Short Vectors in Ideal Lattices 8,000

College of Arts and Sciences Mathematics & Statistics PI: Elhamdadi,Mohamed Spon Simons Foundation Algebraic Structures in Knot Theory 8,400 College of Arts and Sciences Mathematics & Statistics PI: Jonoska,Natasa Spon Georgia Institute of Technology NSF-Simons Research Center: Southeast Center for Mathematics 107,702

College of Arts and Sciences Mathematics & StatisticsPI: Jonoska,Natasa , Co-PI(s): Saito,Masahiko Spon National Science Foundation

Collaborative Research: Discrete and Topological Models for Template-Guided Genome Rearrangements 180,091

College of Arts and Sciences Mathematics & Statistics PI: Khavinson,Dmitry Spon Simons Foundation Problems in Complex Analysis and Applications 8,400 College of Arts and Sciences Mathematics & Statistics PI: Molla,Theodore N Spon National Science Foundation Factors in Graphs and Related Combinatorial Structures 76,937

College of Arts and Sciences Mathematics & Statistics PI: Nagle,Brendan T Spon National Science Foundation Applications and Theory of the Algorithmic Hypertrophy Regularity method 58,832

College of Arts and Sciences Mathematics & Statistics PI: Rosenfeld,Joel A Spon Air Force Office of Scientific ResearchHilbert Spaces from Occupation Kernels and Learning in Nonlinear and Nonlocal Dynamical Systems 149,955

College of Arts and Sciences Mathematics & Statistics PI: Rosenfeld,Joel A Spon National Science FoundationCollaborative Research: Operator theoretic methods for identification and verification of dynamical systems 73,276

College of Arts and Sciences Mathematics & Statistics PI: Rosenfeld,Joel A Spon Oklahoma State University Operator Theoretic Methods for Data-Driven Control Synthesis 144,201 College of Arts and Sciences Mathematics & Statistics Total 815,794

College of Arts and Sciences Physics PI: Arena,Dario , Co-PI(s): Karaiskaj,Denis Spon National Science Foundation All Optical, Tunable THz Magnonic Devices 125,099 College of Arts and Sciences Physics PI: Batzill,Matthias Marcus Spon National Science Foundation Nanostructured 2D-Transition Metal Dichalcogenides 137,402 College of Arts and Sciences Physics PI: Batzill,Matthias Marcus Spon National Science Foundation Van der Waals Heteromaterials 139,999

College of Arts and Sciences Physics PI: Hoy,Robert Scott Spon National Science FoundationStress Testing Theories of the Glass and Jamming Transitions Using Hyperellipsoids 210,000

College of Arts and Sciences Physics PI: Oleynik,Ivan I Spon US Department of EnergyPhase Transitions Under Dynamic Compression: Carbon, Silicon and Germanium 210,000

College of Arts and Sciences Physics PI: Ponomareva,Inna Spon US Department of Energy Complex (anti)Ferroics Oxides: Statics and Dynamics at Finite Temperatures 161,000

College of Arts and Sciences Physics

PI: Ponomareva,Inna , Co-PI(s): Witanachchi,Sarath;Lisenkov,Sergey;Ma,Shengqian Spon National Science Foundation

Unveiling intrinsic functionality of two-dimensional organic-inorganic ferroelectrics for energy storing/converting devices: integrated computational-experimental approach 139,998

College of Arts and Sciences Physics PI: Rodriguez Gutierrez,Humberto Spon Nanobase, Incorporated Nanobase Inc. Award: Optical Properties of New Two-dimensional Materials 10,000

College of Arts and Sciences PhysicsPI: Rodriguez Gutierrez,Humberto , Co-PI(s): Rodriguez Gutierrez,Humberto Spon National Science Foundation REU Site: Applied Physics at the University of South Florida 130,691

College of Arts and Sciences Physics PI: Srikanth,Hariharan Spon US Department of EnergyGround State Magnetism and Cooperative Phenomena in Correlated Electron Oxide Materials 199,594

College of Arts and Sciences Physics PI: Ullah,Ghanim Spon National Institute on AgingA multi-scale data-driven model of the Abeta pore function and Ca2+ toxicity in Alzheimer's disease 412,030

College of Arts and Sciences Physics PI: Witanachchi,Sarath Spon National Science FoundationUSA-Botswana Collaborative Research Towards Portable Power Generation in Rural Africa 100,500

College of Arts and Sciences Physics PI: Woods,Lilia M Spon US Department of EnergyMaterials with Nontrivial Topology as a Platform for Fluctuation Induced Phenomena 118,248

College of Arts and Sciences PhysicsPI: Woods,Lilia M , Co-PI(s): Nolas,George S Spon National Science Foundation

GOALI: Synergistic Computational, Experimental, and Thermoelectric Device-Related Research for Multinary Chalcogenides with Earth-Abundant Constituents 133,678

81


College of Arts and Sciences Physics PI: Zhou,Jiangfeng , Co-PI(s): Lu,Lu Spon Asian Office of Aerospace Research and DReversibly Reconfigurable 3D Micro - and Nano - Photonic Devices by Magnetically Programmable Polymeric Composites 139,628

College of Arts and Sciences Physics Total 2,367,867

College of Arts and Sciences Psychology PI: Allen,Tammy D Spon Soc for Industrial & Organizational PsycEasing the Postpartum Transition to Reemployment: Linking Workplace Resources, Work-Family Conflict, and Health Behaviors 10,000

College of Arts and Sciences Psychology PI: Rancourt,Diana Marie Spon Psi Chi Approach and Avoidance Food Craving: A Dual Cue Reactivity Investigation 1,500 College of Arts and Sciences Psychology PI: Rottenberg,Jonathan A Spon James A. Haley Veteran's Hospital CENC - Longitudinal Cohort Study 54,006 College of Arts and Sciences Psychology PI: Rottenberg,Jonathan A Spon Xcenda, LLC Clinical Psychology Ph. D. Program Student Support Grant 96,058

College of Arts and Sciences Psychology PI: Schotter,Elizabeth R Spon National Science FoundationNeural underpinnings of attention in the real world: Insights from co-registration of eye movements and EEG 25,000

College of Arts and Sciences Psychology PI: Schotter,Elizabeth R Spon Psi ChiIdentifying the Relationship Between Visual Field and Integration Processes Using Event-Related Potentials 1,500

College of Arts and Sciences Psychology PI: Schotter,Elizabeth R Spon Psi ChiIs Parafoveal Vision Sufficient for Semantic Integration?:Evidence from Event-Related Potentials 1,500

College of Arts and Sciences Psychology PI: Verona,Edelyn Spon James A. Haley Veteran's HospitalHealth Outcomes Associated with TBI Screening Study-VA Graduate Assistant Support 27,487

College of Arts and Sciences PsychologyPI: Verona,Edelyn , Co-PI(s): Fox,Bryanna Bryttany Hahn Spon National Institute of Justice

Adapted Risk-Needs-Responsivity Model to Reduce Recidivism in an Underserved Area: A Randomized Controlled Trial of Pre-Release and Post-Release Reentry Components 303,173

College of Arts and Sciences Psychology Total 520,224

College of Arts and Sciences Public AffairsPI: Chen,Peng , Co-PI(s): Williams,Kristine M Spon University of Texas, Arlington

OERTransport - Enabling Transportation Planning Professional Advancement 125,000

College of Arts and Sciences Public Affairs PI: Hafen,Mark R Spon Hillsborough Co City Co Planning Comm 2020-2021 Hillsborough Co City-County Planning Commission Fellowship 13,750

College of Arts and Sciences Public Affairs PI: Hafen,Mark R Spon Hillsborough County Metropolitan PlanninHills. Co. MPO Internship 2020-2021 - Masters of Urban and Regional Planning 13,750

College of Arts and Sciences Public Affairs Total 152,500

College of Arts and Sciences SAR - CriminologyPI: Grosholz,Jessica , Co-PI(s): Stone,Sandra Smith;Ngo,Fawn Tuyet Spon Selah Freedom, Inc. OVC Comprehensive Services for Victims of Human Trafficking 2019 15,672

College of Arts and Sciences SAR - Criminology Total 15,672 College of Arts and Sciences SAR - Information Technologies PI: Holbrook,Karen A Conv University of South Florida Foundation Sylint Cybersecurity 4,000

College of Arts and Sciences SAR - Information Technologies Total 4,000

College of Arts and Sciences School of Information PI: Andrews,James E Spon ALISE Assoc Library and Info Sciences EdExploring Best Practices for Preparing Librarians in Adopting Artificial Intelligence into Libraries 10,000

College of Arts and Sciences School of InformationPI: Borum,William R , Co-PI(s): Andrews,James E Spon National Security Agency 2020 USF/Cyber Florida DoD Cybersecurity Scholarship Program 69,926

College of Arts and Sciences School of InformationPI: Taylor,Natalie Greene , Co-PI(s): Shereff,Denise R;Cannon,Peter J Spon Division of Library and Information Serv Creating a Responsive Librarianship Scheme 160,233

College of Arts and Sciences School of Information Total 240,159

College of Arts and Sciences Sociology PI: Aranda,Elizabeth M Spon National Science Foundation?Estamos Bien?: Emotional Adaptation and Incorporation of Post-Hurricane Maria Puerto Rican Migrants 228,854

College of Arts and Sciences Sociology PI: Tyson JR.,William T Spon National Science FoundationPathTech LISTEN: Mixed Methods Longitudinal Investigations of Students in Technician EducatioN 413,228

College of Arts and Sciences Sociology Total 642,082

College of Arts and Sciences STP - Anthropology PI: O'Leary,Heather Elaine Spon University of Central Florida - FSECEstimating Economic Losses and Impacts of Florida Red Tide (Karenia Brevis) Blooms 28,496

College of Arts and Sciences STP - Anthropology Total 28,496

College of Arts and Sciences STP - ChemistryPI: Osegovic,John P , Co-PI(s): Ivey,James Edward Spon ORCA Greening our lawns and protecting our Bay 5,000

College of Arts and Sciences STP - Chemistry Total 5,000 College of Arts and Sciences STP - English PI: McCracken,Jill L Spon Proteus Fund Complex Rights and Wrongs: The Stories We Deny in Mainst 5,000

College of Arts and Sciences STP - English Total 5,000

College of Arts and Sciences STP - Environmental Science Program PI: Elshorbany,Yasin F. Spon National Science FoundationAn Investigation Into Daytime HONO Chemistry in the Marine Boundary Layer 75,143

College of Arts and Sciences STP - Environmental Science Program Total 75,143 College of Arts and Sciences STP - History PI: Francis,John Michael Conv University of South Florida Foundation Hough Family Endowment Chair 20,000 College of Arts and Sciences STP - History PI: Meindl,Christopher F Spon Ford Motor Company The Fresh N Local Greenhouse Project 10,800

College of Arts and Sciences STP - History Total 30,800 College of Arts and Sciences STP - Infant Family Mental Health Center PI: Butler,LaDonna Nicole Spon Foundation for a Healthy St. Pete Focus on race 116,000

College of Arts and Sciences STP - Infant Family Mental Health Center Total 116,000 College of Arts and Sciences STP - Integrative Biology PI: Judkins,Heather Spon Florida Fish and Wildlife Conservation Southeast Area Monitoring and Assessment Program (SEAMAP) Staffing 52,467

College of Arts and Sciences STP - Integrative Biology Total 52,467 College of Arts and Sciences STP - Journalism and Digital Communications PI: Frechette,Michael Casey Spon Harvard University Web development for the National Ethics Project 600

College of Arts and Sciences STP - Journalism and Digital Communications Total 600

82


College of Arts and Sciences STP - Mass Communications PI: Elliott,Deni Conv University of South Florida Foundation Poynter Jamison Chair for Media Ethics and Press Policy 54,200 College of Arts and Sciences STP - Mass Communications Total 54,200

College of Arts and Sciences STP - Psychology PI: McHale,James P Spon Admin For Children and FamiliesSkills-based healthy marriage and relationship education services for at-risk families through a child welfare diversion program 749,920

College of Arts and Sciences STP - Psychology PI: McHale,James P Spon Juvenile Welfare Board of Pinellas CoInfant-Family Mental Health Center Request-Partnering for Community Infant Mental Health Intervention 310,246

College of Arts and Sciences STP - Psychology PI: McHale,James P Spon Pinellas County Dept of Human ServicesPinellas County Opioid affected youth initiative: Aiding Drug Impacted Children in Out-of-Home Care 63,648

College of Arts and Sciences STP - Psychology PI: Turner,Stephen P Conv University of South Florida Foundation Marie E. and E. Leslie Cole Endowed Chair in Ethics 55,600 College of Arts and Sciences STP - Psychology Total 1,179,414

College of Arts and Sciences Total 27,266,563

College of Behavioral and Co Center for Hearing and Speech ResearchPI: Frisina JR.,Robert D , Co-PI(s): Walton,Joseph P Spon Rochester Institute of Technology Enabling Microsystem Technologies for Advanced Drug Delivery 23,609

College of Behavioral and Comm Center for Hearing and Speech Research Total 23,609

College of Behavioral and Co CFS RIghtpath Research Center PI: Anthony,Jason Lon Spon University of KansasValidity of a Nonspeech, Dynamic Assessment of the Alphabetic Principle (DAAP) 34,993

College of Behavioral and Co CFS RIghtpath Research Center PI: Carlo,Maria S Spon The University of Texas Health Science CEffects of Home and Classroom practices on Language, Cognitive, and Social Development of Young Spanish-Speaking English Learners 15,419

College of Behavioral and Co CFS RIghtpath Research CenterPI: Carlo,Maria S , Co-PI(s): Smith,Sara AshleyAnthony,Jason Lon;Williams,Jeffrey Spon US Department of Education

Effect of Bilingual vs Monolingual Methods of Explicit English Vocabulary Instruction on 4th Grade Spanish-Speaking English Learners (EL): Exploring Accuracy, Retention, and Transfer of Learning 348,961

College of Behavioral and Com CFS RIghtpath Research Center PI: Spencer,Trina D Spon US Department of Education A Close Inspection of the Academic Language Used by K-3 Students 305,896 College of Behavioral and Com CFS RIghtpath Research Center PI: Williams,Jeffrey Spon May Institute 84.324A Modular Approach for Autism Programs in Schools (MAAPS) 45,633

College of Behavioral and Comm CFS RIghtpath Research Center Total 750,902

College of Behavioral and Co Child and Family Behavioral Health PI: Abella,Anna L D , Co-PI(s): Vargo,Amy C Spon National Institute of Justice

Cross-Site Analysis and Case Study of STOP Program Grantee Perspectives on Violence Prevention and Mental Health Training Program Implementation 244,408

College of Behavioral and Co Child and Family Behavioral HealthPI: Burton,Donna L , Co-PI(s): Hodges,Sharon P Spon Childrens Home Society of Florida The Trauma Recovery Institute 79,979

College of Behavioral and Com Child and Family Behavioral Health PI: Callejas,Linda M. Spon Citrus Health Network, Inc. Parent Partners for Families of Miami-Dade County 101,073

College of Behavioral and Co Child and Family Behavioral HealthPI: Cruz,Areana , Co-PI(s): Abella,Anna L DArmstrong,Mary I Spon Florida Department of Health Pediatric Mental Health Care Access Program Evaluation 69,928

College of Behavioral and Com Child and Family Behavioral Health PI: Dollard,Norin Spon Casey (Annie E) Foundation Support various KIDS COUNT activities 100,000 College of Behavioral and Com Child and Family Behavioral Health PI: Dollard,Norin Spon Florida Policy Institute Florida Kids Count 2021 70,000

College of Behavioral and Co Child and Family Behavioral HealthPI: Fox,Lise K , Co-PI(s): Kincaid,Donald K;Perkins,Elizabeth A Spon Administration for Community Living

University Center for Excellence in Developmental Disabilities, Education, Research, and Service 571,732

College of Behavioral and Co Child and Family Behavioral Health

PI: Landers,Monica D , Co-PI(s): Armstrong,Mary I;Dollard,Norin;Abella,Anna L D Spon Family Support Services of North Florida

Regional Partnership Grants to Increase the Well-Being of, and to Improve the Permanency Outcomes for, Children Affected by Substance Abuse 167,776

College of Behavioral and Co Child and Family Behavioral Health PI: Lipien,Leokadia Spon Florida Dept of Children and FamiliesEvaluation of the State Targeted Response and Partnership for Success Projects 9,159

College of Behavioral and Co Child and Family Behavioral HealthPI: Lipien,Leokadia , Co-PI(s): Ismajli,Flandra Spon Florida Dept of Children and Families Evaluation of State Targeted Response and Partnership for Success Projects 34,500

College of Behavioral and Co Child and Family Behavioral HealthPI: Lipien,Leokadia , Co-PI(s): Teague,Gregory B;Robst,John Michael Spon Florida Agency for Health Care Admin Independent Assessment of the Florida Medicaid NET Program 3,868

College of Behavioral and Com Child and Family Behavioral Health PI: Massey,Oliver T Spon National Institute on Drug Abuse Institute for Translational Research Education in Adolescent Drug Abuse 329,145

College of Behavioral and Co Child and Family Behavioral Health PI: McNeish,Roxann R Spon Florida Dept of Children and FamiliesChildren Mental Health System of Care (CMHSOC) Expansion Project Evaluation and Dissemination 50,229

College of Behavioral and Com Child and Family Behavioral Health PI: McNeish,Roxann R Spon Movember Foundation Making Connections for Mental Health 62,500 College of Behavioral and Com Child and Family Behavioral Health PI: Menendez,Pamela M Spon Cuyahoga County Division of Children and Just In Time (JIT) Foster Parent/Caregiver Web-Based Training Program 30,000 College of Behavioral and Com Child and Family Behavioral Health PI: Menendez,Pamela M Spon Florida Dept of Children and Families Florida's Child Welfare Information and Training Gateway 838,551 College of Behavioral and Com Child and Family Behavioral Health PI: Menendez,Pamela M Spon Kentucky Cabinet for Health and Family S Just In Time (JIT) website 55,586 College of Behavioral and Com Child and Family Behavioral Health PI: Menendez,Pamela M Spon Nevada Dept of Child and Family Services Nevada QPI/JIT Website 20,000 College of Behavioral and Com Child and Family Behavioral Health PI: Menendez,Pamela M Spon Turning Points for Children Philadelphia Quality Parenting Initiative/Just in Time (QPI/JIT) 55,067 College of Behavioral and Com Child and Family Behavioral Health PI: Menendez,Pamela M Spon University of California, Berkeley Quality Parenting Initiative (QPI) 87,414 College of Behavioral and Com Child and Family Behavioral Health PI: Mowery,Debra L Spon Arizona Health Care Cost Containment Sys System of Care Practice Review Project 46,063

College of Behavioral and Co Child and Family Behavioral Health PI: Yampolskaya,Svetlana Spon Childrens Home Society of FloridaThe Impact of the S.P.A.R.K. intervention on risky sexual behavior and teen pregnancy prevention 132,809

College of Behavioral and Comm Child and Family Behavioral Health Total 3,159,787

College of Behavioral and Co Child and Family StudiesPI: Albizu-Jacob,Alexandra Gabriela , Co-PI(s): Massey,Oliver T;Fintel,Nichole Marie Spon Family First

All Pro Dad: Fatherhood Involvement in Literacy and Family Engagement Multimedia and Awareness Campaign 31,000

College of Behavioral and Co Child and Family Studies

PI: Blair,Kwang-Sun Cho , Co-PI(s): Crosland,Kimberly;Castillo,Jose M;Cividini-Motta,Catia Spon US Department of Education

Project EBAS: Enhancing Behavior Analytic Services for Children with Severe Emotional and Behavioral disorders 249,657

83


College of Behavioral and Com Child and Family Studies PI: Boone,Nona Elizabeth Spon Florida Department of Education Centers for Autism and Related Disabilities (CARD) 2020-2021 1,444,757

College of Behavioral and Co Child and Family Studies

PI: Cividini-Motta,Catia , Co-PI(s): Crosland,Kimberly;Blair,Kwang-Sun Cho;Salloum,Alison Ann Spon US Department of Education

Project iSED: Advancing Interdisciplinary Services for Students with Severe Emotional and Behavioral Disorders 196,908

College of Behavioral and Co Child and Family StudiesPI: Crosland,Kimberly , Co-PI(s): Iovannone,Rose M Spon US Department of Education

Development and Pilot Testing of Modular-Based Consultation Using Evidence-Based Practices for Teachers of Students with Emotional Disturbance (MOTIVATED) 434,323

College of Behavioral and Com Child and Family Studies PI: Evanovich,Lauren Louise Spon University of Oregon Florida Project Coordination for Educational and Community Supports 2,000 College of Behavioral and Com Child and Family Studies PI: Fox,Lise K Spon Florida Office of Early Learning Statewide Implementation of the Pyramid model 221,412

College of Behavioral and Co Child and Family Studies PI: Fox,Lise K Spon Metro Nashville Public SchoolsPyramid Model Expansion to School-District Implementation in Preschool and Kindergarten Classrooms 54,121

College of Behavioral and Com Child and Family Studies PI: Fox,Lise K Spon University of North Carolina,Chapel Hill Early Childhood Systems Technical Assistance Center 196,345

College of Behavioral and Co Child and Family Studies PI: Fox,Lise K Spon US Department of Education

Technical Assistance Center on Positive Social, Emotional, and Behavioral Outcomes for Young Children with, and at Risk for, Developmental Delays or Disabilities 1,100,000

College of Behavioral and Co Child and Family Studies PI: Fox,Lise K Spon Vanderbilt UniversityNational Center on Early Childhood Development, Teaching, and Learning (NCECDTL) 84,947

College of Behavioral and Co Child and Family Studies PI: Fox,Lise K Spon Vanderbilt UniversityThe Effectiveness of Group Coaching as a Practice-Based Coaching Format for Coaching on Pyramid Model Practices (12,485)

College of Behavioral and Co Child and Family Studies PI: Fox,Lise K , Co-PI(s): Tapley,Kathryn E Spon Florida Department of EducationPartnership for Effective Programs forStudents with Autism 2020-2021 340,819

College of Behavioral and Co Child and Family Studies PI: George,Heather P Spon University of OregonOSEP Technical Assistance Center on Positive Behavioral Interventions and Supports 664,000

College of Behavioral and Com Child and Family Studies PI: Iovannone,Rose M Spon Florida Department of Education FDLRS Multidisciplinary Educational Service 423,000 College of Behavioral and Com Child and Family Studies PI: Iovannone,Rose M Spon May Institute 84.324 A Modular Approach for Autism Programs in Schools (MAAPS) 243,651

College of Behavioral and Co Child and Family Studies PI: Johnson,Melissa H Spon Citrus Health Network, Inc.Citrus Helping Adolescents Negatively Impacted by Commercial Exploitation (CHANCE) 50,496

College of Behavioral and Com Child and Family Studies PI: Jordan,Tracy Payne Spon Children's Board of Hillsborough County Hillsborough HIPPY Parental Involvement Project 1,407,396 College of Behavioral and Com Child and Family Studies PI: Jordan,Tracy Payne Spon Children's Services Council Martin Count HIPPY Martin County (HIMCO) 275,000 College of Behavioral and Com Child and Family Studies PI: Jordan,Tracy Payne Spon Florida Office of Early Learning Florida HIPPY Test of Early Childhood Programs and Applications 57,318 College of Behavioral and Com Child and Family Studies PI: Jordan,Tracy Payne Spon Florida Office of Early Learning Florida HIPPY Training & Technical Assistance Center 18-19 3,900,000

College of Behavioral and Co Child and Family Studies PI: Jordan,Tracy Payne Spon Florida Office of Early LearningHome Instruction for Parents of Pre-School Youngsters (HIPPY) Pre School Development Grant Online Support Pilot 313,384

College of Behavioral and Co Child and Family StudiesPI: Kincaid,Donald K , Co-PI(s): George,Heather P Spon Florida Department of Education Florida Positive Behavioral Interventions and Support (FL PBIS: MTSS) 1,390,289

College of Behavioral and Co Child and Family Studies PI: Perkins,Elizabeth A Spon Administration for Community LivingPromoting the Participation of Individuals with Disabilities in COVID-19Vaccines 59,701

College of Behavioral and Com Child and Family Studies PI: Winneker,Anna Rachel Spon Children's Board of Hillsborough County Program-Wide Positive Behavior Support 20-21 745,166 College of Behavioral and Comm Child and Family Studies Total 13,873,206

College of Behavioral and Co College of Behavioral and Community Sci

PI: Goldstein,Howard , Co-PI(s): Robst,John Michael;Madsen,Keri Marie;Williams,Jeffrey Spon US Department of Education

Efficacy of Story Friends vocabulary Curriculum Targeting Preschoolers At-Risk for Language and Literacy Disabilities 643,931

College of Behavioral and Co College of Behavioral and Community Sci

PI: Goldstein,Howard , Co-PI(s): Wang,Wei;Smith,Glenn Gordon;Haring,Christa Dawn Spon US Department of Education

Professional Development of an MTSS Model for Early Childhood Educators to Prevent Reading Disabilities 50,000

College of Behavioral and Comm College of Behavioral and Community Sci Total 693,931

College of Behavioral and Co Communication Sciences and DisordersPI: Arnold,Michelle Leigh , Co-PI(s): Sanchez,Victoria Ann Spon National Institutes of Health

Development and Assessment of a Spanish-Language Toolkit for Hearing Loss Self Management 142,252

College of Behavioral and Co Communication Sciences and Disorders PI: Bourgeois,Michelle Suzanne Spon Carnegie Mellon University AphasiaBank: A Shared Database for the Study of Aphasic Communication (700)

College of Behavioral and Co Communication Sciences and DisordersPI: Chisolm,Theresa E Hnath , Co-PI(s): Arnold,Michelle Leigh;Eddins,Ann Clock Spon Johns Hopkins University

Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial 86,014

College of Behavioral and Co Communication Sciences and Disorders PI: Eddins,David A , Co-PI(s): Ozmeral,Erol J Spon Aylstock Witkin Kreis & Overholtz, PLLC Hearing Protection Devices: fit, function, and usability 31,548

College of Behavioral and Co Communication Sciences and Disorders PI: Eddins,David A , Co-PI(s): Ozmeral,Erol J Spon Sonova AGToward a More Intelligent Hearing System: Making Sense of the Wearers Head Movements 264,409

College of Behavioral and Co Communication Sciences and DisordersPI: Eddins,David A , Co-PI(s): Ozmeral,Erol J;Anand,Supraja;Williams,Jeffrey Spon Natl Insti on Deafness and Other Comm D A Comprehensive Psychoacoustic Approach to Voice Quality Perception 656,837

College of Behavioral and Co Communication Sciences and DisordersPI: Eddins,David A , Co-PI(s): Ozmeral,Erol J;Anand,Supraja;Williams,Jeffrey Spon Natl Insti on Deafness and Other Comm D

Pediatric dysphonia: Multidisciplinary advances to improve voice quality outcomes 469,229

College of Behavioral and Co Communication Sciences and Disorders PI: Lutfi,Robert A Spon Natl Insti on Deafness and Other Comm D Individual Differences Listening in Noise in Clinically Normal-hearing Adults 568,350

84


College of Behavioral and Co Communication Sciences and Disorders PI: Ozmeral,Erol J Spon National Institutes of Health

A Multi-Modal Streaming Approach to Understanding Aided Speech Perception in Noise: Discovering Relationships Between Device Limitations, Perceptual Abilities, and Neuro-Modulation of Feature Coding 149,500

College of Behavioral and Com Communication Sciences and Disorders PI: Serovich,Julianne Maria Conv University of South Florida Foundation CSD Aging and Brain Health 55,594

College of Behavioral and Co Communication Sciences and Disorders PI: Walton,Joseph P Spon Cognosetta, Inc.Effects of BK channel modulation onan active avoidance measure of tinnitus 12,000

College of Behavioral and Co Communication Sciences and Disorders PI: Walton,Joseph P Spon Cognosetta, Inc.Organ Toxicity Biomarkers Following Administration of a BK Channel Modulator 4,000

College of Behavioral and Comm Communication Sciences and Disorders Total 2,439,033

College of Behavioral and Co Criminology PI: Dembo,Richard Spon University of MiamiCulturally Modified Family Based Therapy for Haitian Youth and Their Families in South Florida 17,509

College of Behavioral and Com Criminology PI: Fridell,Lorie Ann Conv University of South Florida Foundation Convenience Fund for Criminology Operation Fund 2,308

College of Behavioral and Co CriminologyPI: Powers,Rachael , Co-PI(s): Fox,Bryanna Bryttany Hahn Spon City of Tampa City of Tampa CGIC Initiative 150,000

College of Behavioral and Comm Criminology Total 169,817 College of Behavioral and Com Mental Health Law and Policy PI: Aeppel,Pamela E. Spon Eckerd Youth Alternatives, Inc. FY 16-17 Eckerd Child Welfare Training 1,107,836 College of Behavioral and Com Mental Health Law and Policy PI: Aeppel,Pamela E. Spon Florida Dept of Children and Families Child Welfare Trainer Proficiency Training Program 900,000 College of Behavioral and Com Mental Health Law and Policy PI: Aeppel,Pamela E. Spon Florida Dept of Children and Families Family Finder Train-the-Trainer 173,500 College of Behavioral and Com Mental Health Law and Policy PI: Dion,Charles J Spon Pinellas County Dept of Human Services Pinellas County Strategic Information Sharing Partnership 200,584

College of Behavioral and Co Mental Health Law and PolicyPI: Gum,Amber Michelle , Co-PI(s): Conner,Kyaien Oquinn Spon National Institute of Mental Health 3/3 Lay-delivered Behavioral Activation in Senior Centers 320,999

College of Behavioral and Co Mental Health Law and PolicyPI: Gum,Amber Michelle , Co-PI(s): Guerra,Lucy;Salloum,Alison Ann Spon Patient Centered Outcomes Research Insti

Primary Care Patients with Trauma History: Expanding a Safety Research Partnership and Network 130,000

College of Behavioral and Co Mental Health Law and PolicyPI: Johnson,Kimberly , Co-PI(s): Hills,Holly A;Dion,Charles J Spon Northwestern University

Using Agent-Based Modeling to Improve HIV and Drug Abuse Service Systems Affected by COVID-19 /Center for Prevention Implementation Methodology for Drug Use and HIV (Ce-PIM) 28,405

College of Behavioral and Co Mental Health Law and Policy PI: Johnson,Micah Elijah Spon National Institute on Drug AbuseResubmission: Examining the Stress Processes Relating Ethnicity and Sex to Substance Misuse and Services Outcomes (ESPRESSO) 176,469

College of Behavioral and Com Mental Health Law and Policy PI: Johnson,Micah Elijah Spon University of California, San Francisco Mentoring Emerging Scientists for Careers in Substance Use Research 23,760

College of Behavioral and Co Mental Health Law and PolicyPI: Johnson,Micah Elijah , Co-PI(s): Johnson,Kimberly Spon National Institutes of Health The Substance Misuse and Addiction Research Traineeship (SMART) 227,849

College of Behavioral and Co Mental Health Law and Policy PI: Jones,Genevra Spon Temple UniversityTemple University RRTC on Community Living and Participation of Individuals with Psychiatric Disabilities 21,324

College of Behavioral and Com Mental Health Law and Policy PI: Kosyluk,Kristin Ann Spon COPE NOTES LLC Pilot Study of Cope Notes Mental Health Program 9,000 College of Behavioral and Com Mental Health Law and Policy PI: McGaha,Annette E Spon Florida Dept of Children and Families Baker Act Data Infrastructure Project 209,840 College of Behavioral and Com Mental Health Law and Policy PI: McGaha,Annette E Spon Florida Dept of Children and Families Baker Act Data Infrastructure Project-State 190,160 College of Behavioral and Com Mental Health Law and Policy PI: McGaha,Annette E Spon Hills Co Board of Co Commissioners Hillsborough County Enhanced Jail Diversion Program (EJDP) Evaluation 73,309

College of Behavioral and Co Mental Health Law and Policy PI: McGaha,Annette E Spon Michigan State UniversityA Multi-State Evaluation of Extreme Risk Protection Orders: Implementation, Outcomes, and Jurisdictional Variations 124,597

College of Behavioral and Co Mental Health Law and Policy PI: McGaha,Annette E Spon Pinellas County FloridaAssisted Outpatient Treatment Grant Program for Individuals with SMI (AOT) 51,453

College of Behavioral and Com Mental Health Law and Policy PI: McPherson,Marie Andre Spon Florida Agency for Health Care Admin Medicaid Drug Therapy Management Program for behavioral Health 12,018

College of Behavioral and Co Mental Health Law and PolicyPI: McPherson,Marie Andre , Co-PI(s): Murphy,Tanya K Spon Florida Department of Health Pediatric Telepsychiatry Services Throughout Florida 350,000

College of Behavioral and Com Mental Health Law and Policy PI: Moore,Kathleen A. Spon 13th Judicial Court Hillsborough Co Evaluation of Family Dependency Treatment Court (FDTC) Program 71,250 College of Behavioral and Com Mental Health Law and Policy PI: Moore,Kathleen A. Spon 13th Judicial Court Hillsborough Co Marchman Act Drug Court Enhancement 33,514

College of Behavioral and Co Mental Health Law and Policy PI: Moore,Kathleen A. Spon Drug Abuse Comprehensive Office, Inc.Drug Abuse Comprehensive Coordinating Office, Inc. (DACCO) Family Treatment Services 78,600

College of Behavioral and Co Mental Health Law and Policy

PI: Moore,Kathleen A. , Co-PI(s): Rigg,KharyArmstrong,Mary I;Massey,Oliver T;Stover,Carla Smith Spon National Institute on Drug Abuse

Summer Research Institute at the Florida Mental Health Institute (SRI@FMH) 105,087

College of Behavioral and Co Mental Health Law and PolicyPI: Moore,Kathleen A. , Co-PI(s): Rigg,KharyHills,Holly A Spon Ctrs for Disease Control and Prevention

Effects of remote motivational enhancement and MySafeRX on post-detox engagement and retention in buprenorphine treatment 750,000

College of Behavioral and Co Mental Health Law and Policy PI: Rigg,Khary Spon University of KentuckyResearch Examining Factors Associated with the Opioid Crisis among Underserved African Americans (REFOCUS) 17,940

College of Behavioral and Co Mental Health Law and PolicyPI: Shockley,Abigail L , Co-PI(s): Otto,Randy K Spon Florida Dept of Children and Families

Criminal Justice, Mental Health, & Substance Abuse Technical Assistance Center (CJMHSA TAC) 500,000

College of Behavioral and Com Mental Health Law and Policy PI: Young,Matthew S Spon Department of Veterans Affairs Low Demand Safe Haven Project 123,484

College of Behavioral and Co Mental Health Law and Policy PI: Young,Matthew S Spon Meridian Behavioral Healthcare, Inc.2020-2021 Evaluation of Meridian Behavioral Healthcare's Supportive Services for Veteran Families Program 25,000

85


College of Behavioral and Co Mental Health Law and Policy

PI: Conner,Kyaien Oquinn , Co-PI(s): Beckstead,Jason W;Haight,Daniel O;Callejas,Linda M.;Buck,Harleah Graham;Gum,Amber Michelle;Meng,Hongdao Spon Patient Centered Outcomes Research Insti

Enhancing the Care Transitions Intervention with Peer Supportto Reduce Disparities 775,116

College of Behavioral and Comm Mental Health Law and Policy Total 6,811,094

College of Behavioral and Co Psychiatry and Behavioral Medicine PI: Jones,Genevra Spon Columbia UniversityReducing Duration of Untreated Psychosis Through Early Detection in a Large Jail System 19,224

College of Behavioral and Comm Psychiatry and Behavioral Medicine Total 19,224 College of Behavioral and Com Rehabilitation Counseling PI: Dillahunt-Aspillaga,Christina Jane Spon James A. Haley Veteran's Hospital Enhancing Veteran Community Reintegration Research (ENCORE) 10,000

College of Behavioral and Co Rehabilitation Counseling

PI: Dillahunt-Aspillaga,Christina Jane , Co-PI(s): Smith,Tammy JorgensenChou,Chih-Chin Spon US Department of Education

Rehabilitation Counseling Master's Degree Program - A Solution to Personnel Shortages in the Florida Public Vocational Rehabilitation System 199,877

College of Behavioral and Co Rehabilitation CounselingPI: Stern,Marilyn , Co-PI(s): Gray,Heewon Lee;Williams,Jeffrey Spon National Institutes of Health

NOURISH-T+: A Randomized Control Trial Targeting Parents in Promoting Healthy Eating and Exercise Behaviors in Pediatric Cancer Survivors with Overweight/Obesity 189,384

College of Behavioral and Co Rehabilitation Counseling

PI: Stern,Marilyn , Co-PI(s): Redwine,Laura SRodriguez,Carmen S;Rancourt,Diana Marie Spon National Institutes of Health

ADAPT+: Optimizing an Intervention to Promote Healthy Behaviors in Rural, Latino Youth with Obesity and their Parents, Using Mindfulness Strategies 708,974

College of Behavioral and Comm Rehabilitation Counseling Total 1,108,235 College of Behavioral and Com SAR - Social Work PI: Black,Kathy Spon American Association of Retired Persons AARP Florida Age-Friendly Communities Consultation 36,578 College of Behavioral and Com SAR - Social Work PI: Osborn,Terry Conv University of South Florida Foundation Duvall Endowed Chair in Family Development 16,000

College of Behavioral and Comm SAR - Social Work Total 52,578 College of Behavioral and Com School of Aging Studies PI: Andel,Ross Spon University of Alabama, Birmingham Aging in Puerto Rico: Longitudinal Follow-Up of the PREHCO Study 21,438

College of Behavioral and Co School of Aging Studies PI: Andel,Ross , Co-PI(s): Dobbs,Debra Spon National Institute on AgingStrategic Approach to Facilitating Evacuation by Health Assessment of Vulnerable Elderly in Nursing Homes (SAFE HAVEN II Study) 929,904

College of Behavioral and Com School of Aging Studies PI: Black,Kathy Spon American Association of Retired Persons Equity in Aging Public Health Toolkit Report 85,092 College of Behavioral and Com School of Aging Studies PI: Black,Kathy Spon Florida Department of Elder Affairs ADRD Training Program 80,997

College of Behavioral and Co School of Aging Studies PI: Haley,William E Spon National Institutes of HealthIdentifying Pathways Between Daily Stress and Long-Term Well-Being in Caregivers and Non-Caregivers (V. Marino) 36,231

College of Behavioral and Com School of Aging Studies PI: Hueluer,Gizem Spon Alzheimer's Association Project VITAL 20,000 College of Behavioral and Com School of Aging Studies PI: Lee,Soomi Conv University of South Florida Foundation Arthritis Foundation Training Award 23,474

College of Behavioral and Co School of Aging StudiesPI: Lee,Soomi , Co-PI(s): Allen,Tammy D;Andel,Ross Spon National Institutes of Health

Sleep Health Profiles in Middle-Aged Workers in Relation to Cardiovascular and Cognitive Health 412,264

College of Behavioral and Com School of Aging Studies PI: Peterson,Lindsay Spon The Retirement Research Foundation Disaster Preparedness for Caregivers of Persons with Dem 97,390 College of Behavioral and Com School of Aging Studies PI: Serovich,Julianne Maria Conv University of South Florida Foundation Pinellas Community Foundation Aging Research 12,600

College of Behavioral and Co School of Aging Studies PI: Small,Brent J Spon Cedars-Sinai Medical CenterNovel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics, and Behaviors 30,288

College of Behavioral and Co School of Aging Studies PI: Small,Brent J Spon Georgetown University Medical Center Cognitive Aging, Alzheimers disease and Cancer-related Cognitive Decline 36,590

College of Behavioral and Co School of Aging Studies PI: Small,Brent J Spon H. Lee Moffitt Cancer CenterIdentifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors 18,287

College of Behavioral and Co School of Aging Studies PI: Small,Brent J Spon H. Lee Moffitt Cancer CenterIdentifying and Reducing Disparities in Symptom Burden Among African American Prostate Cancer Survivors 18,424

College of Behavioral and Comm School of Aging Studies Total 1,822,979 College of Behavioral and Com School of Social Work PI: Black,Kathy Spon American Association of Retired Persons Age-Friendly Consultation 57,449

College of Behavioral and Co School of Social WorkPI: Fogel,Sondra J. , Co-PI(s): Menendez,Pamela M Spon Department of Veterans Affairs FY20: VISN 8 Behavioral Health Training 208,420

College of Behavioral and Co School of Social Work PI: Galea,Jerome Timothy Spon University of California, RiversideA Solution to Halt Further Isolation of People Aging with HIV During the COVID-19 Pandemic 15,513

College of Behavioral and Com School of Social Work PI: Galea,Jerome Timothy Spon University of California, Riverside Evaluating the Impact of Incentives on Clinical Trial Participation 21,931 College of Behavioral and Com School of Social Work PI: Groeber,Christopher Todd Spon Children's Home Society of North Carolin Consulting for IFF's Unlearning of Child Welfare Podcast 9,000 College of Behavioral and Com School of Social Work PI: Groeber,Christopher Todd Spon Florida Dept of Children and Families DCF Family Safety Consultation and Supervisory Support 34,880 College of Behavioral and Com School of Social Work PI: Littlewood,Kerry A Spon Florida Institute for Child Welfare Assessing the Effectiveness of the Kinship Navigator Program KinTech 25,000 College of Behavioral and Com School of Social Work PI: Littlewood,Kerry A Spon Florida Institute for Child Welfare Inventory of Kinship Practices 25,000

College of Behavioral and Co School of Social Work PI: Park,Nan Sook Spon Florida Department of HealthBuilding Dementia Care Networks and Community Capacity for Older Asian Immigrants with Limited English Pro¿ciency in Florida 46,667

College of Behavioral and Co School of Social Work PI: Salloum,Alison Ann Spon The Norwegian Centre for Violence and Tr

The Stepped Care Project Examining Treatment Trajectories and Progress Among Child Victims of Violence and Their Caregivers Through Trial of an Early Intervention Model in Municipalities 2,690

College of Behavioral and Co School of Social Work PI: Simmons,Christopher J Spon The Stephen Group, LLCComprehensive Community Collaboration Demonstration Model to Strengthen and Preserve High Risk Families (CCCDM) 35,000

College of Behavioral and Co School of Social WorkPI: Van Zyl,Michiel Adriaan , Co-PI(s): Littlewood,Kerry A Spon Florida Institute for Child Welfare

COVID-19 Workforce Disruptions: Implementation Drivers to Promote Change, a Follow-up Study on Child Welfare WorkforceRetention 13,265

86


College of Behavioral and Comm School of Social Work Total 494,815 College of Behavioral and Com STP - Sociology PI: Biafora JR.,Frank Arthur Spon City of St Petersburg Florida Grow Smarter Through World Café Conversational Leadership Training 25,000

College of Behavioral and Comm STP - Sociology Total 25,000

College of Behavioral and Community Sciences Total 31,444,211 College of Education Center for Migrant Education PI: Cranston-Gingras,Ann Spon US Department of Education College Assistance Migrant Program 424,914 College of Education Center for Migrant Education PI: Cranston-Gingras,Ann Spon US Department of Education High School Equivalency Program 472,454

College of Education Center for Migrant Education Total 897,368

College of Education CREAM

PI: Agosto,Vonzell A , Co-PI(s): Cobb-Roberts,Deirdre L;Karanxha,Zorka;Hartman,Jenifer Jo Spon Hillsborough County Public Schools Advancing Leadership for Intersectional Equity 25,000

College of Education CREAM PI: Berson,Michael J Spon Code VirginiaReaching Across the Hallway: An Interdisciplinary Approach to Teaching Computer Science in Rural Schools 28,862

College of Education CREAM PI: Castillo,Jose M Spon Florida Gulf Coast University Data Literacy Part 1: Goal Setting Workshop 33,653 College of Education CREAM PI: Damjanovic,Victoria J Spon US Department of Education USF Preschool for Creative Learning CCAMPIS 323,200

College of Education CREAM PI: Ferron,John M Spon University of OregonImproving the Accessibility of Design Comparable Effect Size Metrics for Single Case Research 57,149

College of Education CREAM PI: Ferron,John M Spon University of Oregon Training Institute in Advanced Single-case Research Design and Analysis 23,703

College of Education CREAMPI: Hadley,Elizabeth , Co-PI(s): Kim,Eunsook Elizabeth Spon American Educational Research Associatio The Impact of COVID-19 on Young Children's Early Literacy Development 4,000

College of Education CREAM PI: Hernandez-Gantes,Victor M Spon Ohio State UniversityFacilitating Pathways to Success for High-Achieving Pre-Collegiate African American Males in STEM 58,087

College of Education CREAM PI: Jones,Willis Spon Association for Institutional ResearchExamining the determination, consistency, and variation of law school cost of living estimations 50,000

College of Education CREAM PI: Jung,Karl Spon University of Florida Project REBEL: Responsive Education in Biology for English Learners 87,005

College of Education CREAMPI: Karanxha,Zorka , Co-PI(s): Semon,Sarah R Spon US Department of Education The Leadership for Literacy Intervention (LLI) scholarship project 247,273

College of Education CREAM PI: Kilpatrick,Marcus Wayne Spon SprainGo, LLCDouble-Blind Endurance Athletes Performance Study Using RelieveIt, Formulated With Resin From The Caribbean Pine 27,715

College of Education CREAM PI: Kilpatrick,Marcus Wayne Spon SprainGo, LLCThe Impact of a Commercially-Available Product on Performance and Muscle Soreness 13,715

College of Education CREAM PI: Sabo,Jennifer Spon Florida Department of Education Arts4All Florida 2020-2021 334,000

College of Education CREAM PI: Sears,Ruthmae Spon National Science FoundationAttaining Excellence in Secondary Mathematics Clinical Experiences with a Lens on Equity 89,822


PI: Sears,Ruthmae , Co-PI(s): McHale,James P;Akiwumi,Fenda Aminata;Reichgelt,Johannes P;Thompson Dorsey,Dana N Spon City of St Petersburg Florida

Examination of historical and modern-day impact of structural racism on the lives of Black people in the City of St. Petersburg, Florida 50,000

College of Education CREAM PI: Smith,Sara Ashley Spon National Science Foundation RAPID: Multimedia Augmented Reality Vocabulary Instruction 50,000

College of Education CREAM PI: Suldo,Shannon M Spon Childrens Home Society of FloridaSupporting Educators and Students Emotional Well-Being through Schoolwide Positive Psychology Practices 42,459

College of Education CREAM PI: Suldo,Shannon M Spon Tampa VA Research & Education FoundationImproved Understanding of Medical And Psychological Needs (I-MAP) in Veterans and Service Members with Chronic TBI 40,068


PI: Suldo,Shannon M , Co-PI(s): Ferron,John M;Kiefer,Sarah MQuast,Troy Clarence;Anthony,Jason Lon Spon US Department of Education

Efficiency of a Selective Intervention to Improve Middle School Students' Subjective Well-Being 799,620

College of Education CREAM PI: Sun,Haichun Spon The Skilled Center Tampa Youth Engaged in Sports (Tampa YES) 71,981

College of Education CREAM PI: von der Embse,Nathaniel Paul Spon Substance Abuse & Mental HealthImproving Access to Mental Health Services through Teaching and Universal Screening 125,000

College of Education CREAM PI: von der Embse,Nathaniel Paul Spon The School District of Philadelphia Project Prevent Grant Program 48,561

College of Education CREAM PI: von der Embse,Nathaniel Paul Spon University of PennsylvaniaPBIS in Challenging Contexts: Evaluating a Replicable Implementation Approach in Philadelphia 95,617

College of Education CREAM PI: von der Embse,Nathaniel Paul Spon University of Wisconsin - MadisonDevelopment of Assessment Tools and Educator Training to Support Tier 2 Behavioral Intervention Selection 73,375

College of Education CREAM Total 2,799,865 College of Education David Anchin Center PI: Bradley-Klug,Kathy L. Conv University of South Florida Foundation David C. Anchin Center / TECO Chair Endowment 110,000

College of Education David Anchin CenterPI: Feldman,Allan , Co-PI(s): Allsopp,David H;Rosengrant,David R;Jung,Karl Spon University of Massachusetts The Wipro Science Education Fellowship 335,426

College of Education David Anchin Center Total 445,426 College of Education Educational and Psychological Studies PI: Castillo,Jose M Spon Florida Gulf Coast University Data Literacy Part 1: Goal Setting 6,669 College of Education Educational and Psychological Studies PI: von der Embse,Nathaniel Paul Spon Hillsborough County Public Schools Technology and Threat Assessment Solutions for Safer Schools Program 238,598

College of Education Educational and Psychological StudiesPI: von der Embse,Nathaniel Paul , Co-PI(s): Christensen,Kenneth J Spon Spencer Foundation Using Discrete Event Simulation to Improve School Mental Health Services 48,121

College of Education Educational and Psychological Studies Total 293,388

87


College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education21st Century Community Learning Centers -Technical Assistance 1,621,971

College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education Problem Solving Response to Intervention 2020 - 2021 1,283,145 College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education Problem-Solving and Response to Intervention Technology 1,384,635 College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education School Improvement Support Plan 3,381,714 College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education Student Support Services 1,534,974 College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education Title I, Part A - Program Improvement and Technical Assistance 932,700 College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of Education Title I, Part C - Education of Migratory Children 378,046

College of Education Institute for School Reform PI: Castillo,Jose M Spon Florida Department of EducationTitle IX, Part A - Education for Homeless Children and Youth State Activities Project 381,120

College of Education Institute for School Reform Total 10,898,305

College of Education STP - Childhood Language Arts and ReadingPI: Gunn,AnnMarie Alberton , Co-PI(s): Bennett,Susan V Spon Community Foundation of Tampa Bay PLAY: Partners in Literacy Advocacy for Youth 10,084

College of Education STP - Childhood Language Arts and Reading Total 10,084

College of Education STP - Education Measures and Research PI: Moore,LaSonya L Spon Florida Education FoundationTHE McKnight Junior Faculty Development Fellowship: Moore: Education and Social Justice 15,000

College of Education STP - Education Measures and Research PI: Moore,LaSonya L Spon Foundation for a Healthy St. Pete Raising Awareness and Changing Behavior: An Evaluation o 770 College of Education STP - Education Measures and Research Total 15,770

College of Education STP - Special EducationPI: Dukes III,Lyman L , Co-PI(s): Dahm,Louise D Spon University of Central Florida Florida Postsecondary Comprehensive Transition Program 299,971

College of Education STP - Special Education PI: Knab,Jordan T Spon Florida Department of Education State Personnel Development Grant 2017-2022 - FY20-21 687,033

College of Education STP - Special Education PI: Knab,Jordan T Spon Florida Department of EducationYouth Mental Health Awareness and Training (YMHAT) Administration FY20-21 5,170,000

College of Education STP - Special EducationPI: Knab,Jordan T , Co-PI(s): Walker,Brenda L;Rosengrant,David R Spon Florida Department of Education Project 10: Transition Education network 1,324,765

College of Education STP - Special Education Total 7,481,769

College of Education Total 22,841,975

College of Engineering AIX Engineering PI: Sarkar,Sudeep Spon National Science Foundation

Collaborative Research: RI:Medium: Understanding Events from Streaming Video-Joint Deep and Graph Representations, Commonsense Priors, and Predictive Learning 102,618

College of Engineering AIX Engineering

PI: Sun,Yu , Co-PI(s): Goldgof,Dmitry B;Maguire,Denise Joan;Huang,Yangxin;Ho,Thao Spon National Institutes of Health A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates 181,755

College of Engineering AIX Engineering Total 284,373 College of Engineering Center for Urban Transportation Research PI: Allen,Carlton C Spon Florida Department of Transportation Transit Research Inspection Procurement Services 805,024 College of Engineering Center for Urban Transportation Research PI: Barbeau,Sean J. Spon Google Technical Assistance for the Android Maps Utility Library 36,000 College of Engineering Center for Urban Transportation Research PI: Barbeau,Sean J. Spon Roadify Technical Assistance for Roadify¿s Data Management 10,000

College of Engineering Center for Urban Transportation Research PI: Barbeau,Sean J. , Co-PI(s): Menon,Nikhil Spon University of Texas, ArlingtonWhere To Origins and Destinations of TNC and Transit Trips Based on Mobile Devices 60,000

College of Engineering Center for Urban Transportation ResearchPI: Barbeau,Sean J. , Co-PI(s): Winters,Philip L Spon City of Tampa Smart Cities Program Support Y3 25,000

College of Engineering Center for Urban Transportation Research PI: Bond,Julie Marie Spon Florida Department of TransportationSafety Education and Outreach for Bicyclists and Pedestrians in Hillsborough, Pinellas, Pasco, Citrus, and Hernando Counties 550,000

College of Engineering Center for Urban Transportation Research PI: Bond,Julie Marie Spon National Safety Council Shifting Public Narratives to Prevent Bicyclist and Pedestrian Deaths 21,281 College of Engineering Center for Urban Transportation Research PI: Catala,Martin W Spon Flagler County Board Flagler County 2020 TDP Annual Report 8,605 College of Engineering Center for Urban Transportation Research PI: Catala,Martin W Spon Florida Department of Transportation Innovation & Service Development (ISD) Grant Technical Assistance 295,809 College of Engineering Center for Urban Transportation Research PI: Catala,Martin W Spon Tampa Bay Regional Transportation Author TD Tampa Bay Performance Evaluation 25,000

College of Engineering Center for Urban Transportation ResearchPI: Catala,Martin W , Co-PI(s): Mistretta,Mark Spon Flagler County Board Flagler County Transit Development Plan (TDP) 2020 84,445

College of Engineering Center for Urban Transportation ResearchPI: Catala,Martin W , Co-PI(s): Mistretta,Mark Spon Florida Department of Transportation GIS Analysis Supporting Transit Needs Analysis 2020-2021 34,391

College of Engineering Center for Urban Transportation ResearchPI: Catala,Martin W , Co-PI(s): Mistretta,Mark Spon St Lucie County TD Treasure Coast Performance Evaluation 30,884

College of Engineering Center for Urban Transportation ResearchPI: Chen,Cong , Co-PI(s): Kourtellis,Achilleas;Lin,Pei-Sung Spon Florida Department of Transportation Pedestrian and Bicycle Crash Typing and Analysis 170,693

College of Engineering Center for Urban Transportation Research PI: Concas,Sisinnio Spon Tampa Hills Co Expressway AuthAssessing the Economic Impacts and Benefits of the FY 2021-2024 Work Program 38,726

College of Engineering Center for Urban Transportation ResearchPI: Concas,Sisinnio , Co-PI(s): Kourtellis,Achilleas Spon Tampa Hillsborough County Expressway Aut Connected Vehicle Pilot Deployment Program Phase 1, 2 & 3 1,088,000

College of Engineering Center for Urban Transportation Research PI: Godfrey,Jodi Spon Florida Department of Transportation Construction Cost Trends 2020-2021 14,328 College of Engineering Center for Urban Transportation Research PI: Godfrey,Jodi Spon Florida Department of Transportation FDOT Vision Action Plan Literature Review and Survey 77,746

College of Engineering Center for Urban Transportation ResearchPI: Hendricks,Sara J , Co-PI(s): Bond,Julie Marie Spon Hillsborough County New North Transportation Alliance FY 2021 County Funding 12,500

88


College of Engineering Center for Urban Transportation Research PI: Islam,Mouyid B Spon University of Texas, ArlingtonAn Equity-Driven Approach for School Zone Safety to Inform Safe Routes to School (SRTS) Programs 65,000

College of Engineering Center for Urban Transportation Research

PI: Jackman,Jason E , Co-PI(s): Kourtellis,Achilleas;Lin,Pei-Sung;Bond,Julie Marie Spon Florida Department of Transportation

Safety by Design: A Safety Marketing and Education Campaign in District One's Priority Counties 408,651

College of Engineering Center for Urban Transportation Research PI: Jackman,Jason E , Co-PI(s): Lin,Pei-Sung Spon Florida Department of TransportationPeer-to-Peer University Bicyclist and Pedestrian Safety Education and Outreach Pilot Program 56,000

College of Engineering Center for Urban Transportation Research PI: Jang,Si Won , Co-PI(s): Lee,Chanyoung Spon Florida Department of Transportation Statewide Implementation of Mentorship Program For Every Rider (MEPER) 95,700

College of Engineering Center for Urban Transportation Research PI: Joslin,Ann C , Co-PI(s): Mistretta,Mark Spon Florida Department of TransportationFLORIDA TRANSIT PLANNING NETWORK (FTPN) TECHNICAL SUPPORT 2020-2021 138,317

College of Engineering Center for Urban Transportation ResearchPI: Kirkland-McMillian,Willa D , Co-PI(s): Wachtler,Stephen Spon Florida Department of Transportation Compliance Oversight and Technical Assistance 2020-2021 976,777

College of Engineering Center for Urban Transportation ResearchPI: Kolpakov,Alexander , Co-PI(s): Sipiora,Austin Marie Spon National Academy of Sciences Shared Micromobility, Policies and Practices 45,000

College of Engineering Center for Urban Transportation ResearchPI: Kolpakov,Alexander , Co-PI(s): Sipiora,Austin Marie Spon National Renewable Energy Laboratory Clean Cities Coalition Pilot Project 114,450

College of Engineering Center for Urban Transportation ResearchPI: Kolpakov,Alexander , Co-PI(s): Sipiora,Austin Marie;Li,Xiaopeng Spon Florida Department of Agriculture Florida Statewide Alternative Fuel Resiliency Plan 150,000

College of Engineering Center for Urban Transportation Research PI: Kramer,Jeffrey H Spon FL Metro Planning Org Advisory Council MPOAC Transportation Planning and Research Services (PL) 55,000 College of Engineering Center for Urban Transportation Research PI: Kramer,Jeffrey H Spon FL Metro Planning Org Advisory Council MPOAC Weekend Institute for Elected Officials 85,000 College of Engineering Center for Urban Transportation Research PI: Kramer,Jeffrey H Spon Florida Department of Transportation MPOAC Support Services 63,026 College of Engineering Center for Urban Transportation Research PI: Kramer,Jeffrey H Spon Florida MPOAC MPOAC Transportation Planning And Research Services (FTA) 37,500 College of Engineering Center for Urban Transportation Research PI: Lee,Chanyoung Spon Florida Department of Transportation Florida Impaired Driving Coalition 207,381 College of Engineering Center for Urban Transportation Research PI: Lee,Chanyoung Spon Florida Department of Transportation Impaired Motorcyclist PSA Campaign 500,000 College of Engineering Center for Urban Transportation Research PI: Lee,Chanyoung Spon Florida Department of Transportation Motorcycle Program Evaluation and Data Collection 115,500 College of Engineering Center for Urban Transportation Research PI: Lee,Chanyoung Spon Florida Department of Transportation Motorcycle Safety Paid Media Campaign 440,000 College of Engineering Center for Urban Transportation Research PI: Lee,Chanyoung Spon Florida Department of Transportation Share the Road PSA Campaign 250,800 College of Engineering Center for Urban Transportation Research PI: Lee,Chanyoung , Co-PI(s): Jang,Si Won Spon Florida Department of Transportation Florida's Comprehensive Motorcycle Safety Program 506,000

College of Engineering Center for Urban Transportation Research PI: Lewis,Stephanie L , Co-PI(s): Staes,Lisa A Spon Florida Department of TransportationFlorida Rural Transit Assistance Program (RTAP) Center and Training Program (FY 2021-2022) 213,977

College of Engineering Center for Urban Transportation ResearchPI: Li,Xiaopeng , Co-PI(s): Williams,Kristine M Spon Department of Transportation Congestion Reduction Research Consortium Continuation 2,443,750

College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung Spon ENSCO, Inc. Public Safety Awareness Technology Evaluation Project - Literature Review 119,998 College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung Spon Florida Department of Transportation Work Zone Safety Campaign 1,000,000 College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung , Co-PI(s): Chen,Cong Spon Florida Department of Transportation FY 20/21 Florida Local Technical Assistance Program 300,000 College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung , Co-PI(s): Chen,Cong Spon Florida Department of Transportation Safety Training Workshops Planning, Promotion, and Delivery 315,576

College of Engineering Center for Urban Transportation Research

PI: Lin,Pei-Sung , Co-PI(s): Concas,Sisinnio;Wang,Zhenyu;Kourtellis,Achilleas;Li,Xiaopeng Spon Florida Department of Transportation

USF-CUTR I-4 FRAME Project Before Study: Data Collection and Analysis of Safety and Mobility Conditions Prior to Implementation 281,019

College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung , Co-PI(s): Jackman,Jason E Spon Florida Department of Transportation Community Traffic Safety Support 520,000

College of Engineering Center for Urban Transportation ResearchPI: Lin,Pei-Sung , Co-PI(s): Jackman,Jason E;Chen,Cong Spon Florida Department of Transportation Safe Routes to School Training Development and Delivery 150,000

College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung , Co-PI(s): Wang,Zhenyu Spon Florida Department of TransportationDevelopment of Crash Modification Factors for Speed Management of Traffic Signal Progression 150,319

College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung , Co-PI(s): Wang,Zhenyu Spon Florida Department of TransportationUSF-CUTR Technical Support to FDOT District 7 Traffic Operations Before-After Studies 50,000

College of Engineering Center for Urban Transportation Research PI: Lin,Pei-Sung , Co-PI(s): Wang,Zhenyu Spon Johnson, Mirmiran & Thompson, Inc. FDOT District 7 Lighting Level Data Collection and Analysis for 2020 51,600

College of Engineering Center for Urban Transportation ResearchPI: Lin,Pei-Sung , Co-PI(s): Wang,Zhenyu;Islam,Mouyid B Spon Florida Department of Transportation

Nighttime Pedestrian Crossing Behavior Study and Work Zone Safety Study for FDOT District 7 50,000

College of Engineering Center for Urban Transportation ResearchPI: Lin,Pei-Sung , Co-PI(s): Wang,Zhenyu;Islam,Mouyid B Spon Florida Department of Transportation

Technical Support for FDOT District 7 on RTMC Operation Performance Audits and TSM&O Projects 50,000

College of Engineering Center for Urban Transportation ResearchPI: Lin,Pei-Sung , Co-PI(s): Wang,Zhenyu;Islam,Mouyid B Spon Florida Department of Transportation Technical Support for FDOT District 7 on Traffic Safety Studies 50,000

College of Engineering Center for Urban Transportation ResearchPI: Menon,Nikhil , Co-PI(s): Bertini,Robert Lawrence Spon Center for Transportation, Equity, Decis

Measuring Transportation Network Performance During Emergency Evacuations: A Case Study of Hurricane Irma and Camp Fire 121

College of Engineering Center for Urban Transportation ResearchPI: Menon,Nikhil , Co-PI(s): Keita,Yaye Mallon Spon Amer Assoc of State Highway & Transport

COMMUTING IN AMERICA (CIA) 2020 Proposal Brief: Understanding Geographic and Demographic Variation in Mode Choice and Travel Behavior 20,000

College of Engineering Center for Urban Transportation Research PI: Perk,Victoria A Spon Florida Department of Transportation2021 Florida Transit Information and Performance Handbook and NTD Assistance 129,969

College of Engineering Center for Urban Transportation Research PI: Staes,Lisa A Spon Florida Department of TransportationFlorida Substance Abuse Management Oversight and Technical Assistance Program FY 2021/2022 199,666

89


College of Engineering Center for Urban Transportation Research PI: Staes,Lisa A , Co-PI(s): Concas,Sisinnio Spon Federal Transit Administration Safety Research and Demonstration Program Evaluation 107,672 College of Engineering Center for Urban Transportation Research PI: Wachtler,Stephen Spon Florida Department of Transportation Transit Maintenance Analysis and Resource Center 361,857

College of Engineering Center for Urban Transportation ResearchPI: Wachtler,Stephen , Co-PI(s): Berry,Stephen Spon Florida Department of Transportation Compliance Program (14,575)

College of Engineering Center for Urban Transportation Research PI: Wang,Zhenyu , Co-PI(s): Lin,Pei-Sung Spon University of Texas, ArlingtonDevelopment of Automated Roadway Lighting Diagnosis Tools for Nighttime Traffic Safety Improvement Phase II 69,744

College of Engineering Center for Urban Transportation Research PI: Williams,Kristine M Spon North Dakota State University Journal of Public Transportation - NDSU 5,000

College of Engineering Center for Urban Transportation ResearchPI: Williams,Kristine M , Co-PI(s): Boyd,Tia Averi Spon Hillsborough County HILLSBOROUGH COUNTY CORRIDOR PLAN BEST PRACTICES STUDY 53,008

College of Engineering Center for Urban Transportation ResearchPI: Williams,Kristine M , Co-PI(s): Boyd,Tia Averi Spon University of Texas, Arlington

Equitable Transportation Planning Curriculum for Urban Planning and Transportation Programs 55,939

College of Engineering Center for Urban Transportation ResearchPI: Williams,Kristine M , Co-PI(s): Lin,Pei-Sung;Chen,Cong;Islam,Mouyid B Spon Florida Department of Transportation Crashes related to type and location of driveway access 339,914

College of Engineering Center for Urban Transportation Research PI: Winters,Philip L Spon LDA Consulting MWCOG Transportation Demand Management Evaluation Project- FY21 3,300 College of Engineering Center for Urban Transportation Research PI: Winters,Philip L Spon University of Texas, Arlington C-TEDD Technology Transfer (T2) project 10,000 College of Engineering Center for Urban Transportation Research PI: Winters,Philip L Spon University of Texas, Arlington Student Transportation Scholarship - Arredondo 800 College of Engineering Center for Urban Transportation Research PI: Winters,Philip L Spon University of Texas, Arlington Student Transportation Scholarship - Coon 800

College of Engineering Center for Urban Transportation Research Total 14,787,988

College of Engineering Chemical & Biomedical Engineering PI: Bhethanabotla,Venkat R Spon University of Central FloridaSurface acoustic wave sensing as a robust, broadly-applicable method for chemical characterization 10,000

College of Engineering Chemical & Biomedical Engineering PI: Gilbert,Richard A Spon CTR for Occupational RSCH & Development ATE 2.0: Preparing Technicians for Future Work 100,000

College of Engineering Chemical & Biomedical Engineering PI: Gilbert,Richard A Spon Florida Makes, Inc. Florida Future of Work Issues Caucus for Manufacturers and State Colleges 5,134

College of Engineering Chemical & Biomedical Engineering PI: Gonzalez,Ramon Spon Northwestern UniversityEngineered Reversal of the -Oxidation Cycle in Clostridia for the Synthesis of fuels and chemicals 139,945

College of Engineering Chemical & Biomedical Engineering PI: Goswami,Dharendra Yogi Spon Advanced Tech & Testing Labs, Inc. Development of CO2 Removal Technology from Indoor Air 60,000

College of Engineering Chemical & Biomedical Engineering PI: Goswami,Dharendra Yogi Spon Molekule, Inc.Analysis and Performance of Molekule Technologies: Plasmonic PECO Technology for COVID-19 & Other Applications 160,000

College of Engineering Chemical & Biomedical Engineering PI: Goswami,Dharendra Yogi Spon Molekule, Inc. Analysis and Performance Testing of Molekule Technologies 292,500 College of Engineering Chemical & Biomedical Engineering PI: Goswami,Dharendra Yogi Spon Molekule, Inc. Analysis of the Performance Testing of Molekule Technologies 80,000

College of Engineering Chemical & Biomedical EngineeringPI: Jaroszeski,Mark J , Co-PI(s): Hoff,Andrew M;Fawcett,Timothy J Spon Natl Insti of Biomedical Imaging

Regulated Heat Combined with Impedance Spectroscopy to Improve and Control Electroporative DNA Delivery to the Skin in Vivo 432,358

College of Engineering Chemical & Biomedical Engineering PI: Koria,Piyush Spon Stemedix Inc. Evaulation of Treatment Efficacy of Stem Cells and Exosomes Therapies 30,230

College of Engineering Chemical & Biomedical Engineering PI: Koria,Piyush Spon Stemedix Inc. Optimization of Current Mesechymal Stem Cell and Exosome Treatments 72,250 College of Engineering Chemical & Biomedical Engineering PI: Kuhn,John Norbert Spon T2C- Energy, LLC TRIFTS Catalytic Conversion of Biogas to Drop-In Renewable diesel Fuel 150,000 College of Engineering Chemical & Biomedical Engineering PI: Kuhn,John Norbert Spon Trash2Cash Energy, LLC TRIFTS Catalytic Conversion of Biogas to Drop-In Renewable diesel Fuel 300,000

College of Engineering Chemical & Biomedical Engineering PI: Passaglia,Christopher Spon National Eye InstituteContinuous Measurement and Control of Intraocular Pressure in Normal and Glaucomatous Eyes 358,389

College of Engineering Chemical & Biomedical Engineering PI: Simmons,David Samuel Spon American Chemical SocietyPrediction and Understanding of Polymer Rheological Response in the Time- Temperature-Superposition-Breakdown Regime 54,297

College of Engineering Chemical & Biomedical Engineering PI: Simmons,David Samuel Spon National Science FoundationCAREER: Glass formation in strongly interacting polymers - predictive understanding from high-throughput simulation and theory 95,000

College of Engineering Chemical & Biomedical Engineering PI: Stern,Lawrence Spon University of Central Florida NASA FSGC MASTERS FELLOWSHIP PROGRAM-Johnny Stephens 10,000

College of Engineering Chemical & Biomedical EngineeringPI: Sunol,Aydin K , Co-PI(s): Tejada,Andres Eligio Spon Hillsborough County

Multi-Scale Modeling and Optimization of Vandyke, South County, Falkenburg and Valrico Wastewater Treatment Plant Models 70,000

College of Engineering Chemical & Biomedical Engineering Total 2,420,103 College of Engineering Civil and Environmental Engineering PI: Alexander,Christopher Lewis Spon Freedom Metal Finishing, Inc. Corrosion Performance of a Novel Anodized Aluminum 150,000

College of Engineering Civil and Environmental Engineering PI: Alexander,Christopher Lewis Spon Solidia Technologies, Inc.Phase 2 Reinforcement Corrosion Control for Specialty Concrete Formulations 150,000

College of Engineering Civil and Environmental Engineering PI: Arias,Mauricio Spon City of Tampa City of Tampa Stormwater Baffle Box Efficiency Study Phase II 49,450 College of Engineering Civil and Environmental Engineering PI: Arias,Mauricio Spon Florida Education Fund, Inc. McKnight Junior Faculty Development Fellowship 15,000

College of Engineering Civil and Environmental Engineering PI: Arias,Mauricio Spon Manchester Waterway Civic Association, IEvaluation of hydrodynamic effects of Manchester Waterway Restoration Project 23,681

College of Engineering Civil and Environmental EngineeringPI: Arias,Mauricio , Co-PI(s): Zhang,Qiong;Diaz Elsayed,Nancy Spon Bureau of Reclamation

Effective Energy Recovery in Desalination and water Reclamation Utilities through Pressure-Retarded Osmosis 51,658

College of Engineering Civil and Environmental Engineering PI: Bishop,Robert Harold Conv University of South Florida Foundation Flom Endowed Chair 91,879

College of Engineering Civil and Environmental EngineeringPI: Cunningham,Jeffrey A , Co-PI(s): Sunol,Aydin K Spon Hillsborough County

Process Optimization at Hillsborough County's Advanced Water Reclamtion Facilities. Part 3: Tuning and Training 58,467

College of Engineering Civil and Environmental Engineering

PI: Ergas,Sarina , Co-PI(s): Feldman,Allan;Ghebremichael,Kebreab Afewerki Spon National Science Foundation

IRES Track I: US-Ghana Collaboration: Providing Opportunities for Global Research on Water Sanitation and Hygiene (WASH) 88,225

College of Engineering Civil and Environmental EngineeringPI: Ergas,Sarina , Co-PI(s): Kuhn,John Norbert Spon National Science Foundation

NSF-BSF: Mainstream Deammonification by Ion Exchange and Bioregeneration via Partial Nitritation/Anammox 72,072

90


College of Engineering Civil and Environmental EngineeringPI: Ergas,Sarina , Co-PI(s): Scott,Kathleen M;Zhang,Qiong Spon National Science Foundation

A Novel Algal-Bacterial Shortcut Nitrogen Removal Process for Wastewater Treatment 23,688

College of Engineering Civil and Environmental Engineering PI: Li,Xiaopeng Spon Leidos, Inc CARMA Proof-of-Concept TSMO Use Case Testing 49,941

College of Engineering Civil and Environmental Engineering PI: Li,Xiaopeng Spon National Science FoundationCPS: Small: Cyber-Physical Phases of Mixed Traffic With Modular & Autonomous Vehicles: Dynamics, Impacts and Management 169,155

College of Engineering Civil and Environmental Engineering PI: Li,Xiaopeng Spon National Science FoundationEAGAR: Collaborative Research: Enable Elastic Capacity for Transportation Infrastructure through a Transmodal Modular Autonomous Vehicle System 90,736

College of Engineering Civil and Environmental EngineeringPI: Li,Xiaopeng , Co-PI(s): Stuart,Amy L;Zhang,Yu Spon WSP USA Inc. Automated Vehicle Access, Mobility and Affordability for System Users 160,955

College of Engineering Civil and Environmental EngineeringPI: Mannering,Fred Laires , Co-PI(s): Maness,Michael Spon Arizona State University

Teaching Old Models New Tricks (TOMNET): Improving the Realism and Predictive Ability of In-Practice Travel Demand Forecasting Models through the Incorporation of Attitudinal Variables 220,000

College of Engineering Civil and Environmental EngineeringPI: Mihelcic,James , Co-PI(s): Zhang,Yu;Zhang,Qiong;Ergas,Sarina Spon US Department of Education

Doctoral Fellowships in Civil Engineering for Redesigning Resilient Transportation and Water Critical Infrastructures 402,960

College of Engineering Civil and Environmental Engineering PI: Mullins,Austin G Spon Florida Department of TransportationPeak Temperature Determination of Drilled Shafts Excluded from Mass Concrete Consideration in Current Specifications 168,697

College of Engineering Civil and Environmental EngineeringPI: Nachabe,Mahmoud H , Co-PI(s): Ergas,Sarina Spon Florida Department of Health

Carry out an analysis of the spatial and temporal data from a subsection of the Philippi Creek catchment to evaluate OSTDSenvironmental impact and whether statistically significant differences can be identified after thesewer conversion. 14,999

College of Engineering Civil and Environmental Engineering PI: Tejada,Andres Eligio Spon National Science FoundationCollaborative Research: Characterization of Langmuir Supercells in the Coastal Ocean 257,525

College of Engineering Civil and Environmental Engineering PI: Tejada,Andres Eligio Spon National Science FoundationCollaborative Research: LES and RANS Simulations of Estuarine Flows: Understanding and Parameterizing the Role of Langmuir Turbulence 143,713

College of Engineering Civil and Environmental Engineering PI: Tejada,Andres Eligio Spon Office of Naval ResearchLangmuir Supercells Under the Influence of Tidal Forcing, Surface Buoyancy, and Misaligned Net Current, Winds, and Waves 53,854

College of Engineering Civil and Environmental Engineering PI: Trotz,Maya Ayanna Spon National Science FoundationCollaborative Research: Converging COVID-19, environment, health, and equity 19,750

College of Engineering Civil and Environmental Engineering PI: Trotz,Maya Ayanna Spon National Science FoundationCollaborative Research: Predictive Intelligence for PandemicPrevention, Theme 4: Social, Behavioral, and Policy Obstacles and Supports 28,147

College of Engineering Civil and Environmental EngineeringPI: Trotz,Maya Ayanna , Co-PI(s): Mihelcic,James Spon Caribbean Community Climate Change Cente

Knowledge Management Research Services for the Water Sector Resilience Nexus for Sustainability in Barbados Project 40,000


PI: Trotz,Maya Ayanna , Co-PI(s): Zarger,Rebecca K;Mihelcic,James;Zhang,Qiong Spon National Science Foundation

Collaborative Research: NRT-INFEWS: Systems Training for Research ON Geography-based Coastal Food Energy Water Systems (STRONG-CFEWS) 507,802

College of Engineering Civil and Environmental Engineering PI: Yeh,Daniel Hungting Spon Eram Scientific SolutionsRTTC India Phase II: Eram - USF collaboration and technology transfer for combined eToilet-NEWgenerator sanitation platform. 397,566

College of Engineering Civil and Environmental Engineering PI: Yeh,Daniel Hungting Spon National Aeronautics & Space Admin

Development of Zero- G Anaerobic Membrane Bioreactors (ZG-AnMBR) for Closed-loop Bioregenerative Water Purification and organic Waste Recycling 184,400

College of Engineering Civil and Environmental Engineering PI: Yeh,Daniel Hungting Spon WEC projects Ltd

WEC-USF Collaboration for SASTEP: Project Proposal to Demonstrate the NEWgenerator off the Grid Treatment System for Multi Use Toilets in a South Africa Informal Settlement 95,419


PI: Zhang,Qiong , Co-PI(s): Rains,Mark C;Mihelcic,James;Ergas,Sarina;Arias,Mauricio;Charkhgard,Hadi Spon Environmental Protection Agency Optimization of Nutrient Management Tech for HABs 322,477

College of Engineering Civil and Environmental Engineering PI: Zhang,Yu Spon AmazonDesign of an Automated Advanced Air Mobility Flight Planning System (AAFPS) 46,966

College of Engineering Civil and Environmental Engineering PI: Zhang,Yu Spon Cornell University UTC Tier 1- Center for Transportation, Environment, and Community Health 352,980

College of Engineering Civil and Environmental Engineering PI: Zhang,Yu Spon University of MarylandLeveraging Deep Learning in Understanding the Impact of Convective Weather on Airfield Efficiency Phase II 121,375

College of Engineering Civil and Environmental Engineering PI: Zhang,Yu , Co-PI(s): Jackman,Jason E Spon City of St Petersburg FloridaPerformance Evaluation of Motorized Scooter Sharing Program in the City of St. Petersburg 70,995

College of Engineering Civil and Environmental Engineering PI: Zhang,Yu , Co-PI(s): Jackman,Jason E Spon City of Tampa Performance Evaluation of e-Scooter Sharing Program in the City of Tampa 39,765 College of Engineering Civil and Environmental Engineering Total 4,734,296

College of Engineering Clean Energy Research Center PI: Goswami,Dharendra Yogi Spon International Solar Energy Society Editorship of the Journal entitled "Solar Energy" 56,140 College of Engineering Clean Energy Research Center Total 56,140

College of Engineering Computer Science and Engineering PI: Andujar,Marvin Spon National Science Foundation EAGER: An Immersive Brain Painting for College Students with ADHD 80,205 College of Engineering Computer Science and Engineering PI: Bishop,Robert Harold Conv University of South Florida Foundation Computer Science Endowed Chair 150,000

91


College of Engineering Computer Science and Engineering PI: Chellappan,Sriram Spon Doolittle InstituteAI-enabled Smart Technologies for Superior Surveillance of Mosquito Vectors to Protect Health of Soldiers and Families 300,000

College of Engineering Computer Science and EngineeringPI: Chellappan,Sriram , Co-PI(s): Fisk,Nathan W Spon National Science Foundation

SaTC: CORE: Small: A Privacy Preserving Meta-Data Analysis Framework For Cyber Abuse Research Foundations, Tools and Algorithms 8,000

College of Engineering Computer Science and Engineering PI: Christensen,Kenneth J Spon National Science Foundation Collaborative Research: Florida IT Pathways to Success (Flit-Path) 251,534

College of Engineering Computer Science and Engineering PI: Ciampaglia,Giovanni Luca Spon National Science FoundationEAGER: SaTC: Early-Stage Interdisciplinary Collaboration: Collaborative: Advances in Socio-Algorithmic Information Diversity 75,091

College of Engineering Computer Science and Engineering PI: Gaspar,Alessio A Spon National Science FoundationCollaborative Research: Using Coevolutionary Algorithms to Identify Distractor Answers for Multiple Choice Questions Used for Peer Instruction 113,939

College of Engineering Computer Science and EngineeringPI: Goldgof,Dmitry B , Co-PI(s): Hall,Lawrence O Spon Stereology Resource Center, Inc.

Microscope-Based Technology for Automatic Cell counts Analysis Unbiased Methods 169,462

College of Engineering Computer Science and EngineeringPI: Goldgof,Dmitry B , Co-PI(s): Sarkar,Sudeep;Sun,Yu Spon Tampa VA Research & Education Foundation

An Automated Pressure Ulcer Monitoring System to Improve Pressure Ulcer Outcomes for Veterans with SCI 8,735

College of Engineering Computer Science and EngineeringPI: Iamnitchi,Adriana Ioana , Co-PI(s): Hall,Lawrence O;Skvoretz JR.,John V Spon Air Force Office of Scientific Research Modeling Information Diffusion Processes with Deep Learning Algorithms 306,741

College of Engineering Computer Science and Engineering PI: Karam,Robert Anthony Spon The Cleveland Clinic FoundationConscious Ambulatory Bladder Monitoring to Understand Neural Control of Lower Urinary Tract Function (20,168)

College of Engineering Computer Science and Engineering

PI: Karam,Robert Anthony , Co-PI(s): Katkoori,Srinivas;Mozaffari Kermani,Mehran Spon National Science Foundation

SaTC: EDU: Improving Student Learning Through Gamified Embedded System Security Challenges 147,858

College of Engineering Computer Science and Engineering PI: Katkoori,Srinivas Spon PolyMaterials App, LLC Feasibility Study of a Portable Hazardous Chemical Detection System 10,000

College of Engineering Computer Science and Engineering PI: Liu,Yao , Co-PI(s): Lu,Zhuo Spon National Science FoundationSaTC: TTP: Small: Creating Content Verification Tools to ProtectDocument Integrity 161,542

College of Engineering Computer Science and Engineering PI: Mozaffari Kermani,Mehran Spon National Science Foundation

SaTC: CORE: Medium: Collaborative: Countermeasures Against Side-Channels Attacks Targeting Hardware and Embedded System Implementations of Post-Quantum Cryptographic Algorithms 76,230

College of Engineering Computer Science and EngineeringPI: Neal,Tempestt Ja'Nice , Co-PI(s): Canavan,Shaun Joseph Spon National Science Foundation

Collaborative Research: SaTC: CORE: Medium: Toward Age-Aware Continuous Authentication on Personal Computing Devices 131,954

College of Engineering Computer Science and EngineeringPI: Ou,Xinming , Co-PI(s): Ligatti,Jarred A;Lende,Daniel H Spon National Science Foundation

SaTC: CORE: Medium: Collaborative: Understanding Security in the Software Development Lifecycle: A Holistic, Mixed-Methods Approach 171,547

College of Engineering Computer Science and Engineering PI: Rosen,Paul Andrew Spon National Science FoundationCAREER: Discovering Structure in Uncertainty: Interactive Visualization of Scalar Uncertainty Data Using Reeb Graph Ensembles 99,462

College of Engineering Computer Science and Engineering PI: Sarkar,Sudeep Conv University of South Florida Foundation Mining Systems Flow Spec Soc 4,829 College of Engineering Computer Science and Engineering PI: Sarkar,Sudeep Spon Northeastern University Center for Inclusive Computing 188,945


PI: Sarkar,Sudeep , Co-PI(s): Fountain,Michael W;Sanberg,Paul R;Conrad,David Spon National Science Foundation I-Corps Site at Unversity of South Florida: Catalyzing Research Translation 59,938


PI: Sarkar,Sudeep , Co-PI(s): Sanberg,Paul R;McDevitt,Valerie L.;Zayas-Castro,Jose L;Mullarkey,Matthew Timothy;Berman,Richard Angel;Conrad,DavidWhichard,Glenn Charles Spon National Science Foundation Type II: I-Corps Site at University of South Florida-Tampa 80,000

College of Engineering Computer Science and Engineering PI: Sun,Yu Conv University of South Florida Foundation Robbot Perception and Action Lab 4,992

College of Engineering Computer Science and Engineering PI: Sun,Yu Spon National Science FoundationCHS: Small: Collaborative Research: Wearable Fingertip Haptic Devices for Virtual and Augmented Reality: Design, Control, and Predictive Tracking 57,896

College of Engineering Computer Science and Engineering PI: Sun,Yu Spon National Science FoundationRI: Small: Generalizing Learned Manipulation Skills to Unseen Situations By Balancing Uncertainties 101,730

College of Engineering Computer Science and Engineering PI: Wang,Jing Spon University of Central Florida - FSEC Navi Augmented Reality Lunar Exploration Heads-Up Display System 2,000

College of Engineering Computer Science and Engineering PI: Weitzenfeld,Alfredo Spon National Science Foundation

RI: Medium: Collaborative Research: Experimental and Robotics Investigations of Multi-Scale Spatial Memory consolidation of Complex Environments 250,223

College of Engineering Computer Science and Engineering PI: Yavuz,Attila Altay Conv University of South Florida Foundation Lightweight & Quantum-Safe Authentication Digital Signat 41,021 College of Engineering Computer Science and Engineering PI: Yavuz,Attila Altay Spon Cisco Systems Inc Trustworthy and Privacy-Preserving Machine Learning Platforms 99,998 College of Engineering Computer Science and Engineering PI: Yavuz,Attila Altay Spon National Science Foundation CAREER: Lightweight and Fast Authentication for Internet of Things 211,715 College of Engineering Computer Science and Engineering PI: Yavuz,Attila Altay Spon University of Illinois, Chicago Cyber Resilient Energy Delivery Consortium (CREDC) 40,425

College of Engineering Computer Science and Engineering PI: Zheng,Hao Spon National Science Foundation

FET: Medium: Collaborative Research: An Efficient Framework for the Stochastic Verification of Computation and Communication Systems Using Emerging Technologies 16,000

College of Engineering Computer Science and Engineering Total 3,401,845

College of Engineering Electrical Engineering PI: Arslan,Huseyin Spon Texas A&M UniversityTowards Intelligent Next Generation Wireless Systems: Multi-Dimensional Intelligent Sensing and Signal Identification 37,169

College of Engineering Electrical Engineering PI: Bhanja,Sanjukta Spon The Koerner Family Foundation The Koerner Family Foundation COVID Stipend 20,000

92


College of Engineering Electrical EngineeringPI: Bhanja,Sanjukta , Co-PI(s): Tyson JR.,William T;Goodwin,Mary Spon National Science Foundation

Curricular, Co-curricular, Social, and Financial Supports for Successful Transfer and Graduation of Engineering Undergraduates from Rural/Nontraditional Backgrounds 479,187

College of Engineering Electrical Engineering PI: Bishop,Robert Harold Conv University of South Florida Foundation CFTB Sensing Airborne 1,002 College of Engineering Electrical Engineering PI: Bishop,Robert Harold Spon Doolittle Institute CubeSat Development, Launch and Mission Operations – Phase2B 300,000 College of Engineering Electrical Engineering PI: Fan,Lingling , Co-PI(s): Miao,Zhixin Spon National Science Foundation Dynamic Model Identification for Inverter-Based Resources 84,692

College of Engineering Electrical Engineering PI: Fan,Lingling , Co-PI(s): Miao,Zhixin Spon US Department of EnergyModeling and Control of Solar PVs for Large Grid Disturbances and Weak Grids 299,470

College of Engineering Electrical Engineering

PI: Ferekides,Christos S , Co-PI(s): Spector,Paul E;Mumcu,Gokhan;Uysal,Ismail Spon National Science Foundation

IUSE/PFE:RED: Breaking Boundaries: An Organized Revolution for the Professional Formation of Electrical Engineers 395,723

College of Engineering Electrical Engineering PI: Ghani,Nasir Spon University of South Carolina NSF Cyber Training for Cyberinfrastructure Center of Expertise (C2E) 25,798

College of Engineering Electrical EngineeringPI: Jain,Vijay K , Co-PI(s): Tufts JR.,Robert W;Wang,Jing Spon National Science Foundation

Integrated Power Grid and Microgrids with Massively Distributed Intelligent Sensors 100,264

College of Engineering Electrical Engineering PI: Lu,Zhuo Spon Intelligent Automation, Inc.QADE: Quantification, Analysis, Defense and Evaluation System for Resilient and Secure Wireless Communication Operations 172,053

College of Engineering Electrical EngineeringPI: Lu,Zhuo , Co-PI(s): Fisk,Nathan W;Naeini,Mia Spon National Science Foundation

Collaborative Research: CyberTraining: Pilot: Interdisciplinary Training of Data-CentricSecurity and Resilience of Cyber-Physical Energy Infrastructures 69,350

College of Engineering Electrical Engineering PI: Lu,Zhuo , Co-PI(s): Yilmaz,Yasin Spon National Science Foundation

Collaborative Research: SWIFT: SMALL: Understanding and Combating Adversarial Spectrum Learning towards Spectrum-Efficient Wireless Networking 87,170

College of Engineering Electrical Engineering PI: Miao,Zhixin , Co-PI(s): Fan,Lingling Spon National Renewable Energy Laboratory Analytical Tools for Participation Factor Analysis for Wind Power Plants 50,000 College of Engineering Electrical Engineering PI: Moreno,Wilfrido A Conv University of South Florida Foundation Experiential Learning Global initiative Fund 4,739

College of Engineering Electrical Engineering PI: Moreno,Wilfrido A Spon Universidad Catolica Boliviana San PabloDesign & Implementation of a Traceability System for the Production, Transformation, & Commercialization of plant-&-animal-based Produce 12,372

College of Engineering Electrical Engineering PI: Mumcu,Gokhan Spon National Science Foundation Microfluidic MM-Wave RF Devices with Integrated Actuation 74,960

College of Engineering Electrical EngineeringPI: Mumcu,Gokhan , Co-PI(s): Arslan,Huseyin;Wang,Jing Spon National Science Foundation

GOALI: SpecEES: Collaborative Research: Lens Antenna Subarrays and 3D Hardware Integration for Energy Efficient and High-Data Rate Mm-Wave Wireless Networks 171,076

College of Engineering Electrical EngineeringPI: Parthasarathy,Ashwin B , Co-PI(s): Eddins,Ann Clock Spon Natl Insti of Gen Medical Science

Noninvasive optical monitoring of tissue with frequency domain diffuse correlation spectroscopy 368,787

College of Engineering Electrical Engineering PI: Saddow,Stephen E Spon Global ETS, LLCElectronics Authentication System Development using AI and Machine Learning 150,000

College of Engineering Electrical Engineering PI: Takshi,Arash Spon PolyMaterials App, LLC Development of a Supercapacitor-battery for Aviation Applications 118,902

College of Engineering Electrical Engineering PI: Takshi,Arash Spon University of Central Florida - FSEC

Dissertation Improvement Fellowship - Sabrina Rosa-Ortiz Copper Electrode Position Assisted by Hydrogen Evolution for Wearable Electronics: Interconnection and Fiber Metallization 5,000

College of Engineering Electrical EngineeringPI: Takshi,Arash , Co-PI(s): Katkoori,Srinivas;Pandit,Sagar Avinash Spon PolyMaterials App, LLC

Cellulose Based Flexible Solid State High Power and High Energy Supercapacitor 136,975

College of Engineering Electrical EngineeringPI: Takshi,Arash , Co-PI(s): Pandit,Sagar Avinash Spon PolyMaterials App, LLC Advanced Supercapbattery for Air Force Applications 59,451

College of Engineering Electrical EngineeringPI: Takshi,Arash , Co-PI(s): Thomas,Sylvia L.Wilson Spon National Science Foundation

An Electrospinning -Electroplating process to Embed Electronics into fabrics for E-textiles and wearables 150,369

College of Engineering Electrical Engineering PI: Thomas,Sylvia L.Wilson Spon National Science Foundation I-CORPS AmpSense 50,000

College of Engineering Electrical Engineering PI: Thomas,Sylvia L.Wilson Spon University of Central FloridaEco-Cycler Arthropod Habitat or Sustaining Human Life and Productivity in Space 4,000

College of Engineering Electrical EngineeringPI: Thomas,Sylvia L.Wilson , Co-PI(s): Saddow,Stephen E Spon National Science Foundation

IRES Track 1: US-Italy bio and Electronic Advanced Material Systems (IRES-BEAMS) 102,245

College of Engineering Electrical EngineeringPI: Thomas,Sylvia L.Wilson , Co-PI(s): Walker,Brenda L Spon Florida A&M University

AGEP Transformation Alliance: Collaborative Research: Improving Pathways in the Professionate for Minority Women in STEM 174,910

College of Engineering Electrical Engineering PI: Wang,Jing Spon Doolittle Institute ComTac VI NIB Headsets 65,422

College of Engineering Electrical Engineering PI: Wang,Jing Spon Harris CorporationPackaging of Microwave/mm-Wave Power Amplifier by Additive Manufacturing 192,500

College of Engineering Electrical Engineering PI: Wang,Jing Spon L3HARRIS TECHNOLOGIES, INCPackaging of Microwave/mm-Wave Power Amplifier by Additive Manufacturing 95,000

College of Engineering Electrical Engineering PI: Wang,Jing Spon Modelithics, Inc. A New Framework for Multi-physics GaN Device Modeling 152,500

College of Engineering Electrical Engineering PI: Wang,Jing Spon Modelithics, Inc.Research and Training Internship for Support of U.S. Air Force related project "A New Framework for Multi-physics GaN Device Modeling 25,000

College of Engineering Electrical Engineering PI: Wang,Jing , Co-PI(s): Mumcu,Gokhan Spon Department of the Army

Laser-Enhanced Direct Print Additive Manufacturing (LE-DPAM) Enabled 3D Hybrid IC Electronics Packaging for High Performance and Low-Cost Active Phased Antenna Arrays 85,166

College of Engineering Electrical Engineering PI: Yilmaz,Yasin Spon Department of TransportationAutonomous Track Inspection System Based on Passive Sensing and Anomaly Detection 24,356

93


College of Engineering Electrical Engineering PI: Yilmaz,Yasin , Co-PI(s): Uysal,Ismail Spon National Institute of Standards and TechScalable Multimodal Data Representation from Video, Text, Audio for Real-Time Event Detection 30,000

College of Engineering Electrical Engineering Total 4,375,608

College of Engineering Industrial & Management Sys Engineering PI: Charkhgard,Hadi Spon National Science FoundationCRII: AF: Theory and Algorithms for Maximum Multiplicative Programs Through the Lens of Multi-objective Optimization 88,634

College of Engineering Industrial & Management Sys Engineering PI: Das,Tapas K Spon University of Massachusetts

Evaluating Portfolio Interventions for HIV Incidence Reduction in the United States: Development of a Novel Agent-Based Decision-Analytic Model For Dynamic Evaluations of Interventions 56,461

College of Engineering Industrial & Management Sys Engineering PI: Kwon,Changhyun Spon Cobblestone Milk Cooperative, Inc. Cobblestone OR1 6,502

College of Engineering Industrial & Management Sys Engineering PI: Li,Mingyang , Co-PI(s): Meng,Hongdao Spon National Science FoundationGOAL/Collaborative Research: Consistent Nursing Home Staff Planning Under Heterogeneous Service Demand 104,093

College of Engineering Industrial & Management Sys EngineeringPI: Reeves JR.,Kingsley Anthony , Co-PI(s): Hughes Miller,Michelle Spon National Science Foundation

Collaborative Research: Standard: Enhancing Internships with Professional Ethics Training: Cultivating an Ethical Engineer Identiy 72,373

College of Engineering Industrial & Management Sys Engineering PI: Shah,Ankit Spon AvaWatz An AI-based Hazard Detection Approach Towards Securing Airfield Runways 125,000

College of Engineering Industrial & Management Sys Engineering PI: Shah,Ankit Spon Jabil Circuit, Inc.An AI approach for Cosmetic Defect Detection to Improve Product Quality Control 253,500

College of Engineering Industrial & Management Sys EngineeringPI: Shah,Ankit , Co-PI(s): Zayas-Castro,Jose L Spon Jabil Circuit, Inc.

An AI approach for Cosmetic Defect Detection to Improve Product Quality Control 100,000

College of Engineering Industrial & Management Sys Engineering PI: Vandeweerd,Carla L Spon Xtend Villages, LLC.Innovation in Late Life: Understanding older adults preferences, decision making, and baseline in adopting novel wellness technologies 20,000

College of Engineering Industrial & Management Sys Engineering PI: Vandeweerd,Carla L , Co-PI(s): Yalcin,Ali Spon The Villages Health System, LLC.

Using Sensor Data to Increase Understanding of Aging Brains- Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain: Brain Network Activation Analysis for the Adult and Elderly Population Using Evoked Potentials 52,500

College of Engineering Industrial & Management Sys Engineering PI: Zayas-Castro,Jose L Spon Florida A&M University 2020-2025 FGLSAMP Drive 21,000

College of Engineering Industrial & Management Sys Engineering PI: Zayas-Castro,Jose L Spon Ntnl Action Cncl for Minorities in EnginSloan University Center of Exemplary Mentoring (UCEM) Phase III Pathway to Institutionalization 150,000

College of Engineering Industrial & Management Sys EngineeringPI: Zayas-Castro,Jose L , Co-PI(s): Smith,Dwayne,Dwayne Spon National Science Foundation

LSAMP BD: University of South Florida Florida-Georgia Louis Stokes Alliance for Minority Participation (FGLSAMP) 538,017

College of Engineering Industrial & Management Sys Engineering Total 1,588,080 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon Department of the Air Force SAF/CDMA USF Academic Applied Research 64,036 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command DEVOPS Interns 20,023 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Establish redundant salary only: Task Order 013 127,993 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 006 - 93,161 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 009 P 58,974 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 011 A 990,092 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 014 - 23,062 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 015: 66,119 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 016 U 72,692 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project - IDIQ Task Order 10 28,272 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Redundant Salary for IAE Project 10002.005 - Task Order 51,369 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Salary IAE Project - IDIQ Task Order No. 008 JATF Lead 172,905 College of Engineering Institute of Applied Engineering PI: Baxter,Timothy Richard Spon US Special Operations Command Salary only: Task Order 012 PM MSS Lead 255,016 College of Engineering Institute of Applied Engineering PI: Bishop,Robert Harold Spon US Special Operations Command Establish redundant Salary only: IDIQ Task Order No. H92 96,588 College of Engineering Institute of Applied Engineering PI: Chang,Ji-En Morris Spon US Special Operations Command Data-Driven Intelligence for Active Identification and C 569,339 College of Engineering Institute of Applied Engineering PI: Chellappan,Sriram Spon Defensewerx Task Order 5 Defensewerx Internship Program 202,576 College of Engineering Institute of Applied Engineering PI: Chellappan,Sriram Spon Defensewerx Task Order 6 Defensewerx JobWERX Program 14,816 College of Engineering Institute of Applied Engineering PI: Wang,Jing , Co-PI(s): Mumcu,Gokhan Spon Defensewerx ComTac VI NIB Headsets 548

College of Engineering Institute of Applied Engineering Total 2,907,580 College of Engineering Mechanical Engineering PI: Carey,Stephanie L Spon MacLean Engineering & Applied Technologi Robotics Simulation and Graphics Support (RSGS) FY 20 8,821 College of Engineering Mechanical Engineering PI: Carey,Stephanie L Spon University of Central Florida USF KSC Senior Design Projects 4,000 College of Engineering Mechanical Engineering PI: Carey,Stephanie L Spon University of Central Florida USF MINI-RASSOR EXCAVATOR 500

College of Engineering Mechanical Engineering

PI: Dubey,Rajiv V , Co-PI(s): Sarkar,Sudeep;Alqasemi,Redwan M;Reed,Kyle Brandon Spon National Science Foundation

Achieving Autonomy by Learning from Sensor-Assisted Control in a Wheelchair-Based Human-Robot Collaborative System 186,135

College of Engineering Mechanical Engineering

PI: Dubey,Rajiv V , Co-PI(s): Sundarrao,Stephen;Alqasemi,Redwan M;Carey,Stephanie L Spon Florida Department of Education Rehabilitation and Engineering Technology Program 1,629,130

College of Engineering Mechanical Engineering PI: Gaines,Jonathan Elliot Spon National Aeronautics & Space Admin AEROKATS and ROVER Education Network 22,991 College of Engineering Mechanical Engineering PI: Guldiken,Rasim Spon Transtek International Group (TIG) LLC Fast Track Ultrasonic Imaging of Concrete Bridge Decks 129,880 College of Engineering Mechanical Engineering PI: Guldiken,Rasim Spon Transtek International Group (TIG) LLC Fast Track Ultrasonic Imaging of Concrete Bridge Decks. 120,001

94


College of Engineering Mechanical Engineering PI: Guldiken,Rasim , Co-PI(s): Kaw,Autar K Spon National Science Foundation

Collaborative Proposal: Structured Use of Metacognitive Activities in a FlippedUndergraduate Engineering Course to Enhance Learning and Professional Skill Development 73,625

College of Engineering Mechanical Engineering PI: Kaw,Autar K , Co-PI(s): Yalcin,Ali Spon National Science FoundationTransforming Undergraduate Engineering Education through Adaptive Learning and Student Data Analytics 204,555

College of Engineering Mechanical Engineering PI: Mao,Wenbin Spon American Heart AssociationThe impact of MitraClip treatment on intraventricular flow and ventricular remodeling in heart failure patients with SMR 216,633

College of Engineering Mechanical Engineering PI: Murphy,David Wayne Spon National Science Foundation CAREER: Aerial and Aquatic Flapping Flight at Low Reynolds Numbers 108,662

College of Engineering Mechanical Engineering PI: Murphy,David Wayne Spon National Science FoundationCollaborative Research: Individual based approaches to understanding krill distributions and aggregation 94,181

College of Engineering Mechanical EngineeringPI: Reed,Kyle Brandon , Co-PI(s): Kim,Seok Hun Spon National Science Foundation

CHS: Small: Feedback-Based Stroke Rehabilitation Using Multiple Simultaneous Therapies 163,891

College of Engineering Mechanical Engineering PI: Wang,Cai Mike Spon National Science FoundationCAREER: Ångström-Precise Manufacturing Guided by Incommensurate Interfaces and Surfaces in Two-dimensional Layered Materials. 16,000

College of Engineering Mechanical Engineering PI: Wang,Cai Mike Spon Oak Ridge Associated UniversitiesMechanocaloric Effects in Nanoscale 2D Materials for Next Generation Solid-State Cooling and Refrigeration Technologies 5,000

College of Engineering Mechanical Engineering PI: Yucelen,Tansel Spon ARCTOS Technology Solutions, LLCControl and Decision Making for the Intelligent Cooperative autonomy of Aerial Systems 136,000

College of Engineering Mechanical Engineering PI: Yucelen,Tansel Spon OptoXense Inc

Developing Embedded Distributed Electric Propulsion Control System for Electric Vertical Takeoff and Landing (eVTOL) / Urban Air Mobility (UAM) Vehicles 50,000

College of Engineering Mechanical Engineering PI: Yucelen,Tansel Spon OptoXense IncDistributed Intelligent Robust Control Technologies for open Open Systems Control of Integrated Propulsion, Power, and Thermal 15,000

College of Engineering Mechanical Engineering PI: Yucelen,Tansel Spon OptoXense IncOptimal Adaptive Control Architecture Development for TBCC Engines Integrated with MIPCC Systems 121,001

College of Engineering Mechanical Engineering Total 3,306,006 College of Engineering Medical Engineering PI: Frisina JR.,Robert D Spon Indiana University Genetic Susceptibility and Biomarkers of Platinum-related Toxicities 39,960 College of Engineering Medical Engineering PI: Jiang,Huabei Spon National Institutes of Health Fetal alcohol exposure and cerebrovascular development 320,670 College of Engineering Medical Engineering PI: Passaglia,Christopher Spon Icahn School of Medicine at Mount Sinai Systems Pharmacology for Overcoming Cell Variability 56,467 College of Engineering Medical Engineering PI: Spirou,George Arthur Spon Natl Insti on Deafness and Other Comm D The Nanoscale Connectome of the Cochlear Nucleus 620,597

College of Engineering Medical Engineering PI: Spirou,George Arthur Spon Oregon Health & Science UniversityModulation of Exocytosis and Excitability in Mature Auditory Brainstem Neurons 89,002

College of Engineering Medical Engineering Total 1,126,696

College of Engineering Total 38,988,715

College of Marine Science College of Marine SciencePI: Ainsworth,Cameron H , Co-PI(s): Stallings,Christopher Spon University of Florida Omnibus 2018-2021_Florida Sea Grant Proposal 86,855

College of Marine Science College of Marine Science PI: Barnes,Brian B Spon Environmental Protection AgencyDetermining long-term water quality trends in Biscayne Bay using satellite and in situ data 70,586

College of Marine Science College of Marine Science PI: Barnes,Brian B Spon Fish and Wildlife Research Institute

Improving Remote Sensing algorithms for Water Quality and Primary Production in Apalachee Bay Florida An Optically Complex and Biologically divers Coastal Region in the northeastern Gulf of Mexico 64,792

College of Marine Science College of Marine Science PI: Barnes,Brian B , Co-PI(s): Hu,Chuanmin Spon National Aeronautics & Space AdminSpectral Matching Inversion Algorithms for PACE Application in Optically Shallow Waters: An Assessment Using HICO and PRISM Data 283,930

College of Marine Science College of Marine Science PI: Barnes,Brian B , Co-PI(s): Hu,Chuanmin Spon National Aeronautics & Space AdminSynergistic Multi-sensor Calibration for Global and Coastal Observations of Aquatic Environments 149,570

College of Marine Science College of Marine Science PI: Buck,Kristen N Spon National Science Foundation

Collaborative Research: Diatoms, Food Webs and Carbon Export-Leveraging NASA EXPORTS to Test the Role of Diatom Physiology in the Biological Carbon Pump 196,212

College of Marine Science College of Marine Science PI: Buck,Kristen N Spon National Science Foundation

Collaborative Research: The Effect of Ocean Acidification on Fe Availability to Phytoplankton in Coastal and Oceanic Waters of the Eastern North Pacific 194,565

College of Marine Science College of Marine Science PI: Buck,Kristen N Spon National Science FoundationNSFGEO-NERC: Collaborative Research: Collaborative Rsearch: Using Time-Series Field Observations to Constrain an Ocean Iron Model 231,565

College of Marine Science College of Marine Science

PI: Buck,Kristen N , Co-PI(s): Weisberg,Robert H;Hu,Chuanmin;Lembke,Chad E;Liu,Yonggang;Breitbart,Mya E Spon Florida Fish and Wildlife Conservation

New interdisciplinary approaches to red tide tracking and forecasting on the West Florida Shelf 503,250

College of Marine Science College of Marine Science PI: Byrne,Robert H Spon National Science FoundationCharacterization of Aragonite and Calcite Solubility Products in Seawater Using Modern CO2 System Measurement Techniques 107,059

College of Marine Science College of Marine Science PI: Byrne,Robert H Spon National Science FoundationSpectrophotometric Determinations of Carbonic Acid Dissociation Constants for Esturine Conditions 115,693

College of Marine Science College of Marine Science PI: Chambers,Don P Spon NASA Jet Propulsion Laboratory Homage-Heat and Ocean Mass From Gravity ESDR 103,469

College of Marine Science College of Marine Science PI: Chambers,Don P Spon NASA Jet Propulsion LaboratoryImpact of Short-Timescale Variability on Local, Regional and Global Sea Level Change 191,848

95


College of Marine Science College of Marine Science PI: Chambers,Don P Spon National Aeronautics & Space Admin Understanding Surface Wave Signals in SWOT Altimetry 40,868

College of Marine Science College of Marine SciencePI: Chambers,Don P , Co-PI(s): Bonin,Jennifer A Spon National Aeronautics & Space Admin

Determining Decadal Variability in Deep Ocean Currents from GRACE and GRACE Follow-on 180,000

College of Marine Science College of Marine SciencePI: Chambers,Don P , Co-PI(s): Galperin,Boris Spon University of Miami

CIMAS Innovative Science, Service and Stewardship "Sub-contractual Award to a CIMAS Consortium Academic Institution: University of South Florida 150,569

College of Marine Science College of Marine Science PI: Conway,Timothy Mark Spon National Science FoundationCollaborarive Research: Determining the Isotopic Signature of Iron Released via Ligand-Mediated dissolution of Atmospheric Dust in the Surface Ocean 107,374

College of Marine Science College of Marine Science PI: Daly,Kendra L Spon University of Rhode IslandOcean Observatories Initiative Facility Board (OOIFB) Administrative Support Office 63,032

College of Marine Science College of Marine Science PI: Dixon,Jacqueline Eaby Conv University of South Florida Foundation St. Petersburg Progress Postdoctoral Fellowship 196,288

College of Marine Science College of Marine SciencePI: Dixon,Jacqueline Eaby , Co-PI(s): Mitchum,Gary T Spon US Geological Survey Support of Facilities at the USF/USGS St. Petersburg Science Center 1,412,519

College of Marine Science College of Marine SciencePI: Grasty,Sarah E , Co-PI(s): Kusek,Kristen M;Greely,Teresa M Spon Tampa Bay Estuary Program

Development of Activity Packages for Guardians of the Gulf, a STEAM Program that Empowers Underserved Florida Youth toChampion our Coasts 2,000

College of Marine Science College of Marine SciencePI: Grasty,Sarah E , Co-PI(s): Murawski,Steven Spon Fish and Wildlife Research Institute

Assessing the Efficacy of Mobile and Stationary Camera Surveys to Evaluate Reef Fish Relative Abundance and Size Distributions Along With Associated Habitats on the West Florida Shelf 62,512

College of Marine Science College of Marine SciencePI: Grasty,Sarah E , Co-PI(s): Murawski,Steven Spon Ocean Conservancy

Preliminary Assessment of Marine Debris and Discarded Fishing Gear on the West Florida Shelf via Towed Camera Footage 5,000

College of Marine Science College of Marine Science PI: Greely,Teresa M Spon National Marine Sanctuary Foundation NMSF Education Alliance Partnership - 2021 6,000 College of Marine Science College of Marine Science PI: Hu,Chuanmin Spon Global Science & Technology, Inc. Calibration/Validation Support for NPP VIIRS Data Product Continuity 115,948

College of Marine Science College of Marine Science PI: Hu,Chuanmin Spon National Aeronautics & Space Admin

Deciphering Sargassum Physics, Biology, and Physiology Through PACE Measurements: Implications to Ocean Ecology, Biogeochemistry, and Management Decision Support 99,300

College of Marine Science College of Marine Science PI: Hu,Chuanmin Spon National Aeronautics & Space Admin

Forecasts of Pelagic Sargassum Blooms and Transports in the Intra-Americas Sea and Tropical Atlantic: Improving a Prototype Decision-making Tool 48,284

College of Marine Science College of Marine Science PI: Hu,Chuanmin Spon National Aeronautics & Space AdminSub-Mesoscale Eddies Derived From Novel Ocean Color Imagery and ICES at Missions in Support of the SWOT Mission 41,846

College of Marine Science College of Marine Science PI: Hu,Chuanmin Spon National Aeronautics & Space Admin Thermal Stress in South Florida Estuaries: A Multi-Sensor Assessment 36,366

College of Marine Science College of Marine Science PI: Hu,Chuanmin Spon Pennsylvania State University Response of Carbon Cycling in two North American Subtropical Estuaries 23,694

College of Marine Science College of Marine Science PI: Hu,Chuanmin , Co-PI(s): Li,Xiaopeng Spon National Aeronautics & Space AdminPrecipitation, Water Management and Algae Blooms in South Florida Estuaries 405,135

College of Marine Science College of Marine Science PI: Lembke,Chad E Spon Florida Atlantic UniversityAn in situ holographic imaging system for measuring distributions of Karenia brevis 26,647

College of Marine Science College of Marine Science PI: Lembke,Chad E Spon Southeast Coastal Ocean Observing RegionSECOORA: Supporting Resilient Ecosystems, Communities and Economies - SECOORA - Regional Glider Component - University of South Florida 50,000

College of Marine Science College of Marine Science PI: Luther,Mark E Spon Greater Tampa Marine Advisory Council Tampa Bay Ports Cooperative II 20,000

College of Marine Science College of Marine Science PI: Luther,Mark E Spon Southeast Coastal Ocean Observing RegionImproving the Management of Maritime Traffic in Southeast US Waters Using Machine Learning 64,873

College of Marine Science College of Marine SciencePI: Luther,Mark E , Co-PI(s): Merz,Clifford R;Scudder,Jeffrey J Spon Southeast Coastal Ocean Observing Region

SECOORA: Supporting Resilient Ecosystems, Communities and Economies - Operate and Maintain USF Costal Stations as Part of SECOORA 51,000

College of Marine Science College of Marine SciencePI: Luther,Mark E , Co-PI(s): Meyers,Steven D Spon Pinellas County Florida Old Tampa Bay Philippe Park Seawall Enhancement 21,000

College of Marine Science College of Marine SciencePI: Luther,Mark E , Co-PI(s): Muller-Karger,Frank E;Hu,Chuanmin Spon Texas A&M University

Continued Operation and Maintenance of the CenGoos Buoy and HFR Stations 160,000

College of Marine Science College of Marine Science PI: Muller-Karger,Frank E Spon Oregon State UniversityDynamic Seascapes to Form a Biogeographic Framework for a Global Marine Biodiversity Observing Network 44,998

College of Marine Science College of Marine Science PI: Muller-Karger,Frank E Spon University of Puerto RicoImminent Risks due to Interactions between SARS-CoV-2 (COVID-19) and Environmental Factors in Puerto Rico, Summer 2020 38,500

College of Marine Science College of Marine SciencePI: Muller-Karger,Frank E , Co-PI(s): Dixon,Timothy Hugh Spon National Science Foundation

Spokes: MEDIUM: SOUTH: Collaborative: Enhanced 3-D Mapping for Habitat, Biodiversity, and Flood Hazard Assessments of Coastal and Wetland Areas of the Southern US 262,861

College of Marine Science College of Marine SciencePI: Muller-Karger,Frank E , Co-PI(s): Montes Herrera,Enrique Spon National Aeronautics & Space Admin

Implementing a Marine biodiversity Observatin Network (MBON) in South Florida to Advance Ecosystem-Based Management 99,547

College of Marine Science College of Marine SciencePI: Muller-Karger,Frank E , Co-PI(s): Montes Herrera,Enrique Spon Natl Oceanic & Atmospheric Admin

Implementing a Marine biodiversity Observatin Network (MBON) in South Florida to Advance Ecosystem-Based Management 343,348

College of Marine Science College of Marine SciencePI: Muller-Karger,Frank E , Co-PI(s): Murray,Tylar WC Spon Florida International University

Resilience of the Mangrove Coast: Understanding Links between Degradation, Recovery, and Community Benefits 66,895

96


College of Marine Science College of Marine SciencePI: Murawski,Steven , Co-PI(s): Pulster,Erin L Spon Tampa Bay Estuary Program Are PFAS Compounds a Significant Contaminant Threat to Tampa Bay? 65,378

College of Marine Science College of Marine Science

PI: Murawski,Steven , Co-PI(s): Weisberg,Robert H;Luther,Mark E;Naar,David F;Lembke,Chad E;Hapke,Cheryl J;Graham,Alastair Spon Natl Oceanic & Atmospheric Admin Center for Ocean Mapping and Innovative Technologies (COMIT) 1,557,499

College of Marine Science College of Marine SciencePI: Otis,Daniel B , Co-PI(s): Muller-Karger,Frank E Spon National Aeronautics & Space Admin

Examining the Relation Between Biodiversity an dSurface Temperature Regimes in Localized Coastal Upwelling Zones Using ECOSTRESS 88,843

College of Marine Science College of Marine SciencePI: Otis,Daniel B , Co-PI(s): Muller-Karger,Frank E;Murray,Tylar WC Spon Florida Fish and Wildlife Conservation Coral Disease Response Data Management 30,000

College of Marine Science College of Marine SciencePI: Otis,Daniel B , Co-PI(s): Muller-Karger,Frank E;Murray,Tylar WC Spon Florida Fish and Wildlife Conservation

Florida's Coral Reef water quality data compilation, analysis, and decision support 24,000

College of Marine Science College of Marine Science PI: Peebles,Ernst B Spon Florida Gulf Coast University

Monitoring and analyses of zooplankton and ichthyoplankton responses to flow for evaluation of the Caloosahatchee River estuary minimum flow and minimum water level and recovery strategy 37,297

College of Marine Science College of Marine Science PI: Peebles,Ernst B Spon Southeast Coastal Ocean Observing RegionOral presentation of a novel stable isotope method at an international fisheries conference 2,500

College of Marine Science College of Marine Science PI: Romero,Isabel C Spon National Academy of Sciences The National Academy of Sciences Gulf of Mexico Study 41,934

College of Marine Science College of Marine Science PI: Romero,Isabel C Spon Nova Southeastern UniversityTrends and Drivers of Faunal Abundance of the Offshore Gulf of Mexico: Narrowing the data Gap in the Gulfs Largest Ecosystem 51,570

College of Marine Science College of Marine Science PI: Rosenheim,Brad E Spon National Science FoundationCR: What Happens to Terrestrial Organic Matter in the Ocean? Solving the Mystery Behind an Iconic Question 114,276

College of Marine Science College of Marine SciencePI: Rosenheim,Brad E , Co-PI(s): Shevenell,Amelia Spon National Science Foundation

Collaborative Research: Time Matters- A Comparison of Diatom14C and Thermochemical 14C Dating Methods in Sediment Records of Ice Retreat from the East and West Antarctic Margins 70,064

College of Marine Science College of Marine Science PI: Seibel,Brad A Spon Florida Atlantic UniversityNext Generation Sensor Systems for Natural Oceanic Bioluminescence Assessments 24,331

College of Marine Science College of Marine Science PI: Shevenell,Amelia Spon National Science FoundationCollaborative Proposal: Miocene Climate Extremes: A Ross Sea Perspective (DSDP Leg 28 and IODP Exp 374) 164,856

College of Marine Science College of Marine Science PI: Shevenell,Amelia Spon National Science Foundation

Deglacial to Recent Paleoceanography of the Sabrina Coast, East Antarctica: A Multi-Proxy Study of Ice-Ocean Interactions at the Outlet of the Aurora Subglacial Basin 148,706

College of Marine Science College of Marine Science PI: Stallings,Christopher Spon Florida Department of Agriculture Non-target species effects of mosquito treatments 69,182 College of Marine Science College of Marine Science PI: Stallings,Christopher Spon Florida Fish and Wildlife Conservation Spatial expansion of long-term monitoring program on artificial reefs 31,571

College of Marine Science College of Marine Science PI: Weisberg,Robert H Spon Mote MarineECOHAB19: Life and Death of Karenia Brevis Blooms in the Eastern Gulf of Mexico 146,673

College of Marine Science College of Marine SciencePI: Weisberg,Robert H , Co-PI(s): Liu,Yonggang Spon Southeast Coastal Ocean Observing Region

SECOORA: Supporting Resilient Ecosystems, Communities and Economies - A Coordinated Observing and Modeling for the West Florida Continental Shelf as part of SECOORA: Moored Observing and Modeling Component 255,000

College of Marine Science College of Marine SciencePI: Weisberg,Robert H , Co-PI(s): Merz,Clifford R Spon Southeast Coastal Ocean Observing Region

SECOORA: Supporting Resilient Ecosystems, Communities and Economies - Operate and Maintain University of South Florida IOOS Priority High Frequency Radars in SECOORA 156,000

College of Marine Science College of Marine SciencePI: Williams,Nancy , Co-PI(s): Chambers,Don P Spon National Science Foundation The role of cyclonic upwelling eddies in Southern Ocean CO2 flux 715,702

College of Marine Science College of Marine Science Total 10,341,180 College of Marine Science Florida Institute of Oceanography PI: Graham,William Montrose Spon US Department of Treasury Florida RESTORE Act Centers of Excellence Program 983,632

College of Marine Science Florida Institute of Oceanography Total 983,632

College of Marine Science Total 11,324,812

College of The Arts Florida Ctr for Community Design & Res PI: Cook,Brian Ray , Co-PI(s): Sabia,Taryn E Spon City of Tampa Land Regulatory Response to Sea Level Rise Analysis 75,000

College of The Arts Florida Ctr for Community Design & Res PI: Robles,Josue M , Co-PI(s): Sabia,Taryn E Spon City of St Petersburg Florida St. Petersburg Mayor's SACD Fellows 18,000

College of The Arts Florida Ctr for Community Design & Res PI: Robles,Josue M , Co-PI(s): Sabia,Taryn E Spon New Life Village New Life Village's Facility Improvements 42,000 College of The Arts Florida Ctr for Community Design & Res PI: Sabia,Taryn E Spon City of Tampa Green House Gas (GHG) Inventory Study 19,000 College of The Arts Florida Ctr for Community Design & Res PI: Sabia,Taryn E Spon Hillsborough Co City Co Planning Comm City of Tampa Neighborhood Commercial Districts Service Learning 4,000 College of The Arts Florida Ctr for Community Design & Res PI: Sabia,Taryn E Spon Hillsborough Co City Co Planning Comm Wimauma Community Vision Plan 14,500

College of The Arts Florida Ctr for Community Design & ResPI: Sabia,Taryn E , Co-PI(s): Bohn JR.,Herman Joseph;Cook,Brian Ray Spon Hillsborough County Board of Hillsborough County Community Vulnerability Study: Policy and 2100 30,328

College of The Arts Florida Ctr for Community Design & ResPI: Sabia,Taryn E , Co-PI(s): Cook,Brian RayWinter,Margaret Spon Hillsborough County Hillsborough County Sustainability Plan 98,800

College of The Arts Florida Ctr for Community Design & Res Total 301,628 College of The Arts Graphicstudio PI: Lee,Barton W Conv USF Research Foundation College of the Arts Faculty Awards 192,832

97


College of The Arts Graphicstudio Total 192,832 College of The Arts Sch of Architecture and Community Design PI: Moy,James S Conv University of South Florida Foundation Markborough Endowed Chair in Urban Design 69,543 College of The Arts Sch of Architecture and Community Design PI: Moy,James S Conv University of South Florida Foundation Sam Gibbons Endowed Chair, FY-1994 113,802

College of The Arts Sch of Architecture and Community Design Total 183,345 College of The Arts Theatre PI: Moy,James S Conv University of South Florida Foundation Theatre Fine Arts Endowed Chair 48,443

College of The Arts Theatre Total 48,443 College of The Arts USF Art Museum PI: Miller,Margaret A Spon Florida Division of Cultural Affairs General Program Support 2021 43,068

College of The Arts USF Art MuseumPI: Smith,Noel M , Co-PI(s): Miller,Margaret A Spon Arts Council of Hillsborough County CAIG For Colleges and Universities: Braking Barriers 12,500

College of The Arts USF Art MuseumPI: Smith,Noel M , Co-PI(s): Miller,Margaret A Spon National Endowment for the Arts

To support the exhibition Constant Storm: Art from Puerto Rico and the Diaspora at the USF Contemporary Art Museum 25,000

College of The Arts USF Art Museum Total 80,568 College of The Arts Visual Arts PI: Fraser,Elisabeth A Spon National Endowment for the Humanities Dressing the Ottoman Empire: Costume Books and Transculturation 16,800 College of The Arts Visual Arts PI: Wilson IV,William W Conv University of South Florida Foundation Chair African Arts 104,767

College of The Arts Visual Arts Total 121,567

College of The Arts Total 928,382 Muma College of Business Center for Entrepreneurship PI: Libaers,Dirk Paul Conv University of South Florida Foundation Kennedy Innovation Fund 6,414 Muma College of Business Center for Entrepreneurship PI: Limayem,Moez Conv University of South Florida Foundation COBA / Free Enterprise and Entrepreneurship 49,503

Muma College of Business Center for Entrepreneurship Total 55,917 Muma College of Business Finance PI: Limayem,Moez Conv University of South Florida Foundation Bank of America Chair in Banking 86,748 Muma College of Business Finance PI: Limayem,Moez Conv University of South Florida Foundation Lykes Chair in Banking and Finance 212,470 Muma College of Business Finance PI: Limayem,Moez Conv University of South Florida Foundation Serge Bonanni Scholarship 5,972

Muma College of Business Finance Total 305,190

Muma College of Business Information Systems & Decision Sciences PI: Kong,Dejun Spon Negotiation and Team ResourcesThe Not-So-Small Potential of Small Talk in Negotiations: A Regulatory Focus Perspective 2,500

Muma College of Business Information Systems & Decision Sciences PI: Limayem,Moez Conv University of South Florida Foundation Salomon Brothers / HRCP Eminent Scholar / Endowed Chair 83,967 Muma College of Business Information Systems & Decision Sciences PI: Limayem,Moez Conv University of South Florida Foundation WLP Faculty Research Award - MacAulay 1,603 Muma College of Business Information Systems & Decision Sciences PI: Mullarkey,Matthew Timothy Spon Tampa General Hospital TGH IT Analytics Practice Center Project 50,364 Muma College of Business Information Systems & Decision Sciences PI: Padmanabhan,Balaji Spon Fintech SISM Practice Center Project sales tool 14,545

Muma College of Business Information Systems & Decision Sciences Total 152,979 Muma College of Business Marketing PI: Limayem,Moez Conv University of South Florida Foundation Frank Harvey Endowed Chair 6,711 Muma College of Business Marketing PI: Limayem,Moez Conv University of South Florida Foundation Monica Wooden Professorship 14,494 Muma College of Business Marketing PI: Ozkul,Seckin Spon Jabil Circuit, Inc. Forging the Pathway for Digital Supply Chain Transformation 201,750

Muma College of Business MarketingPI: Ozkul,Seckin , Co-PI(s): Davis,Donna Franklin;Hooker,Robert E. Spon Florida Department of Transportation

FDOT Identification of Prospective Solutions for the Florida Trade Imbalance and Empty Backhauls 122,180

Muma College of Business MarketingPI: Ozkul,Seckin , Co-PI(s): Hooker,Robert E.;Davis,Donna Franklin Spon Florida Department of Transportation

FDOT Land Use Analysis to Enhance Successful Logistics Activity Center Development in Florida 126,541

Muma College of Business MarketingPI: Ozkul,Seckin , Co-PI(s): Watkins,Alison L;Davis,Donna Franklin Spon Jabil Circuit, Inc. Forging the Pathway for Jabil's Digital Supply Chain Transformation 100,000

Muma College of Business Marketing Total 571,676 Muma College of Business Muma College of Business PI: Limayem,Moez Conv University of South Florida Foundation Exide Professorship for Business Ethics 42,762

Muma College of Business Muma College of Business Total 42,762 Muma College of Business School of Accountancy PI: Limayem,Moez Conv University of South Florida Foundation Advisory Council Professorship 9,559 Muma College of Business School of Accountancy PI: Limayem,Moez Conv University of South Florida Foundation Quinn Endowed Chair in Accounting Taxation 86,134 Muma College of Business School of Accountancy PI: Limayem,Moez Conv University of South Florida Foundation Rooks Distinguished Professor of Accounting 19,905

Muma College of Business School of Accountancy Total 115,598 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon Greater Hernando County Chamber of Comme 2020-2021 Hernando County 15,450 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon Highlands County Board of County Commiss 2020-2021 Highlands County Board of County Commissioners 11,330 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon Pinellas County Economic Development Pinellas County CARES 50,000 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon University of West Florida 2020 Small Business Development Center 12,500 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon University of West Florida 2020-2021 State Performance Funding 300,000 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon University of West Florida 2021 Small Business Development Center 1,100,000 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon University of West Florida 2021 State Performance Funding 455,813 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon University of West Florida CARES ACT 2020 - USF 1,340,000 Muma College of Business Small Business Development Center PI: Rodriguez,Eileen Spon University of West Florida PTAC 2021 144,000

Muma College of Business Small Business Development Center Total 3,429,093

Muma College of Business Total 4,673,216

Patel College of Global Susta Patel Center for Global Understanding PI: Philippidis,George Spon Mote Marine LaboratoryBioprospecting of natural algicidal bacteria associated with Harmful Algal Blooms to develop a sustainable mitigation strategy for red tides 21,807

Patel College of Global SustainaPatel Center for Global Understanding Total 21,807

Patel College of Global Sustainability Total 21,807 USF Health-College of Nursing College of Nursing PI: Bricker,Christina Spon CVS Health Foundation The CVS Health Foundation FNP/PA Scholarship 3,000 USF Health-College of Nursing College of Nursing PI: Canale,Michelle L Spon Health Resources and Srvcs Admin Nurse Anesthetisit CRNA Education Funding 82,822

98


USF Health-College of Nursi College of Nursing

PI: Groer,Maureen E , Co-PI(s): Bruder,Karen L;Seyfang,Andreas G;Duffy,Allyson Radford;Ji,Ming;Louis-Jacques,Adetola F Spon Natl Insti of Child Health

Chronic Toxoplasma Gondii, Pregnancy Reactivation, and Perinatal Depression 494,892


PI: Hyer,Kathryn , Co-PI(s): Hyer,Kathryn;Roetzheim,Richard G;Sneed,Kevin B Spon Health Resources and Srvcs Admin Geriatrics Workforce Enhancement Program (7,074)

USF Health-College of Nursi College of Nursing PI: Ji,Ming Spon Corporal Michael J. Crescenz Medical CenIntra-Individual Changes in Ambulation and Functional Outcomes among Frail Elders 35,599

USF Health-College of Nursi College of Nursing PI: Ji,Ming Spon Kaiser Permanente Center for Health RSCHThe Bariatric Experience Long Term (BELONG) II for Racial and Ethnic Minority Patients 79,301

USF Health-College of Nursing College of Nursing PI: Maguire,Denise Joan Spon American Psychiatric Nurses Association Substance Use Disorder (SUD) Curriculum 5,000 USF Health-College of Nursing College of Nursing PI: Maye,John P Spon Pacira Pharmaceuticals, Inc Advanced Pain Management Fellowship 18,703 USF Health-College of Nursing College of Nursing PI: Maye,John P Spon Pacira Pharmaceuticals, Inc Pacira Pharmaceuticals, Inc. Educational Grant 18,703

USF Health-College of Nursi College of NursingPI: Menon,Usha , Co-PI(s): Szalacha,Laura A Spon Ohio State University Integenerational Refugee and Immigrant Cancer Screening Project 46,304

USF Health-College of Nursi College of NursingPI: Menon,Usha , Co-PI(s): Szalacha,Laura A Spon University of Arizona

Dissemination of a Colorectal Cancer Screening Program Across American Indian Communities in Southern Plains and Southwest United States 93,650


PI: Rodriguez,Carmen S , Co-PI(s): Katkoori,Srinivas;Mifsud,Matthew J;Cairns,Paula Louise;Ji,Ming Spon American Association of Nurse Practition

Intervention to Facilitate Communication Between Suddenly Speechless Patients and Healthcare Providers 5,000

USF Health-College of Nursi College of Nursing PI: Rowe,Meredeth A Spon Corporal Michael J. Crescenz Medical CenIntra-Individual Changes in Ambulation and Functional Outcomes among Frail Elders 47,318

USF Health-College of Nursi College of Nursing PI: Szalacha,Laura A Spon Ohio State UniversityHealthy Lifestyle Intervention for High-Risk Minority Pregnant Women: A RCT 11,473


PI: Visovsky,Constance G , Co-PI(s): Vu,Tuan;Ji,Ming;Haladay,Douglas E;Teran Wodzinski,Patricia Spon National Institutes of Health Home-Based Physical Activity Intervention for Taxane-Induced CIPN 651,985


PI: Wang,Hsiao-Lan , Co-PI(s): Buck,Harleah Graham;Smith,Barbara A.;Szalacha,Laura A Spon National Cancer Institute

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain After Head and Neck Cancer Treatment 581,576

USF Health-College of Nursing College of Nursing Total 2,168,252

USF Health-College of Nursing Total 2,168,252

USF Health-College of Public Community and Family Health PI: Best,Alicia Lynette Spon National Cancer Institute

Improving Routine Asymptomatic Cancer Screening Among Federally Qualified Health Center Users in Florida: Application of a Health Literacy Framework 154,620

USF Health-College of Public H Community and Family Health PI: Marshall,Jennifer T Spon FL Assoc of Healthy Start Coalitions Early Childhood Comprehensive System (ECCS) Impact Grant Evaluation 77,680 USF Health-College of Public HeCommunity and Family Health Total 232,300

USF Health-College of Public H COPH MHA Program PI: Pracht,Etienne E. Spon Florida Department of Health Development of New Survival Risk Ratios 5,600

USF Health-College of Public COPH MHA Program PI: Pruitt,Zachary S Spon Fast Pathway Inc.DocClocker: Check-in priority when seeking care during a pandemic: perceived safety or convenience? 9,950

USF Health-College of Public COPH MHA Program PI: Quast,Troy Clarence Spon Baylor College of MedicineInternet-delivered cognitive behavioral therapy (iCBT) for Anxiety in Youth ASD: A Novel Model to Improve Access to Treatment 16,890

USF Health-College of Public COPH MHA Program PI: Quast,Troy Clarence Spon Hillsborough County Hillsborough County Health Care Plan (HCHCP) Specialist Care Assessment 40,672 USF Health-College of Public HeCOPH MHA Program Total 73,112

USF Health-College of Public H COPH OSHA Education Center PI: Bernard,Thomas E Spon Florida Division of Workers Compensation State Match: FY21 Osha 21D Consultation Program 235,000 USF Health-College of Public H COPH OSHA Education Center PI: Bernard,Thomas E Spon Occupational Safety & Health Admin FY21 OSHA 21D Consultation Program 2,577,300 USF Health-College of Public H COPH OSHA Education Center PI: Bernard,Thomas E Spon Occupational Safety & Health Admin OSHA 21D Consultation Program FY20 134,200

USF Health-College of Public HeCOPH OSHA Education Center Total 2,946,500

USF Health-College of Public COPH Sunshine ERCPI: Bernard,Thomas E , Co-PI(s): Burns,Candace M;Allen,Tammy D Spon Natl Inst for Occupational Safety & Hlth Sunshine Education and Research Center at USF 1,628,849

USF Health-College of Public HeCOPH Sunshine ERC Total 1,628,849 USF Health-College of Public H Ctr for Leadership in Pub Health Pract PI: Levine,Marissa Janae Spon Florida Department of Health Leadership Development Program 30,000

USF Health-College of Public HeCtr for Leadership in Pub Health Pract Total 30,000

USF Health-College of Public Epidemiology and Biostatistics PI: Alman,Amy Spon Natl Insti of Dental and CraniofThe Oral Microbiome in Type 1 Diabetes and Sub-Clinical Cardiovascular Disease 593,401

USF Health-College of Public HeEpidemiology and Biostatistics Total 593,401

USF Health-College of Public Florida Health Information Center PI: Wolfson,Jay Spon Health Resources and Srvcs AdminRyan White HIV/AIDS Program Part D WICY COVID19Response 96,542

USF Health-College of Public Florida Health Information CenterPI: Wolfson,Jay , Co-PI(s): Rodriguez,Carina A Spon Health Resources and Srvcs Admin

Ryan White HIV/AIDS Program Part D Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY) 1,465,108

USF Health-College of Public HeFlorida Health Information Center Total 1,561,650

99


USF Health-College of Public Florida Prevention Research Center PI: Parvanta,Claudia Fishman Spon Ctrs for Disease Control and PreventionIntergovernmental Personnel Act (IPA) - CDC Assignment agreement 20IPA2014115 33,065

USF Health-College of Public Florida Prevention Research CenterPI: Parvanta,Claudia Fishman , Co-PI(s): Hammond,Robert Walter Spon Morehouse School of Medicine

The National COVID-19 Reiliency Network (NCRN) Mitigating the Impact of COVID-19 on Vulnerable Populations 766,099

USF Health-College of Public HeFlorida Prevention Research Center Total 799,164

USF Health-College of Public GHIDR Global Health Center PI: Adams,John H Spon Natl Inst of Allergy and InfectiousAccelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine 1,036,232

USF Health-College of Public H GHIDR Global Health Center PI: Adams,John H Spon Natl Inst of Allergy and Infectious Discovering the Essential Genome of Plasmodium Falciparum 643,737

USF Health-College of Public GHIDR Global Health Center PI: Adams,John H Spon Natl Inst of Allergy and InfectiousEvaluation of ivermectin as an antimalarial therapy against P. falciparum liver stage 157,252

USF Health-College of Public H GHIDR Global Health Center PI: Adams,John H Spon Natl Inst of Allergy and Infectious Immunological characterization of the P. vivax DBP 611,722

USF Health-College of Public GHIDR Global Health Center PI: Adams,John H Spon University of Alberta International InstExploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria 176,221

USF Health-College of Public GHIDR Global Health Center PI: Adams,John H Spon University of North Carolina,Chapel HillPlasmodium ovale hypnozoite development and relapse: a coordinated in vivo in vitro study 74,750

USF Health-College of Public GHIDR Global Health Center PI: Adams,John H Spon Washington University, St. LouisStructural Vaccinology and Design of Novel Immunogens for Malaria Development 229,026

USF Health-College of Public GHIDR Global Health Center PI: Cragun,Deborah L Spon Geisinger Clinic, Henry Hood Center

Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational contexts 36,238

USF Health-College of Public GHIDR Global Health CenterPI: Cragun,Deborah L , Co-PI(s): Beckstead,Jason W;Kruzel,Marleah Dean Spon Vanderbilt University IMproving Care After Inherited Cancer Testing (IMPACT) Study 183,471

USF Health-College of Public H GHIDR Global Health Center PI: Jiang,Hong Yuan Spon Virginia Commonwealth University Targeting Mutant KRAS for Cancer Therapy 29,900

USF Health-College of Public GHIDR Global Health CenterPI: Jiang,Hong Yuan , Co-PI(s): Ferreira,Gloria C Spon Florida Department of Health Targeting Heme Dependency in Leukemia 268,886

USF Health-College of Public H GHIDR Global Health Center PI: Liu,Xiaoming Spon National Human Genome Research Institute Extend and improve the functional annotation tools dbNSFP and WGSA 74,750

USF Health-College of Public GHIDR Global Health CenterPI: Martin II,Lynn Bloxom , Co-PI(s): Jiang,Hong Yuan Spon National Science Foundation

IMAGiNE: Collaborative Research: Epigenetic potential and rangeexpansion in the house sparrow 257,526

USF Health-College of Public H GHIDR Global Health Center PI: Michael,Edwin Spon Blue Cross and Blue Shield of FL, Inc. USF/ND COVID Model and Web Portal 29,297 USF Health-College of Public H GHIDR Global Health Center PI: Michael,Edwin Spon Chan Mas & Scholars of the Uni Oxford NTD Modelling Consortium: moving towards elimination 108,866 USF Health-College of Public H GHIDR Global Health Center PI: Michael,Edwin Spon Hillsborough County Susceptible-Exposed-Infectious-Removed (SEIR) Model Simulator 75,000

USF Health-College of Public GHIDR Global Health Center PI: Uddin,Eva Monica Spon Emory University The Impact of Traumatic Stress on the Methylome: implications for PTSD 95,415

USF Health-College of Public GHIDR Global Health Center PI: Uddin,Eva Monica Spon Sigma Xi

Differentially expressed genes following glucocorticoid exposure in microglia as potential biomarkersof PTSD 986

USF Health-College of Public H GHIDR Global Health Center PI: Uddin,Eva Monica Spon University of South Carolina Epigenetic Mechanisms of T Cell Disregulation in PTSD 15,354

USF Health-College of Public GHIDR Global Health CenterPI: Uddin,Eva Monica , Co-PI(s): Wildman,Derek Edward Spon University of Rwanda Transgenerational Epigenomics of Trauma and PTSD in Rwanda 215,424

USF Health-College of Public H GHIDR Global Health Center PI: Unnasch,Thomas R Spon Boehringer Ingelheim Pharm., Inc. Adapting PiggyBac transfection to Dirofilaria immitis 141,162

USF Health-College of Public GHIDR Global Health Center PI: Unnasch,Thomas R Spon Natl Inst of Allergy and InfectiousCommunity-directed vector control to enhance mass drug administrative for onchocerciasis elimination in Africa 519,585

USF Health-College of Public H GHIDR Global Health Center PI: Unnasch,Thomas R Spon The Carter Center Onchocerciasis Infection and Exposure Evaluations 167,208

USF Health-College of Public GHIDR Global Health Center PI: Unnasch,Thomas R Spon University of Florida Southeastern Regional CoE in Vector-Borne Diseases: The Gateway Program 244,192

USF Health-College of Public GHIDR Global Health Center PI: Unnasch,Thomas R Spon University of FloridaUsing vector blood meals to predict transmission of zoonoticarboviruses in Florida 20,787

USF Health-College of Public HeGHIDR Global Health Center Total 5,412,987

USF Health-College of Public Global Health PI: Adams,John H Spon Tres Cantos Open Lab FoundationAntimalarial Drug Discovery Targeting Pre-Erythrocytic Stages of Plasmodium Falciparum 334,210

USF Health-College of Public HeGlobal Health Total 334,210 USF Health-College of Public H Lawton & Rhea Chiles Center PI: Alexander,Donna P Conv University of South Florida Foundation Endowed Chair Marrell 124,633

USF Health-College of Public Lawton & Rhea Chiles Center PI: Kirby,Russell S Spon Baylor College of MedicineIdentifying Novel Cancer Predisposition Syndromes: An Integrative Epidemiologic and Genomic Approach 35,855

USF Health-College of Public H Lawton & Rhea Chiles Center PI: Kirby,Russell S Spon Florida Department of Health Birth Defects Surveillance Program 580,000

USF Health-College of Public Lawton & Rhea Chiles Center PI: Kirby,Russell S Spon University of Wisconsin - MadisonPrenatal Opioid Exposure: Birth, health, socioeconomic, and educational outcomes of mothers and their children 24,710

USF Health-College of Public Lawton & Rhea Chiles Center

PI: Kirby,Russell S , Co-PI(s): Salinas Miranda,Abraham Antonio;Marshall,Jennifer T Spon Health Resources and Srvcs Admin Autism Secondary Data Analysis Research (SDAR) Program 99,860

USF Health-College of Public H Lawton & Rhea Chiles Center PI: Marshall,Jennifer T Spon Drug Free Charlotte Kids Thrive Navigator Project Evaluation 8,000

USF Health-College of Public Lawton & Rhea Chiles Center PI: Marshall,Jennifer T Spon FL Assoc of Healthy Start Coalitions

FLORIDA MATERNAL, INFANT AND EARLY CHILDHOOD HOME VISITING (MIECHV) INITIATIVE PARTNER ORGANIZATIONS 10,000

100


USF Health-College of Public Lawton & Rhea Chiles Center PI: Marshall,Jennifer T Spon Florida State University2020 - 2021 Early Childhood Court Evaluation aka Infant Toddler Court Program 65,000

USF Health-College of Public Lawton & Rhea Chiles Center

PI: Marshall,Jennifer T , Co-PI(s): Fryer,Kimberly ElizabethBeckstead,Jason W;Salemi,Jason L;Sappenfield,William Spon Florida Department of Health Assessing Quality and Access of Prenatal Care 75,000

USF Health-College of Public Lawton & Rhea Chiles CenterPI: Marshall,Jennifer T , Co-PI(s): Shaffer,Emily J Spon Florida Office of Early Learning PDGR Infant Early Mental Health Infrastructure 100,000

USF Health-College of Public H Lawton & Rhea Chiles Center PI: Newman,Jodi A,Jodi Spon Center on Budget and Policy Priorities Consumer Assistance Coordination Hub (CACH) Contract Year 3 7,000

USF Health-College of Public Lawton & Rhea Chiles Center PI: Newman,Jodi A,Jodi Spon Ctrs for Medicare and Medicaid SvcsConnecting Kids to Coverage (CKC) Outreach and Enrollment Cooperative Agreement 483,924

USF Health-College of Public Lawton & Rhea Chiles Center PI: Newman,Jodi A,Jodi Spon Ctrs for Medicare and Medicaid SvcsCooperative Agreement to Support Navigators in Federally-facilitated Exchanges 1,850,000

USF Health-College of Public H Lawton & Rhea Chiles Center PI: Newman,Jodi A,Jodi Spon Florida Health Justice Project Protecting Immigrant Families 11,000 USF Health-College of Public H Lawton & Rhea Chiles Center PI: Newman,Jodi A,Jodi Spon Florida Healthy Kids Corporation Florida Healthy Kids Kidcare Training 45,878 USF Health-College of Public H Lawton & Rhea Chiles Center PI: Sappenfield,William Spon American College of OBGYN ACOG Alliance for Innovation of Maternal health (AIM) 9,000 USF Health-College of Public H Lawton & Rhea Chiles Center PI: Sappenfield,William Spon Ctrs for Disease Control and Prevention Expanding FPQC Participation 300,000 USF Health-College of Public H Lawton & Rhea Chiles Center PI: Sappenfield,William Spon Florida Department of Health FPQC DOH Contract 2019-21 607,620 USF Health-College of Public H Lawton & Rhea Chiles Center PI: Sappenfield,William Spon Florida Department of Health FPQC Maternal Opioid Use Disorder Contract 59,250

USF Health-College of Public HeLawton & Rhea Chiles Center Total 4,496,730 USF Health-College of Public H PH Interdisciplinary Research & Education PI: Alexander,Donna P Spon Buena Fe Product Dos (9,000) USF Health-College of Public H PH Interdisciplinary Research & Education PI: Alman,Amy Spon James A. Haley Veteran's Hospital IPA: Whole Health Funded Quality Improvement Projects 42,943

USF Health-College of Public PH Interdisciplinary Research & EducationPI: Alman,Amy , Co-PI(s): Couluris,Marisa;Rosen,Paul Andrew Spon National Institutes of Health

Feasibility of mHealth Technology for Improving Self-Management and Adherence Among Asthmatic Adolescents 438,188

USF Health-College of Public H PH Interdisciplinary Research & Education PI: Bohn JR.,Herman Joseph Spon The Florida Dept of Veterans Affairs Alternative Treatment Options for Veterans 200,000 USF Health-College of Public H PH Interdisciplinary Research & Education PI: Calvo,Arlene E Spon CENTRO DE VACUNACl6N E INVESTIGACl6N S.A Covid Vaccine Clinical Trial In Panama' 12,506

USF Health-College of Public PH Interdisciplinary Research & Education PI: Calvo,Arlene E Spon Gorgas Memorial Institute for Health StuPsychomotor and cognitive development problems in a cohort of children after respiratory infection during pregnancy and/or early childhood 25,500

USF Health-College of Public H PH Interdisciplinary Research & Education PI: Calvo,Arlene E Spon University of New Mexico The Audacious COVID Project 29,069 USF Health-College of Public H PH Interdisciplinary Research & Education PI: Corvin,Jaime Antoinette Spon Champions for Children, Inc Champions for Children: Positive Parenting & Partnership (P3) 187,500 USF Health-College of Public H PH Interdisciplinary Research & Education PI: Corvin,Jaime Antoinette Spon City of Tampa Housing Authority Tampa Housing Authority Tax Credit Tool (T3) 149,610

USF Health-College of Public PH Interdisciplinary Research & Education PI: DeBate,Rita Digiocchino Spon Hillsborough County Anti-Drug Alliance

Tobacco Prevention & Control Program: Grantee of Bureau of Tobacco Prevention Program (BTFF) Creation of Policy to Prevent andReduce Tobacco Use Among Young Adults (YAI) 14,000

USF Health-College of Public H PH Interdisciplinary Research & Education PI: DeBate,Rita Digiocchino Spon Substance Abuse & Mental Health The Reality of Recovery: discussion with Zac Clark & Justin Gurland 750 USF Health-College of Public H PH Interdisciplinary Research & Education PI: Liller,Karen D Spon American Public Health Association ACTION APHA Award 500 USF Health-College of Public H PH Interdisciplinary Research & Education PI: Liller,Karen D Spon Florida Department of State National Violent Death Registry System 275,710

USF Health-College of Public PH Interdisciplinary Research & Education PI: Liller,Karen D Spon Research AmericaThe World Has Changed!!: Environmental Health, ClimateChange, and Advocacy to Improve Health! 1,000

USF Health-College of Public PH Interdisciplinary Research & Education PI: Luther,Stephen L Spon Yale UniversityPain Care Quality and Integrated and Complementary Health Approaches - Administrative Supplement 18,498

USF Health-College of Public H PH Interdisciplinary Research & Education PI: Luther,Stephen L Spon Yale University Pain Management Collaboratory Coordinating Center (PMC3) 26,565

USF Health-College of Public PH Interdisciplinary Research & EducationPI: Marhefka-Day,Stephanie L , Co-PI(s): Meng,Hongdao;Chen,Henian Spon National Institutes of Health

The Positively Quit Trial: Addressing Disproportionate Smoking Rates Among People Living with HIV 596,083

USF Health-College of Public H PH Interdisciplinary Research & Education PI: Pasha,Mahmooda Khaliq Spon Pan American Health Organization Online Program Social Marketing for Public Health - Technical Assistance 21,324

USF Health-College of Public PH Interdisciplinary Research & EducationPI: Pasha,Mahmooda Khaliq , Co-PI(s): Hendricks,Sara JWinters,Philip L Spon Florida Department of Transportation State Safety Office Vital Few Safety Campaign 79,486

USF Health-College of Public H PH Interdisciplinary Research & Education PI: Salemi,Jason L Spon The Children's Hosp. of San Antonio Foun Epidemiology of Neurological Birth Defects in Texas from 1999 to 2014 15,000

USF Health-College of Public PH Interdisciplinary Research & EducationPI: Vamos,Cheryl , Co-PI(s): Salinas Miranda,Abraham Antonio Spon Health Resources and Srvcs Admin Maternal and Child Health Public Health Training Program 812,632

USF Health-College of Public H PH Interdisciplinary Research & Education PI: Wilson,Ronee E Spon REACH UP, Inc. Healthy Start Initiative - Eliminating Racial/Ethnic Disparities 82,236 USF Health-College of Public HePH Interdisciplinary Research & Education Total 3,020,100

USF Health-College of Public Health Total 21,129,003 USF Health-Morsani College o Area Health Education Center PI: Lockwood,Charles J Spon Florida Department of Health Tobacco Free Florida AHEC Cessation Program 2,791,647 USF Health-Morsani College o Area Health Education Center PI: Wenders,Anna Maynard Spon Florida State University USF AHEC State Opioid Training and Education Project 12,608 USF Health-Morsani College o Area Health Education Center PI: Wenders,Anna Maynard Spon University of Florida AHEC COVID-19 Training for CHWs and AHEC Scholars 17,562 USF Health-Morsani College o Area Health Education Center PI: Wenders,Anna Maynard Spon University of Florida Model State-Supported Area Health Education Centers 284,905

USF Health-Morsani College of Area Health Education Center Total 3,106,722 USF Health-Morsani College o Cardiology CRISP PI: Berlowitz,Michael S Spon Sanofi-Aventis U.S., Inc. Protocol #EFC11570 882 USF Health-Morsani College o Cardiology CRISP PI: Chae,Sanders Spon Boston Scientific Corporation Protocol #NAVIGATE X4 2,420 USF Health-Morsani College o Cardiology CRISP PI: Fernandez,Joel Spon Endotronix, Inc. Protocol #CLEAN ETX 29,742 USF Health-Morsani College o Cardiology CRISP PI: Fernandez,Joel Spon Lexicon Pharmaceuticals, Inc. Protocol #EFC15156 (6,575) USF Health-Morsani College o Cardiology CRISP PI: Fernandez,Joel Spon Zoll Services LLC Protocol #90D0182 8,400 USF Health-Morsani College o Cardiology CRISP PI: Fradley,Michael G Spon Medtronic, Inc. Protocol #ARCHER (8,000)

101


USF Health-Morsani College o Cardiology CRISP PI: Herweg,Bengt Spon Abbott Laboratories Protocol #ABT-CIP-10253 1,625 USF Health-Morsani College o Cardiology CRISP PI: Herweg,Bengt Spon Abbott Laboratories Protocol #CRD 863 LESS-VT 2,635 USF Health-Morsani College o Cardiology CRISP PI: Herweg,Bengt Spon Biosense Webster, Inc. Protocol #BWI_2017_06 (VISITAG) 8,140 USF Health-Morsani College o Cardiology CRISP PI: Herweg,Bengt Spon Boston Scientific Corporation Protocol #ASAP-TOO 1,983 USF Health-Morsani College o Cardiology CRISP PI: Herweg,Bengt Spon Medtronic, Inc. Protocol# AdaptResponse 10,891 USF Health-Morsani College o Cardiology CRISP PI: Herweg,Bengt Spon University of Utah Protocol #DECAAF2 6,071 USF Health-Morsani College o Cardiology CRISP PI: Labovitz,Arthur J Conv University of South Florida Foundation Schiller - Cardiology Research 116,472 USF Health-Morsani College o Cardiology CRISP PI: Matar,Fadi A Spon Ablative Solutions Protocol #CR0002 7,214 USF Health-Morsani College o Cardiology CRISP PI: Matar,Fadi A Spon CVRx, Inc. Protocol #360043-001 BeAT-HF 10,438 USF Health-Morsani College o Cardiology CRISP PI: McDonald,Thomas Spon Array BioPharma Protocol #ARRAY-797-301 42,237 USF Health-Morsani College o Cardiology CRISP PI: Oliveira,Guilherme Spon Bristol-Myers Squibb Company Protocol #CV185-370 5,000 USF Health-Morsani College o Cardiology CRISP PI: Patel,Aarti A Spon Boehringer Ingelheim Pharm., Inc. Protocol #1245.110 2,922 USF Health-Morsani College o Cardiology CRISP PI: Patel,Aarti A Spon Dia Cardio Ltd Protocol #Echo Exam (7,800)

USF Health-Morsani College of Cardiology CRISP Total 234,696

USF Health-Morsani College Clinical and Translational Science Inst PI: Kumar,Ambuj Spon James A. Haley Veteran's HospitalIPA Tea Reljic - Long Term Impact of Relevant Brain Injury Consortium-Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC) 80,002

USF Health-Morsani College Clinical and Translational Science Inst PI: Kumar,Ambuj Spon Tampa VA Research & Education FoundationCharacterization of Persistent Post-Concussive Symptoms in Injured Soldiers: A Retrospective Review 1,250

USF Health-Morsani College Clinical and Translational Science Inst PI: Kumar,Ambuj Spon Tampa VA Research & Education FoundationImproved Understanding of Medical and Psychological Needs (I-MAP) in Veterans and Service Members and Chronic TBI 142,299

USF Health-Morsani College of Clinical and Translational Science Inst Total 223,551 USF Health-Morsani College o College of Medicine PI: Liggett,Stephen B Conv University of South Florida Foundation Anna Valentine for Cancer Research 17,444 USF Health-Morsani College o College of Medicine PI: Lockwood,Charles J Conv University Medical Service Associates House Staff 2,468

USF Health-Morsani College of College of Medicine Total 19,912 USF Health-Morsani College o College of Medicine Housestaff PI: Lockwood,Charles J Conv University Medical Service Associates House Staff 57,475,028

USF Health-Morsani College of College of Medicine Housestaff Total 57,475,028

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Abate-Daga,Daniel Spon Bluebird Bio Inc

Exploratory and IND-enabling Preclinical Studies to Assess Pharmacology and Safety of Anti-BCMA γδ2 CAR-T cells Using In vitro and In vivo Models for the Treatment of Multiple Myeloma 766,771

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Abate-Daga,Daniel Spon National Cancer InstituteUnderstanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment. 501,190

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Adeegbe,Dennis Spon American Lung AssociationHDAC6 inhibition and Treg-targeting as immunotherapeutic strategy for Non-small cell lung cancer 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Adeegbe,Dennis Spon Mike Slive FoundationValidating and tailored targeting of identified immune signature in the tumors of African-American Prostate cancer patients 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Adeegbe,Dennis Spon National Cancer Institute

Dissecting the immunological mechanisms associated with prostate cancer progression in African-American men and exploring epigenetics-based immune modulation for therapy 423,486

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Adeegbe,Dennis Spon National Cancer Institute

Investigating Mechanistic Underpinnings and Therapeutic Potential of Selective Histone Deacetylase and Bromodomain Inhibition for the Treatment of Non-Small Cell Lung Cancer 182,485

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Alexandrow,Mark G Spon Natl Insti of Gen Medical Science Direct Control of the human CMG Helicase by Myc and Rb 329,400

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Alsina,Melissa Spon Bluebird Bio, Inc.A Phase 1 Study of bb21217, an anti-BCMA CAR T Cell Drug Product, in Relapsed and/or Refractory Multiple Myeloma 455,834

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Alsina,Melissa Spon Celgene Corporation

A Phase 2, Multi-Cohort, Open-Label, Multicenter Study To Determine The Efficacy And Safety Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma And In Subjects With High-Risk Multiple Myeloma Having Progressed Within One Year Of Initial T 1,111,233

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Alsina,Melissa Spon International Myeloma Foundation (IMF)

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT): A Phase 2 Trial of Induction, Consolidation and Maintenance in Subjects with High Risk Smoldering Multiple Myeloma (SMM)

118,494

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Alsina,Melissa Spon Mayo Clinic

International Myeloma Foundation Assessing Outcomes after Initial Relapse and Impact on Health Care Utilization in the Current Era: Medical Chart Review 44,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Alsina,Melissa Spon Onyx Pharmaceuticals, Inc.Phase 1b Study of Carfilzomib Administered Once Weekly in Combination with Lenalidomide and Dexamethasone in Subjects with Multiple Myeloma 9,219

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Altrock,Philipp Spon H. Lee Moffitt Cancer Center

Predicting Clinical Response to CAR T Cell Therapy Through Evolutionary Modeling by Quantifying the Likelihood of Tumor Extinction vs. Tumor Escape 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Anaya,Daniel Spon DNAtrix, Inc

A Phase I Safety and Window-of-Opportunity Study of Preoperative Intratumoral Injection of OX40-Ligand Expressing Oncolytic Adenovirus (DNX-2440) in Patients with Resectable liver Metastasis 216,857

102


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Anaya,Daniel Spon H. Lee Moffitt Cancer CenterInduction of Innate and Adaptive Anti-Tumor Immunity Against Colorectal Liver Metastases 150,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Anderson,Alexander Spon National Cancer InstituteEco-Evolutionary Dynamics of NSCLC to Immunotherapy: Response and Resistance 557,164

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Anderson,Alexander Spon US Department of Energy Evolving, understanding and optimising novel Cancer therapies 148,186 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Andor,Noemi Spon National Cancer Institute A clone's genomic stability as biomarker of its DNA-damage resilience 248,930 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Arrington,John A Spon HealthMyne Arrington - Healthmyne/Moffitt Collaboration 73,961 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Avram,Dorina A Spon Natl Inst of Allergy and Infectious Role of Bcl11b in CD4+ T Cells and Innate Lymphoid Cells 559,958

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Avram,Dorina A Spon University of ArizonaHigh throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase 213,608

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Avram,Dorina A Spon University of Florida Tolerogenic Dual Microparticle System for Treatment of Multiple Sclerosis 315,768

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Basanta Gutierrez,David Spon National Cancer InstituteMulti-Scale Modeling of Bone Environment Responses to Metastatic Prostate Cancer 120,555

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon AbbVie Inc.

A Phase 1/2, Multicenter, Dose-Escalation and Expansion Study of Combination Therapy with Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Subjects with Relapsed or Refractory Multiple Myeloma 153,556

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Celgene Corporation

A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of BB2121 Versus Standard Triplet Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (Rrmm) (Karmma-3) 373,493

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Janssen Pharmaceutica IncPhase II Study of Daratumumab Based Response Adapted Therapy for Older Adults with Newly Diagnosed Multiple Myeloma 86,079

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Karyopharm Therapeutics Inc.

A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) plus Low-Dose Dexamethasone in Patients with Multiple Myeloma Quad-refractory to Prior Therapies 34,704

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Karyopharm Therapeutics Inc.Investigator-Initiated Phase I/II Clinical Trial of Selinexor (KPT-330) and Liposomal Doxorubicin for Relapsed and Refractory Multiple Myeloma 48,727

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Leidos, Inc CTEP-Leidos Payment Agreement 750

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Merck & Company

A Phase III Study of Lenalidomide and Low-dose Dexamethasone With or Without Pembrolizumab (MK3475) in Newly Diagnosed and Treatment Naïve Multiple Myeloma (KEYNOTE 185) 3,293

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Baz,Rachid Spon Sanofi Pharmaceuticals

A Phase 1b Study of SAR650984 (Anti-CD38 mAb) in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma 79,425

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Beg,Amer A Spon H. Lee Moffitt Cancer CenterDeveloping an Oncolytic Virus to induce de novo T cell priming: impact on TIL generation and therapeutic efficacy 100,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Beg,Amer A Spon Memgen Preclinical studies of MEM-288 168,934

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Beg,Amer A Spon National Cancer InstituteAugmenting T Cell Trafficking and Functionality through Novel Combinations of Epigenetic Agents and PD-1 Blockade 393,450

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Beg,Amer A Spon US Army Medical Research & Material CommDefining Impact of HDAC Inhibitors on Tumor Immunogenicity, T Cell Functionality and PD-1 Blockade Response in NSCLC Patients 258,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon Blood & Marrow Transplant CT NetworkHaplo-Identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM) 9,088

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon City of HopePilot Trial of Enasidenib Maintenance Post Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2 Mutation 131,067

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon Florida Department of Health Donor gamma delta T-cell infusion for treatment of high-risk leukemia 267,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon H. Lee Moffitt Cancer Center

The impact of donor γδ T cells on immune escape and relapse of acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT) 46,910

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon Marker Therapeutics

A Phase 2 Study of Donor-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-401) Administered to Patients with Acute Myeloid Leukemia (AML) following Hematopoietic Stem Cell Transplantation 60,293

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon Ohio State UniversityMIDAS: Microangiopathy, endothelial Damage in Adults undergoing Stem cell transplantation 171,267

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Bejanyan,Nelli Spon Tampa Community Foundation

The impact of donor gamma delta T-cell reconstitution and expression of leukemic cell ligands on immune escape and relapse of AML after allogeneic hematopoietic cell transplantation 223,526

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Binning,Jennifer Spon H. Lee Moffitt Cancer Center Engineering inhibitory nanobodies against HPV oncoproteins 50,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Binning,Jennifer Spon Natl Insti of Gen Medical Science Biophysical basis for enzyme mediated deglycation in protein repair 411,750

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Binning,Jennifer Spon Univ of South FloridaMolecular mechanisms of innate immune suppression by the HPV oncoprotein E6 1,746

103


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Boyle,Theresa Spon Bristol-Myers Squibb Company

Use of Tumor Samples from Rapid Tissue Donation to Explore Inflammation, Mechanisms of I-O Resistance, and Tumor Neoantigen Landscape 676,279

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brandon,Thomas H Spon National Cancer InstituteAdministrative Supplement: Behavioral Oncology Education & Career Development 70,535

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Brandon,Thomas H Spon National Cancer Institute Behavioral Oncology Education & Career Development 452,995

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brandon,Thomas H Spon National Cancer InstituteExpanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish Language RCT 733,543

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brandon,Thomas H Spon National Institute on Drug AbuseSmoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes 297,807

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Brayer,Jason B Spon Bristol-Myers Squibb Company Correlative Studies for MCC 19197 37,959

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brayer,Jason B Spon CARsgen Therapeutics Corp

Open Label, Multi-Center, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma 348,878

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brayer,Jason B Spon Merck & Company

A Phase III Study of Pomalidomide and Low Dose Dexamethasone with or without Pembrolizumab (MK3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (KEYNOTE 183) 1,079

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brayer,Jason B Spon Regeneron Pharmeceuticals, Inc.Phase 1/2 FIH Study of Regn5458 (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Patients with Relapsed or Refractory Multiple Myeloma 441,623

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brayer,Jason B Spon Seattle Genetics, Inc.A Phase 1 Study of SGN-CD48A in Patients with Relapsed or Refractory Multiple Myeloma 838

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Cancer Immunotherapy Trials Network (CIT A Phase II Study of MK-3475 in Patients with Advanced Merkel Cell Carcinoma (MCC) 900

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon ECOG

A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma 6,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Fred Hutchinson Cancer Research Center

A Multicenter, Randomized, Double Blinded, Placebo Controlled, Phase 3 trial of Adjuvant Avelumab (anti PDL1 antibody) in Merkel Cell Carcinoma Patients with Clinically Detected Lymph Node Metastases 13,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Kartos Therapeutics, Inc.

A Phase 1b/2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients with p53 Wild-Type (p53WT) Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy, or in Combination with Avelumab in MCC Patients who are 29,583

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Merck & CompanyNeoadjuvant Lenvatinib Plus Pembrolizumab in Resectable Merkel Cell Carcinoma 144,562

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Morphogenesis

Phase 1 Trial of Intralesional Immunotherapy with IFx-Hu2.0 Vaccine in Patients with Advanced Merkel Cell Carcinoma or Cutaneous Squamous Cell Carcinoma 57,116

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Nektar Therapeutics

The Reveal Study: A Phase 1/2, Open-Label, Multicenter, Dose Escalation And Dose Expansion Study Of Nktr-262 In Combination With Bempegaldesleukin (Nktr-214) And In combination With Bempegaldesleukin (Nktr-214) Plus Nivolumab In Patients With Locally Adv 100,772

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brohl,Andrew Spon Novartis Pharmaceutical Corporation

COMBI-AD: A Phase III Randomized Double Blind Study of Dabrafenib (GSK2118436) in COMBInation with Trametinib (GSK1120212) Versus Two Placebos in the ADjuvant Treatment of High-Risk BRAF V600 Mutation-Positive Melanoma After Surgical Resection 45,959

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brown,Joel Spon National Cancer InstituteCancer as a Complex Adaptive System-Administrative Supplement-The Tumor-Host Evolutionary Arms Race 53,528

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Brownstein,Naomi Spon Breast Cancer Research FoundationBarriers to Screening Breast MRI Utilization among Patients at Elevated Risk (B-SUPER) 9,908

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Bui,Marilyn M Spon Boston Children's Hospital The Genomics of MPNST (GeM) Consortium 14,953

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Carson,Tiffany L Spon National Cancer Institute

Determining the Structural- and Functional-Level Effects of Diet-Specific Interventions on the Gut Microbiota of a Diverse Sample of Southern United States Adults 651,908

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Caudell,Jimmy J Spon NRG Oncology

A Randomized Phase II/III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors 5,450


A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16 Positive, Non-Smoking Associated Oropharyngeal Cancer 28,375


Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck 3,250

104


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Caudell,Jimmy J Spon Radiation Therapy Oncology Group (RTOG)

Keystroke: A Randomized Phase II Study of Pembrolizumab (Keytruda) Plus Stereotactic Re-irradiation versus SBRT Alone For Locoregionally Recurrent or Second Primary Head and Neck Carcinoma 3,174

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Caudell,Jimmy J Spon University of California

Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients with Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN Trial) 8,451

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Caudell,Jimmy J Spon Varian Medical Systems, Inc.

Objective Evaluation of Machine Learning Potential for Automated Segmentation and Generation of Head and Neck Plans with Proven Reduced Toxicity 112,892

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Celgene Corporation

A Global Randomized Multicenter Phase 3 Trial to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects with High-Risk, Transplant-Eligible Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas (TRANSFORM) 413,179


A Phase 1, Multi-center, Open-label, Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of an Orally Available Small Molecule CC-99282 Alone and in Combination with Rituximab in Subjects with Relapsed and/or Refracto 148,806


A Phase 1, Open-Label, Multicenter Trial of Oral Azacitidine (CC-486) Plus R-Chop in Subjects with IPI 2 or More Previously Untreated Diffuse Large B-Cell Lymphoma or Grade 3B Follicular Lymphoma, or Transformed Lymphoma 11,640


A Phase 1B, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma 2,893

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Curis, Inc.

Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma including Patients with MYC Alterations 19,883

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Epizyme, Inc. Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study 15,834

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Hoffmann-La Roche Inc

An Open-Label, Randomized, Multicenter, Phase Ib/II Trial Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Mosunetuzumab (Btct4465a) In Combination With Polatuzumab Vedotin In Patients With B-Cell Non-Hodgkin Lymphoma 838,401

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Janssen Pharmaceutica IncPhase II Trial of Ibrutinib and PD-1 Blockade in High Risk Chronic Lymphocytic Leukemia to Improve Immune Function. 1,536

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Kite Pharma Inc.

A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-12) 796,052

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Kite Pharma Inc.A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (iNHL) 104,036

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Novartis Pharmaceutical Corporation

A Phase Ib, Multicenter Study To Determine The Safety And Tolerability of Tisagenlecleucel in Combination with Ibrutinib in Adult Patients With Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma 7,265

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Novartis Pharmaceutical Corporation

A Phase II, Single Arm, Multicenter Open Label Trial to Determine the Efficacy and Safety of Tisagenlecleucel (CTL019) In Adult Patients with Refractory or Relapsed Follicular Lymphoma

28,080

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon Regeneron Pharmeceuticals, Inc.

An Open-Label, Multi-Center Phase 1 study to Investigate the Safety and Tolerability of REGN1979, an Anti-CD20X Anti-CD3 Bispecific Monoclonal Antibody, in patients with CD20+ B-Cell Malignancies Previously Treated with CD20-Directed Antibody Therapy 8,892

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chavez,Julio C Spon TG Therapeutics, Inc.

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 With or W 264,871

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chellappan,Srikumar P Spon American Cancer Society ACS-IRG 245,404

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chellappan,Srikumar P Spon National Cancer Institute CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer 437,443 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chellappan,Srikumar P Spon US Army Medical Research & Material Comm Targeting TBK1 and CARM1 to combat lung adenocarcinoma 164,700

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chen,Dung-Tsa Spon Ponce School of Medicine & Health SciencAdrenergic Signaling Inhibition to Enhance the Immunogenecity of the Ovarian Tumor Microenvironment Prior to PD-1 Checkpoint Therapy 15,956

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chen,Jiandong Spon Florida Department of Health Development of novel TAF1 inhibitors as cancer therapeutics 89,810 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chen,Jiandong Spon Florida Department of Health Discovery of p53 inhibitors for reducing toxicity of chemotherapy 224,041 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chen,Jiandong Spon National Cancer Institute Anti-tumor Potential of Temperature-Sensitive p53 Mutants 444,590 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Chen,Jiandong Spon National Cancer Institute Function and Regulation of MDMX Intra-molecular Interactions 50,445

105


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chen,Jiandong Spon Univ of South FloridaIntrinsic Disorder Controls the Function of p53 and Other Cancer-assocoiated IDPs 126,621

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon AbbVie Inc.

A Phase 1b Efficacy and Safety Study of Cofetuzumab Pelidotin (ABBV-647, a PTK7-Targeting Antibody Drug Conjugate) in Subjects with PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer 32,442

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon AmgenA Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With Relapsed/Refractory Small Cell Lung Cancer 79,278

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon AmgenA Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of AMG 757 in Subjects with Small Cell Lung Cancer 84,783

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Amgen

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With A 157,954

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Ariad Pharmaceuticals, Inc.A Randomized Phase 2 Study of AP26113 in Patients with ALK-positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib 35,596

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon AstraZeneca Ltd

A Phase III, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, International Study of MEDI4736 as Sequential Therapy in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Defini 19,415

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon BerGenBioA Multi-Center Open-Label Phase 1/2 Study of BGB324 in Combination with Erlotinib in Patients with Stage IIIb or Stage IV Non-Small Cell Lung Cancer 500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Big Ten Cancer Research Consortium

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients with Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium BTCRC-LUN17-127 9,264

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Bristol-Myers Squibb Company

A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors 26,102

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Bristol-Myers Squibb Company

A Phase III, Randomized, Open Label Trial of Nivolumab in combination with Ipilimumab versus Pemetrexed with Cisplatin or Carboplatin as First Line Therapy in unresectable Pleural Mesothelioma 26,376

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Bristol-Myers Squibb CompanyEnhancement of Immune Checkpoint inhibition with Lurbinectedin modulation in relapsed/recurrent small cell lung cancer (SCLC) 184,007

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Debiopharm SA

A Dose-Optimization, Exploratory Phase Ib/II Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143, When Given in Combination with the Anti-PD-1 Antibody Nivolumab in Patients with Specifi 38,451

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Eli Lilly Research LaboratoriesPhase 1b Study of LY3295668 Erbumine Monotherapy in Patients with Platinum-Sensitive, Extensive-Stage Small-Cell Lung Cancer 26,265

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon EpicentRx, Inc.

REPLATINUM: A Phase 3, Controlled, Open-label,Randomized Study of RRx-001 Administered Sequentially with a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond Small Cell Lung Cancer 11,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon HealthPartners Regions Cancer Care and FPhase II Study of Nivolumab and Ramucirumab for Patients with Previously-Treated Mesothelioma 40,058

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Janssen Pharmaceutica Inc

A Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-Tumor Activity of YH25448 in Patients with EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC) 140,823

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Multi Vir

Combination Immunotherapy with Ipilimumab and Nivolumab plus a Dendritic Cell based p53 Vaccine (Ad.p53-DC) in patients with relapsed Small Cell Lung Cancer (SCLC) 41,287

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Novartis Pharmaceutical Corporation

A Phase 2, Multi-Center, Open Label Study of NIR178 in Combination with PDR001 in Patients with Selected Advanced Solid Tumors and Non-Hodgkin lymphoma 8,043

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Novartis Pharmaceutical Corporation

A Phase I/Ib, Open-Label, Multi-Center Study of NZV930 as a Single Agent and in Combination with PDR001 and/or NIR178 in Patients with Advanced Malignancies 88,869

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Pfizer, Inc.

A Phase 1, Open-Label Dose Escalation Study of PF-04518600 as a Single Agent and in Combination with PF-05082566 in Patients with Selected Locally Advanced or Metastatic Carcinomas 857

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Xcovery

Phase I/II, First-in-Human, Dose-Escalation Study of X-396 in Patients with Advanced Solid Tumors and Expansion Phase in Patients with ALK+ Non-Small Cell Lung Cancer 54,352

106


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chiappori,Alberto A Spon Xcovery

XALT3: Phase 3 Randomized Study Comparing X-396 to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients 27,163

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Christy,Shannon Spon H. Lee Moffitt Cancer CenterCARES-HCV Promoting Concurrent Hepatitis C Virus Screening and Colorectal Cancer Screening Uptake Among Diverse Baby Boomers 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Christy,Shannon Spon H. Lee Moffitt Cancer CenterHealth Beliefs, Behaviors, and Healthcare Experiences among a National Sample of United States Young and Mid-Age Adults 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon AstraZeneca Ltd

A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients (KESTREL) 47,005

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Bristol-Myers Squibb Company

A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination with Ipilimumab versus Nivolumab in Combination with Ipilimumab Placebo In Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) 5,266


An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) 29,794


An Open Label, Randomized, Two Arm Phase III Study of Nivolumab in Combination with Ipilimumab versus Extreme Study Regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as First Line Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the 9,272

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Bristol-Myers Squibb CompanyEvaluation of MHC class I methylation as a mechanism of checkpoint inhibitor resistance in head and neck squamous cell carcinoma (HNSCC) 138,285


Non-Comparative, Open-Label, Multiple Cohort, Phase 1/2 Study of Nivolumab Monotherapy and Nivolumab Combination Therapy in Subjects with Virus-Positive and Virus-Negative Solid Tumors 13,940

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Cue Biopharma, Inc.

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent / Metastatic Head and Neck Squamous Cell Carc 405,955

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Florida Department of HealthEffects of hypoxia in tumor immune microenvironment in tobacco-related head and neck squamous cell carcinoma (HNSCC) 327,403

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Florida Department of HealthMolecular Signatures of Immunotherapy Response and Improved Survival in Tobacco-Related Head and Neck Cancer 374,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Ignyta, Inc.

STARTRK-2: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements 18,708

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Iovance Biotherapeutics, Inc

A Phase 2 Study to Evaluate the Safety, Tolerability and Efficacy of Cell Transfer Therapy Using Autologous Tumor Infiltrating Lymphocytes (LN-145) followed by IL-2 in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck 259,880

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon IRX Therapeutics, Inc. A Phase 1b Trial of the IRX-2 Regimen and Durvalumab (MEDI4736), in Patients with Incurable Head and Neck Squamous Cell Carcinoma 227,936

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Kura Oncology

The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma(HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First 30,882

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Merck & CompanyA Phase Ib Multi-Cohort Study of MK-3475 in Subjects with Advanced Solid Tumors 2,974

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Pfizer, Inc.

A Randomized Double-Blind Phase 3 Study of Avelumab in Combination with Standard of Care Chemoradiotherapy (Cisplatin Plus Definitive Radiation Therapy) Versus Standard of Care Chemoradiotherapy in the Front-Line Treatment of Patients with Locally Advanc 6,911

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon Regeneron Pharmeceuticals, Inc.

A Single Arm Phase II Study of Cemiplimab-rwlc in Immunocompromised Patients with Unresectable Locally Recurrent and/or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) 41,462

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Chung,Christine Spon University of Arizona

A Randomized, Phase II Study of Ficlatuzumab with or without Cetuximab in Patients with Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma 10,679

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network 57,500

107


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute

Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Training, and Outreach Capacity of the Geographic Management of Cancer Health Disparities Program 250,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer InstituteAge-related Clonal Hematopoiesis in People Living with HIV and a Non-AIDS Defining Cancer Diagnosis 127,964

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer InstituteCancer Clinical Investigator Team Leadership Award (CCITLA) P30 Administrative Supplement 60,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer InstituteCancer Moonshot Tobacco Cessation Treatment Capacity and Infrastructure-CCSG Supplement 64,810

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute CCSG Admin Supplement for Interdisciplinary Research Leading to P01s 49,999 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute Moffitt Cancer Center Support Grant- Years 19-23 2,990,966 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute Moffitt Cancer Center Support Grant-CHE Supplement 57,500 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma 277,365 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer Institute Patterns of Cannabis Use Among Cancer Patients in Florida 30,104

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Cleveland,John Spon National Cancer InstituteTherapeutic Targeting of Casein Kinase-1-delta in Primary Metastatic Breast Cancer 490,391

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cleveland,John Spon The Scripps Research Institute Targeted degradation of RNAs by using small molecules 136,703 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Coghill,Anna Spon H. Lee Moffitt Cancer Center Differences in prostate cancer molecular features by HIV status 100,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Coghill,Anna Spon The Emmes Company AIDS Malignancy Consortium (AMC) 82,350

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Colon-Echevarria ,Claudia Spon H. Lee Moffitt Cancer Center

Prognostic and predictive significance of circulating HPV levels in patients with HPV associated oropharyngeal cancer treated with definitive radiation therapy 50,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon Certainty Therapeutics, Inc. Development of CAR-T/CER-T Therapies for Ovarian Cancer 245,198

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon Cornell UniversityGlobal Control of Ovarian Cancer Immunity by Aberrant ER Stress Responses 30,778

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon H. Lee Moffitt Cancer CenterActionable cell stress mechanisms governing αb and gd T cell responses against ovarian cancer 150,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon H. Lee Moffitt Cancer Center Role of Butyrophilins in Regulating T-Cell Activity 100,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon National Cancer Institute B Cell-dependent Anti-tumor Immunity in Ovarian Cancer 781,585

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon National Cancer InstituteInitiation and Evolution of the Ovarian Cancer Microenvironment-Transfer App 408,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon National Cancer InstituteRapid Exoproteome Antigen Profiling of antibodies produced in the ovarian cancer microenvironment 125,001

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon National Cancer Institute Regulatory Dendritic Cells in Cancer 367,650 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Conejo-Garcia,Jose R Spon National Cancer Institute Targetable Epidgenetic Mechanism Driving Cutaneous T Cell Lymphoma 274,265

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Achilles Therapeutics

An Open-Label, Multi-Center Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T cells in Patients with Advanced Non-Small Cell Lung Cancer (CHIRON) 42,676

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Apollomics Inc.

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors 117,402

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Bristol-Myers Squibb Company

A Multi-arm Phase I Safety Study of Nivolumab in Combination with Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in First-Line or in Switch Maintenance in Subjects wit 24,149


A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab anti-PD-1 Monoclonal Antibody) and in Combination with Both Nivolumab and Ipilimumab (anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant Tumors 10,367


A Phase IIIb/IV Safety Trial of Nivolumab (BMS-936558) in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen 32,635


An Open-label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) 260


An Open-label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer 44,047


An Open-Label, Randomized, Phase 3 Trial Of Nivolumab Versus Investigator's Choice Chemotherapy As First-Line Therapy For Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer 34,183

108


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Iovance Biotherapeutics, IncA Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144 or LN-145) in Patients with Solid Tumors (IOV-COM-202) 447,100

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Kite Pharma Inc.

A Phase 1 Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*0401 Positive Subjects with Advanced Cancers 310,463

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Polaris Group

Randomized, Double-Blind, Phase 2/3 Study in Subjects with Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 with Pemetrexed and Cisplatin (ATOMIC-Meso Phase 2/3 Study) 83,790

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Tmunity

A Phase 1 Open-Label, Multi-Center First in Human Study of TnMUC1-Targeted Genetically-Modified Chimeric Antigen Receptor T Cells in Patients with Advanced TnMUC1-Positive Solid Tumors and Multiple Myeloma 40,680

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon Turning Point Therapeutics

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients with Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1) 93,941

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Creelan,Ben C Spon WindMIL Therapeutics

A Phase 2a, Open-Label, Multi-Center Study to Assess the Efficacy and Safety of Marrow Infiltrating Lymphocytes NonSmall Cell Lung Cancer (MILs - SCLC) Alone or in Combination with Nivolumab with or without Tadalafil in Subjects with Locally Advanced an 89,387

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Cress,W. Douglas Spon National Cancer Institute Integrated Program in Cancer and Data Science 294,797

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Czerniecki,Brian Spon Florida Department of HealthOvercoming Resistance in HER2 Breast Cancer through a Novel Immunotherapy Approach 310,230

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Czerniecki,Brian Spon H. Lee Moffitt Cancer CenterAssociation of gut microbiome with pathological complete response after immune based or standard neoadjuvant therapy in Breast cancer 12,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Czerniecki,Brian Spon H. Lee Moffitt Cancer CenterRole of anti-oncodriver Th1 immune response on disseminated cancer cells to prevent breast cancer metastasis 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Czerniecki,Brian Spon US Army Medical Research & Material CommCorrecting the Anti-HER-2 CD4 Th1 Response in Breast Cancer Therapy to Prevent Recurrence 3,142,375

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Czerniecki,Brian Spon US Army Medical Research & Material Comm Novel Immunotherapy for Brain-Metastatic Breast Cancer 1,472,055 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Davila,Marco Spon Atara Biotherapeutics, Inc. Development of T-Cells that target B-Cell Antigens 512,570 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Davila,Marco Spon Atara Biotherapeutics, Inc. Gene Engineered T-Cell Therapy (AML) 682,735 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Davila,Marco Spon Atara Biotherapeutics, Inc. Gene Engineered T-Cell Therapy (Co-Stimulatory Domains) 640,068 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Davila,Marco Spon Elicio Therapeutics CD19 CAR-T Plus Elicio Amphiphile Combination Therapy 651,078

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Davila,Marco Spon Johns Hopkins UniversityAdrenergic modulation of cellular immune functions in CAR T cell–induced cytokine release syndrome 27,683

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Davila,Marco Spon Kite Pharma Inc.Study to develop a predictive model of immune-related adverse events in patients treated with axicabtagene ciloleucel 838,859

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Davila,Marco Spon Novartis Pharmaceutical CorporationIdentification of biomarkers to predict the development of immune-related adverse events in patients treated with Tisagenlecleucel 201,775

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Davila,Marco Spon University of Texas Southwestern Med CtrRegulation of Zbtb44-Eomes complex in CD8+T cells and anti-tumor immunity 19,304

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: DeNicola,Gina Spon Florida Department of Health Pyridine Nucleotides: Missing Link between Aging and Lung Cancer 201,757 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: DeNicola,Gina Spon Florida Department of Health Therapeutic strategies for KEAP1/NRF2 mutant lung cancer 253,177 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: DeNicola,Gina Spon H. Lee Moffitt Cancer Center Interrogating NAD+ synthetic pathways in lung cancer cells 67,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: DeNicola,Gina Spon Montana State UniversityMetabolic basis of the NADPH-independent disulfide reductase system in mouse liver 231,898

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: DeNicola,Gina Spon National Cancer Institute Investigation of NRF2-Dependent Metabolic Liabilities 463,660

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Donovan,Kristine A Spon Univ of South FloridaA Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain After Head and Neck Cancer Treatment 71,136

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon Adaptimmune

A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (SPEARHEAD 1 Study) 173,893


A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Non-Small Cell Lung Cancer (N 13,818


Phase 1 Dose Escalation, Multi-Tumor Study To Assess The Safety, Tolerability And Antitumor Activity Of Genetically Engineered Mage-A4c1032t In Hla-A2+ Subjects With Mage-A4 Positive Tumors 2,885

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon BioAtla, LLC

A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 in Patients with Advanced Solid Tumors

578,861

109


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon Blueprint Medicines

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST) 34,715

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon Deciphera Pharmaceuticals

A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib 328,845

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon Florida Department of Health

A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma 180,494

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon GlaxoSmithKlineA Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1c259T Cells in HLA-A2+ Patients with Synovial Sarcoma 32,739

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon GlaxoSmithKlineA Pilot Study Of NY-ESO-1c259T Cells In Subjects With Advanced Myxoid/ Round Cell Liposarcoma 69,829

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon GlaxoSmithKlineLong Term Follow-Up of Subjects Exposed to NY-ESO-1c259T, A Genetically Engineered NY-ESO-1 Specific T Cell Receptor 5,255

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon Immunocore, Ltd.

A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCnyeso, an HLA- A*0201-Restricted, NY-ESO-1- and LAGE-1A-specific Soluble T Cell Receptor and Anti-CD3 Bispecific Molecule, as a Single Agent in HLA-A*0201 Positive Patients with 5,821

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Druta,Mihaela Spon TRACON Pharmaceuticals, Inc.

Envasarc: A Pivitol Trial of Envafolimab, and Envafolimab in Combination with Ipilimumab, in Patients with Advanced or Metastatic Undifferentiated Pleomorphic Sarcoma or Myxofibrosarcoma Who Have Progressed on Prior Chemotherapy 116,034

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Egan,Kathleen M Spon Florida Department of Health Biobanking for Breast Cancer Prevention and Disparity Research in Florida 256,794

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Egan,Kathleen M Spon University of AlabamaGenetic Epidemiology of Adult-Onset Brain Tumor (Southeastern Region Case-Control Study of Adult Brain Tumors) 14,170

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Egan,Kathleen M Spon University of AlabamaTransplanting Unique Human Microbiomes to Improve Immunotherapy in Glioblastoma 153,936

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Egan,Kathleen M Spon University of FloridaPilot Study of Commensal Gut Microbiome as a Modifier of Checkpoint Inhibitor Efficacy in Glioblastoma 492

USF Health-Morsani College Department of Interdisciplinary Oncology PI: El Haddad,Ghassan E Spon Endocyte, Inc.

VISION: An International, Prospective, Open-Label, Multicenter, Randomized Phase 3 Study of 177LU-PSMA-617 in the Treatment of Patients with Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (MCRPC) 121,987

USF Health-Morsani College Department of Interdisciplinary Oncology PI: El Haddad,Ghassan E Spon University of Pennsylvania

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET): A Phase 3 Randomized Multicenter Trial to Compare Hepatic Progression-Free Survival Following Bland Embolization, Lipiodol Chemoembolization, and Drug-Eluting Bead C 24,369

USF Health-Morsani College Department of Interdisciplinary Oncology PI: El Naqa,Issam M Spon Endectra LLCCerenkov Multi-Spectral Imaging (CMSI) for Adaptation and Real-Time Imaging in Radiotherapy 195,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: El Naqa,Issam M Spon National Cancer InstituteCombined Radiation Acoustics and Ultrasound Imaging for Real-Time Guidance in Radiotherapy 261,820

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: El Naqa,Issam M Spon National Cancer Institute Optimal Decision Making in Radiotherapy Using Panomics Analytics 466,542

USF Health-Morsani College Department of Interdisciplinary Oncology PI: El Naqa,Issam M Spon University of ChicagoMedical Imaging and Data Resource Center (MIDRC) for Rapid Response to COVID-19 Pandemic 89,120

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Elmariah,Hany Spon Blood & Marrow Transplant CT Network

A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation 152,316

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Elmariah,Hany Spon US Food and Drug AdministrationPhase I/II Study of CD8-Reduced T Cells for Treatment of Myelodysplastic Syndrome or Acute Myeloid Leukemia IND17305-(12/30/2016) 250,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Enderling,Heiko Spon Florida Breast Cancer FoundationImmunological consequence of single vs. fractionated ablative radiation in breast cancer 20,417

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Enderling,Heiko Spon H. Lee Moffitt Cancer CenterOptimal Therapy to Maximally Delay Time to Progression in Non-Small Cell Lung Cancer 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Enderling,Heiko Spon Jayne Koskinas & Ted Giovanis FoundationValidation of Prostate Cancer Stem Cell Model in First and Second Line Hormone Therapy 5,744

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Enderling,Heiko Spon National Cancer Institute

Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy 247,986

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Enderling,Heiko Spon National Cancer InstitutePredicting patient-specific responses to personalize androgen deprivation therapy for prostate cancer 127,016

110


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Enderling,Heiko Spon Ocala Royal DamesSimulating the effect of photoimmunotherapy on the ovarian cancer immune ecosystem 25,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Array BioPharma

A Phase Ib/II, Multicenter, Open-Label, Dose Escalation Study of LGX818 in Combination with MEK162 in Adult Patients with BRAF V600 - Dependent Advanced Solid Tumors 1,617

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Asana BioSciencesA Phase 1, Open-Label, Dose Finding Study of ASN007 in Patients with Advanced Solid Tumors 9,060

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Bristol-Myers Squibb Company

A Randomized, Double-Blind Phase 2/3 Study of Relatlimab Combined with Nivolumab versus Nivolumab in Participants with Previously Untreated Metastatic or Unresectable Melanoma 183,884

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon ECOGA Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma 16,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Hoffmann-La Roche Inc

A Phase III, Open-Label, Multicenter,Two-Arm, Randomized Study To Investigate The Efficacy And Safety Of Cobimetinib Plus Atezolizumab Versus Pembrolizumab In Patients With Previously Untreated Advanced Brafv600 Wild-Type Melanoma 4,655

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Immunocore, Ltd.

A Phase I/II, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 using the Intra-patient Escalation Dosing Regimen in Patients with Advanced Uveal Melanoma 4,049

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Merck & Company

Adjuvant Therapy with Pembrolizumab versus Placebo in Resected High-Risk Stage II Melanoma: A Randomized, Double-Blind Phase 3 Study (Keynote 716) 294,676

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Novartis Pharmaceutical CorporationPhase 1 Study of Trametinib + Ceritinib in Patients with Unresectable Melanoma 89,415

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Pfizer, Inc.

A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma 19,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Regeneron Pharmeceuticals, Inc.

A Phase 2 Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or were Intolerant of Prior Hedgehog Pathwa 109,079

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Senhwa Biosciences, Inc

A Phase I, Multi-Center, Open-Label, Treatment Duration Increment, Expansion, Safety, and Pharmacodynamic Study of CX-4945 Administered Orally Twice Daily to Patients with Advanced Basal Cell Carcinoma 94,272

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon SWOG - Southwest Oncology GroupA Phase II and Pilot Trial of PD-1 Blockade with MK-3475 (Pembrolizumab) in Patients with Resectable or Unsectable Desmoplastic Melanoma (DM) 31,466

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Tesaro, Inc.A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors 65,257

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon The HOPE Foundation

S2000: A Randomized Phase 2 trial of Encorafenib + Binimetinib + Nivolumab vs Ipilimumab + Nivolumab in BRAFV600-Mutant Melanoma Brain Metastases 12,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Eroglu,Zeynep Spon Vedanta BiosciencesPhase 1 Study of VE800 and Nivolumab in Patients with Selected Types of Advanced or Metastatic Cancer 162,183

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Etame,Arnold B Spon National Institute of Neurological DisorModulating Glioblastoma Stem Cell Clonal Evolution Towards Therapeutic Responsiveness 247,050

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Etame,Arnold B Spon Northwest BioTherapeutics, Inc.

A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme (GBM) 6,399

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Extermann,Martine Spon SWOG - Southwest Oncology Group

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. E3 Breast Cancer Study - Evalua 10,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Extermann,Martine Spon SWOG - Southwest Oncology GroupProspective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III 9,345

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Extermann,Martine Spon V Foundation for Cancer Research Personalizing the Care of Older Women with Ovarian Cancer 120,573 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Fleming,Jason Spon Houston Methodist Research Institute Center for Immunotherapeutic Transport Oncophysics PSOC-Project 2 18,150 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Fleming,Jason Spon Myst Therapeutics Myst – Moffitt Collaboration - Melanoma & Colorectal 957,970

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Fleming,Jason Spon NewLink Genetics CorporationLong Term Follow-Up Study for Subjects Previously Treated with Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy 4,350

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Fleming,Jason Spon University of Texas Targeted Inhibition in Stromal TGF Beta Activity in Pancreatic Cancer 73,214

111


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Flores,Elsa Spon APIS Assay Technologies - UKAssessing the role of TROLLs as markers of response to chemotherapy in TNBCs 455,788

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Flores,Elsa Spon H. Lee Moffitt Cancer Center Identifying metabolic vulnerabilities in lung cancer 150,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Flores,Elsa Spon National Cancer InstituteIdentification of Non-Coding RNAs to Therapeutically Target Undruggable Pathways in Metastatic Lung Adenocarcinma and Squamous Cell Carcinoma 938,802

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Flores,Elsa Spon National Cancer Institute Identifying metabolic vulnerabilities in lung cancer 2,060,040

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Alliance For Clinical Trials In Oncology

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation 3,300

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Bristol-Myers Squibb Company

A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects with Melanoma Metastatic to the Brain treated with Nivolumab in Combination with Ipilimumab followed by Nivolumab Monotherapy 1,325

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon ECOGChange in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma 2,680

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Global Coalition for Adaptive Research GBM Agile: Global Adaptive Trial Master Protocol 54,073

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Inovio Pharmaceuticals

An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma (GBM) 8,876

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Orbus Therapeutics, Inc.

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy 44,681

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Pfizer, Inc.Phase IB Study of Avelumab with Radiotherapy in Patients with Leptomeningeal Disease 88,379

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Forsyth,Peter A Spon Yale University

A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases 36,444

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Frakes,Jessica M Spon American Medical Association (AMA)Developing Video Content to Foster Leadership Education through Coaching and Emotional Intelligence 22,625

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Fridley,Brooke Spon Dana-Farber Cancer InstituteCurated Prostate Cancer Data for Novel and Reproducible Prognostic Modeling 64,211

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Fridley,Brooke Spon Natl Inst of Child Health & Human DeveloGenomic- and Ontogeny-Linked Dose Individualization and Clinical Optimization for Kids 29,104

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Fridley,Brooke Spon Univ of South FloridaAnalytical Interpretation of Unknown Metabolites in Untargeted Mass Spectrometry Cancer Studies 16,011

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Gatenby,Robert A Spon National Cancer Institute Cancer as a Complex Adaptive System 367,964

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gatenby,Robert A Spon National Cancer Institute Cancer as a Complex Adaptive System - FIU Diversity Supplement - Stimphill 3,979

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gatenby,Robert A Spon National Cancer InstituteThe Eco-Evolutionary Dynamics of Small Metastatic Population in Treatment Strategies for Prevention and Cure 500,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gilbert,Scott M Spon Patient Centered Outcomes Research InstiComparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) for Recurrent Bladder Cancer 12,308

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gilbert,Scott M Spon SWOG - Southwest Oncology Group

S1602: A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG‐Naïve High‐Grade Non‐Muscle Invasive Bladder Cancer. 32,466

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gillies,Robert J Spon Florida Department of HealthTargeting the Lipogenic Phenotype Induced by Extracellular Acidosis in Breast Cancer 71,076

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gillies,Robert J Spon Helix Biopharma CorpYear 3 of DOS47 (Cecam6-Targeted Urease) in Combination with Checkpoint Blockade 191,219

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Gillies,Robert J Spon National Cancer Institute Imaging Acidosis and Immune Therapy in PDAC 341,752 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Gillies,Robert J Spon National Cancer Institute Radiomics and Pathomics to Predict Upstaging of DCIS 666,847 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Gillies,Robert J Spon National Cancer Institute Radiomics of NSCLC 288,374

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gillies,Robert J Spon Vanderbilt UniversityCellular, Molecular and Quantitative Imaging Analysis of Suspicious Screening-Detected Lung Nodules 13,787

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon American Cancer Society Prevention of Infection Related Cancers 80,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon Cornell UniversityPartnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico 640,933

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon H. Lee Moffitt Cancer Center SARS-CoV-2 Immune Study Among Hillsborough County, Florida Residents 160,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon IQVIAHuman Papillomavirus (HPV) Oral Infection Study in the General Population: The PROGRESS Study 448,355

112


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon Medical College of WisconsinAnnual Anal Sampling Using DNA Screening to Identify Men Who Have Sex with Men at Increased Risk for Anal Cancer 120,348

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon Merck & Company

A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo- controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the Prevention of Oral Persisten 484,028

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon Merck & CompanySARS-CoV-2 Immune Surveillance Among a Population Based Sample of Adults in Florida 197,901

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Giuliano,Anna R Spon National Cancer InstituteInvestigation of Oral HPV Infection Natural HIstory and Biomarkers of Persistent Infection: The HIM Study 711,793

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gonzalez,Brian David Spon Gateway for Cancer Research FdtnImpact of Cytoreductive Radical Prostatectomy on Oncologic and Quality of Life Outcome in Men with Newly Diagnosed Metastatic Prostate Cancer 44,192

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gonzalez,Brian David Spon National Cancer InstituteIdentifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors 331,896

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gonzalez,Brian David Spon US Army Medical Research & Material CommIdentifying and Reducing Disparities in Symptom Burden Among African American Prostate Cancer Survivors 202,102

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gonzalez,Brian David Spon US Army Medical Research & Material CommMeasuring Patient-Reported Outcomes Related to Radiopharmaceuticals for Prostate Cancer 217,175

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Grass,George Spon H. Lee Moffitt Cancer CenterEvaluation of the Immunologic Contexture and Nectin-4 Axis in Penile Squamous Cell Carcinoma 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Grass,George Spon H. Lee Moffitt Cancer Center

Parallel Analysis of the Transcriptome, Proteome, and Phosphoproteome to IdentifyRegulators of Intrinsic Radiosensitivity in Muscle Invasive Bladder Cancer 33,725

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Aeglea Biotherapeutics

A Phase 1/2 Study Of Pegzilarginase (AEB1102, Co-Argi-PEG) In Combination With Pembrolizumab In The Treatment Of Patients With Extensive Disease (ED) Small Cell Lung Cancer (SCLC) 2,600

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Alliance For Clinical Trials In OncologyAdjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) 38,790

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Alliance For Clinical Trials In OncologyIntegration of Immunotherapy into Adjuvant Therapy For Resected NSCLC: Alchemist Chemo-IO 19,050

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Alliance For Clinical Trials In Oncology

Randomized Study of Erlotinib vs. Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) 6,750

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon AstraZeneca LtdA Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer 12,459

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon AstraZeneca Ltd

A Phase III, Open-label, Randomized Study of Osimertinib with or without Platinum Plus Pemetrexed Chemotherapy, as First-line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive, Locally Advanced or Metastatic Non-small C 95,017

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Bristol-Myers Squibb Company

A Phase 3, Randomized, Double-blind Study of Neoadjuvant Chemotherapy plus Nivolumab versus Neoadjuvant Chemotherapy plus Placebo, followed by Surgical Resection and Adjuvant Treatment with Nivolumab or Placebo for Participants with Resectable Stage II-I 51,856

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Calithera Biosciences, Inc.

A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat with Pembrolizumab and Chemotherapy Versus Placebo with Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small C 32,442

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Duke UniversityRace-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer 94,874

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon ECOG

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers 2,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Florida Department of HealthTargeting Immunosuppressive Cancer Associated Fibroblasts and Immune Checkpoints in NSCLC 368,828

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon G1 Therapeutics

Phase 1b/2 Safety, Pharmacokinetic, and Efficacy Study of G1T38 in Combination with Osimertinib in Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) 6,499

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon GenentechA Phase I/Ib Trial of Pirfenidone Combined with Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC 38,337

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Immunomedics, IncA Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients with Epithelial Cancer 35,034

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Ludwig Institute for Cancer ResearchA Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects with Non-small Cell Lung Cancer (NSCLC) 140,620

113


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Merck & Company

A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) 179,100


A Phase 3 Study of Pembrolizumab in Combination with Pemetrexed/Platinum (Carboplatin or Cisplatin) Followed by Pembrolizumab and Maintenance Olaparib vs Maintenance Pemetrexed in the First-Line Treatment of Participants with Metastatic Nonsquamous Non-S 308,036


A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants with Medically Inoperable Stages I or IIA Non Small Cell Lung Ca 5,600


A Randomized, Double-Blind, Phase III Study of Platinum+ Pemetrexed Chemotherapy with or without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-189) 2,554

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Novartis Pharmaceutical Corporation

A Phase II, Multicenter, Randomized, Two-Arm Study Of Capmatinib (INC280, An Oral MET Inhibitor) And Spartalizumab (PDR001, A PD-1 Inhibitor) Combination Therapy Versus Docetaxel In Pretreated Adult Patients With EGFR Wild-Type, ALK Rearrangement Negativ 5,365

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Pfizer, Inc.

A Phase 1B/2 Open-Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB00100718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies 169,285

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon Regeneron Pharmeceuticals, Inc.A Phase 1/2 Study of REGN5093 in Patients with Met-Altered Advanced Non-Small Cell Lung Cancer 50,252

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon SWOG - Southwest Oncology Group

LungMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer(Lung-MAP Screening Study)

3,758

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon SWOG - Southwest Oncology GroupPhase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer (Screening Step) 15,586

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gray,Jhanelle Elaine Spon US Army Medical Research & Material CommDefining Impact of HDAC Inhibitors on Tumor Immunogenicity, T Cell Functionality and PD-1 Blockade Response in NSCLC Patients 262,446

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Green,B. Lee Spon Florida Blue FdtnHealth Equity Leadership Program (HELP): An Equity of Care Catalyst Development Program 217,986

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gwede,Clement K Spon Florida Blue FdtnMoffitt Cancer Center Community CARES (Colorectal Cancer Awareness, Research, Education and Screening) Project 35,375

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gwede,Clement K Spon Florida Department of HealthCommunity CARES: A Multilevel Intervention to Increase Colorectal Cancer Screening Adherence in Community Clinics 161,590

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Gwede,Clement K Spon National Cancer InstituteCARES-REACH (Colorectal Cancer Awareness, Research, Education and Screening-Rural Expansion, Access and Capacity for Health) 617,969

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon AbbVie Inc.

A Phase 1, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combinations of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Subjects with Locally Advanced or Metastat 37,031


A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer 14,485


A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in 5,479

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Arvinas, Inc.

A Phase 1/2, Open-label, Dose Escalation, and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of ARV-471 in Patients with ER+/HER2- Locally Advanced or Metastatic Breast Cancer, Who Have Received Prior Hormonal T 844,910

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Bristol-Myers Squibb Company

Phase 1/2 Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab Combined with Daratumumab in Participants with Advanced or Metastatic Solid Tumors 7,350

114


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Carrick Therapeutics�

A Modular, Multipart, Multi-arm, Open-label, Phase 1/2a Study to Evaluate the Safety and Tolerability of CT7001 Alone and in Combination with Anti-Cancer Treatments in Patients with Advanced Malignancies 43,146

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Daiichi Sankyo Pharma Development (DSI)

A Phase 3, Multicenter, Randomized, Open-label, Active-Controlled Trial Of Ds-8201a, An Anti-Her2-Antibody Drug Conjugate (Adc), Versus Treatment Of Physicians Choice For Her2-low, Unresectable And/Or Metastatic Breast Cancer Subjects

112,694

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Eisai Company LtdA Phase I Dose Escalation Study of Eribulin in Combination with Weekly Carboplatin for the Treatment of Metastatic Breast Cancer 32,017

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon G1 Therapeutics

Phase 2 Study of the Safety, Efficacy, and Pharmacokinetics of G1T28 in Patients with Metastatic Triple Negative Breast Cancer Receiving Gemcitabine and Carboplatin Chemotherapy 28,740

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Hoffmann-La Roche Inc

A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine versus Trastuzumab as Adjuvant Therapy for Patients with HER2-Positive Primary Breast Cancer who Have Residual Tumor Present Pathologically 5,751

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon MD Anderson Cancer Center

A Randomized, Double-Blind, Placebo-Controlled Study of 4-Hydroxytamoxifen Topical Gel Among Women with Mammographically Dense Breast - TO11 (Project 4886) 11,610

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Novartis Pharmaceutical CorporationA Phase Ib/II, Multicenter, Study of the Combination of LEE011 and BYL719 with Letrozole in Adult Patients with Advanced ER+ Breast Cancer 937

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Pfizer, Inc.

Phase 1b Study To Assess The Safety, Tolerability, and Clinical Activity of Gedatolisib in Combination with Palbociclib and Either Letrozole Or Fulvestrant in Women with Metastatic or Locally Advanced/Recurrent Breast Cancer (Mbc)

119,048

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Phoenix Molecular Designs

Phase 1/1b Multicenter, Open-Label, First-in-Human Dose Escalation and Dose Expansion Study to Assess Safety and Tolerability of Orally Administered PMD-026 in Patients with Metastatic Breast Cancer with Expansion in Metastatic Triple Negative Breast Can 32,972

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Prescient Therapeutics Limited

A Phase I-II Study of PTX-200 Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients with Metastatic and Locally Advanced Breast Cancer 2,160

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon QuantumLeap Heathcare CollaborativeI-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) 160,403

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Seattle Genetics, Inc.

A phase 1, open-label, dose-escalation study to evaluate the safety and tolerability of SGN-LIV1A in patients with metastatic breast cancer

185,053

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Seattle Genetics, Inc.

Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination with Pembrolizumab for First-Line Treatment of Patients with Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer 26,021

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon TapImmune

A Randomized Multicenter Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of Vaccination with Folate Receptor Alpha Peptides with GM-CSF in Patients with Triple Negative Breast Cancer Defined as Primary Tumor that is Her2-neu Negativ 9,462

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Tesaro, Inc.

An Open-Label, Single-Arm Pilot Study Evaluating The Antitumor Activity And Safety Of Niraparib As Neoadjuvant Treatment In Localized, Her2-Negative, Brca-Mutant Breast Cancer Patients 2,688

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Han,Hyo Sook Spon Zymeworks, Inc.A Phase 1 Study of ZW49 in Patients with Locally Advanced (Unresectable) or Metastatic HER2-Expressing Cancers 433,817

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Criterium, Inc.Phase 2 Trial of Brigatinib After Treatment with Next-Generation ALK Inhibitors in Refractory ALK Rearranged NSCLC 11,965

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Elevation Oncology, Inc

CRESTONE: A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors 20,569

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Genentech

A Phase II, Open-Label, Multicenter, Single-Arm Study To Investigate TheEfficacy And Safety Of Atezolizumab As Neoadjuvant And Adjuvant Therapy In Patients With Stage Ib, Ii, Iiia Or Selected Iiib Resectable And Untreated Non-Small Cell Lung Cancer 42,504

115


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon H. Lee Moffitt Cancer Center

Defining KRAS-G12C Inhibitor Antitumor Synergy with Adoptive T Cell Therapy Through Potentiation of Cytokine Signaling and Sensitization to Cell Death 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Janssen Pharmaceutica Inc

A First-in-Human Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of JNJ-74699157 in Participants with Advanced Solid Tumors Harboring the KRAS G12C Mutation 41,704


A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Subjects with Advanced Non-Small Cell Lung Cancer 251,729


An Open-label Phase 1/1b Study to Evaluate the Safety and Pharmacokinetics of JNJ-73841937 (Lazertinib), a Third Generation EGFR-TKI, as Monotherapy or in Combinations With JNJ-61186372, a Human Bispecific EGFR and cMet Antibody in Participants with Adva 32,442

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Haura,Eric B Spon National Cancer Institute Validation of EGFR Protein Complexes as Molecular Diagnostics 313,587

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Revolution MedicinesA Phase 1, Open-Label, Multicenter, Dose-Escalation Study of RMC-4630 Monotherapy in Adult Participants with Relapsed/Refractory Solid Tumors 338,913

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Revolution MedicinesA Phase 1/1b, Open-Label, Multicenter, Dose-Escalation Study of RMC-5552 Monotherapy in Adult Subjects with Relapsed/Refractory Solid Tumors 32,972

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Revolution Medicines

A Phase 1b/2, Open-Label, Multicenter Dose-Escalation and Dose-Expansion Study of the Combination of RMC-4630 and Cobimetinib in Adult Participants with Relapsed/Refractory Solid Tumors with Specific Genomic Aberrations 135,180

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Revolution MedicinesExploring Correlation Between EGFR/MET Activation Status and RMC-4630 Sensitivity in Tumor Tissue Using PLA Assays 179,066

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Revolution Medicines

Exploring Correlation Between RTK Activation Status and KRAS G12C(ON) Inhibitor Sensitivity, and Developing New PLA Assays to Inform RAS and mTOR Pathways 137,953

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Spectrum Pharmaceuticals

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer, (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) 485,493

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Haura,Eric B Spon Stand Up To Cancer Tumor Infiltrating Lymphocyte Adoptive T Cell Therapy for NSCLC 128,690 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Haura,Eric B Spon The Salah Foundation Lung Cancer Diagnostic Testing Program 469,647

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon University of California Los AngelesPrecision Lung Cancer Therapy Design Through Multiplexed Adapter Measurement 138,073

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Haura,Eric B Spon University of ColoradoThe Role of EGFR as a Mechanism of Therapeutic Resistance in Gene Fusion Positive Lung Cancer 26,365

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Heine,John J Spon National Cancer Institute Moffitt Imaging Biomarker Validation Center 124,225

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Hwu,Patrick Spon Adelson (Miriam & Sheldon) Medical Res FIdentifying tumor-intrinsic resistance mechanisms in melanoma patients upon treatment with immunotherapy. 450,319

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Michael Spon H. Lee Moffitt Cancer CenterPlasma Exosomes as Mediators of Systemic Inflammation and Resistance to Therapy in Large B Cell Lymphoma 41,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Michael Spon Kite Pharma Inc.

A Phase 1/2 Multicenter Study Evaluating the Safety And Efficacy Of Axicabtagene Ciloleucel in Combination with Utomilumab in Subjects with Refractory Large B-Cell Lymphoma (Zuma-11) 419,493

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Bavarian Nordic

A Phase 2, Multicenter, Single-Arm Trial of CV301 in Combination with PD-1/L1 Blockade in Patients with Locally Advanced or Metastatic Urothelial Bladder Cancer 47,272

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Bristol-Myers Squibb Company

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-I 26,256

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Bristol-Myers Squibb CompanyA Phase 3b/4 Safety Trial of Nivolumab (BMS-936558) in Subjects with Advanced or Metastatic Renal Cell Carcinoma 11,299

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Bristol-Myers Squibb Company

A Randomized, Open-Label, Phase 3 Study of Nivolumab (BMS-936558) vs Everolimus in Subjects with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy 15,372

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Calithera Biosciences, Inc.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination with Cabozantinib (CB-Cabo) vs. Placebo with Cabozantinib (Pbo-Cabo) in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC) 40,886

116


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Cancer Immunotherapy Trials Network (CIT

A Randomized Phase II Study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma 22,400

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Eisai Company Ltd

A Single-Arm, Multicenter, Phase 2 Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination with Everolimus in Subjects with Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received any Chemotherapy 12,072

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Huntsman Cancer InstituteCabozantinib plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma (PemCab) 106,220

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Immunomedics, Inc

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy 277,127

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Immunomedics, IncCombination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients 68,326

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Mirati Therapeutics

A Phase 2 Study of Sitravatinib in Combination with PD-(L)1 Checkpoint Inhibitor Regimens in Patients with Advanced or Metastatic Urothelial Carcinoma 32,442

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon PrECOG, LLCPhase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer 6,318

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jain,Rohit Kumar Spon Seattle Genetics, Inc.

An Open-Label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination with Pembrolizumab with or without Chemotherapy, versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer 151,322

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Ji,Haitao Spon H. Lee Moffitt Cancer CenterFirst-in-Class Beta-Catenin/BCL9 Antagonists for Treatment of Triple Negative Breast Cancer 40,700

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jim,Heather S Spon Cedars-Sinai Medical CenterNovel Biomarkers for Cancer-Related Fatigue: Integrating Metabolomics, Genomics and Behaviors 277,702

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Jim,Heather S Spon Georgetown University Older Breast Cancer Patients: Risk for Cognitive Decline 6,807

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jim,Heather S Spon H. Lee Moffitt Cancer CenterUnderstanding Cellular Mechanisms Associated with Chemotherapy-Induced Mytoxicity in Ovarian Cancer Patients 37,492

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jim,Heather S Spon Kite Pharma Inc.Survivorship in Lymphoma Patients Treated with Axocabtagene Ciloleucel: Neurocognitive and Patient-Reported Outcomes 192,704

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jim,Heather S Spon National Cancer InstituteImproving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome 683,533

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jim,Heather S Spon National Cancer InstituteRandomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue 241,906

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Jim,Heather S Spon Ponce School of Medicine & Health SciencPHSU Specialized Center in Health Disparities: Biopsychosocial Predictors of Tumor Associated Inflammation and Progression 37,186

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Johnson,Nancy Gillis Spon H. Lee Moffitt Cancer Center Clonal Hematopoiesis as a Risk Factor for Patients with Multiple Myeloma 100,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kanetsky,Peter A Spon American Cancer Society Using MC1R Genotype to Impact Melanoma Risk Behavior 10,331 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kanetsky,Peter A Spon H. Lee Moffitt Cancer Center Exercise to Boost Response to Checkpoint Blockade Immunotherapy 25,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kanetsky,Peter A Spon National Cancer Institute Epidemiology and Biology of lnc RNAs in Ovarian Cancer 786,838

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kanetsky,Peter A Spon National Cancer Institute Moffitt Postdoctoral Training Program in Molecular Epidemiology of Cancer 8,039 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kanetsky,Peter A Spon University of Pennsylvania Post Genome-wide Association Studies in Testicular Germ Cell Tumors 287,080 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Karreth,Florian Spon Florida Department of Health Elucidating PTEN tumor suppression in melanoma 200,408 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Karreth,Florian Spon H. Lee Moffitt Cancer Center Elucidate the Tumor Suppressive Function of BACH2 in Melanoma 25,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Karreth,Florian Spon H. Lee Moffitt Cancer CenteriGEMMs: Using Chimeras to Study Immune Cell Functions in Autochthonous Melanomas 75,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Karreth,Florian Spon Melanoma Research Foundation Using the ESC-GEMM Approach to Study Mucosal Melanoma In-Vivo 8,470 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Karreth,Florian Spon National Cancer Institute Chromosome 1q ceRNAs in melanoma progression and metastasis 416,938

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kelley,Linda L Spon Natl Heart Lung and Blood InstProduction Assistance for Cellular Therapies (PACT) - Cell Processing Facilities 136,682

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khong,Hung Spon AstraZeneca Ltd

A Phase II Trial With Safety Run-In Of Neoadjuvant Therapy With An Aromatase Inhibitor In Combination With Durvalumab (Medi4736) In Postmenopausal Patients With Hormone-Receptor-Positive Breast Cancer

28,035

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khong,Hung Spon NSABP Foundation

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal R 66,633

117


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khong,Hung Spon Radius Pharmaceuticals, Inc.

Elacestrant Monotherapy VS. Standard of Care for the Treatment of Patients with ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-Label, Active-Controlled, Multicenter Trial (EMERALD) 217,210

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Bristol-Myers Squibb Company

A Phase 1/2 Dose Escalation and Cohort Expansion Study of the Safety and Tolerability of Urelumab Administered in Combination with Nivolumab in Advanced /Metastatic Solid Tumors and B Cell Non-Hodgkins Lymphoma 53,700


A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced 75,258


A Phase 3, Randomized Study of Adjuvant Immunotherapy with Nivolumab Combined with Ipilimumab Versus Ipilimumab or Nivolumab Monotherapy after Complete Resection of Stage IIIb/c/d or Stage IV Melanoma 105,652


A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Nivolumab versus Ipilimumab after Complete Resection of Stage IIIb/c or Stage IV Melanoma in Subjects who are at High Risk for Recurrence 31,654


A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic Melanoma 346,889

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Bristol-Myers Squibb CompanyA Phase 4 Pan-Tumor Study of Long Term Follow up for Cancer Survivors treated with Nivolumab or Nivolumab Combination Therapy 104,586


A Randomized, Open-Label Phase 3 Trial of BMS-936558 (Nivolumab) versus Investigator's Choice in Advanced (Unresectable or Metastatic) Melanoma Patients Progressing Post Anti-CTLA-4 Therapy. 9,350

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Bristol-Myers Squibb CompanyA US Multisite Observational Study in Patients with Unresectable and Metastatic Melanoma: the OPTIMIzE Study 30,124


An Open-Label, Randomized, Phase 2 Study of Nivolumab Given Sequentially with Ipilimumab in Subjects with Advanced or Metastatic Melanoma 3,716


Phase IIIb/IV, Randomized, Double Blinded, Study of Nivolumab 3 mg/kg in Combination with Ipilimumab 1 mg/kg vs Nivolumab 1 mg/kg in Combination with Ipilimumab 3 mg/kg in Subjects with Previously Untreated, Unresectable or Metastatic Melanoma 81,791

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon HUYA Bioscience

A Phase 1b/2 Study to Assess the Safety and Efficacy of HBI-8000 in Combination with Nivolumab in Patients with Advanced Solid Tumors Including Melanoma, Renal Cell Carcinoma (RCC) and Non-Small Cell Lung Cancer (NSCLC) 661,556

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon National Cancer InstituteImmune Checkpoint Blockade for Kidney Transplant Recipients with Selected Unresectable or Metastatic Cancers 12,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Novartis Pharmaceutical Corporation

A Randomized, Open-label, Multi-arm, Two-part, Phase II Study to Assess the Efficacy and Safety of Multiple LXH254 Combinations in Patients with Previously Treated Unresectable or Metastatic BRAFV600 or NRAS Mutant Melanoma 72,483

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Regeneron Pharmeceuticals, Inc.A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II to IV (M0) Cutaneous Squamous Cell Carcinoma (CSCC) 255,466

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Regeneron Pharmeceuticals, Inc.

A Phase 2 Study of REGN2810, A Fully Human Monoclonal Antibody to Programmed Death 1(PD-1), in Patients with Advanced Cutaneous Squamous Cell Carcinoma 97,150

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Regeneron Pharmeceuticals, Inc.

A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma 28,901

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Regeneron Pharmeceuticals, Inc. CemiplimAb Survivorship Epidemiology (CASE) Study 48,069

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon Replimune, Inc

A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination with RP1 in Patients with Advanced Cutaneous Squamous Cell Carcinoma

183,709

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon SWOG - Southwest Oncology Group

A Phase II Randomized Study of Nivolumab (NSC-748726) with Ipilimumab (NSC-732442) OR Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD-1 or Anti-PD-L1 Agent 7,250

118


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Khushalani,Nikhil Spon SWOG - Southwest Oncology Group

A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma 47,899

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kim,Dae Won Spon Bold Therapeutics - Canada Evaluation of BOLD-100 and combination therapy for PDAC 70,621

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Bayer Healthcare Pharmaceuticals

A Multicenter, Non-Randomized, Open-label Dose Escalation Phase Ib Study of Regorafenib in Combination with Pembrolizumab in Patients with Advanced Hepatocellular Carcinoma (HCC) with No Prior Systemic Therapy 53,249

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Bayer Healthcare PharmaceuticalsMulti Institutional Phase II Trial of Single Agent Regorafenib in Refractory Advanced Biliary Cancers 59,111

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Bayer Healthcare PharmaceuticalsPhase II study of Copanlisib (BAY 80-6946) in Combination with Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma.. 23,538

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Bristol-Myers Squibb Company

A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma Who Are at High Risk of Recurrence after Curative Hepatic Resection or Ablation 67,948

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Eisai Company LtdPhase I Study of Pre-operative Capecitabine and Lenvatinib with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma 67,264

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon EMD Serono, Inc

A Phase II, Multicenter, Open-label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or are Intolerant to First-line Platinum-Based Chemotherapy 9,367

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Hoffmann-La Roche Inc

A Phase III, Open-Label, Randomized Study Of Atezolizumab In Combination With Bevacizumab Compared With Sorafenib In Patients With Untreated Locally Advanced Or Metastatic Hepatocellular Carcinoma 22,415

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Janssen Pharmaceutica IncA Phase I/II Study of Pembrolizumab in Combination with Ibrutinib for Advanced, Refractory Colorectal Cancers 1,012

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Lexicon Pharmaceuticals, Inc.

A Phase 2, Multicenter, Open-label, Safety and Efficacy Study of XERMELO® (Telotristat Ethyl) plus First-line Chemotherapy in Patients with Locally Advanced, Unresectable, Recurrent or Metastatic Biliary Tract Cancer (BTC) 367,161

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon MacroGenics, Inc.

A Phase 1b/2, Open Label, Dose Escalation Study of MGD007, a Humanized gpA33 x CD3 DART Protein in Combination with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Metastatic Colorectal Carcinoma 4,182

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon MedImmune LLCA Phase 1/2 Study of Durvalumab and Monalizumab in Adult Subjects with Select Advanced Solid Tumors 5,850

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Merck & Company

A Phase 1b Multi-cohort Study of the Combination of Pembrolizumab (MK-3475) plus Binimetinib alone or the Combination of Pembrolizumab plus Chemotherapy with or without Binimetinib in Participants with Metastatic Colorectal Cancer (KEYNOTE-651) 383,676

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon NeoImmuneTech, Inc.

An Open-label Phase 1b/2a Study of NT-I7 (Hyleukin-7) in Combination with Pembrolizumab in Subjects with Relapsed/Refractory Advanced Solid Tumors 834,347

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Relay Therapeutics, Inc.

A First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors 102,111

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Takeda Pharmaceuticals USA, Inc.

An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-164, an Antibody-Drug Conjugate, in Patients with Advanced Gastrointestinal Cancers Expressing Guanylyl Cyclase C 66,725

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Richard Spon Tesaro, Inc.

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-033, an anti-LAG-3 Monoclonal Antibody, alone and in combination with an anti-PD-1 in Patients with Advanced Solid Tumors 391,587

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Sungjune Spon Bristol-Myers Squibb Company

Companion Biomarker Study for the Phase II Randomized study of Nivolumab, Ipilimumab with or without Stereotactic Body Radiation Therapy in Metastatic or Recurrent Merkel Cell Carcinoma 73,550

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kim,Sungjune Spon National Cancer InstituteEpigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy 164,160

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kim,Sungjune Spon National Cancer Institute Role of Sirt2 in T Cell Metabolism 376,751

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kirtane,Kedar Spon ECOGAssessing distress in family caregivers of patients receiving cellular therapies: a mixed-methods needs assessment 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kirtane,Kedar Spon Kite Pharma Inc.

A Phase 1 Study Evaluating the Safety and Efficacy of HPV16 E7 T Cell Receptor Engineered T Cells (KITE-439) in HLA-A*02:01+Subjects with Relapsed/Refractory HPV16+ Cancers 197,243

119


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kirtane,Kedar Spon National Comprehensive Cancer Network (N

The feasibility of a digitized peer-to-peer patient support system for patients with locally advanced head and neck cancer undergoing chemoradiation 74,306

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon AbbVie Inc.A Phase 2 Single-Arm, Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax in Combination with Ruxolitinib in Subjects with Myelofibrosis 93,391

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon Boehringer Ingelheim Pharm., Inc.

A Phase I/II, Multicenter, Open-label, Dose Escalation and Randomized Trial of BI 836858 in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes 16,395

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon Celgene Corporation

A Phase 2, Multicenter, Open-Label Study To Evaluate The Efficacy And Safety Of Luspatercept (Ace-536) In Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis And Anemia With And Without Red Blood Cell-Transfusion Dependence 120,591


A Phase 3, Double-Blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept(ACE-536) Versus Placebo for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndrome in Subjects with Ring Sideroblasts 23,021


A Phase 3, Open-Label, Randomized Study To Compare The Efficacy And Safety Of Luspatercept (Ace-536) Versus Epoetin Alfa for the Treatment Of Anemia Due To IPSS-R Very Low, Low Or Intermediate Risk Myelodysplastic Syndromes (Mds) In Esa Naïve Subjects Wh 46,968


A Phase 3B, Open-Label, Single-Arm, Rollover Study to Evaluate Long-Term Safety in Subjects Who Have Participated in Other Luspatercept(ACE-536) Clinical Trials 20,595

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon ECOG

Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia

47,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon Geron Corporation

A Randomized, Single-Blind, Multicenter Phase 2 Study to Evaluate the Activity of 2 Dose Levels of Imetelstat in Subjects with Intermediate-2 or High-Risk Myelofibrosis (MF)Relapsed/Refractory to Janus Kinase (JAK) Inhibitor 10,842

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon H3 Biomedicine, Inc.

An Open-label, Multicenter Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia 7,262

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon Incyte Corporation

Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving Et-Directed Therapy 46,074

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon Lixte Biotechnology Holdings, Inc

A Phase 1b/2 Study Evaluating the Safety and Efficacy of Intravenous LB-100 in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) who had Disease Progression or are Intolerant to Prior Therapy 34,580

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon MedPacto, IncPhase 1/2 Study of TEW-7197 Monotherapy in Patients with Low or Intermediate Myelodysplastic Syndromes (MDS) 250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Komrokji,Rami S Spon Millenium Pharmaceuticals

A Phase 2, Randomized, Controlled, Open-Label, Clinical Study of the Efficacy and Safety of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Low-Bla 69,299

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Koomen,John M Spon Florida Department of HealthProteogenomics of Metastatic Heterogeneity and Therapeutic Resistance inLung Cancer 115,737

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Koomen,John M Spon Leidos, Inc CPTAC Phase III 58,083

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kumar,Nagalakshmi Bhagavath Spon ECOG

ECOG-ACRIN NCORP Research Base -CT (A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers) 110,303

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kumar,Nagalakshmi Bhagavath Spon Florida Department of HealthPhase II Trial of Investigational Agents to Modulate Intermediate Endpoint Biomarkers, Including Pulmonary Nodules, in Former Smokers 142,081

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kumar,Nagalakshmi Bhagavath Spon MD Anderson Cancer Center


120


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Kumar,Nagalakshmi Bhagavath Spon MD Anderson Cancer Center


USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Kumar,Nagalakshmi Bhagavath Spon National Cancer Institute Phase II Clinical Trial of GTC in Men on Active Surveillance 615,210

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon Celator Pharmaceuticals

Phase III, Multicenter, Randomized, Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients 60-75 Years of Age with Untreated High Risk (Secondary) AML 1,646

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon Celgene Corporation

A Phase 1/2, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-221 in Subjects with Advanced Hematologic Malignancies with an IDH2 Mutation 7,783

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon Celgene Corporation

A Randomized Multicenter, Open-label, Phase 2 Study Evaluating the Efficacy and Safety of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects with Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly ( 21,373

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon H. Lee Moffitt Cancer CenterNovel First in Class Drug Combination for the Treatment of Acute Myeloid Leukemia 33,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon National Cancer InstituteNCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study 8,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon Pfizer, Inc.A Phase II Study Evaluating the Oral Smoothened Inhibitor PF-04449913 in Patients with Myelodysplastic Syndrome 34,862

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon Pfizer, Inc.

Gemtuzumab Ozogamicin (Mylotarg) Expanded Access Protocol for Treatment of Patients in the United States with Relapsed/Refractory Acute Myelogenous Leukemia Who May Benefit from Treatment and Have No Access to Other Comparable/Alternative Therapy 300

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon Prescient Therapeutics LimitedA Phase I-II Study of Triciribine Phosphate Monohydrate (PTX-200) Plus Cytarabine in Refractory or Relapsed Acute Leukemia 62,576

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Lancet,Jeffrey E Spon University Health Network North American Star Consortium 223,009

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lau,Eric Spon H. Lee Moffitt Cancer CenterBridging the Melanoma Gender Gap: How Androgen Regulates Fucosylation & Immunotherapy Efficacy 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lau,Eric Spon National Cancer InstituteEnhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation 457,831

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Lawrence,Harshani R Spon National Cancer Institute Developing Chemical Probes for Oncogenic Signaling Pathways 197,614

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lawrence,Nicholas Spon Florida Department of HealthNovel Monovalent and Bivalent JAK2 Inhibitors for Targeted MPN and Cancer Therapies 275,987

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lazaryan,Aleksandr Spon H. Lee Moffitt Cancer Center

Targeting GM-CSF to reduce toxicity and enhance efficacy of Axicabtagene Ciloleucel and Tisagenlecleucel recipients with Aggressive Large B-cell Lymphoma 44,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lazaryan,Aleksandr Spon Incyte CorporationA Phase 2, Single-Arm, Open-Label Study of Itacitinib, for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy 232,743

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lazaryan,Aleksandr Spon Kadmon Corporation, LLC

A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study) 71,408

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lazaryan,Aleksandr Spon Kite Pharma Inc.

A Phase 1/2 Open-label, Multicenter Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-Cell Lymphoma (ZUMA 19) 32,622

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Lazaryan,Aleksandr Spon US Army Medical Research & Material Comm Promoting an Effective Immune Response in Lymphoma 122,920

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lee,M. Catherine Spon Avelas Biosciences, Inc.An Open-Label, Single-Arm, Phase 2 Study Of Avb-620 In Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery 5,925

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lee,M. Catherine Spon Elucent MedicalPhysician Initiated Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses 26,113

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Lee,M. Catherine Spon H. Lee Moffitt Cancer Center Conjugates for Detection of Breast Cancer Nodal Metastasis 30,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lee,M. Catherine Spon Lumicell

Pivotal Study of the Lum Imaging System For Assisting Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Patient with Breast Cancer 70,717

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Liu,James Spon Oncosynergy, Inc. Correlative study on OS2966 binding activity in glioma 99,512

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Allogene Therapeutics

A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-501, an Anti-CD19 Allogeneic Car T Cell Therapy, and ALLO-647, an Anti-CD52 Monoclonal Antibody, in Patients with Relapsed/Refractor 781,946

121


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Allogene Therapeutics

A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmocodynamics of ALLO-501A, an Anti-CD19 Allogeneic Car T Cell Therapy in Subjects with Relapsed/Refractory Large B-Cell Lymphoma (LBCL) 395,278

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon I.R.I.S. Servier

Long-term Follow-Up Study of Patients Who Have Previously Been Exposed to UCART19/ALLO-501 (Allogeneic Engineered T-Cells Expressing a Lentiviral-Based Anti-CD19 Chimeric Antigen Receptor) 29,574

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Kite Pharma Inc.

A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Combination with Atezolizumab in Subjects with Refractory Diffuse Large B-Cell Lymphoma (DLBCL) 43,908

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Kite Pharma Inc.A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL) 72,510

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Kite Pharma Inc.A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-X19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) 130,602


A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7) 278,654


Multicenter, Open-Label, Expanded Access Study of Axicabtagene Ciloleucel or the Treatment of Subjects with Relapsed/Refractory Large B-Cell Lymphoma

192,442

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Kite Pharma Inc.Predictive Markers and Evolutionary Dynamics of Axicabtagene Ciloleucel in NHL patients 570,389

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Kite Pharma Inc. Severe ER stress limits the efficacy of promising CAR-T cell treatments 262,933

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Locke,Frederick L Spon Leukemia and Lymphoma SocietyClinical investigation to improve efficacy of CAR-T Cell Therapy for Large B Cell Lymphoma 60,803

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lopchuk,Justin Spon American Chemical SocietyThe Design of Novel Stable, Strained Diazirines for Fuctionalization in Organic Synthesis 55,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Lopchuk,Justin Spon National Science Foundation Novel Methods for Radical and Electrophilic Amination 149,688 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Luca,Vincent Spon Florida Department of Health Notch signaling boosts T cell-based immunotherapy 68,964

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Luca,Vincent Spon Natl Insti of Gen Medical ScienceIlluminating Notch receptor-ligand selectivity through structure-guided protein engineering 430,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Luca,Vincent Spon Rita Allen FoundationReprogramming Transmembrane ubiquitin Ligases To Control Cell Surface Receptor Landscapes. 100,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Luca,Vincent Spon V Foundation for Cancer Research Structure-guided engineering of Lag3 immunomodulatory function 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lynch,Conor Spon National Cancer Institute

Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach 499,493

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lynch,Conor Spon National Cancer InstituteLocal and Systemic Control of Multiple Myeloma Colonization and Growth by MMP-13 326,532

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Lynch,Conor Spon US Army Medical Research & Material CommMesenchymal Stem Cell Control of Metastatic Prostate Cancer Cell Evolution and Therapy Resistance in the Bone Microenvironment 344,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Malafa,Mokenge P Spon H. Lee Moffitt Cancer CenterResponse to Aspirin Prevention of Colorectal Cancer Mortality in African Americans 75,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Malafa,Mokenge P Spon Oncologie, Inc. Phenotyping the Microenvironment in GI Cancers 413,481

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Manley,Brandon Spon Kidney Cancer Association (KCA)Investigation of the Aberrant Epidermal Growth Factor Receptor Splicing Proteome to Determine Drug Repurposing Strategies for ccRCC 75,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Manley,Brandon Spon US Army Medical Research & Material CommKC180036-Modeling Spatial Ecology in Clear Cell Renal Cell Carcinoma Model: A Novel Tool to Support Drug Sequencing Decisions 16,095

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Manley,Brandon Spon US Army Medical Research & Material CommKC180139-Deciphering the Role of EGFR Splice Variants and Tumor-Immune Microenvironment in Renal Cell Carcinoma 161,864

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Mann,Karen Spon Pancreatic Cancer Action Network RBFOX2-mediated Alternative Splicing in Pancreatic Cancer Metastasis 2,414

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mann,Michael B Spon H. Lee Moffitt Cancer CenterDissecting the Roles of ZMIZ1 Isoforms in Cutaneous Squamous Cell Carcinoma Initiation and Progression 25,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Markowitz,Joseph Spon Merck & Company

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial 19,410

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Markowitz,Joseph Spon Microba Pty Ltd - AustraliaFeasibility Assessment and Design of Microbiota Collection Study from Patients Receiving Checkpoint Blockade 19,266

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Markowitz,Joseph Spon Morphogenesis

Phase 1 Study Using a Plasmid DNA Coding for Emm55 Streptococcal Antigen in Patients with Unresectable Stage III or Stage IV Cutaneous Melanoma 36,365

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Markowitz,Joseph Spon The Jackson LaboratoryCompartmentalized and Systemic Interactions of the Skin Microbiome in Cancer Immunotherapy Response 20,153

122


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Martinez Pradeda,Ursula Spon National Cancer InstituteMotivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility 30,997

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Marusyk,Andriy Spon American Cancer SocietyPerturbing the Evolutionary Drivers of Targeted Therapy Resistance in NSCLC 65,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Marusyk,Andriy Spon Cleveland Clinic FloridaExploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer 133,407

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Marusyk,Andriy Spon Florida Breast Cancer FoundationDisrupting Microenvironment-Mediated Tumor Repopulation Dynamics During Therapy to Improve Cure Rates in Triple Negative Breast Cancer 34,975

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Marusyk,Andriy Spon Florida Department of HealthImpact of Stromal Architecture on the Response of Lung Cancers to Targeted Therapies 247,571

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Marusyk,Andriy Spon H. Lee Moffitt Cancer CenterDeciphering Evolutionary Dynamics of Acquired Resistance to Targeted Therapies in Lung Cancers. 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Marusyk,Andriy Spon US Army Medical Research & Material CommDisrupting Resistance to Targeted Therapies in NSCLC with Evolutionary Informed Therapies 288,225

USF Health-Morsani College Department of Interdisciplinary Oncology PI: McDonald,Patricia Spon H. Lee Moffitt Cancer Center“Interrogating Synergy between GPR161 inhibition and RAF/MEK inhibition” 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: McDonald,Patricia Spon H. Lee Moffitt Cancer CenterPromoting healthy adipocyte function: a novel therapeutic strategy to uncouple obesity from metabolic disease and co-morbidities 65,350

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: McDonald,Patricia Spon Montana Molecular A robust assay for detecting agonist bias in living cells 144,747

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Meade,Cathy D Spon National Cancer Institute1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities 126,244

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Bristol-Myers Squibb Company

A Randomized Phase 3 Study of Nivolumab plus Ipilimumab or Nivolumab Combined with Fluorouracil plus Cisplatin versus Fluorouracil plus Cisplatin in Subjects with Unresectable Advanced, Recurrent or Metastatic Previously Untreated Esophageal Squamous Cel 4,516

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Cornell University

Phase II Study of Short Course FOLFOX Chemotherapy with Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) 32,916

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Debiopharm SA

A Phase II basket study of the oral selective pan-FGFR inhibitor Debio 1347 in subjects with solid tumors harboring a fusion of FGFR1, FGFR2 or FGFR3 "The FUZE Clinical Trial" 27,642

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Indiana University

A Phase II Study Evaluating Safety and Efficacy of Niraparib in Patients with Previously Treated Homologous Recombination (HR) Defective or Loss of Heterozygosity (LOH) high Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma 4,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Karyopharm Therapeutics Inc.

An Investigator-Initiated Phase II Study of Selinexor in Combination with Pembrolizumab in Advanced PD-L1 Positive Gastroesophageal Junction and Gastric Adenocarcinomas 11,452

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Washington University, St. LouisRamucirumab Plus Irinotecan in Patients with Previously Treated Advanced Gastric or Gastro-Esophageal Junction Adenocarcinoma 10,800

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mehta,Rutika Spon Zymeworks, Inc.Phase 2 Study of ZW25 Plus First-line Combination Chemotherapy in HER2-Expressing Gastroesophageal Adenocarcinoma (GEA) 6,440

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mo,Qianxing Spon Cedars-Sinai Medical CenterTumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches 3,497

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mo,Qianxing Spon University of Texas(00007009) Mechanisms of Radioresistance and Strategies for Radiosensitization in OCCC 14,842

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Monastyrskyi,Andrii Spon Florida Breast Cancer FoundationIrreversible targeting of the CDK12 active site tyrosine residue for treatment of brain metastatic breast cancers 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Monteiro,Alvaro N Spon European Commission A Systems Biology Approach to Tackle PARP-Inhibitors Resistance and Identify Novel Therapeutic Targets to Overcome It 15,709

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Monteiro,Alvaro N Spon H. Lee Moffitt Cancer CenterModeling the Effects of BRCA1 Mutations in Ovarian Cancer in African-American Women 75,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Monteiro,Alvaro N Spon National Cancer Institute Resistance and Response Signaling to PARP1 inhibitors in Ovarian Cancer 230,992

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mullinax,John E Spon AmgenA Phase II Study of Talimogene Laherparepvec (T-VEC) in the Treatment of Locally Advanced Cutaneous Angiosarcoma 43,789

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mullinax,John E Spon National Cancer InstituteLeveraging the Lymphocytic Infiltration of Soft Tissue Sarcoma for Autologous Cellular Immunotherapy 245,296

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Mullinax,John E Spon Ocala Royal DamesDevelopment of Expanded Access Criteria for Adoptive Cell Therapy in Soft Tissue Sarcoma 25,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Muzaffar,Jameel Spon Weil Foundation Introducing Integrative Oncology at Moffitt Cancer Center 20,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Naghavi,Arash O Spon H. Lee Moffitt Cancer CenterGenomic Based Personalization of Radiotherapy for Retroperitoneal Sarcoma 40,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Nieder,Michael L Spon All Children's Hospital Cancer Care Delivery Research Study Chair: COG NCORP Research Base 3,877

123


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Nieder,Michael L Spon Columbia UniversityProbiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer 27,876

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Nishihori,Taiga Spon Celyad

An Open-Label Phase I, Multi-Center Study to Determine the Recommended Dose of the Chimeric Antigen Receptor T-cell Treatment CYAD-211 After a Non-Myeloablative Preconditioning Chemotherapy in Multiple Myeloma Patients with Relapsed or Refractory Disease 76,065

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Nishihori,Taiga Spon GlaxoSmithKline

Open-Label Randomized Pilot Study to Assess the Safety, Tolerability and Antitumor Activity of Genetically Engineered NY-ESO-1 Specific (c259) T Cells Alone or in Combination with Pembrolizumab in HLA-A2+ Subjects with NY-ESO-1 and/or LAGE-1a Positive Re 12,756

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Nishihori,Taiga Spon Novartis Pharmaceutical CorporationEvaluation of Panobinostat (LBH589) as Maintenance Therapy in Multiple Myeloma Following Autologous Hematopoietic Cell Transplantation 6,336

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Nishihori,Taiga Spon SWOG - Southwest Oncology Group

Phase III Study Of Daratumumab/Rhuph20 (Nsc- 810307) + Lenalidomide Or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapy In Patients With Multiple Myeloma (MM) Using Minimal Residual Disease To Direct Therapy Duration (DRAMMATIC ST 50,180

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Nishihori,Taiga Spon University of NebraskaA Single Arm, Open Label, Phase II Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease after Failure of Systemic Glucocorticoids 55,835

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Oswald,Laura B Spon H. Lee Moffitt Cancer CenterPilot Feasibility Study to Collect PROs and Biometric Data during Cellular Immunotherapy for Solid Tumors 75,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pabbathi,Smitha Spon Florida Breast Cancer Foundation SOAR (Survivors overcoming and Achieving Resilience) 8,582

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon American Cancer SocietyCytokine-dependent Genetic Selection in Chronic Myelomonocytic Leukemia 198,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon H. Lee Moffitt Cancer CenterMEG3 as a therapeutically relevant target for TET2 mutant myeloid neoplasms 33,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon Incyte Corporation

A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML) and Cataloging the Molecular Consequences of JAK2 Inhibition in Chronic Myelomonocytic Leukemia: A 1,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon Incyte Corporation

A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib for the treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion 427,719

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon Kura OncologyA Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia 15,710

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon Kura OncologyDetermine if Subtypes of CMML Segregated by RAS Pathway Mutations are Differentially Sensitive to Tipifamib in vitro (phase 1) in vivo (phase 2) 83,399

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon National Cancer InstituteDeveloping and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia 283,518

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Padron,Eric Spon Natl Heart Lung and Blood InstThe National Myelodysplastic Syndromes Natural History Study (The National MDS Study) 2,219,194

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Park,Jong Y Spon Johns Hopkins University Epigenomic Landscape of Primary Prostate Cancer in African-American Men 30,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Park,Jong Y Spon V Foundation for Cancer ResearchGenomic Predictors of Aggressive and Lethal Prostate Cancer in African American Men 77,445

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Patel,Krupal Spon H. Lee Moffitt Cancer Center Immunomethylomics Biomarkers in Oral Cavity Squamous Cell Carcinoma 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Patel,Krupal Spon NRG OncologyNRG Oncology NCORP Research Base: Assessing the Impact of Financial Toxicity in Head and Neck Cancer Patients and Their Caregivers 45,131

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Peres,Lauren Spon Emory University Ovarian Cancer Survival in African-American Women 56,695

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Peres,Lauren Spon H. Lee Moffitt Cancer CenterUsing radiomics to optimize treatment decisions and predict patient outcomes in serous ovarian carcinoma 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Peres,Lauren Spon National Cancer Institute The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival 247,267

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Bradford Spon Bristol-Myers Squibb CompanyRadiation and Chemotherapy with Ipilimumab followed by Nivolumab for Patients with Stage III Unresectable NSCLC 52,755

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Bradford Spon H. Lee Moffitt Cancer Center

Evaluating Serially Collected Peripheral Blood Samples from MCC 19704: Radiation and Chemotherapy with Ipilimumab followed by Nivolumab for Patients with Stage III Unresectable NSCLC 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Bradford Spon National Cancer InstituteFinding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung cancer 238,752

124


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Bradford Spon NRG OncologyA Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer 13,950

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Bradford Spon NRG OncologyLimited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III randomized study of chemoradiation versus chemoradiation plus Atezolizumab 5,775

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Bradford Spon NRG Oncology

Maintenance Systemic Therapy versus Local Consolidative Therapy (Lct) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (Nsclc): A Randomized Phase II/III Trial

11,250

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Perez,Lia E Spon Novartis Pharmaceutical CorporationPhase II Trial Evaluating the use of a Histone Deacetylase Inhibitor Panobinostat for Graft Versus Host Disease (GVHD) Prevention 145,800

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Permuth,Jennifer B Spon Florida Department of HealthThe Florida Pancreas Collaborative Next-Generation Biobank-Reducing Health Disparities and Improving Survival in Pancreatic Cancer 389,764

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Permuth,Jennifer B Spon H. Lee Moffitt Cancer CenterEvaluating Radiogenomic Landscape of Pancreatic Cancer among African Americans 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Permuth,Jennifer B Spon H. Lee Moffitt Cancer CenterExtracellular Vesicles and Imaging Biomarkers to Explore Pancreatic Cancer Risk in African Americans 37,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Permuth,Jennifer B Spon National Cancer Institute

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 438,827

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Permuth,Jennifer B Spon Tampa Community FoundationProtease Activity and Genomic Expression for the Early Detection of Pancreatic Cancer in High-Risk Pancreatic Cystic Lesions. 34,820

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Amgen

A Phase 1b/2 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 592 in Adult Subjects With Steroid Refractory Chronic Graft versus Host Disease 40,419

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Blood & Marrow Transplant CT Network

A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD Following Allogeneic Hemat 9,088

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Blood & Marrow Transplant CT NetworkClinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (CTRL-ALT-D) 22,536

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Blood & Marrow Transplant CT NetworkProspective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT 38,810

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Equillium, Inc.

A Phase 1B/2 Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of Eq001 In Subjects With Newly Diagnosed Acute Graft Versus Host Disease 45,042

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Fred Hutchinson Cancer Research CenterClose Assessment and Testing for Chronic Graft-versus-Host Disease (The CATCH Study) 37,396

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Incyte Corporation

A Phase III Randomized Open-Label Multi-Center Study of Ruxolitinib vs. Best Available Therapy in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Stem Cell Transplantation (REACH 3) 37,948

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon National Marrow Donor Program

Defining the Transplantation Tolerance Transcriptome: A Path Toward Individualized Management of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation 155,373

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Natl Heart Lung and Blood InstA Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression 14,220

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Natl Heart Lung and Blood InstCore Clinical Centers for Blood and Marrow Transplant Clincial Trials Network 206,400

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon Seattle Genetics, Inc.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of SGN-35 (Brentuximab Vedotin) and Best Supportive Care (BSC) versus Placebo and BSC in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma (HL) Following Autologous Stem Cell 1,500

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pidala,Joseph Spon US Food and Drug Administration Ustekinumab for Graft vs Host Disease Prevention (IND 144540) 170,657

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon Celgene CorporationA Phase II Biomarker Trial of CC-122 in Combination with Nivolumab in Advanced Melanoma 230,200

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon Intellia TherapeuticsIntellia Research Collaboration - Project 1: Advancing Neoantigen-Specific T Cells 535,920

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon Iovance Biotherapeutics, Inc NSG Mouse Models to Evaluate the Efficacy of TIL 324,384

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon Merck & CompanySARS-CoV-2 Immune Surveillance Among a Population Based Sample of Adults in Florida 197,901

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon Myst Therapeutics Myst – Moffitt Collaboration - Melanoma & Colorectal 1,277,294 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon National Cancer Institute Imaging Acidosis and Immune Therapy in PDAC 341,752

125


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pilon-Thomas,Shari A Spon National Cancer Institute

Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy 247,986

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon Hoffmann-La Roche Inc

A Prospective, Open-Label, Multicenter, Randomized Phase III Trial to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) versus Obinutuzumab and Chlorambucil in Previously Untreated Patients with CLL a 34,643

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon Incyte Corporation

Treatment Free Remission After Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation 82,309

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon Iovance Biotherapeutics, Inc

A Phase 1/2 Study Evaluating the Safety and Efficacy of IOV-2001 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 242,130

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon Kite Pharma Inc.

A Phase 1 Multicenter Study Evaluating the Safety and Tolerability of KTE-X19 in Adult Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma 191,721

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon MEI Pharma Efficacy and immune-profilking post treatment with ME-401 9,854 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon National Cancer Institute Targetable Epidgenetic Mechanism Driving Cutaneous T Cell Lymphoma 274,265

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon Novartis Pharmaceutical Corporation

A Single-Arm, Multicenter, Nilotinib Treatment-Free Remission Study in Patients with BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib Treatment 22,562

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon Novartis Pharmaceutical CorporationPhase I, Open Label, Multicenter, Dose Escalation Study of YTB323 in Adult Patients with CLL/SLL and DLBCL 23,894

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Pinilla-Ibarz,Javier V Spon TG Therapeutics, Inc.

A Phase 2 Study to Assess the Efficacy, Safety, Pharmacokinetic Parameters, and Pharmacodynamics of TGR-1202 (Umbralisib) in Treatment Naïve Patients with Chronic Lymphocytic Leukemia (CLL) 10,819


A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with TGR-1202 Compared to Obinutuzumab in Combination with Chlorambucil in Patients with Chronic Lymphocytic Leukemia (CLL) 40,493


ULTRA-V: Phase 2 Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax (U2-V) in Subjects with Chronic Lymphocytic Leukemia (CLL) 315,755

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Poch,Michael A Spon FKD Therapies Oy

A Phase III, Open Label Study to Evaluate the Safety and Efficacy of Instiladrin (rAd-IFN/Syn3)Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer 8,432

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Poch,Michael A Spon SWOG - Southwest Oncology Group

A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer 4,500

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Powers,Benjamin Spon H. Lee Moffitt Cancer CenterAddressing Patient - and Neighborhood - Level Socioeconomic Disparities in Foregut Cancers in Florida 100,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Premi,Sanjay Spon H. Lee Moffitt Cancer Center NOS/NOX in Melanoma Therapy Resistance and Immune Escape 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Raghunand,Natarajan Spon Halozyme TherapeuticsQuantitative Analysis of Diffusion MRI and DCE-MRI from Subjects in Early-Phase Clinical Investigations with PEGPH20 100,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Raghunand,Natarajan Spon Imaging EndpointsQuantitative Fe-MRI Analysis and Creation of Fe-Agar Phantom Tube Sets and Manual Consultancy 144,299

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reblin,Maija Spon National Cancer Institute A stepped-care psychosocial intervention for brain tumor family caregivers 337,068

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Redler,Gage Spon Varian Medical Systems, Inc.

Ethos Workflow Development for Adaptive Low Dose Radiation Treatment of Widespread Metastases in Stage IV NSCLC Patients Receiving Systemic Immunotherapy 84,147

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Redler,Gage Spon Varian Medical Systems, Inc.

Non-Clinical Product Evaluation and Testing Agreement between Varian Medical Systems, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. 70,721

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reed,Damon Spon All Children's HospitalCOMMITTEE LEADERSHIP: NIH National Clinical Trials Network (NCTN) Grant (2U10CA 180886) 3,779

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reed,Damon Spon All Children's Hospital

STUDY CHAIRNIH PEDIATRIC EARLY PHASE CLINICAL TRIALS NETWORK (PEP-CTN) GRANT(UM1CA228823) SUCCESSOR TO NIH PHASE I GRANT (2UM1CA097452); COG protocol PEPN1924 19,385

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reed,Damon Spon Florida Department of HealthEvolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma 277,337

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Reed,Damon Spon National Pediatric Cancer Foundation Sunshine Project-2016-2021 671,734

126


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reed,Damon Spon Salarius Pharmaceuticals

Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) with and without Topotecan and Cyclophosphamide in Patients with Relapsed or Refractory Ewing Sarcoma and Select Sarcomas

51,382 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Reed,Damon Spon University of Chicago Building the Osteosarcoma Data Commons 26,842

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Rejniak,Katarzyna A Spon National Cancer Institute Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer 470,293

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Rejniak,Katarzyna A Spon Vanderbilt UniversityPhysical Dynamics of Cancer Response to Chemotherapy in 3D Microenvironments 58,786

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Reuther,Gary W Spon Florida Department of Health Targeting Heme Dependency in Leukemia 64,970

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reuther,Gary W Spon H. Lee Moffitt Cancer CenterOvercoming the inefficacy of ruxolitinib in myeloproliferative neoplasm patients bytargeting the SHP2 tyrosine phosphatase 100,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Reuther,Gary W Spon Incyte Corporation Incyte/Moffitt Master Research Agreement 117,279

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Reuther,Gary W Spon Natl Heart Lung and Blood InstTargeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms 485,801

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Reuther,Gary W Spon Revolution Medicines An Assessment of SOS1 inhibitors in MPN 288,043 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Rix,Uwe Spon Florida Department of Health Characterization of PARP16 as a novel target in Ewing’s sarcoma 99,394

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Rix,Uwe Spon National Cancer Institute Harnessing Beneficial Off-Target Effects of Kinase Inhibitors in Lung Cancer 15,256 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Rix,Uwe Spon National Cancer Institute Targeting Bidirectional Signaling in Lung Stroma and Cancer Stems 506,795

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Robinson,Timothy Spon Janssen Pharmaceutica IncDevelopment of a splicing-based theragnostic biomarker for sensitivity to PRMT5 inhibitors 423,741

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Robinson,Timothy Spon US Army Medical Research & Material Comm Splice Ablation Kinase Inhibition (SAKI) of Receptor Tyrosine Kinases 204,309 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Rodriguez,Paulo Spon Florida Department of Health Notch signaling boosts T cell-based immunotherapy 160,917

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Rodriguez,Paulo Spon National Cancer InstituteFunctional reprogramming of tumor-MDSC through antibody-based therapies Targeting Notch Ligands 393,450

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Rollison,Dana E Spon Natl Heart Lung and Blood InstThe National Myelodysplastic Syndromes Natural History Study (The National MDS Study) 2,219,194

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Rounbehler,Robert Spon H. Lee Moffitt Cancer Center ODC A allele and aggressive prostate cancer in African American men 75,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Ruffell,Brian Spon National Cancer Institute Regulation of dendritic cell function and tumor immunity by TIM-3 393,450 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Ruffell,Brian Spon US Army Medical Research & Material Comm Breast cancer immunotherapy with anti-TIM-3 247,050

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Actuate Therapeutics

Phase 1/2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3beta) Inhibitor, as a Single Agent and Combined with Chemotherapy, in Patients with Refractory Hematologic Malignancies or Solid Tumors 71,113

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Bristol-Myers Squibb Company

A Randomized Phase 3 Open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (GBM) 11,710


A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination with Radiation Therapy in Newly Diagnosed Adult Subjects with Unmethylated MGMT (tumor O-6-methylguanine DNA methyltransferase) Glioblastoma 19,500


A Randomized Phase 3 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6-methylguanine DNA methyltransferase) Glioblastoma 46,185

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Clovis Oncology

A Phase 2 Multicenter, Open-label Study of Rucaparib as Treatment for Solid Tumors Associated with Deleterious Mutations in Homologous Recombination Repair Genes (LODESTAR) 166,440

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Eli Lilly Research LaboratoriesA Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer 25,811

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Genentech

An Open-Label, Single-Arm, Phase II Study of Pertuzumab with High-Dose Trastuzumab for the Treatment of Central Nervous System Progression Post-Radiotherapy in Patients with Her2-Positive Metastatic Breast Cancer (Patricia) 1,510

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon H. Lee Moffitt Cancer Center

Piloting the Feasibility of 11C-AMT PET Imaging in Recurrent High Grade Glioma Patients Treated on Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined with Nivolumab 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Incyte Corporation

A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors 10,957

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon IRX Therapeutics, Inc.

The IRX-2 Regimen Combined with Nivolumab in Recurrent/Metastatic Solid Tumors: A Phase 1b Study to Evaluate the Safety, Determine Recommended Phase 2 Dose (RP2D), and Investigate the Biologic and Clinical Activity 16,532

127


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Kyowa Hakko Kirin Pharma, Inc.

Multicenter, Open-label, Phase 1, Dose-escalation,Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination with Mogamulizumab (KW-0761) in Adult Subjects with Locally Advanced or Metastatic Solid Tumors 16,916

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Merck & CompanyA Phase I Trial of Pembrolizumab and Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma 47,948

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon NewLink Genetics Corporation

A Phase 1/2 Study of the Combination of Indoximod and Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors 11,684

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Oxford BioTherapeutics

A Phase I, Open-Label, Dose Finding Study To Assess The Safety, Tolerability, Pharmacokinetics, And Preliminary Efficacy Of OBT076, A CD205-Directed Antibody-Drug Conjugate, In Recurrent And/Or Metastatic CD205 Positive Solid Tumors And In Women With CD2 98,424

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon Pfizer, Inc.

A Phase 1b, Open Label, Dose Finding Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Axitinib (AG-013736) In Combination With MK-3475 In Patients With Advanced Renal Cell Cancer 7,415

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sahebjam,Solmaz Spon University of FloridaPilot Study of Commensal Gut Microbiome as a Modifier of Checkpoint Inhibitor Efficacy in Glioblastoma 492

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Aileron Therapeutics

A Phase 1/1b Open-Label Study to Determine the Safety and Tolerability of ALRN-6924 alone and in Combination with Cytarabine (Ara-C) in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome with Wild-Type TP53 39,047

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Amphivena

A Phase 1, Multicenter, Open Label Study of AMV564, a Bispecific CD33/CD3 T-cell Engager, in Patients with Intermediate or High-Risk Myelodysplastic Syndromes 3,505

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Aprea AB

A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms 45,861


A Phase III Multicenter, Randomized, Open Label Study of APR-246 in Combination with Azacitidine Versus Azacitidine Alone for the Treatment of TP53 Mutant Myelodysplastic Syndromes 613,348

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Aprea AB Aprea Central Lab Study 113,612


Phase 1/2 Study to Evaluate Safety and Efficacy of APR-548 in Combination with Azacitidine for the Treatment of TP53-Mutant Myelodysplastic Syndromes 32,972

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Aprea ABPhase I Study of APR-246 in Combination with Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies 488,870

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Astex Pharmaceuticals

A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects with Lower Risk (IPSS Low or Intermediate-1) Myelodysplastic Syndromes (MDS) 18,754

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Cellectis S.A

Phase I, Open Label Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence and Clinical Activity of UCART123 (Allogeneic Engineered T Cells Expressing anti-CD123 Chimeric Antigen Receptor), Administered in Patients with R 68,299

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Celyad

A Multinational Open-Label, Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Administrations of NKR-2 in Patients with Different Metastatic Tumor Types 56,215

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Celyad

An Open-Label, Phase I/II Study to Assess the Safety and Clinical Activity of NKR-2 Treatment Administration after a Non-Myeloablative Preconditioning Chemotherapy in Relapse/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients. 6,919

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Forty Seven, Inc.A Phase 1b Trial of Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination with Azacitidine in Patients with Hematological Malignancies 1,586,776

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Gilead Sciences, Inc.

ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome 327,772

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon H. Lee Moffitt Cancer CenterTP53 mutation drives immune escape in the setting of allogeneic stem cell transplantation via MHC-II downregulation 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Jazz Pharmaceuticals, Inc.Prognostic Significance of Serial Molecular Annotation in Secondary Acute Myeloid Leukemia (sAML) in Patients Treated with CPX-351 104,884

128


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon KaloBios Pharmaceuticals

A Phase 1 Study of KB003 in Patients with Previously Treated Chronic Myelomonocytic Leukemia (CMML)

16,460

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Novartis Pharmaceutical Corporation

A Phase 1b/2 Study Evaluating the Safety and Efficacy of Canakinumab with Darbepoetin alfa in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) who have Failed Erythropoietin Stimulating Agents (ESA) 51,754

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Precigen

A Phase 1/1b Safety Study of PRGN-3006 Adoptive Cellular Therapy in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome 978,762

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Siteman Cancer CenterA Pilot Study of CPX-351 (Vyxeos) for Transplant Eligible, Higher Risk Patients with Myelodysplastic Syndrome 33,491

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sallman,David Andrew Spon Syntrix Pharmaceuticals

Phase 1-Open-Label-Dose-Escal w Expansion Study-SX-682 in Subjects w Myelodysplastic Syndrome w Disease Progression or Intolerant to Prior Therapy 911,411

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon AstraZeneca Ltd

Prospective, Interventional Pilot Study of Mobile Devices and Digital Applications to Detect Early Pneumonitis and Other Pulmonary Adverse Events in Unresectable Stage III Non-Small Cell Lung Cancer Patients on Durvalumab 18,524

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon BioAtla, LLC

A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 Alone and in Combination with Nivolumab in Patients with Advanced Solid Tumors

227,288

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon Daiichi Sankyo Pharma Development (DSI)

A Phase 2, Multicenter, Open-Label, 2-Cohort Study Of Trastuzumab Deruxtecan (DS-8201a), An Anti-HER2 Antibody Drug Conjugate (ADC), For HER2-Over-Expressing Or -Mutated, Unresectable And/Or Metastatic Non-Small Cell Lung Cancer (NSCLC) 57,026

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon Genentech

Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Alectinib, Entrectinib, or Vemurafenib Plus Cobimetinib in Patients with Stages I-III Non-Small Cell Lung Cancer with ALK, ROS1, NTRK, or BRAF V600E Molecular Alterations 30,173

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon GenMab A/S

First-in-Human, Open-Label, Dose-Escalation Trial with Expansion Cohorts to Evaluate Safety of Axl-Specific Antibody-Drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients with Solid Tumors 94,401

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon MacroGenics, Inc.

A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination with Pembrolizumab in Patients with B7-H3-Expressing Melanoma, Squamous Cell Cancer of the Head and Neck, or Squamous Cell Non-Small Cell Lung Cancer

15,306

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon MD Anderson Cancer Center

An Open-Label Randomized Phase II Study of Combining Osimertinib with and without Ramucirumab in TKI-naïve EGFR-mutant Locally Advanced or Metastatic NSCLC 111,438

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon Mersana Therapeutics, Inc.A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b 245,953

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon Novartis Pharmaceutical CorporationPhase I Study of Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC 73,179

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Saltos,Andreas Spon Turning Point Therapeutics

Phase 1/2 Study of TPX-0046, A Novel Oral RET/SRC Inhibitor in Adult Subjects with Advanced/Metastatic Solid Tumors Harboring Oncogenic RET Fusions or Mutations

33,721

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sarnaik,Amod Spon Iovance Biotherapeutics, Inc

A Phase 2, Multicenter Study to Assess the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma 72,141

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sarnaik,Amod Spon Iovance Biotherapeutics, IncA Pilot Clinical Trial Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma 4,341

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sarnaik,Amod Spon Iovance Biotherapeutics, Inc

Co-stimulation with Ipilimumab to Enhance Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Patients with Metastatic Melanoma

14,863

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sarnaik,Amod Spon Prometheus Laboratories, Inc.A Phase II Clinical Trial of Vemurafenib with Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Patients with Metastatic Melanoma 43,773

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Schabath,Matthew Spon Bristol-Myers Squibb CompanyThe Curriculum for Oncologists on LGBT populations to Optimize Relevance & Skills (COLORS) Trial 170,812

129


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Schabath,Matthew Spon Bristol-Myers Squibb CompanyThe Curriculum for Oncologists on LGBTQ populations to Optimize Relevance & Skills (COLORS) Trial 40,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Schabath,Matthew Spon Florida Department of HealthNon-invasive radiomic biomarkers to predict treatment response for immunotherapy of lung cancer 298,509

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Schabath,Matthew Spon National Cancer Institute Moffitt Imaging Biomarker Validation Center 124,225 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Schabath,Matthew Spon National Cancer Institute Radiomics of NSCLC 288,374 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Schonbrunn,Ernst Spon Florida Department of Health Development of novel TAF1 inhibitors as cancer therapeutics 179,620

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Schonbrunn,Ernst Spon Natl Inst of Child Health & Human DeveloAllosteric CDK2 Inhibitor Discovery and Development for Male Contraception 86,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shafique,Michael R Spon Amphivena

A Phase 1 Dose Escalation With Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMV564 Alone and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors 88,635

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shafique,Michael R Spon ECOG

EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non©\Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNatur 35,350

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shafique,Michael R Spon EMD Serono, Inc

A Multicenter, Open-Label, Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the DNA-PK Inhibitor M3814 in Combination with Avelumab with and without Palliative Radiotherapy in Participants with Selected Advanced 30,525

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shafique,Michael R Spon Genentech

An Open-Label, Multicenter Extension Study In Patients Previously Enrolled In A Genentech and/or F Hoffmann La Roche Ltd. Sponsored Atezolizumab Study 13,854

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shafique,Michael R Spon Nektar Therapeutics

A Phase 1/2, Open-Label, Multicenter Study of the Combination of NKTR-214 and Nivolumab or the Combination of NKTR-214, Nivolumab and Other Anti-Cancer Therapies in Patients with Select Locally Advanced or Metastatic Solid Tumor Malignancies 95,128

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shafique,Michael R Spon Pfizer, Inc.

A Phase 1b/2 Open Label Umbrella Study of Sasanlimab Combined With Anti-Cancer Therapies Targeting Multiple Molecular Mechanisms in Participants with Non-Small Cell Lung Cancer (NSCLC) 33,549

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shah,Bijal D Spon Kite Pharma Inc.

T-Cell, Monocyte, and Cytokine Profiling to Identify Correlates of KTE-C19 Persistence, Toxicity, and Long Term Remission in B-cell Acute Lymphoblastic Leukemia - ISR-2018-10055 280,302

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon AbbVie Inc.Ex Vivo Studies of AbbVie’s Proprietary Compounds in Multiple Myeloma #2 415,680

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon Amgen

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination with Pomalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma 7,152

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon Celgene Corporation

A Phase 1/2, Multicenter, Open-Label, Study to Determine the Recommended Dose and Regimen, and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination with Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM 31,274

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon Florida Department of HealthDevelopment of Novel Cancer Drugs for the Treatment of Multiple Myeloma and Acute Myeloid Leukemia 179,682

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon Janssen Pharmaceutica Inc

A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant 3,400

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon Janssen Pharmaceutica Inc

Phase 2, Randomized, Open-Label Study Comparing Daratumumab, Lenalidomide, Bortezomib,and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma Eligible for High-Dose Chemotherapy 53,727

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Shain,Kenneth H Spon Onyx Pharmaceuticals, Inc.

Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma 19,052

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Siegel,Erin M Spon H. Lee Moffitt Cancer CenterEffect of Sample Preparation Methods on Cancer Biomarker Detection of Extra Cellular Vesicles and Other Plasma Components 202,194

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Siegel,Erin M Spon Univ of Tennessee - MemphisEpigenomic Signatures in Cancer with an Emphasis on HPV-associated Cancer 79,332

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Siegel,Erin M Spon University of Utah Fee for Service Agreement 14,000

130


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Siegel,Erin M Spon University of UtahMetabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence 23,061

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Siegel,Erin M Spon University of UtahTransdisciplinary Team Science in Colorectal Cancer Prognosis - The ColoCare Study 196,026

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Silva,Ariosto S Spon West Virginia UniversityTargeting CD44-Mediated Calcium Homeostasis for the Treatment of Relapsed Myeloma 6,819

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Simmons,Vani N Spon Florida Department of Health Facilitating Smoking Cessation with Reduced Nicotine Cigarettes 27,972

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Smalley,Inna Spon H. Lee Moffitt Cancer CenterImproving the understanding and diagnosis of leptomeningeal lymphoma metastasis 33,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Smalley,Inna Spon National Cancer InstituteDefining the Role of Metabolic Heterogeneity in Melanoma Dissemination and Therapy Escape 249,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Smalley,Keiran S Spon Florida Department of Health Defining and modeling pediatric melanoma development 83,332

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Smalley,Keiran S Spon H. Lee Moffitt Cancer CenterImproving Immunotherapy Responses in Melanoma Brain Metastases by Targeting the Suppressive Immune Microenvironment 65,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Smalley,Keiran S Spon Melanoma Research FoundationInvestigating the Role of a Novel Dendritic Cell Population as a Central Regulator of a Favorable Immune Environment in Melanoma 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Aileron Therapeutics

A Phase 1/2a Open-Label Study to Determine the Safety and Tolerability of ALRN-6924 in Patients with Advanced Solid Tumors or Lymphomas Expressing Wild-Type p53 Protein 774

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Amgen A Phase 2 Open Label Extension Study of Conatumumab and AMG 479 51,797

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Bioniz TherapeuticsA Dose-Ranging Study of Intravenous BNZ132-1-40 in Patients with Large Granular Lymphocyte Leukemia or Refractory Cutaneous T-Cell Lymphoma 5,532

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Columbia University

Phase I/IIA Study of the Oral 5-Azacitidine in Combination with the Histone Deacetylase Inhibitor Romidepsin for the Treatment of Patients with T-Cell Lymphoma

1,200

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Cornell UniversityA Multi-center Phase II Study of CC486-CHOP in Patients with Previously Untreated Peripheral T-cell Lymphoma 6,630

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Eisai Company LtdA Clinical Study to Demonstrate Safety and Efficacy of E7777 in Persistent or Recurrent Cutaneous T-Cell Lymphoma 30,833

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Kura OncologyAn Open Label Phase II Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell Lymphoma 47,498

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon miRagen Therapeutics, Inc.

SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects with Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype 8,487

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Seattle Genetics, Inc.Pilot Study of Brentuximab vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 Receptor 6,770

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Sokol,Lubomir Spon Trillium Therapeutics Inc.

A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors 46,702

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Calithera Biosciences, Inc.

A Multicenter Phase 2 Study of the Glutaminase Inhibitor CB-839 in Combination with Paclitaxel in Patients with Advanced Triple Negative Breast Cancer (TNBC) Including Patients of African Ancestry and Non-African Ancestry 3,310

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Eli Lilly Research Laboratories

MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant with or without Abemaciclib, a CDK4/6 Inhibitor, for Women with Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer 30,370

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon GenentechPhase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer 10,882

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Hoffmann-La Roche Inc

A Phase Ib/II, Open-Label, Multicenter,Randomized Umbrella Study Evaluating the Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-TNBC) 37,225

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Infinity Pharmaceuticals, Inc

A Phase 2, Multi-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of IPI-549 Administered in Combination with Front-line Treatment Regimens in Patients with Locally Advanced and/or Metastatic Triple-Negative Breast Cancer or Renal C 810,884

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Mersana Therapeutics, Inc.

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1522 in Patients with Advanced Breast Cancer and Other Advanced Tumors Expressing HER2 23,948

131


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon NewLink Genetics Corporation

A Phase 2 Double-Blinded, Randomized, Placebo-Controlled Study of Indoximod in Combination with a Taxane Chemotherapy in Metastatic Breast Cancer 20,358

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Oncorus, Inc.

A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of ONCR-177, an Oncolytic Herpes Simplex Virus for Intratumoral Injection, Alone and in Combination with PD-1 Blockade in Adult Subjects with Advanced and/or Refractory Cutaneous, Su 185,709

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Oncosec Medical, Inc

A Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid Plus Electroporation in Combination with Intravenous Pembrolizumab Therapy in Patients with Inoperable Locally Advanced or Metastatic Triple Negative Breast Cancer 10,405

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Pfizer, Inc.

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses and Treatment Intensification of a Vaccine-Based Immunotherapy Regimen-2 (VBIR-2) (PF-06936308) for Advanced Non-Small Cell Lung Cancer and Metastatic Trip 8,364

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Seattle Genetics, Inc.

Randomized, Double-Blind, Phase 3 Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine (T DM1) for Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB) 7,352

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon Seattle Genetics, Inc.

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine (T-DM1) for Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02) 57,642

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon V Foundation for Cancer ResearchImplementation of a Tailored Mobile Application to Improve Clinical Trial Engagement in Breast Cancer Patients 52,905

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Soliman,Hatem Spon V Foundation for Cancer Research Prescreening Strategies to Increase Clinical Trial Participation 9,981 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Sondak M.D.,Vernon K Spon V Foundation for Cancer Research Pediatric Clinical Research - Cutaneous 25,421

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Spiess,Philippe E Spon Bristol-Myers Squibb Company

A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma 3,750

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Spiess,Philippe E Spon ECOGInPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) 12,900

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Spiess,Philippe E Spon Evans Fdtn. Advancements in HPV-related Penile Cancer 166,667

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Spiess,Philippe E Spon Hoffmann-La Roche Inc

A Phase III, Multicenter, Randomized,Placebo-Controlled, Double-Blind Study of Atezolizumab (AntiPd-L1 Antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy

52,819

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Spiess,Philippe E Spon Prometheus Laboratories, Inc.Proleukin® Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy 25,587

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Advanced Accelerator

A Multicentre, Stratified, Open, Randomized, Comparator-Controlled, Parallel Group Phase III Study Comparing Treatment with 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients with Inoperable, progressive, Somatostatin Receptor Positive, Midgut Car 40,856

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Advanced Accelerator

A Phase III Multi-Center, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Lutathera in Patients with Grade 2 and Grade 3 Advanced GEP-NET 81,619

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Advanced AcceleratorSomatostatin receptor expression in poorly-differentiated neuroendocrine carcinomas of the GI tract: analysis using 68Ga-dotatate PET scan 15,948

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Alliance For Clinical Trials In OncologyProspective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients with Progressive Carcinoid Tumors 31,078

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Alliance For Clinical Trials In Oncology

Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus (Cabinet) 96,388

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon ECOGA Randomized Phase II Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors 30,068

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon ITM Solucin GmbH

A Prospective, Randomised, Controlled, Open-label, Multicentre Phase III Study to Evaluate Efficacy and Safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide Compared to Targeted Molecular Therapy with Everolimus in Patients with 83,479

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Merck & CompanyA Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158) 9,895

132


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Merck & CompanyPhase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors 80,955

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon National Cancer Institute

A Phase 2 Study of XL184 (Cabozantinib) in Combination with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas 12,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Novartis Pharmaceutical Corporation

An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastrointestinal (GI), or thoracic origin or poorly-differentiate 10,875

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon SWOG - Southwest Oncology Group DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors 8,100

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Strosberg,Jonathan R Spon Xencor, Inc.

A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®18087 in Subjects with Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1) 11,579

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Talati,Chetasi Spon Novartis Pharmaceutical CorporationAnalysis of Clinical and Economic Outcomes in Patients with Myelodysplastic Syndrome in Academic Centers, a Multisite Cohort Study 297,963

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Tao,Jianguo Spon Florida Department of Health New Therapeutic Vulnerabilities for Pediatric Burkitt Lymphoma 73,274

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tao,Jianguo Spon Lymphoma Research Foundation of AmericaNew Therapeutic Vulnerabilities for Ibrutinib Resistance Mantle Cell Lymphoma (MCL) 5,458

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tao,Jianguo Spon National Cancer Institute Epigenetic Regulation of Drug Resistance to ABT-199 in B-cell Malignancies 24,802 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Tao,Jianguo Spon National Cancer Institute New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma 277,365

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tao,Jianguo Spon National Cancer InstituteTranscriptional and Epigenetic Adaptation as Novel Therapeutic Vulnerabilities for Mantle Cell Lymphoma 497,197

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tarhini,Ahmad Spon Clinigen Group

A Phase II Study of High Dose Bolus IL2 in Combination with Low Dose Ipilimumab Followed Sequentially by Nivolumab in Patients with Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy 181,658

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tarhini,Ahmad Spon Genentech

A Phase II, Open-Label, Multicenter, Randomized Study of Efficacy and Safety of RO7198457 in Combination with Pembrolizumab versus Pembrolizumab in Patients with Previously Untreated Advanced Melanoma 183,455

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tarhini,Ahmad Spon Oncosec Medical, Inc

Neoadjuvant Immunotherapy with Intratumoral Tavokinogene Telseplasmid (Tavo) plus Electroporation in Combination with Intravenous Nivolumab in Patients with Operable Locally- Regionally Advanced Melanoma 36,849

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tarhini,Ahmad Spon Oncosec Medical, Inc

The PISCES study: A Multicenter Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid (tavo, pIL-12) plus Electroporation in Combination with Intravenous Pembrolizumab in Patients with Stage III/IV Melanoma who are Progressing on either Pem 204,971

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tarhini,Ahmad Spon Tampa Community FoundationPredictors of Immunotherapeutic Benefits in Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors 93,191

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Teer,Jamie K Spon Cleveland Clinic FloridaBiological Determinants of Colorectal Cancer Outcomes in Latinos of Diverse Ancestral Origins 34,584

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Teer,Jamie K Spon Myst Therapeutics Myst – Moffitt Collaboration - Melanoma & Colorectal 957,970

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tinsley,Sara Spon Gulf Coast Community FoundationFunds for Senior Care and Mental Health Priorities - AML Research and Patient Support 30,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tinsley,Sara Spon National Institute of Nursing ResearchDevelopment of a Quality of Life Decision-Making Model for Older Patients with Acute Myeloid Leukemia 157,892

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon Florida Department of Health Sensitizing Melanoma to Immunotherapy 206,326

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon Leo Foundation - Netherlands Compartmentalized and Systemic Interactions of the Skin Microbiome in Cancer Immunotherapy Response 3,271

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon National Cancer InstituteEco-Evolutionary Drivers of Clonal Dynamics During UV-Induced Skin Carcinogenesis (PQ3) 640,021

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon National Cancer Institute MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma 102,258

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon Regeneron Pharmeceuticals, Inc.

A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810) Administered Intralesionally, for Patients with Recurrent Cutaneous Squamous Cell Carcinoma (CSCC) 3,416

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon Yale University Applying Genomic Dosimeters of UV Damage for Skin cancer Risk Prediction 28,532

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tsai,Kenneth Spon Yale UniversityUsing Clonal and Non-Clonal UV Signature Mutations to Predict Skin Cancer Risk 96,968

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Turner,Kea Spon H. Lee Moffitt Cancer CenterHead and Neck Cancer Pre-Surgery Education and Discharge Planning: Key Stakeholder Perceptions 12,050

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Turner,Kea Spon Univ of South Florida Optimizing Cancer Screening for Safety-Net, Primary Care Practices 43,548

133


USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon Brigham and Women's Hospital Changing Contraceptive Patterns and Ovarian Cancer Risk 148,638

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon Brigham and Women's HospitalDietary and Hormonal Determinants of Cancer in Women: Project 3 Ovarian Cancer 249,203

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon Florida Department of Health Early Life Exposures and Risk of Developing Ovarian Cancer 151,820

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon University of Hawaii Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study 45,227

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon US Army Medical Research & Material CommA Presurgical Window of Opportunity Trial of the Effect of Aspirin on Immunological Features of Ovarian Tumors 456,764

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon US Army Medical Research & Material Comm

Making the CASE: Chemopreventive Use of Aspirin for Ovarian Cancer - Integrating Epidemiological Data to Evaluate Population Subgroups and Tumor Expression 255,732

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Tworoger,Shelley Spon US Army Medical Research & Material Comm PREDICT: The Prospective Early Detection Consortium for Ovarian Cancer 13,457 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon American Cancer Society Cervical Cancer: PROGRESS for Prevention 136,789

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon American Cancer SocietyUnderstanding the Impact of COVID-19 on Cervical Cancer Screening and Management of Abnormal Results in Underserved Women 30,600

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon Florida Breast Cancer FoundationLIFE Project (LEARNING About the IMPACT of Breast Health Education: FACEBOOK Live EVENTS) 8,783

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon Fred Hutchinson Cancer Research CenterAdvancing Equity in Colorectal Cancer Genetic Risk Prediction Through Expansion of Racial/Ethnic Minority Representation 46,081

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon Georgetown UniversityPrograma de ARBOLES Familiares; Assessing Risk of Breast Cancer through Outreach to Latinas with Education and Support 118,333

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon Gilead Sciences, Inc. HCV: Activating Patients Providers and Systems (HCV APPS) 17,692

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon H. Lee Moffitt Cancer CenterCervical Cancer: Understanding Patient and Provider Perspectives on Vaccine Based Treatment Trials 35,470

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon National Cancer InstituteEnriching Communication Skills for Health Professionals in Oncofertility (ECHO) 190,726

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon National Cancer Institute Ethical Issues in Fertility Preservation Among Terminal AYA 16,009

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon University of MiamiFlorida Community-Engaged Research Alliance Against COVID-19 in Disproportionately Affected Communities (FL-CEAL) 59,799

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vadaparampil,Susan T Spon Vanderbilt UniversityBreast Cancer in Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT) 41,567

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vidrine,Damon J Spon National Cancer InstitutePartnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers 572,068

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vidrine,Damon J Spon National Cancer InstituteRandomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV 437,579

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vidrine,Damon J Spon University of OklahomaMobile Health Technology for Personalized Tobacco Cessation Support in Laos 28,958

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vidrine,Damon J Spon University of OklahomaSmartphone Based Smoking Cessation Intervention for Socioeconomically Disadvantaged Adults 7,240

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vinci,Christine Spon National Cancer InstituteEfficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers 563,424

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vinci,Christine Spon National Institute on Drug AbuseUtilizing Augmented Reality as an Adjunct for Smoking Cessation: Development and Initial Validation 258,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Vinci,Christine Spon Natl Ctr Complementary & Integrative Hea Adaptation of Mindfulness Training to Treat Moral Injury in Veterans 14,867

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vinci,Christine Spon Natl Ctr Complementary & Integrative HeaDevelopment of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation 46,088

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vogelbaum,Michael Spon Celgene Corporation

A Phase 1, Open-Label Study to Assess The Pharmacokinetics, Pharmacodynamics and Central Nervous System (CNS) Penetration of CC-90010 in Preoperative Subjects with Progressive or Recurrent who Grade II Diffuse Astrocytoma, Grade III Anaplastic Astrocytom 215,663

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Vogelbaum,Michael Spon Cleveland Clinic Florida Deciphering MDSC function for GBM targeting 18,461

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Vogelbaum,Michael Spon Infuseon Therapeutics, Inc.

A Pilot Trial of Intratumorally-Administered Topotecan using Convection-Enhanced Delivery (CED) in Patients with Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Undergoing Stereotactic Biopsy (IND 117,240) 21,939

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Vogelbaum,Michael Spon Nat Radiation Gynecologic Cooperative Gr NRG Oncology Network Group Operations Center 7,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Wan,Lixin Spon American Cancer Society Targeting USP9X-mediated RIT1 stabilization for cancer therapy 30,600 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Wan,Lixin Spon Florida Department of Health Characterizing oncogenic function of ITCH in melanoma 225,408

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wan,Lixin Spon H. Lee Moffitt Cancer CenterElucidating Cdc20-mediated transcriptional reprogramming in ovarian cancer 100,000

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Wan,Lixin Spon Melanoma Research Alliance Targeting the JNK-ITCH Signaling Pathway in Melanoma 75,000 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Wang,Liang Spon National Cancer Institute Cell free nucleic acid-based biomarkers in advanced prostate cancer 661,028

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wang,Liang Spon National Cancer InstituteFunctional characterization of prostate cancer risk loci by high throughput sequencing 368,766

134


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wang,Xia Spon H. Lee Moffitt Cancer CenterEpidermal Growth Factor Receptor HER (ErbB4) and NF1 Tumor Evolution from Normal Schwann Cells to MPNST 47,355

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wang,Xuefeng Spon Natl Insti of Dental and CraniofInvestigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC 398,052

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon AbbVie Inc.

A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, o 3,510

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Acerta Pharma BVA Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination with Pembrolizumab in Subjects with Recurrent Ovarian Cancer 14,608

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon AstraZeneca Ltd

A Phase III Randomised, Double-Blind, Placebo-Controlled,Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (D 981,319

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon AstraZeneca Ltd

A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy 2,026

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Bristol-Myers Squibb CompanyA Phase II Safety and Efficacy Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Subjects 15,342

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Eisai Company Ltd

A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability and Efficacy of MORAb-202, a Folate Receptor Alpha (FRA)-Targeting Antibody-Drug Conjugate (ADC) in Subjects with Selected Tumor Types 435,864

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Iovance Biotherapeutics, Inc

A Phase 2 Study to Evaluate the Safety, Tolerability and Efficacy of Cell Transfer Therapy Using Autologous Tumor Infiltrating Lymphocytes (LN-145) followed by IL-2 in Patients with Recurrent and/or Metastatic Cervical Carcinoma 194,874

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Millenium Pharmaceuticals

A Phase 2, Randomized Study of MLN0128 (a Dual TORC1/2 Inhibitor), MLN0128 + MLN1117 (a PI3Ka Inhibitor), Weekly Paclitaxel, or the Combination of Weekly Paclitaxel and MLN0128 in Women With Advanced, Recurrent, or Persistent Endometrial Cancer 585

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Morphotek

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Efficacy and Safety of Farletuzumab (MORAb-003) in Combination with Carboplatin plus Paclitaxel or Carboplatin plus Peglyated Liposomal Doxorubicin (PLD) in Subjects with Low CA1 27,829

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon New Mexico Cancer Care Alliance (NMCCA)A Phase 1-2 Study of the Combination of Olaparib and Tremelimumab in BRCA1 and BRCA2 Mutation Carriers with Recurrent Ovarian Cancer 1,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon NRG Oncology

GOG-0240: A Randomized Phase III Trial of Cisplatin Plus Paclitaxel with and without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Nonplatinum Doublet, Topotecan Plus Paclitaxel, with and without NCI-Supplied Bevacizumab, in Stage IVB, Re 330

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon On Target Laboratories, LLC

A Phase 3, Randomized, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer 4,671

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon OncoMed Pharmaceuticals

A Phase 1b Study of Navicixizumab (OMP-305B83) plus Weekly Paclitaxel in Subjects with Platinum Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer 9,742

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon Prescient Therapeutics LimitedA Phase IA/IB Trial of PTX-200 and Carboplatin in Patients with Platinum-Resistant Recurrent Ovarian Cancer 1,400

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wenham,Robert M Spon TapImmune

A Randomized Multicenter Phase II Trial To Evaluate The Safety, Efficacy And Immunogenicity Of Vaccination With Folate Receptor Alpha Peptides Admixed With GM-CSF As A Vaccine Adjuvant Versus GM-CSF Alone In Patients With Platinum Sensitive Ovarian Cance 6,879

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Wright,Kenneth L Spon George Washington University Targeting SIRT1 in Mantle Cell Lymphoma - 2 19,511 USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Wright,Kenneth L Spon National Cancer Institute 2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership 1,708,606

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Wright,Kenneth L Spon Tolero Pharmaceuticals

Determine the effects of the TP-0184 and its derivatives (second generation) on myeloid-derived suppressor cell (MDSC)-mediated suppressive functions and improve the local bone marrow (BM) microenvironment in patients with MDS 294,625

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon American Cancer Society Biomarkers Predictive of Tumor Location in African American Men with PCa 145,868

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon Bristol-Myers Squibb Company

Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer 105,304

135


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon Dana-Farber Cancer InstitutePrecision Interception of Aggressive Prostate Cancer in African American Men 321,135

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon H. Lee Moffitt Cancer CenterCorrelative studies to validate immune-oncologic targets for adaptive management of PCa in a prospective clinical study for AAM. 47,898

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon H. Lee Moffitt Cancer CenterProstate cancer-derived explants as a novel model system to study disparities between African American and European American Patients 75,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon National Cancer InstituteGhana IntegRative Approach to Cancer ResEarch Training: The Grace Program 271,721

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon PCCTC (Prostate Cancer Clinical Trial Co IRONMAN: International Registry for Men with Advanced Prostate Cancer 10,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon Prostate Cancer Fdtn

Identification & Validation of a Biomarker Signature That Can Improve Predictability of Aggressive Disease in Men of African Descent with Prostate Cancer 73,896

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon Prostate Cancer FdtnThe John and Daria Barry Foundation Precision Oncology Center of Excellence in the VA Sunshine Healthcare Network 500,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yamoah,Kosj Spon US Army Medical Research & Material Comm

Characterize the immune-oncologic profile of lethal prostate cancer in African American men and develop new therapeutic avenues of therapy for this patient population. 571,895

USF Health-Morsani College o Department of Interdisciplinary Oncology PI: Yun,Seongseok Spon Amer Society of Hematology Tumor Suppressor Role of TFEB in MYC-driven Myeloid Leukemogenesis 50,000

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Yun,Seongseok Spon National Cancer InstituteTumor Suppressor Roles of TFEB in the Development and Maintenance of Myeloid Leukemia 238,752

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zager,Jonathan S Spon Delcath Systems, IncDevelopment of Educational Materials and Educational Guidance Related to Limb/Hepatic Perfusion of Chemotherapy 85,050

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Astellas Pharma US, Inc.

A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects with Metastatic Urothelial Cancer and Other Malignant Solid Tumors that Express Nectin-4 7,096

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon AstraZeneca Ltd

A Modular Phase 2a Multicentre Open-Label Study to Investigate DNA-damage Response Agents (or Combinations) in Patients With Advanced Cancer Whose Tumours Contain Molecular Alterations (PLANETTE) 11,300


A Phase 2 Study of Check Point Inhibitor, Durvalumab (MEDI4736) for Bacillus Calmette-Guérin (BCG) Refractory Urothelial Carcinoma in Situ (CIS) of the Bladder 16,601


A Phase II, Open-Label, Study to Assess the Efficacy, Safety, and Tolerability of AZD4635 in Combination with Durvalumab and in Combination with Cabazitaxel and Durvalumab in Patients Who Have Progressive Metastatic Castrate-Resistant Prostate Cancer (AA 222,987


A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients With Unresectable Stage IV Urothelial Ca 16,313


A Phase III, Randomized, Open-label, Controlled, Multi-Center, Global Study of First-Line MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Patients with Unresectable Stage IV Urothelial Bladder Ca 7,661

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Bayer Healthcare Pharmaceuticals

A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer 29,867

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Bayer Healthcare Pharmaceuticals

An Open-Label, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Maximum Tolerated Dose and / or Recommended Phase II Dose of the ATR Inhibitor BAY 1895344 in Patients with Advanced Solid 507,185

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Bayer Healthcare PharmaceuticalsAssess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 Treatment 24,621

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon BioXcel Therapeutics

A Phase 1b/2 Study of BXCL701, a Small Molecule Inhibitor of Dipeptidyl Peptidases (DPP), Administered in Combination with the Anti-Programmed Cell Death 1 (PD-1) Monoclonal Antibody Pembrolizumab (PEMBRO; Keytruda®) in Patients with Small Cell Neuroendo 470,388

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Bristol-Myers Squibb Company

A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versus Placebo in Subjects with High Risk Invasive Urothelial Carcinoma 23,246

136


USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Clovis Oncology

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency. 41,146

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Constellation Pharmaceuticals

ProSTAR: A Phase 1b/2 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer 94,637

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Exelixis, Inc.

A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors 383,553

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Inovio Pharmaceuticals

An Open-Label, Multi-Center Trial of INO-5401 + INO-9012 in Combination with Atezolizumab in Subjects with Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma 15,942

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Karyopharm Therapeutics Inc.

A Phase 1/2 Open-Label Study of the Safety, Tolerability and Efficacy of the Selective Inhibitor of Nuclear Export (SINE)Compound KPT-8602 in Patients with Relapsed/Refractory Cancer Indications 41,238

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Northwestern University

A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects 80,093

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Pfizer, Inc.

A Phase 3, Multinational, Randomized, Open-Label, Parallel-Arm Study of Avelumab (MSB0010718C) in Combination with Axitenib (INLYTA®) Versus Sunitinub (SUTENT®) Monotherapy in the First-Line Treatment of Patients with Advanced Renal Cell Carcinoma 11,432

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Regeneron Pharmeceuticals, Inc.A Phase 1/2 Study of Regn5678 (Anti-psmaxcd28) with Cemiplimab (Anti-pd-1) in Patients with Metastatic Castration-Resistant Prostate Cancer 890,708

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Seattle Genetics, Inc.

A Single-Arm, Open-Label, Multicenter Study Of Enfortumab Vedotin (ASG-22CE) For Treatment Of Patients With Locally Advanced Or Metastatic Urothelial Cancer Who Previously Received Immune Checkpoint Inhibitor (CPI) Therapy. 13,670

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon SWOG - Southwest Oncology Group

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Sensitive Prostate Cancer 7,058

USF Health-Morsani College Department of Interdisciplinary Oncology PI: Zhang,Jingsong Spon Tmunity

A Phase 1 Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer 32,974

USF Health-Morsani College of Department of Interdisciplinary Oncology Total 140,341,846 USF Health-Morsani College o Dermatology PI: Bennett,Adam E Spon AbbVie Inc. Protocol #H13-147 (4,458) USF Health-Morsani College o Dermatology PI: Bennett,Adam E Spon Corrona, LLC Protocol #Corrona-PSO-500 (6,125) USF Health-Morsani College o Dermatology PI: Brown,Haywood Laverne Spon Boehringer Ingelheim Pharm., Inc. Protocol #1368-0032 6,712 USF Health-Morsani College o Dermatology PI: Patel,Nishit S Spon Amgen Protocol #CC-10004-PSOR-022 8,957 USF Health-Morsani College o Dermatology PI: Patel,Nishit S Spon Eli Lilly and Company Foundation Protocol #I4V-MC-JAIX 8,916 USF Health-Morsani College o Dermatology PI: Patel,Nishit S Spon UCB Biosciences, Inc Protocol #PS0009 (5,650) USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Amgen Protocol #CC-10004-PPSO-003 2,667

USF Health-Morsani College Dermatology PI: Seminario Vidal,Lucia Spon AnaptysBio Inc.

¿ A Phase 2a, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of ANB019 in the Treatment of Acneiform Rash in Subjects with Cancer Receiving EGFRi or MEKi Therapy 21,000

USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Boehringer Ingelheim Pharm., Inc. Protocol #1368-00139 6,249 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Boehringer Ingelheim Pharm., Inc. Protocol #1368-0027 30,500 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Bristol-Myers Squibb Company Protocol #IM011047 (1,256) USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Eisai Inc. Protocol #E777-G000-302 269,546

USF Health-Morsani College Dermatology PI: Seminario Vidal,Lucia Spon Eli Lilly and Company Foundation

A LONG-TERM STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS 10,000

USF Health-Morsani College Dermatology PI: Seminario Vidal,Lucia Spon Eli Lilly and Company Foundation

A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients with Moderate-to-Severe Atopic Dermatitis¿, protocol DRM06-AD18/ J2T-MC-KGAK (¿Protocol¿), 29,534

USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Eli Lilly and Company Foundation Protocol #I1F-MC-RHCD 8,190 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Henry Jackson Foundation for the Advance Comprehensive Genomic Analysis of Cutaneous Adverse Drug Reaction 11,428 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon INNATE PHARMA Protocol #IPH-4102-201 61,490 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Novartis Pharmaceutical Corporation Protocol #CAIN457A2324 1,043 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Novartis Pharmaceutical Corporation Protocol #CAIN457M2301 134,891 USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Novartis Pharmaceutical Corporation Protocol #CAIN457M2301E1 44,899

137


USF Health-Morsani College Dermatology PI: Seminario Vidal,Lucia Spon Pfizer

A PHASE 2a, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF 06651600 IN ADULT PARTICIPANTS WITH ALOPECIA AREATA 29,579

USF Health-Morsani College o Dermatology PI: Seminario Vidal,Lucia Spon Soligenix Protocol #HPN-CTCL-01 3,490

USF Health-Morsani College DermatologyPI: Seminario Vidal,Lucia , Co-PI(s): Patel,Nishit S Spon Glenmark Pharmaceuticals S.A. Protocol #GBR 830-204 3,346

USF Health-Morsani College DermatologyPI: Seminario Vidal,Lucia , Co-PI(s): Patel,Nishit S Spon Novartis Pharmaceutical Corporation Protocol #ZPL389A2203 3,043

USF Health-Morsani College of Dermatology Total 677,993

USF Health-Morsani College Diabetes Center PI: Candelario-Cosme,Madeline Spon Spruce Biosciences, Inc.

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classical Congenital Adrenal Hyperplasia¿ 28,125

USF Health-Morsani College o Diabetes Center PI: Candelario-Cosme,Madeline Spon Spruce Biosciences, Inc. Protocol #SPR001-203 29,425 USF Health-Morsani College o Diabetes Center PI: Rodriguez,Henry Spon MannKind Corporation Protocol #MKC-TI-155 2,227

USF Health-Morsani College Diabetes Center PI: Rodriguez,Henry Spon Novo Nordisk Pharmaceuticals Inc

Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes, trial phase 3b 32,500

USF Health-Morsani College o Diabetes Center PI: Rodriguez,Henry Spon Novo Nordisk Pharmaceuticals Inc Protocol # NN2211-3659 300 USF Health-Morsani College o Diabetes Center PI: Sevilla,Marla Elaine Spon Alexion Pharmaceuticlas, Inc. Protocol #AA-HPP-406 12,500 USF Health-Morsani College o Diabetes Center PI: Shulman,Dorothy I Spon Medtronic, Inc. Protocol #CEP 302 398

USF Health-Morsani College of Diabetes Center Total 105,474

USF Health-Morsani College Family Medicine PI: Roetzheim,Richard G Spon H. Lee Moffitt Cancer Center A stepped-care psychological intervention for brain tumor family caregivers 25,050 USF Health-Morsani College o Family Medicine PI: Roetzheim,Richard G Spon H. Lee Moffitt Cancer Center Facilitating Smoking Cessation with Reduced Nicotine Cigarettes 6,929 USF Health-Morsani College o Family Medicine PI: Roetzheim,Richard G Spon H. Lee Moffitt Cancer Center HCV: Activating Patients Providers and Systems (HCV APPS) (8,151)

USF Health-Morsani College of Family Medicine Total 23,828 USF Health-Morsani College o Health Informatics Institute PI: Bundy,Brian N Spon University of Rochester Accelerate Clinical Trials in CMT (ACTCMT) Study 86,241 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Baylor College of Medicine Atypical Diabetes Research and Evaluation (CADRE) 1,506,646 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Baylor College of Medicine Type 1 Diabetes Genetic Risk Score in TrialNet 105,352 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Cincinnati Children's Hospital Rare Lung Diseases Consortium (RLD) PharmPaP Project 27,367 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Houston Methodist Research Institute USF - U01 NS104326 (Database) - Year 2 104,377 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon National Ataxia Foundation Clinical Research Consortium for Spinocerebellar Ataxias 54,203

USF Health-Morsani College Health Informatics Institute PI: Krischer,Jeffrey P Spon National Institutes of Health

Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY) 11,124,697

USF Health-Morsani College Health Informatics Institute PI: Krischer,Jeffrey P Spon Natl Heart Lung and Blood InstMulticenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED TRIAL) - DCC 301,440

USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Natl Insti of Diabetes (NIDDK) Data Coordinating Center for Type 1 Diabetes TrialNet 31,792,647

USF Health-Morsani College Health Informatics Institute PI: Krischer,Jeffrey P Spon Natl Insti of Diabetes (NIDDK)

Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY) 28,378,781

USF Health-Morsani College Health Informatics Institute PI: Krischer,Jeffrey P Spon Novo Nordisk Pharmaceuticals Inc

A Multiple Ascending Dose Trial Investigating Safety, Tolerability AndPharmacokinetics Of NNC0361-0041 Administered Subcutaneously To PatientsWith Type 1 Diabetes Mellitus (TN-27) 4,724,847

USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Osteogenesis Imperfecta Foundation Osteogenesis Imperfecta Foundation Contact Registry 29,000

USF Health-Morsani College Health Informatics Institute PI: Krischer,Jeffrey P Spon University of Alabama, BirminghamRett Syndrome, MECP2 Duplications and Rett Related Disorders Natural History 69,936

USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon University of California, San Francisco Primary Immune Deficiency Treatment Consortium 33,533

USF Health-Morsani College Health Informatics Institute PI: Krischer,Jeffrey P Spon University of FloridaUnderstanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes 349,774

USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon University of Pennsylvania Vasculitis Clinical Research Consortium FY 19-20 53,733 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon University of Pennsylvania VCRC EGPA Project 163,207 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Vasculitis Foundation DMCC for the Vasculitis Patient-Powered Research Network (V-PPRN) 21,500 USF Health-Morsani College o Health Informatics Institute PI: Krischer,Jeffrey P Spon Washington State University Natural History of SSADHD, a Heritable Disorder of GABA Metabolism 40,364

USF Health-Morsani College Health Informatics Institute PI: Li,Qian , Co-PI(s): Krischer,Jeffrey P Spon University of California, San DiegodkNET Coordinating Unit: An information network for FAIR resources and data 224,200

USF Health-Morsani College Health Informatics Institute PI: Lynch,Kristian F Spon Baylor College of Medicine Gut Viral and Bacterial associations with Celiac Disease in the TEDDY Cohort 12,978 USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Boehringer Ingelheim Pharm., Inc. Protocol #1218-0091 35,377 USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Dexcom, Inc. Protocol #PTL-901895 7,519 USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Eli Lilly and Company Foundation Protocol #I8B-MC-ITSB 76,544 USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Intrexon T1D Partners LLC Protocol #AG019-T1D-101 1,145 USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Provention Bio, Inc. Protocol #PRV-031-001 35,909

138


USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Takeda Pharmaceuticals USA, Inc. Protocol #SYR-322_309 2,600 USF Health-Morsani College o Health Informatics Institute PI: Rodriguez,Henry Spon Tolerion, Inc. Protocol #TOL-3021-231-01 18,510

USF Health-Morsani College Health Informatics Institute PI: Rodriguez,Henry Spon University of Colorado Denver

Novel Culturally Sensitive Group Clinic Model for Education and Diabetes Care for Latino Patients: Feasibility and Dissemination to Other DiabetesCenters in the USA 14,836

USF Health-Morsani College o Health Informatics Institute PI: Shulman,Dorothy I Spon Medtronic, Inc. Protocol #CEP304 1,308 USF Health-Morsani College o Health Informatics Institute PI: Shulman,Dorothy I Spon Medtronic, Inc. Protocol #CIP324 26,924 USF Health-Morsani College o Health Informatics Institute PI: Shulman,Dorothy I Spon Medtronic, Inc. Protocol #CIP326 156,591 USF Health-Morsani College o Health Informatics Institute PI: Shulman,Dorothy I Spon Medtronic, Inc. Protocol #MDT18007321 200,173 USF Health-Morsani College o Health Informatics Institute PI: Shulman,Dorothy I Spon Medtronic, Inc. Protocol:CIP330 78,217

USF Health-Morsani College Health Informatics Institute PI: Tamura,Roy Spon Prader-Willi Syndrome AssociationData Management and Coordinating Center [DMCC] at The University of South Florida Support for Protocol 5202 and 8208 25,000

USF Health-Morsani College Health Informatics Institute PI: Tamura,Roy Spon University of MichiganInnovative randomized trial design and Bayesian analysis for the registration of a drug for rare disease in small samples 40,811

USF Health-Morsani College of Health Informatics Institute Total 79,926,287 USF Health-Morsani College o Heart Inst - Cardiology PI: Wickline,Samuel Alan Conv University of South Florida Foundation TGH Heart Institute Cardiovascular Chair 37,187

USF Health-Morsani College of Heart Inst - Cardiology Total 37,187 USF Health-Morsani College o Heart Inst - Surgery PI: Li,Ji Spon National Institutes of Health Activated Protein C and Cardiac Inflammatory Response 484,258

USF Health-Morsani College Heart Inst - Surgery PI: Li,Ji Spon University of Louisville Research FoundaA Novel Mechanism of Stromal Cell-Derived Factor 1 Protection Against Diabetic Cardiomyopathy 29,120

USF Health-Morsani College of Heart Inst - Surgery Total 513,378 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Halade,Ganesh Spon Natl Heart Lung and Blood Inst Lipoxygenase Signaling in Heart Failure Pathology 747,500 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Halade,Ganesh Spon Natl Heart Lung and Blood Inst Resolution of Inflammation in Heart Failure Post-myocardial Infarction 380,378 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Halade,Ganesh Spon Tulane University Mice Heart function study 600 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Lockwood,Charles J Conv University of South Florida Foundation Center for Cardiology Research 51,020 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Lockwood,Charles J Conv University of South Florida Foundation Stem Cell Model Generic Fund 19,926 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Lockwood,Charles J Conv University of South Florida Foundation USF Health Heart Institute 149,070 USF Health-Morsani College o Heart Institute - Internal Medicine PI: Pan,Hua Conv University of South Florida Foundation Charles Donegan Fund Supp USF HEALTH Assistant Professor 30,562

USF Health-Morsani College Heart Institute - Internal MedicinePI: Pan,Hua , Co-PI(s): Wickline,Samuel Alan Spon Natl Heart Lung and Blood Inst Prediction and Treatment for Cancer Immunotherapy Induced Myocarditis 186,875

USF Health-Morsani College Heart Institute - Internal MedicinePI: Pan,Hua , Co-PI(s): Zhou,Qingyu Stephanie;Wickline,Samuel Alan Spon Natl Insti of Diabetes (NIDDK)

Mitigate Cisplatin Induced Acute Kidney Injury Through Preservation of Vasculature and Proximal Tubule 424,049

USF Health-Morsani College of Heart Institute - Internal Medicine Total 1,989,980

USF Health-Morsani College Internal Medicine PI: Bandyopadhyay,Debabrata Spon Bellerophon

A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects with Mild to Moderate Coronavirus Disease (COVID-19) 10,000

USF Health-Morsani College Internal Medicine PI: Bandyopadhyay,Debabrata Spon Bellerophon

A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term 25,775

USF Health-Morsani College Internal Medicine PI: Bandyopadhyay,Debabrata Spon FibroGen, Inc.A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis 10,000

USF Health-Morsani College o Internal Medicine PI: Bandyopadhyay,Debabrata Spon Galecto Biotech AB Protocol #GALACTIC-1 30,031 USF Health-Morsani College o Internal Medicine PI: Bezerra,Hiram Spon Case Western Reserve University Computer assisted coronary artery stent interventions 25,295 USF Health-Morsani College o Internal Medicine PI: Calero,Karel Spon Angion Biomedica Corp. Protocol #ANG3777-ALI-201 17,500 USF Health-Morsani College o Internal Medicine PI: Calero,Karel Spon Clear Creek Bio, Inc. Protocol #CCB-CRISIS-01 aka ¿CRISIS¿ study 95,469

USF Health-Morsani College Internal Medicine PI: Calero,Karel Spon Fulcrum Therapeutics, Inc.A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Losmapimod in Adult Subjects with COVID-19 127,117

USF Health-Morsani College Internal Medicine PI: Calero,Karel Spon Hope Pharmaceuticals

Treatment of Lung Injury from COVID-19 Infection with Intravenous Sodium Nitrite: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Study 21,750

USF Health-Morsani College o Internal Medicine PI: Calero,Karel Spon Incyte Corporation Protocol #INCB18424-369 327,376 USF Health-Morsani College o Internal Medicine PI: Calero,Karel Spon Veracyte Protocol #BRAVE-3 (3,692) USF Health-Morsani College o Internal Medicine PI: Calero,Karel Spon Veracyte Protocol #DHF 009-011 (NOBLE) 20,732

USF Health-Morsani College Internal Medicine PI: Cardet-Guisasola,Juan Carlos Spon Brigham and Women's HospitalPATINA - Precision Administration of Treatment in Neutrophillic Severe Asthma 24,708

USF Health-Morsani College o Internal Medicine PI: Cardet-Guisasola,Juan Carlos Spon University of North Carolina,Chapel Hill Data, Modeling, and Coordination Center for PrecISE Network 5,000

USF Health-Morsani College Internal MedicinePI: Cardet-Guisasola,Juan Carlos , Co-PI(s): Kolliputi,Narasaiah;Casale,Thomas B Spon Natl Inst of Allergy and Infectious K23: Enterolactone and Asthma 192,839

USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon AbbVie Inc. Protocol #M13-542 11,089 USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon AbbVie Inc. Protocol #M15-554 18,100 USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon AbbVie Inc. Protocol #M15-555 9,075 USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon AbbVie Inc. Protocol #M15-998 12,030

139


USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon Amgen Protocol #CC-10004-PSA-013 20,000 USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon Bristol-Myers Squibb Pharmaceuticals Protocol #IM011084 (9,250) USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon Corbus Pharmaceuticals Inc. Protocol #JBT101-DM-002 50,806 USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon GlaxoSmithKline Protocol #201790 11,580 USF Health-Morsani College o Internal Medicine PI: Carter,John D Spon Pfizer Protocol #A3921133 2,075 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Aimmune Therapeutics, Inc. Protocol #ARC004 (8,100) USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Aimmune Therapeutics, Inc. Protocol #ARC008 118,592 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Benaroya Research Inst at Virginia Mason Immune Tolerance Network 585,150 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Eli Lilly Research Laboratories Protocol #J1B-MC-FRCF 4,250 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Food allergy Research & Education, Inc. Chief Medical Advisor - Food Allergy Research & Education (FARE) 262,500 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Incyte Corporation Protocol #INCB 18424-303 6,875 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Knopp Biosciences LLC Protocol #KNS-760704-AS201 (7,000) USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Pfizer Inc US Pharmaceuticals Group Protocol #B7451014 (3,318) USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Regeneron Pharmeceuticals, Inc. Protocol #R668-ALG-16114 94,850 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Regeneron Pharmeceuticals, Inc. Protocol #R668-ALG-1702 (5,525) USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon Sanofi Pharmaceuticals Protocol #EFC16461 3,625 USF Health-Morsani College o Internal Medicine PI: Casale,Thomas B Spon TEVA Pharmaceutical USA Protocol #TPI-18-03 (4,000)

USF Health-Morsani College Internal Medicine PI: Casanas,Beata C Spon GlaxoSmithKline

oA Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administered every two mo 10,000

USF Health-Morsani College o Internal Medicine PI: Cho,Seong Spon AOBiome, LLC. Protocol #Nasal Fluid Test (500) USF Health-Morsani College o Internal Medicine PI: Cho,Seong Spon Regeneron Pharmeceuticals, Inc. SINUS813 428,959

USF Health-Morsani College Internal Medicine PI: Cho,Seong Spon Sanofi Pharmaceuticals

A Randomized Double-Blind Placebo-Controlled Parallel Group Study Assessing the Efficacy and Safety of Dupilumab in Patients with Allergic Fungal Rhinosinusitis 42,327

USF Health-Morsani College o Internal Medicine PI: Cui,Liwang Spon Natl Inst of Allergy and Infectious Southeast Asia Malaria Research Center 1,046,700 USF Health-Morsani College o Internal Medicine PI: Cui,Liwang Spon Natl Inst of Allergy and Infectious Training in Malaria Research in Myanmar 248,408

USF Health-Morsani College Internal Medicine PI: Cui,Liwang Spon New York UniversityCenter for the Study of Complex Malaria in India (India ICEMR Administrative Supplement) 21,484

USF Health-Morsani College o Internal Medicine PI: Cui,Liwang , Co-PI(s): Miao,Jun Spon Natl Inst of Allergy and Infectious Molecular Mechanisms of Artemisinin Resistance 190,204

USF Health-Morsani College Internal MedicinePI: Cui,Liwang , Co-PI(s): Unnasch,Thomas R;Miao,Jun Spon Natl Inst of Allergy and Infectious Southeast Asia Malaria Research Center 2,075,596

USF Health-Morsani College o Internal Medicine PI: Doumit,Elias Spon Equillium, Inc. Protocol #EQ001-19-002 31,500 USF Health-Morsani College o Internal Medicine PI: Doumit,Elias Spon Reata Pharmaceuticals, Inc. Protocol #402-C-1808 (aka FALCON) 26,121 USF Health-Morsani College o Internal Medicine PI: Doumit,Elias Spon Reata Pharmaceuticals, Inc. Protocol: 402-C-1803 10,000 USF Health-Morsani College o Internal Medicine PI: Doumit,Elias Spon Retrophin, Inc. Protocol #021FSGS16010 21,289 USF Health-Morsani College o Internal Medicine PI: Doumit,Elias Spon Vascular Therapies, Inc Proposal #VT-304 13,268 USF Health-Morsani College o Internal Medicine PI: Fernandez,Joel Spon Alnylam, Inc - Discovery Study Team Protocol #ALN-TTR02-012 23,321 USF Health-Morsani College o Internal Medicine PI: Fernandez,Joel Spon Relypsa, Inc. Protocol #PAT-CR-302 16,600

USF Health-Morsani College Internal Medicine PI: Floreth,Timothy Spon All Children's Research Institute Cystic Fibrosis Foundation Therapeutic Development Center Award (TDN) 66,959

USF Health-Morsani College Internal Medicine PI: Floreth,Timothy Spon Armata Pharmaceuticals, Inc.

A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects with Cystic Fibrosis and C 36,381

USF Health-Morsani College o Internal Medicine PI: Floreth,Timothy Spon Corbus Pharmaceuticals Inc. Protocol #JBT101-LTS-001 6,000 USF Health-Morsani College o Internal Medicine PI: Floreth,Timothy Spon Seattle Children's Hospital Research Ins Simplify-IP-19 18,898 USF Health-Morsani College o Internal Medicine PI: Goldman,Allan L Conv University of South Florida Foundation GERI SAL (Geriatric Salary Support, Saunders) 40,019 USF Health-Morsani College o Internal Medicine PI: Goldman,Allan L Conv University of South Florida Foundation Support for D. Djulbegovic 82,526 USF Health-Morsani College o Internal Medicine PI: Kim,Kami Spon Abbott Diagnostics Scarborough Inc. ID NOW¿ COVID-19 22,638

USF Health-Morsani College Internal Medicine PI: Kim,Kami Spon Merck Sharp & Dohme Research Corp

Phase 2/3 Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19 10,000

USF Health-Morsani College Internal Medicine PI: Kim,Kami Spon Regeneron Pharmeceuticals, Inc.A Phase 2 Study to Assess the Virologic Efficacy of REGN10933 + 10987 Across Different Dose Regimens in Outpatients with SARS-CoV-2 Infection 59,481

USF Health-Morsani College Internal Medicine PI: Kim,Kami Spon Regeneron Pharmeceuticals, Inc.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety Of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2 48,523

USF Health-Morsani College o Internal Medicine PI: Kim,Kami Spon Regeneron Pharmeceuticals, Inc. Protocol #6R88-COV-2040 11,083 USF Health-Morsani College o Internal Medicine PI: Kim,Kami Spon Regeneron Pharmeceuticals, Inc. R10933-10987-COV-2066 1,164,027 USF Health-Morsani College o Internal Medicine PI: Kim,Kami Spon Regeneron Pharmeceuticals, Inc. R10933-10987-COV-2067 448,689

140


USF Health-Morsani College Internal Medicine PI: Kim,Kami Spon Romark, L.C.

A Randomized, Double-Blind, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers 38,580

USF Health-Morsani College Internal Medicine PI: Kim,Kami , Co-PI(s): Suvorova,Elena S Spon Natl Inst of Allergy and InfectiousToxoplasma Gondii cAMP-Dependent Kinase PKAc3 Regulation of Bradyzoite Formation 186,875

USF Health-Morsani College o Internal Medicine PI: Kolliputi,Narasaiah Spon Natl Heart Lung and Blood Inst Molecular Mechanisms of Hyperoxic Lung Injury (41,582) USF Health-Morsani College o Internal Medicine PI: Lakshmi,Seetha Spon Duke University Protocol #COVID-19-2020-01 149,740

USF Health-Morsani College Internal Medicine PI: Ledford,Dennis K Spon Dyax Corp

A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema with Normal C1-Inhibitor (C1-INH) and Acquired Angioedema ( 21,238

USF Health-Morsani College o Internal Medicine PI: Ledford,Dennis K Spon Genentech Protocol #WA40169 (2,792) USF Health-Morsani College o Internal Medicine PI: Ledford,Dennis K Spon Novartis Pharmaceutical Corporation Protocol #QGE031C2302 21,341 USF Health-Morsani College o Internal Medicine PI: Lin,Yih Chang Chen Spon Kiniksa Pharmaceuticals Corp. Protocol #KPL-301-C001 (7,000) USF Health-Morsani College o Internal Medicine PI: Lockey,Richard F Conv University of South Florida Foundation Simmons Professorship in Asthma Research 228,999 USF Health-Morsani College o Internal Medicine PI: Lockey,Richard F Spon ARS Pharmaceuticals, Inc. Protocol #EPI-10 225,567 USF Health-Morsani College o Internal Medicine PI: Lockey,Richard F Spon BioCryst Pharmaceuticals, Inc. Protocol #BCX7353-204 34,447 USF Health-Morsani College o Internal Medicine PI: Lockey,Richard F Spon Takeda Pharmaceuticals USA, Inc. Protocol #SHP643-403 2,500 USF Health-Morsani College o Internal Medicine PI: Lockwood,Charles J Conv University of South Florida Foundation Ed Wright Cardiovascular Chair 25,000 USF Health-Morsani College o Internal Medicine PI: Malone,John I Spon Case Western Reserve University Epidemiology of Diabetes Interventions & Complications (EDIC) 106,941 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon AbbVie Inc. Protocol #P11-282 5,012 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon Arena Pharmaceuticals, Inc. Protocol #APD334-301 42,648 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon Arena Pharmaceuticals, Inc. Protocol #APD334-302 34,984 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon Arena Pharmaceuticals, Inc. Protocol #APD334-303 16,050 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon Corrona, LLC Protocol #IBD-600 14,620 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon Eli Lilly and Company Foundation Protocol #I6T-MC-AMAM 20,000 USF Health-Morsani College o Internal Medicine PI: Marchioni Beery,Renee Spon Pfizer Proocol #C2501003 8,000 USF Health-Morsani College o Internal Medicine PI: Matar,Fadi A Spon Abbott Cardiovascular Systems, Inc. Protocol #ABT-CIP-10331 36,322 USF Health-Morsani College o Internal Medicine PI: Matar,Fadi A Spon Edwards Lifesciences, LLC Protocol #2502-0003 8,600 USF Health-Morsani College o Internal Medicine PI: Matar,Fadi A Spon Gentuity, LLC 003175 RevB Vis-Rx PME 20,982 USF Health-Morsani College o Internal Medicine PI: Menezes,Lynette J Spon The Arnold P. Gold Foundation 2020 Student Summer Fellowship 2,400

USF Health-Morsani College Internal Medicine PI: Miao,Jun , Co-PI(s): Cui,Liwang Spon Natl Inst of Allergy and InfectiousDevelopment of CRISPR/dCas-Based Epigentic Gene Regulation Tools in Malaria Parasite 186,875

USF Health-Morsani College o Internal Medicine PI: Mohanty,Bibhu Spon Boston Scientific Corporation Protocol #PROTECTED TAVR 44,777 USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam Spon TransGenex Nanobiotech, Inc. Pre-clinical and New Drug (IND) Enabling Studies of Anti-cancer Leads 225,000 USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital IPA Eleni Markoutsa 11.01.19-09.30.20 RSV (22,174) USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital VA IPA Andrew McGill 31,100 USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital VA IPA Eleni Markoutsa 8,250 USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital VA IPA Mark Howell 52,710 USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital VA IPA Ryan Green 42,740 USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital VA IPA Ryan Green, 05.01.2020-09.30.2020 RSV (21,000) USF Health-Morsani College o Internal Medicine PI: Mohapatra,Shyam S Spon James A. Haley Veteran's Hospital VA IPA Tao Wang 68,500

USF Health-Morsani College Internal MedicinePI: Mohapatra,Shyam S , Co-PI(s): Markoutsa,Eleni Spon American Federation for Aging Research

Redirecting Neurogenesis in the Aged Using atRA Pulsed Exosomes Derived From Educated-hMSCs (postdoctoral fellowship for Eleni Markoutsa, PhD) 59,728

USF Health-Morsani College o Internal Medicine PI: Montero,Jose A Spon Merck Sharp & Dohme Research Corp Protocol #MK-1439-018 (1,784) USF Health-Morsani College o Internal Medicine PI: Morano,Jamie Spon Amgen Protocol #20130286 (602) USF Health-Morsani College o Internal Medicine PI: Myers,Andrew W. Spon Blade Therapeutics, Inc. Protocol #B-2660-204 17,918

USF Health-Morsani College Internal Medicine PI: Oxner,Asa Z Spon Becton, Dickinson and CompanyIDS-20VERCOVASYM02 BD Respiratory Sample Collection for COVID Asymptomatic Pediatric Population 12,750

USF Health-Morsani College o Internal Medicine PI: Oxner,Asa Z Spon Becton, Dickinson and Company Protocol #BDX-GSCP01 45,419 USF Health-Morsani College o Internal Medicine PI: Oxner,Asa Z Spon Heart Rhythm Society Protocol #Heart Rhythm Society (7,500) USF Health-Morsani College o Internal Medicine PI: Oxner,Asa Z Spon Kaligia Biosciences Protocol #KBS005 412,176 USF Health-Morsani College o Internal Medicine PI: Oxner,Asa Z Spon Notitia Biotechnologies Company Protocol: NBT-NM108 15,500 USF Health-Morsani College o Internal Medicine PI: Oxner,Asa Z Spon Sanofi Pharmaceuticals Protocol #EFC16855 (3,222) USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon AbbVie Inc. Protocol #M19-530 3,731 USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon Corbus Pharmaceuticals Inc. Protocol #JBT101-CF-002 9,052 USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon Cystic Fibrosis Foundation Protocol #Cystic Fibrosis 31,097 USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon Respivant Sciences, Inc. Protocol #RVT1601-CC-04 (2,361) USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon Tampa General Hospital Protocol #CTMB100C2407 4,438 USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon Vertex Pharmaceuticals Protocol #VX17-445-105 48,455 USF Health-Morsani College o Internal Medicine PI: Patel,Kapilkumar Spon Vertex Pharmaceuticals Protocol #VX18-561-101 7,849 USF Health-Morsani College o Internal Medicine PI: Pepper,Amber N Spon Molekule, Inc. Protocol #not assigned 1,978 USF Health-Morsani College o Internal Medicine PI: Pepper,Amber N Spon Pfizer Protocol #B7451015 8,352

141


USF Health-Morsani College o Internal Medicine PI: Pepper,Amber N Spon Regeneron Pharmeceuticals, Inc. Protocol #R668-AD-1434 40,344 USF Health-Morsani College o Internal Medicine PI: Pepper,Amber N Spon Regeneron Pharmeceuticals, Inc. Protocol #R668-AD-1539 68,682 USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon Actelion Clinical Research, Inc. Protocol #AC-065A402 3,000 USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon Tampa General Hospital Protocol #AC-055-503 5,000 USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon Tampa General Hospital Protocol #RIN-PH-201 5,618 USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon Tampa General Hospital Protocol #RIN-PH-202 6,952 USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon Tampa General Hospital Protocol #TDE-PH-401 3,504

USF Health-Morsani College Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon United Therapeutics Corporation

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Rece 10,000

USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon United Therapeutics Corporation Protocol #RIN-PH-304 21,718 USF Health-Morsani College o Internal Medicine PI: Restrepo-Jaramillo,Ricardo Spon United Therapeutics Corporation Protocol #TIP-PH-101 78,045

USF Health-Morsani College Internal Medicine PI: Richardson,Risa Thompson Spon Craig HospitalCharacterization and Treatment of Chronic Pain after Moderate to Severe Traumatic Brain Injury 44,982

USF Health-Morsani College Internal Medicine PI: Richardson,Risa Thompson Spon Tampa VA Research & Education FoundationImproved Understanding of Medical And Psychological Needs (I-MAP) in Veterans and Service Members with Chronic TBI 48,912

USF Health-Morsani College o Internal Medicine PI: Richter,Joel E Conv University of South Florida Foundation Hugh Culverhouse Chair in Esophageal Disorders 100,000 USF Health-Morsani College o Internal Medicine PI: Seminerio- Diehl,Jennifer L Spon Takeda Pharmaceuticals USA, Inc. Florida IBD Live 38,885 USF Health-Morsani College o Internal Medicine PI: Seminerio- Diehl,Jennifer L Spon University of North Carolina,Chapel Hill Protocol #TOUR 7,700 USF Health-Morsani College o Internal Medicine PI: Sinnott,John T Conv University of South Florida Foundation Holt - Andor Szentivanyi Endowed Professorship 75,031 USF Health-Morsani College o Internal Medicine PI: Sinnott,John T Conv University of South Florida Foundation Infectious Disease - Salaries Support 165,487

USF Health-Morsani College Internal Medicine PI: Sinnott,John T , Co-PI(s): Bari,Shahla Spon Circle of Hope Cancer Research Inc.Changes in gut microbiome -Can it help us predict response to immunotherapy in advanced head and neck cancer? 10,000

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon Brigham and Women's HospitalRandomized Trail to Prevent Vascular Events in HIV-REPRIEVE (A5332) U01 HL 12336 and U01HL123339) 24,426

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon Florida Department of Health(FDOH, HB378): Physician Oversight, Medical Director & Research Coordination 445,024

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon Institute for Clinical Research, Inc.International COVID-19 Observational Study (ICOS or INSIGHT 011) Task Order 8 30,500

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon Institute for Clinical Research, Inc.Therapeutics for Inpatients with COVID-19 or ITAC or INSIGHT 013 Task Order 10 56,000

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon International Network for Strategic InitTherapeutics for Inpatients with COVID-19 (TICO or ACTIV-3 or INSIGHT 014) 46,438

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon Massachusetts Dept. of Public HealthComponent A Regional Training Center: Subcomponent A1. Scaling Up Regional HIV Preventive Services in STD Specialty Clinics 180,088

USF Health-Morsani College o Internal Medicine PI: Somboonwit,Charurut Spon PPD Investigator Services, LLC Brii_: Adaptive Platform Treatment Trial for Outpatients with COVID-19 23,450

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon PPD Investigator Services, LLCPhase II: Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID) 136,371

USF Health-Morsani College o Internal Medicine PI: Somboonwit,Charurut Spon RTI International Red Carpet Entry Program Implementation Evaluation 268,343

USF Health-Morsani College Internal Medicine PI: Somboonwit,Charurut Spon University of Florida(UFlorida sub, R01): Health Outcomes and Cognitive Effects of Marijuana Use Among Persons Living with HIV/AIDS 105,810

USF Health-Morsani College Internal MedicinePI: Somboonwit,Charurut , Co-PI(s): Somboonwit,Charurut Spon University of Florida

Southern HIV Alcohol Research consortium (SHARC) Administrative and Research Support Core 70,585

USF Health-Morsani College Internal Medicine PI: Stachura,Zachary Spon Hill-Rom Company, Inc.

A NOVEL PROPORTIONAL OPEN VENTILATION (POV) DEVICE AND ITS EFFICACY IN MANAGING ACUTE RESPIRATORY FAILURE IN COVID-19 PATIENTS 40,900

USF Health-Morsani College Internal Medicine PI: Suvorova,Elena S Spon Natl Inst of Allergy and InfectiousNew Reporter System for Spatiotemporal Visualization of Toxoplasma Gondi Growth and Development 74,750

USF Health-Morsani College Internal MedicinePI: Suvorova,Elena S , Co-PI(s): Chaput,Dale Isabelle;Kim,Kami Spon Natl Inst of Allergy and Infectious Cyclin-mediated control of Toxoplasma development 373,750

USF Health-Morsani College Internal Medicine PI: Visweshwar,Nathan Spon Freeline Therapeutics

Screening and Lead-in Observational Protocol to Determine Potential Patient Eligibility for Inclusion in AAV Gene Therapy Clinical Trials in Haemophilia B 21,912

USF Health-Morsani College o Internal Medicine PI: Visweshwar,Nathan Spon Hemophilia of Georgia Community Counts Public Health Surveillance for Bleeding Disorders 19,500 USF Health-Morsani College o Internal Medicine PI: Visweshwar,Nathan Spon Hemophilia of Georgia Hemophilia Treatment Centers (SPRANS) 12,400 USF Health-Morsani College o Internal Medicine PI: Visweshwar,Nathan Spon Pfizer Protocol #B7841005 8,115 USF Health-Morsani College o Internal Medicine PI: Visweshwar,Nathan Spon Pfizer Protocol #SB-525-1603 26,040 USF Health-Morsani College o Internal Medicine PI: Visweshwar,Nathan Spon uniQure Biosciences, Inc. Protocol #CT-AMT-061-02 28,695 USF Health-Morsani College o Internal Medicine PI: White,Michael W Spon Natl Inst of Allergy and Infectious Developmental Switches That Regulate Tissue Cyst Formation 546,310 USF Health-Morsani College o Internal Medicine PI: White,Michael W Spon University of California, Riverside Defining the cell and molecular basis of Toxoplasma recrudescence 304,831 USF Health-Morsani College o Internal Medicine PI: Wilson,Jason Wayne Spon University of Florida COVID 19 Outpatient Thrombosis Prevention Trial within ACTIV-IV 41,750

USF Health-Morsani College of Internal Medicine Total 14,422,873

142


USF Health-Morsani College Molecular Medicine PI: Bahner,Ingrid Spon University of Chicago

Boosting Mentor Effectiveness iN Training of Research Scientists (MENTORS) Using Social Cognitive Career Theory to Support Entry of Women & Minorities into Physician-Scientist Careers 11,500

USF Health-Morsani College o Molecular Medicine PI: Bhat,Krishna Spon Natl Insti of Gen Medical Science Developmental Genetics of Neural Stem Cells 299,000 USF Health-Morsani College o Molecular Medicine PI: Blair,Laura J Spon Alzheimer's Association ER Stress as a Mediator of Tau-Induced Neurotoxicity 50,000 USF Health-Morsani College o Molecular Medicine PI: Blair,Laura J Spon James A. Haley Veteran's Hospital FY20 VA IPA Danielle Gulick 13,000 USF Health-Morsani College o Molecular Medicine PI: Blair,Laura J Spon James A. Haley Veteran's Hospital FY20 VA IPA Shannon Hill 65,000 USF Health-Morsani College o Molecular Medicine PI: Blair,Laura J Spon James A. Haley Veteran's Hospital FY21 VA IPA Beaulieu Abdelahad 59,500 USF Health-Morsani College o Molecular Medicine PI: Blair,Laura J Spon James A. Haley Veteran's Hospital FY21 VA IPA Gulick 12,750 USF Health-Morsani College o Molecular Medicine PI: Blair,Laura J Spon James A. Haley Veteran's Hospital FY21 VA IPA Hill 45,000

USF Health-Morsani College Molecular MedicinePI: Blair,Laura J , Co-PI(s): Criado-Marrero,Marangelie Spon Alzheimer's Association Exploring Aha1 and tau relationship 58,333

USF Health-Morsani College Molecular Medicine PI: Blanck,George Spon American Society of Hematology

Novel bioinformatics-based approach for characterizing biochemical diversity of T-cell receptors and identifying T-cell receptors likely directed against specific multiple myeloma antigens 6,000

USF Health-Morsani College o Molecular Medicine PI: Chandran,Bala Spon National Institutes of Health KSHV Interactions with Host Nuclear Innate Response Components 355,063 USF Health-Morsani College o Molecular Medicine PI: Chen,Yu Spon Medical College of Wisconsin Sulfotyrosine-Guided Discovery of Small Molecule Chemokine Inhibitors 181,171

USF Health-Morsani College Molecular MedicinePI: Chen,Yu , Co-PI(s): Leahy,James Williams;Darch,Sophie Spon National Institutes of Health Novel Inhibitor Discovery Against Psedomonas Aeruginosa PBP3 186,875

USF Health-Morsani College o Molecular Medicine PI: Cooper,Denise Spon James A. Haley Veteran's Hospital FY20 VA IPA Xiaoqi Sun 27,000 USF Health-Morsani College o Molecular Medicine PI: Cooper,Denise Spon James A. Haley Veteran's Hospital FY2019 VA IPA Dobbins (3,333) USF Health-Morsani College o Molecular Medicine PI: Cooper,Denise Spon James A. Haley Veteran's Hospital FY21 VA IPA Xiaoqi Sun 27,000

USF Health-Morsani College Molecular MedicinePI: Darch,Sophie , Co-PI(s): Sharma,Nirmal Shyam Spon Cystic Fibrosis Foundation Bacterial Aggregate Formation and Tolerance in the CF Lung 125,000

USF Health-Morsani College Molecular Medicine PI: Gamsby,Joshua J Spon Florida Department of HealthInvestigation of Alzheimer's Disease-induced Circadian Dysfunction on Tau Production and Phosphorylation 82,039

USF Health-Morsani College Molecular Medicine PI: Ghansah,Tomar , Co-PI(s): Chen,Henian Spon Florida Department of HealthSHIP-1: A Potential New Molecular Target for the Treatment of Pancreatic Cancer. 226,807

USF Health-Morsani College o Molecular Medicine PI: Kang,David E Spon James A. Haley Veteran's Hospital FY20 VA IPA Xinming Wang 35,000 USF Health-Morsani College o Molecular Medicine PI: Kang,David E Spon James A. Haley Veteran's Hospital FY2021 VA IPA Wang 9,000 USF Health-Morsani College o Molecular Medicine PI: Kang,David E Spon James A. Haley Veteran's Hospital FY21 IPA Tian Liu 19,000 USF Health-Morsani College o Molecular Medicine PI: Kang,David E Spon James A. Haley Veteran's Hospital FY21 VA IPA Beaulieu Abdelahad 19,750 USF Health-Morsani College o Molecular Medicine PI: Kang,David E Spon James A. Haley Veteran's Hospital FY21 VA IPA Rodriguez Ospina 15,750 USF Health-Morsani College o Molecular Medicine PI: Kang,David E Spon National Institute on Aging Role of the Slingshot-1 pathway in APP and Tau pathogenesis 373,750

USF Health-Morsani College Molecular MedicinePI: Kang,David E , Co-PI(s): Blair,Laura J;Wang,Xinming;Woo,Jung A;Liu,Tian Spon National Institute on Aging Deubiquitinase USP11 in Tau Regulation and Age-Related Tauopathy 747,500

USF Health-Morsani College Molecular MedicinePI: Liu,Tian , Co-PI(s): Kang,David E;Wang,Xinming;Woo,Jung A Spon National Institute on Aging Targeting CHCHD10 to mitigate Alzheimer's disease pathogenesis 411,125

USF Health-Morsani College o Molecular Medicine PI: Lockwood,Charles J Conv University of South Florida Foundation Gay Culverhouse Brain Injury Fund 19,444 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY20 VA IPA Alison Willing 2,750 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY20 VA IPA Mahasweta Das 38,000 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY20 VA IPA Rinku Dutta 68,700 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY20 VA IPA Roukiah Khalil 31,100 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY20 VA IPA Srinivas Bharadwaj 10,000 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY20 VA IPA Taylor Martinez 12,800 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY21 VA IPA Das 57,225 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY21 VA IPA Dutta 52,200 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY21 VA IPA Khalil 13,000 USF Health-Morsani College o Molecular Medicine PI: Mohapatra,Subhra Spon James A. Haley Veteran's Hospital FY21 VA IPA Penn 25,500 USF Health-Morsani College o Molecular Medicine PI: Ouyang,Zhiming Spon National Institutes of Health Virulence-associated genes in the Lyme disease spirochete 74,750 USF Health-Morsani College o Molecular Medicine PI: Ouyang,Zhiming Spon Natl Inst of Allergy and Infectious Analysis of the DksA regulon in the Lyme disease spirochete 224,250 USF Health-Morsani College o Molecular Medicine PI: Ouyang,Zhiming Spon Natl Inst of Allergy and Infectious Virulence regulation by BadR in the Lyme disease spirochete 373,750

USF Health-Morsani College Molecular Medicine PI: Parent,Angele Spon National Institutes of HealthAPP-Mediated Signaling, Sleep Perturbations, and Alzheimer's Disease Mouse Models 687,065

USF Health-Morsani College o Molecular Medicine PI: Patel,Niketa A Spon James A. Haley Veteran's Hospital 06/01/2020 - 09/30/2020 IPA Sparks 10,500 USF Health-Morsani College o Molecular Medicine PI: Patel,Niketa A Spon James A. Haley Veteran's Hospital FY 20 VA IPA Ashley Lui 31,100 USF Health-Morsani College o Molecular Medicine PI: Patel,Niketa A Spon James A. Haley Veteran's Hospital FY20 VA IPA Derek Sode 21,000 USF Health-Morsani College o Molecular Medicine PI: Patel,Niketa A Spon James A. Haley Veteran's Hospital FY20 VA IPA Rea Rupani 19,000 USF Health-Morsani College o Molecular Medicine PI: Patel,Niketa A Spon James A. Haley Veteran's Hospital FY20 VA IPA Rekha Patel (35,090) USF Health-Morsani College o Molecular Medicine PI: Patel,Niketa A Spon James A. Haley Veteran's Hospital FY21 VA IPA Lui 31,100 USF Health-Morsani College o Molecular Medicine PI: Thinakaran,Gopal Spon Alzheimer's Association ALZ AARF-17-501228 Research Stipend 10,000

USF Health-Morsani College Molecular Medicine PI: Thinakaran,Gopal Spon National Institute on AgingCell autonomous and non-cell autonomous roles of the GWAS risk factor BIN1 in Alzheimer's disease neuropathology 875,883

USF Health-Morsani College Molecular Medicine PI: Thinakaran,Gopal Spon National Institutes of HealthHigh-plex Protein and Gene Expression Digital Spatial Profiler for Core Facility 450,000

143


USF Health-Morsani College o Molecular Medicine PI: Thinakaran,Gopal Spon NorthShore University Health System Modeling Alzheimer's Disease Genetic Variants in HiPSC 180,560

USF Health-Morsani College Molecular MedicinePI: Thinakaran,Gopal , Co-PI(s): Parent,Angele Spon National Institutes of Health The role of elevated BIN1 expression in Alzheimer's disease 762,027

USF Health-Morsani College Molecular MedicinePI: Thinakaran,Gopal , Co-PI(s): Parent,Angele Spon University of Kentucky Programming amylin secretion to slow brain aging - an animal model 373,079

USF Health-Morsani College o Molecular Medicine PI: Walter,Jolan Spon Octapharma AG Protocol #SCGAM-06 54,419

USF Health-Morsani College Molecular Medicine PI: Webster,Jack Mathew Spon Florida Department of Health Intracellular anti-Tau Proteins Engineered on a Hyperthermophilic Scaffold 29,033

USF Health-Morsani College Molecular MedicinePI: Chen,Yu , Co-PI(s): Shaw,Lindsey Neil;Gelis,Ioannis;Madsen,Jesper Spon Natl Inst of Allergy and Infectious Evolution and inhibition of carbapenemase in beta-lactam resistance 751,397

USF Health-Morsani College of Molecular Medicine Total 8,713,121

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Cuevas,Javier Spon National Institute of Neurological DisorRisk factor convergence in the development of lacunar strokes and vascular cognitive impairment and dementia 224,250

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Davis,George Edward Spon Natl Heart Lung and Blood InstMolecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations 785,030

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Davis,George Edward Spon University of Texas Southwestern Med CtrMolecular Regulation of Rho and Ras Family GTPase Activity Controls Vascular Lumen Formation 168,188

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Dean,Jay B Spon Office of Naval ResearchMitigation of CNS Oxygen Toxicity: Mitochondria Targeted Anti-Oxidant Therapy and Aquaporin Gas Channels 360,166

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Jackson,Travis Corey Spon National Institute of Neurological Disor The Role of RNA Binding Motif 5 in Traumatic Brain Injury 327,031 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Liu,Ruisheng Spon Natl Heart Lung and Blood Inst Renal Hemodynamics and Hypertension During Pregnancy 387,823

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Liu,Ruisheng Spon Natl Heart Lung and Blood InstRole of Tubuloglomerular Feedback in the Development of Hypertension in Diabetes 591,074

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Morris,Kendall F Spon University of Florida Influence of opioids on the brainstem respiratory network 244,856 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Nash,Kevin R Spon Sanford Burnham Medical Research Inst Targeting Neuroinflammation in AD with Novel CX3CR1 Agonists 456,892 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Nash,Kevin R Spon The Healthy Aging Company (THAC) Innovative Therapy for AD (ITAD) 50,000 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Nash,Kevin R Spon University of Texas, San Antonio Microglia Mediated Inflammation in the Diabetic Retina 8,514 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Nash,Kevin R , Co-PI(s): Joly,Aurelie HG Spon The Healthy Aging Company Innovative Therapy for AD (ITAD) 25,000 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Noujaim,Sami F Spon Northeastern University Structural Determinants of PIP2 Regulation 80,483

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Rieg,Timo Marcel Spon American Heart AssociationPharmacological Npt2a Inhibition as an Approach for Treating Impaired Phosphate Homeostasis 100,000

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Rieg,Timo Marcel Spon University of Texas Regulation of K + Balance by Distal Nephron TRPV4 Channel 35,912 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Scallan,Joshua Paul Spon American Heart Association eNOS regulates lymphatic valve development during embryogenesis 31,520

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Scallan,Joshua Paul Spon Natl Heart Lung and Blood Inst Pathways Regulating Lymphatic Vessel Permeability and Valve Formation 429,240

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Taylor-Clark,Thomas Spon Natl Insti of Diabetes (NIDDK)Identification and Activation Mechanisms of Vagal and Spinal Nociceptors in Esophageal Mucosa 352,407

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Taylor-Clark,Thomas Spon Natl Insti of Diabetes (NIDDK)Ionic and Structural Mechanisms for Sensory Neuromodulation of the Esophagus 53,277

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Taylor-Clark,Thomas Spon Natl Insti of Diabetes (NIDDK) Vagal Nociceptive Pathway Mediating Pain from the Esophagus 186,875

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Taylor-Clark,Thomas Spon University of FloridaFunctional mapping of peripheral and central circuits for airway protection and breathing 326,260

USF Health-Morsani College Molecular Pharmacology and Physiology

PI: Taylor-Clark,Thomas , Co-PI(s): Morris,Kendall F;McDonald,Thomas;Kollarik,Marian;Ma,Yonggang Spon Natl Heart Lung and Blood Inst

Remodeled airway irritant reflexes as a cause of serious cardiovascular events 541,038

USF Health-Morsani College Molecular Pharmacology and PhysiologyPI: Taylor-Clark,Thomas , Co-PI(s): Teng,Michael;Kollarik,Marian Spon National Institute of Neurological Disor

Comparative Mapping of Functionally Distinct Visceral Afferent Nociceptive Pathways 735,694

USF Health-Morsani College Molecular Pharmacology and PhysiologyPI: Totary-Jain,Hana , Co-PI(s): Breslin,Jerome W Spon Natl Heart Lung and Blood Inst Cell-Selective Therapies for Coronary Artery Disease 481,755

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Wang,Lei Spon Natl Insti of Diabetes (NIDDK) Macula densa NOS1 and transplanted renal graft function 328,900 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Wang,Lei , Co-PI(s): Liu,Ruisheng Spon American Heart Association Macula Densa NOS1-Beta and Acute Kidney Injury 77,000 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Wang,Lianchun Spon Florida Department of Health The role of extracellular tau in endothelial cell biology 125,000 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Wang,Lianchun Spon National Cancer Institute Heparan Sulfate in Prostate Cancer 539,856

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Wang,Lianchun Spon Rensselaer Polytechnic InstituteHeparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy inAlzheimer's Disease 112,125

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Wei,Jin Spon American Society of Nephrology Role of macula densa RXFP1 in gestational hypertension 100,000 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Woo,Jung A , Co-PI(s): Kang,David E Spon Florida Department of Health Divergent SSH1 signaling in mitochondria toxicity and clearance 125,974

USF Health-Morsani College Molecular Pharmacology and PhysiologyPI: Woo,Jung A , Co-PI(s): Nash,Kevin R;Liggett,Stephen B;Kang,David E Spon National Institute on Aging Novel Role of B-arrestins in Tauopathy 373,750

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Yang,Xiaoyuan Spon Shock SocietyPalmitoylation-Promoted Extracellular Vesicle Production inEndothelial-Leukocyte Crosstalk During Burn Injury 40,000

USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Yang,Ying Spon Natl Heart Lung and Blood Inst Molecular Mechanisms Enhancing Lymphatic Valve Formation 405,769 USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Yuan,Sarah Y Conv University of South Florida Foundation Bob and Evelyn Desiro Endowed Chair 238,000

144


USF Health-Morsani College o Molecular Pharmacology and Physiology PI: Yuan,Sarah Y Spon Natl Heart Lung and Blood Inst Vascular Barrier Leakage in Inflammation 893,838

USF Health-Morsani College Molecular Pharmacology and Physiology PI: Zhang,Jie Spon American Society of NephrologyA new mechanism for the sex differences in diabetic glomerular hyperfiltration and kidney injury 100,000

USF Health-Morsani College Molecular Pharmacology and PhysiologyPI: Noujaim,Sami F , Co-PI(s): Teng,Michael;McDonald,Thomas Spon National Institutes of Health Cardiac Toxicity of Flavorings in Electronic Nicotine Delivery Systems 429,195

USF Health-Morsani College of Molecular Pharmacology and Physiology Total 10,872,692

USF Health-Morsani College Morsani College of Medicine PI: Liggett,Stephen B Spon Rutgers UniversityNovel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma 388,947

USF Health-Morsani College o Morsani College of Medicine PI: Lockwood,Charles J Conv H. Lee Moffitt Cancer Center GME Moffitt Support 299,446 USF Health-Morsani College o Morsani College of Medicine PI: Lockwood,Charles J Conv University Medical Service Associates House Staff - GME Administration 630,686 USF Health-Morsani College o Morsani College of Medicine PI: Lockwood,Charles J Conv University Medical Service Associates House Staff - Graduate Medical Education 1,856,400 USF Health-Morsani College o Morsani College of Medicine PI: Quinn,Joann Farrell Spon Rochester Institute of Technology NSF INCLUDES Alliance: Inclusive Graduate Education 19,143

USF Health-Morsani College Morsani College of MedicinePI: Quinn,Joann Farrell , Co-PI(s): DeWaay,Deborah J Spon International Association of Med Sci Edu

Leadership Essentials in Undergraduate Medical Education and the Barriers to Implementation 2,500

USF Health-Morsani College of Morsani College of Medicine Total 3,197,122

USF Health-Morsani College Neurology PI: Aradi,Stephen D Spon Prilenia Therapeutics Development Ltd.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early State of Huntington Disease 20,600

USF Health-Morsani College o Neurology PI: Beba Abadal,Kanita Spon University of Cincinnati Statins Use in Intracerebral Hemorrhage Patients (SATURN) 1,500 USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon Biogen Protocol #101EP201 13,139 USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon Brain Sentinel, Inc. Protocol #Case Series (888)

USF Health-Morsani College Neurology PI: Benbadis,Selim R Spon Cerevel Therapeutics, LLC

A 57-WEEK, MULTICENTER, ACTIVE-TREATMENT, OPEN-LABEL EXTENSION TRIAL OF CVL-865 AS ADJUNCTIVE THERAPY IN ADULTS WITH DRUG-RESISTANT FOCAL ONSET SEIZURES 21,000

USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon Cerevel Therapeutics, LLC Protocol #CVL-865-SZ-001 3,682 USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon GW Pharmaceuticals Protocol #Typical Absence 99,145

USF Health-Morsani College Neurology PI: Benbadis,Selim R Spon Otsuka America Pharmaceutical

A Phase 1b, Single-blind, Placebo-controlled, Adaptive Design, Outpatient Trial to Assess the Effects of Single Oral Tablet Doses of OPC-214870 on Photic-induced Paroxysmal Electroencephalogram Responses in Subjects Who have Demonstrated Photoepileptifor 31,950

USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon Ovid Therapeutics, Inc. Protocol #TAK-935-18-001 9,077 USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon SK Life Science, Inc. Protocol #YKP3089C025 3,612 USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon SK Life Science, Inc. Protocol #YKP3089C033 38,699 USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon UCB Biosciences, Inc Protocol #EP0088 (7,145) USF Health-Morsani College o Neurology PI: Benbadis,Selim R Spon Xenon Pharmaceuticals Inc. Protocol #XPF-008-201 13,233 USF Health-Morsani College o Neurology PI: Burgin,William Scott Spon Bristol-Myers Squibb Company Protocol #CV010-031 49,047 USF Health-Morsani College o Neurology PI: Burgin,William Scott Spon Duke University Protocol #ARAMIS 375

USF Health-Morsani College Neurology PI: Burgin,William Scott Spon University of Cincinnati Sleep for Stroke Management and Recovery Trial (Sleep SMART) Stroke Trial 1

USF Health-Morsani College Neurology PI: Burgin,William Scott Spon University of MiamiDisparities in Transition of Care after Acute Stroke Hospitalization: The Transition of Care Stroke Disparity Study (TCSD-S) 44,850

USF Health-Morsani College o Neurology PI: Burke,Deborah A Spon University of Rochester Protocol #WPD-01 22,093 USF Health-Morsani College o Neurology PI: Hauser,Robert A Conv University of South Florida Foundation Prostate Cancer Cell Research 6,536

USF Health-Morsani College Neurology PI: Hauser,Robert A Spon AbbVie Inc.

An Open-Label Extension Of Study M15-736 To Evaluate The Safety And Tolerability Of24-Hour Daily Exposure Of ABBV-951 In Subjects With Advanced Parkinson's Disease 31,260

USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon AbbVie Inc. Protocol #M15-736 90,470 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon AbbVie Inc. Protocol #M19-304 22,680 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Biogen Protocol #228PD201 151,025 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Centogene AG Protocol #ROPAD 01-2019 104,260 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Cerevance Beta, Inc. Protocol #CVN424-201 28,519 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Cerevel Therapeutics, LLC 58 Week Open-Label Trial of Tavapadon in Parkinson¿s Disease 23,700 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Cerevel Therapeutics, LLC Protocol #CVL-751-PD-001 29,043 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Cerevel Therapeutics, LLC Protocol #CVL-751-PD-003 22,340 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon CYNAPSUS Therapeutics Inc Protocol #CTH-301 (293) USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Enterin, Inc. Protocol #ENT-01-030 6,864 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Global Kinetics Corporation Protocol #Study 002 12,550 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Hoffmann-La Roche Inc Protocol #BP39529 232,146 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Impax Laboratories, Inc. Protocol #IPX203-B16-02 67,987 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Impax Laboratories, Inc. Protocol #IPX203-B16-03 48,863

USF Health-Morsani College Neurology PI: Hauser,Robert A Spon Integrative Research Laboratories Sweden

A Randomized, Double-Blind, Placebo-Controlled, Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily ON-Time Without Troublesome Dyskinesia in Patients with Parkinson¿s Disease 22,500

USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Michael J Fox Found for Parkinson's Rsch Protocol: 002 28,750

145


USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Michael J Fox Found for Parkinson's Rsch The Parkinson's Progression Markers Initiative (PPMI) 7,188

USF Health-Morsani College Neurology PI: Hauser,Robert A Spon National Parkinson FoundationUniversity of South Florida Parkinson's Disease and Movement Disorders Center 60,000

USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Neuraly Inc. Protocol #NLY01-PD-1 113,465 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon NeuroDerm Ltd. Protocol #ND0612-317 2,500 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon NeuroDerm Ltd. Protocol #ND0612H-012 (2,231) USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Pharma Two B Ltd. Protocol #P2B001/003 59,431 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Prexton Therapeutics Protocol #PXT-CL17-003 (1,000) USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Revance Therapeutic, Inc. Protocol #1720302 (14,085) USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Revance Therapeutic, Inc. Protocol #1720304 48,602 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Sanofi Pharmaceuticals Protocol #OBS16136 24,957 USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon Sunovion Pharmaceuticals Protocol #SEP361-2030 (2,025) USF Health-Morsani College o Neurology PI: Hauser,Robert A Spon SunPharma Protocol #CLR_18_06 2,000

USF Health-Morsani College Neurology PI: Hauser,Robert A Spon UCB BIOPHARMA SRL

¿A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, 18-MONTH PHASE 2A STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF ORAL UCB0599 IN STUDY PARTICIPANTS WITH EARLY PARKINSON¿S DISEASE 23,500

USF Health-Morsani College Neurology PI: Kalidas,Kavita Spon Allergan, Inc.

othA Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine When Administered During the Prodrome (the ¿Protocol¿) incor 62,165

USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Allergan, Inc. Protocol #3101-301-002 (2,000) USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Allergan, Inc. Protocol #3101-309-002 16,489 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Amgen Protocol #20170703 15,028 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Biogen Protocol #802NP302 31,050 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol #H8H-MC-LAHV 20,250 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol #I5Q-MC-B004 12,680 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol #I5Q-MC-CGAS 18,785 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol #I5Q-MC-CGAT(b) 20,500 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol #I5Q-MC-CGAW 1,772 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol #J1H-MC-LAJB 22,000 USF Health-Morsani College o Neurology PI: Kalidas,Kavita Spon Eli Lilly and Company Foundation Protocol: H8H-MC-LAHW(PIONEER-PEDS1) 20,250 USF Health-Morsani College o Neurology PI: Lockwood,Charles J Conv University of South Florida Foundation Francis Zesiewicz Memorial Fund 8,966 USF Health-Morsani College o Neurology PI: Lockwood,Charles J Conv University of South Florida Foundation Thylen Acceleration Fund USF Stroke Center 246,339 USF Health-Morsani College o Neurology PI: MacIver,Stephanie E Spon NeuroPace, Inc. Protocol #P10026_PAS_NP10012 14,475 USF Health-Morsani College o Neurology PI: Maldonado,Janice Yvonne Spon Genentech Protocol #ML40269 15,285 USF Health-Morsani College o Neurology PI: Maldonado,Janice Yvonne Spon Genentech Ctr for Clincial Research Protocol #BA39731 6,309

USF Health-Morsani College Neurology PI: Moreo,Natalie Spon Novartis Pharmaceutical Corporation

A single-arm, prospective, multi-center, study to explore maintained efficacy with ofatumumab therapy in patients with relapsing Multiple Sclerosis who discontinue intravenously delivered anti-CD20 monoclonal antibody (aCD20mAb) therapy (OLIKOS) (¿Protoc 20,700

USF Health-Morsani College Neurology PI: Murphy,Jennifer L Spon Northern CA Institute for Research & Edu

Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Functioning, and Quality of Life in Veterans (41,916)

USF Health-Morsani College o Neurology PI: Renati,Swetha Spon Bayer Healthcare Pharmaceuticals Protocol #19766 ¿ 14003 33,165 USF Health-Morsani College o Neurology PI: Renati,Swetha Spon Biogen Protocol #252LH301 2,500 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Biogen Protocol #101MS329 236,666 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Biogen Protocol #215MS202 93,247 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Biogen IDEC Inc Protocol #109MS401/ESTEEM 19,820 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon EMD Serono, Inc Protocol #MS200527_0082 91,141 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon EMD Serono, Inc Protocol #MS700568_0079 5,824

USF Health-Morsani College Neurology PI: Robertson,Derrick Scott Spon Genentech

A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis 21,000


A PHASE IIIB MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY AND PHARMACOKINETICS OF A HIGHER DOSE OF OCRELIZUMAB IN ADULTS WITH RELAPSING MULTIPLE SCLEROSIS 87,632


PHASE IIIB MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY AND PHARMACOKINETICS OF A HIGHER DOSE OF OCRELIZUMAB IN ADULTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 23,400

USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Protocol # WA21093 17,908 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Protocol #BN29739 91,720

146


USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Protocol #GN41791 23,000 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Protocol #MA30143 178,992 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Protocol #MN30035 (3,346) USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Protocol# WA21092 118,349 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Ctr for Clincial Research Protocol #CN41144 338,055 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genentech Ctr for Clincial Research Protocol #MN39159 117,525 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Genzyme Corporation Protocol #OBS13434 3,600 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon GW Pharmaceuticals Protocol #GWSP18023 26,147 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Janssen Pharmaceutica Inc Protocol #AC-058B303 23,722 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Johns Hopkins University Protocol #TREATMS 34,817 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Mallinckrodt Medical Protocol #MNK4069 1,025 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Novartis Pharmaceutical Corporation Protocol #BAF312A2304 8,781 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Novartis Pharmaceutical Corporation Protocol #CBAF312AUS02 12,075 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Novartis Pharmaceutical Corporation Protocol #COMB157G2302 5,840 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Novartis Pharmaceutical Corporation Protocol #OMB157G23101 87,748 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Novartis Pharmaceutical Corporation Protocol #OMB157G2399 146,106 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon PRIME Education, Inc. Protocol #PRIMEMS 48,874 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Sanofi Pharmaceuticals Protocol #EFC16033 133,456 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Sanofi Pharmaceuticals Protocol #EFC16035 68,528 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Sanofi Pharmaceuticals Protocol #EFC16645 30,840 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Sanofi Pharmaceuticals Protocol #LTS16004 78,984 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon Sanofi-Aventis U.S., Inc. Protocol #DRI15928 6,450 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon TG Therapeutics, Inc. Protocol #TG1101-RMS302 9,482 USF Health-Morsani College o Neurology PI: Robertson,Derrick Scott Spon TG Therapeutics, Inc. Protocol #TG1101-RMS303 85,383 USF Health-Morsani College o Neurology PI: Rose,David Z Spon Massachusetts General Hospital Protocol #¿Neuro-AFib Study¿ 2,500 USF Health-Morsani College o Neurology PI: Rose,David Z Spon Medtronic, Inc. Protocol: MDT20034 11,500 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Conv University of South Florida Foundation Ellis Endowed Chair 94,074 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon CHDI Foundation, Inc. Protocol#EnrollHD 79,335

USF Health-Morsani College Neurology PI: Sanchez-Ramos,Juan R Spon EvideraPatient Experience Interviews to Inform a Digital Assessment of Huntington¿s Disease 3,000

USF Health-Morsani College Neurology PI: Sanchez-Ramos,Juan R Spon Genentech

A PHASE II, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE SAFETY / TOLERABILITY OF INTRATHECALLY ADMINISTERED TOMINERSEN IN PATIENTS WITH LATE-ONSET MANIFEST HUNTINGTON¿S DISEASE 5,250

USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon Genentech Protocol #BN40423 253,485 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon Genentech Ctr for Clincial Research Protocol #BN40955 64,238 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon Huntington's Disease Society of America Huntington's Disease Clinic - Center of Excellence 31,500 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon James A. Haley Veteran's Hospital 2020 IPA Vasyl Sava 8,235 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon James A. Haley Veteran's Hospital 2020-2021 IPA Bangmei Wang 52,000 USF Health-Morsani College o Neurology PI: Sanchez-Ramos,Juan R Spon SGN Nanopharma, Inc. Nanoformulation of Cannabinoids for Nose-to-Brain Delivery 200,000

USF Health-Morsani College NeurologyPI: Sanchez-Ramos,Juan R , Co-PI(s): Sava,Vasyl M Spon SGN Nanopharma, Inc. Nanoformulation of Cannabinoids for Nose to Brain Delivery 100,000

USF Health-Morsani College o Neurology PI: Suresh,Niraja S Spon Alexion Pharmaceuticlas, Inc. Protocol #ECU-MG-303 71,186 USF Health-Morsani College o Neurology PI: Suresh,Niraja S Spon Argenx BVBA Protocol #ARGX-113-1802 42,143 USF Health-Morsani College o Neurology PI: Suresh,Niraja S Spon Argenx BVBA Protocol #ARGX-113-1902 20,500 USF Health-Morsani College o Neurology PI: Suresh,Niraja S Spon Ra Pharmaceuticals, Inc. Protocol #RA101495-02.202 38,325 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Alexion Pharmaceuticlas, Inc. Protocol #ALXN1210-ALS-308 108,610 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Alexion Pharmaceuticlas, Inc. Protocol #ALXN1210-MG-306 147,511 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Alexion Pharmaceuticlas, Inc. Protocol #ALXN-MG-501 14,800

USF Health-Morsani College Neurology PI: Vu,Tuan Spon Annexon Biosciences, Inc.Phase 2a Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Intravenous ANX005 in Subjects with Amyotrophic Lateral Sclerosis 27,000

USF Health-Morsani College Neurology PI: Vu,Tuan Spon Apellis Pharmaceuticals, Inc.

A Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of APL-2 (pegcetacoplan) in subjects with Amyotrophic Lateral Sclerosis (ALS) 25,300

USF Health-Morsani College Neurology PI: Vu,Tuan Spon Argenx BVBA

¿A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokinetics, Efficacy, Safety, Tolerability, and Immunogenicity of Multiple Subcutaneous Injections of Efgartigimod PH20 SC With Multiple Intravenous Infusions 10,000

USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Argenx BVBA Protocol #ARGX-113-1704 9,488 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Baxalta US, Inc. Protocol #161403 5,000 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Baxalta US, Inc. Protocol #161505 27,500 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Biogen Protocol #261AS101 80,649 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon CSL Behring Protocol #Hizentra 41,809 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon CSL Behring Protocol #IgPro20_3007 35,271

147


USF Health-Morsani College Neurology PI: Vu,Tuan Spon CytoKinetics, Inc

A Phase 3, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Reldesemtiv in Patients with Amyotrophic Lateral Sclerosis (ALS) 26,800

USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Inc. Research, LLC Protocol #ARGX-113-1705 335,374 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Mallinckrodt Medical Protocol #MNK14042068 12,300 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Massachusetts General Hospital HEALEY ALS Platform Trial 25,500 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Massachusetts General Hospital Protocol #Task Order 1 14,422 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Massachusetts General Hospital Protocol #Task Order 2 10,000 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Massachusetts General Hospital Protocol #Task Order 3 16,496 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Massachusetts General Hospital Protocol #Task Order 4 15,920 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Massachusetts General Hospital RSA D | Pridopidine | Double-Blind Phase 15,816

USF Health-Morsani College Neurology PI: Vu,Tuan Spon Mitsubishi Pharma Corporation

A Phase 3b, Multicenter, Randomized, Double-blind Study to Evaluate Efficacy and Safety of Oral Edaravone Administered for a Period of 48 Weeks in Subjects with Amyotrophic Lateral Sclerosis (ALS) 22,000

USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Mitsubishi Pharma Corporation Protocol #Biomarker Study 17,440 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Mitsubishi Pharma Corporation Protocol #MT-1186-A01 (8,000) USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Octapharma AG Protocol #GAM10-08 101 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Orion Corporation Protocol #3119002 11,728 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Orion Corporation Protocol #3119003 764 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Ra Pharmaceuticals, Inc. Protocol #RA101495-02.201 4,556 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Ra Pharmaceuticals, Inc. Protocol #RA101495-02.301 56,457 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon Ra Pharmaceuticals, Inc. Protocol #RA101495-02.302 123,854

USF Health-Morsani College Neurology PI: Vu,Tuan Spon Sanofi-Aventis U.S., Inc.

A Phase 2, multicenter, open-label, non-randomized, proof-of-concept study evaluating the efficacy, safety, and tolerability of BIVV020 in adults with chronic inflammatory demyelinating polyneuropathy (CIPD)¿ (¿Protocol¿). 29,071

USF Health-Morsani College Neurology PI: Vu,Tuan Spon UCB BIOPHARMA SRLAN OPEN-LABEL EXTENSION STUDY TO EVALUATION ROZANOLIXIZUMAB IN STUDY PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS¿ 23,200

USF Health-Morsani College o Neurology PI: Vu,Tuan Spon UCB Pharma, Inc. Protocol #MG0003 63,175 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon UCB Pharma, Inc. Protocol #MG0004 84,387 USF Health-Morsani College o Neurology PI: Vu,Tuan Spon UCB, Inc. Protocol #CIDP01 (8,385)

USF Health-Morsani College Neurology PI: Vu,Tuan Spon Viela Bio

titled A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults with Myasthenia Gravis 20,000

USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Conv University of South Florida Foundation Fredreich Ataxia Research Alliance (FARA) 110,809 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon AbbVie Inc. Protocol #M15-562 153 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon AbbVie Inc. Protocol #M15-563 (4,734) USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Addex Pharmaceuticals SA Protocol #ADX48621-301 28,700 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Allon Therapeutics, Inc. Protocol#AL-108-231 16,500 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Biogen IDEC Inc Protocol #CN002-012 (500) USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Biohaven Pharmaceuticals, Icn Protocol #BHV3241-301 139,490 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Biohaven Pharmaceuticals, Icn Protocol #BHV4157-201 84,254 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Biohaven Pharmaceuticals, Icn Protocol #BHV4157-206 255,969 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Boston Scientific Corporation Protocol #A4170 11,828 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Boston Scientific Corporation Protocol #Vercise DBS A4069 35,963 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Bristol-Myers Squibb Company Protocol #CN002004 (2,110) USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Bukwang Pharmaceutical Co., Ltd. Protocol: BK-JM-201 3,500 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Cadent Therapeutics, Inc. Protocol #: Synchrony-1 23,000

USF Health-Morsani College Neurology PI: Zesiewicz,Theresa A Spon Merz Pharmaceuticals, LLC

Prospective, randomized, double-blind, placebo-controlled, parallel-group trial with an open-label period to investigate the efficacy and safety of NT 201 in the unilateral and bilateral treatment of essential tremor of the upper limb 27,000

USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon National Ataxia Foundation Protocol #NAF CRC-SCA 11,350 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Prilenia Therapeutics Development Ltd. Protocol #PL101-LID201 8,828

USF Health-Morsani College Neurology PI: Zesiewicz,Theresa A Spon PTC Therapeutics, Inc.

A RANDOMIZED, PARALLEL-ARM, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION TO ASSESS THE SAFETY AND EFFICACY OF VATIQUINONE FOR THE TREATMENT OF FRIEDREICH ATAXIA 99,519

USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Reata Pharmaceuticals, Inc. Protocol #408-C-1402 52,425 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Retrotope, Inc Protocol #RT001-006 140,411 USF Health-Morsani College o Neurology PI: Zesiewicz,Theresa A Spon Sagene Pharmaceuticals, Inc Protocol #Sagene 2014 (35,028)

148


USF Health-Morsani College Neurology PI: Zesiewicz,Theresa A Spon Takeda Pharmaceuticals USA, Inc.

A Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevat 10,000

USF Health-Morsani College of Neurology Total 7,973,559

USF Health-Morsani College Neurosciences Center for Aging PI: Bickford,Paula C Spon Michigan State UniversityInfluence of Systemic Immune Inflammation Upon the Tauopathy Phenotype in Mouse Models - Bickford Subcontract 160,056

USF Health-Morsani College Neurosciences Center for Aging PI: Borlongan,Cesario V Spon Florida State UniversityMR Analysis of Pre-Conditioned Human Mesenchymal Stem Cells for Stroke Therapy 37,375

USF Health-Morsani College Neurosciences Center for AgingPI: Bickford,Paula C , Co-PI(s): Blair,Laura J;Uversky,Vladimir N Spon National Institute on Aging Controlling TAU Toxicity From Inside and Outside of Neurons 463,006

USF Health-Morsani College of Neurosciences Center for Aging Total 660,437 USF Health-Morsani College o Neurosurgery PI: Alikhani,Puya Spon NuVasive, Inc. Protocol #NUVA.X1801 (1,200) USF Health-Morsani College o Neurosurgery PI: Bezchlibnyk,Yarema Basil Spon Abbott Laboratories Protocol #ABT-CIP-10300 37,922 USF Health-Morsani College o Neurosurgery PI: Bezchlibnyk,Yarema Basil Spon InVivo Therapeutics Corporation Protocol #InVivo-100-105 21,500

USF Health-Morsani College Neurosurgery PI: Bezchlibnyk,Yarema Basil Spon SetPoint Medical, Inc.

A Randomized, Sham-Controlled, Double-Blind Study of Vagus Nerve Stimulation for Moderate-to-Severe Rheumatoid Arthritis: The RESET-RA Study 18,000

USF Health-Morsani College o Neurosurgery PI: Bezchlibnyk,Yarema Basil Spon SetPoint Medical, Inc. Protocol #SPM-011 17,850 USF Health-Morsani College o Neurosurgery PI: Freeman,Thomas B Spon Cerapedics, Inc. Protocol #CP-1006 29,588

USF Health-Morsani College Neurosurgery PI: Guerrero,Waldo R Spon NC Medical Research, Inc.

A Phase 1/2, dose-finding, double-blind, placebo-controlled, multi-center study to evaluate the safety, tolerability of intracarotid artery administration of NCS-01 in patients with acute ischemic stroke 28,275

USF Health-Morsani College o Neurosurgery PI: Guerrero,Waldo R Spon Penumbra Protocol #CLP 13669.A [SURF] 15,950 USF Health-Morsani College o Neurosurgery PI: Guerrero,Waldo R Spon Penumbra Protocol #CLP-14788.A (LOTUS) 178

USF Health-Morsani College Neurosurgery PI: Hill-Jarrett,Tanisha Spon American Psychological Foundation The Neurocognitive and Psychosocial Outcomes of Coronavius Disease 2019 18,438 USF Health-Morsani College o Neurosurgery PI: Mokin,Maxim V Spon Medtronic, Inc. Protocol #EMBOLISE 26,000

USF Health-Morsani College Neurosurgery PI: Mokin,Maxim V Spon MIVI Neuroscience, Inc.,

A Prospective, Multi-Center, Single Arm Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke, protocol #101773 25,225

USF Health-Morsani College Neurosurgery PI: Mokin,Maxim V Spon Neurovascular Diagnostics, Inc.SBIR Phase II: A Blood-Based Test to Identify Patients with Intracranial Aneurysm 12,500

USF Health-Morsani College o Neurosurgery PI: Mokin,Maxim V Spon Stryker Corporation Protocol #ASSIST 10,000 USF Health-Morsani College o Neurosurgery PI: Mokin,Maxim V Spon Tampa General Hospital Protocol #NV-PED-07 (100) USF Health-Morsani College o Neurosurgery PI: Mokin,Maxim V Spon Tesla Protocol #TESLA Trial Protocol (Version 1.0) 400 USF Health-Morsani College o Neurosurgery PI: Shytle,Douglas C Spon Alzamend Neuro, Inc. Brain and Plasma Levels of LiProSal Following Oral Administration 350,000 USF Health-Morsani College o Neurosurgery PI: Van Loveren,Harry R Conv University of South Florida Foundation Lincoln Endowed Chair 1

USF Health-Morsani College of Neurosurgery Total 610,526

USF Health-Morsani College Obstetrics and Gynecology PI: Anderson,Matthew Linley Spon Baylor College of Medicine

A Randomized Controlled Trial of Mail-Self Stamped HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System 18,916

USF Health-Morsani College o Obstetrics and Gynecology PI: Anderson,Matthew Linley Spon Caris MPI, Inc. The Caris Biorepository Research Protocol 18,000 USF Health-Morsani College o Obstetrics and Gynecology PI: Anderson,Matthew Linley Spon ImmunoGen, Inc. Protocol #IMGN853-0417 (SORAYA) 27,775

USF Health-Morsani College Obstetrics and Gynecology PI: Anderson,Matthew Linley Spon Leidos Biomedical Research, Inc.USF as a Tissue Source Site for the Clinical Proteomic Tumor Analysis Consortium - Task Order 19X148F 67,524

USF Health-Morsani College o Obstetrics and Gynecology PI: Anderson,Matthew Linley Spon Sutro Biopharma, Inc. Protocol #STRO-002-GM1 29,375

USF Health-Morsani College Obstetrics and Gynecology PI: Anderson,Matthew Linley Spon University of HoustonSubset of Preexisting, Poly-Resistant Cancer Stem Cells in High-Grade Serous Ovarian Cancer 30,375

USF Health-Morsani College Obstetrics and GynecologyPI: Anderson,Matthew Linley , Co-PI(s): Lakshmi,Seetha Spon University of Florida Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) 345,994

USF Health-Morsani College o Obstetrics and Gynecology PI: Imudia,Anthony N Spon AbbVie Inc. Protocol #M16-283 11,411 USF Health-Morsani College o Obstetrics and Gynecology PI: Imudia,Anthony N Spon AbbVie Inc. Protocol #P16-836 1,500 USF Health-Morsani College o Obstetrics and Gynecology PI: Imudia,Anthony N Spon Myovant Sciences Inc. Protocol #MVT-601-3002 (234) USF Health-Morsani College o Obstetrics and Gynecology PI: Imudia,Anthony N Spon Myovant Sciences Inc. Protocol #MVT-601-3003 (6,500)

USF Health-Morsani College Obstetrics and Gynecology PI: Kayisli,Umit A , Co-PI(s): Sprague,Rachel Spon Alpha Omega Alpha Honor Medical Society

Transcriptomic Analysis of Catecholestrogen (4-OHE2)-induced Human Endometrial Stromal Cell Survival via AdrenergicReceptor(s): Implications for Development of Endometriosis. 2,000

USF Health-Morsani College o Obstetrics and Gynecology PI: Lockwood,Charles J Conv University Medical Service Associates House Staff 204,167 USF Health-Morsani College o Obstetrics and Gynecology PI: Lockwood,Charles J Conv University of South Florida Foundation Ryan Residency Training Program 50,995 USF Health-Morsani College o Obstetrics and Gynecology PI: Louis,Judette M Spon Cedars-Sinai Medical Center Protocol #PRAECIS 13,500 USF Health-Morsani College o Obstetrics and Gynecology PI: Louis-Jacques,Adetola F Conv University of South Florida Foundation James Ingram Endowed Professor 232,877

149


USF Health-Morsani College Obstetrics and Gynecology

PI: Louis-Jacques,Adetola F , Co-PI(s): Groer,Maureen E;Guzeloglu-Kayisli,Ozlem;McSkimming,Daniel Ian Spon American Association of Obstetricians & 2020-2021 AAOGF Bridge Award 75,000

USF Health-Morsani College o Obstetrics and Gynecology PI: Mikhail,Emad Spon AbbVie Inc. Protocol #M14-702 23,746 USF Health-Morsani College o Obstetrics and Gynecology PI: Mikhail,Emad Spon AbbVie Inc. Protocol #M18-969 24,000

USF Health-Morsani College Obstetrics and Gynecology PI: Mikhail,Emad Spon Dot Laboratories, Inc.EMPOWER: Endometriosis diagnosis using MicroRNA Prospective study in Women to allow Early disease Recognition 10,000

USF Health-Morsani College o Obstetrics and Gynecology PI: Mikhail,Emad Spon Myovant Sciences Inc. Protocol #MVT-601-3102 (2,373) USF Health-Morsani College o Obstetrics and Gynecology PI: Mikhail,Emad Spon Myovant Sciences Inc. Protocol #MVT-601-3103 2,020 USF Health-Morsani College o Obstetrics and Gynecology PI: Mikhail,Emad Spon ObsEva S.A. Protocol #18-OBE2109-002 / 18-OBE2109-003 (5,600) USF Health-Morsani College o Obstetrics and Gynecology PI: Obican,Sarah Gloria Spon Children¿s Hospital of Wisconsin Foundat Gastroschisis Outcomes of Delivery (GOOD) Study 4,000 USF Health-Morsani College o Obstetrics and Gynecology PI: Obican,Sarah Gloria Spon Organization Teratology Information Spec OTIS HRSA Grant Sub-Awardee Year 6 46,000 USF Health-Morsani College o Obstetrics and Gynecology PI: Odibo,Anthony O Spon AMAG Pharmaceuticals, Inc. Protocol #Progesterone (8,847) USF Health-Morsani College o Obstetrics and Gynecology PI: Odibo,Anthony O Spon Ariosa Diagnostics, Inc Protocol #AD202 (5,680) USF Health-Morsani College o Obstetrics and Gynecology PI: Odibo,Anthony O Spon Women & Infants Hospital of Rhode Island Protocol #VALUE (7,900)

USF Health-Morsani College Obstetrics and Gynecology PI: Rapkin,Rachel B Spon University of Cincinnati

A multi-center, randomized study of the efficacy of ulipristal acetate (UPA) 30mg, levonorgestrel (LNG) 1.5mg, and LNG 3.0mg for emergency contraception (EC) in women with weight equal or greater that 80Kg 89,194

USF Health-Morsani College o Obstetrics and Gynecology PI: Wyman,Allison M Spon Pelvalon Protocol #CA007 (11,298) USF Health-Morsani College of Obstetrics and Gynecology Total 1,279,938

USF Health-Morsani College o Oncologic Sciences PI: Alberts,William M Conv H. Lee Moffitt Cancer Center Faculty Support Account 369,637 USF Health-Morsani College of Oncologic Sciences Total 369,637

USF Health-Morsani College o Ophthalmology PI: Ayyala,Ramesh S Spon Allergan, Inc. Protocol #192024-093 75,567

USF Health-Morsani College Ophthalmology PI: Beck,Roy W Spon Beta BionicsFinal clinical studies for submission of a pre-market approval application to the FDA for a bionic pancreas that automates Type 1 Diabetes management 1,119,735

USF Health-Morsani College Ophthalmology PI: Beck,Roy W Spon Critical Path InstituteSpecific Aim 6: Exploring Quantitative Measures Beyond HbA1c in Diabetes Drug Development 92,018

USF Health-Morsani College o Ophthalmology PI: Beck,Roy W Spon Helmsley Trust CGM Monitoring of Maternal Dysglycemia 453,159 USF Health-Morsani College o Ophthalmology PI: Beck,Roy W Spon Helmsley Trust PERL CGM Study 7,995 USF Health-Morsani College o Ophthalmology PI: Beck,Roy W Spon National Eye Institute Pediatric Eye Disease Investigator Group 5,631,832 USF Health-Morsani College o Ophthalmology PI: Beck,Roy W Spon Natl Insti of Diabetes (NIDDK) Data Coordinating Center for Artificial Pancreas Studies 854,732

USF Health-Morsani College Ophthalmology PI: Beck,Roy W Spon Natl Insti of Diabetes (NIDDK)One year day-and-night home closed loop in young people with type 1 diabetes 22,000

USF Health-Morsani College Ophthalmology PI: Beck,Roy W Spon Tandem Diabetes CareClinical Acceptance of the Artificial Pancreas in Pediatrics, A Study of t:slim X2 with Control-IQ Technology 45,682

USF Health-Morsani College o Ophthalmology PI: Beck,Roy W Spon United Health Group CGM Monitoring of Maternal Dysglycemia 554,408 USF Health-Morsani College o Ophthalmology PI: Bhaleeya,Swetangi D Spon Ionis Pharmaceuticals Protocol #ISIS 696844 ¿ CS5 72,554 USF Health-Morsani College o Ophthalmology PI: Bhaleeya,Swetangi D Spon IVERIC bio, Inc. Protocol #ISEE2008 22,800 USF Health-Morsani College o Ophthalmology PI: Bhaleeya,Swetangi D Spon NGM Biopharmaceuticals, INC. Protocol: NGM621-GA-201 19,000 USF Health-Morsani College o Ophthalmology PI: Bhaleeya,Swetangi D Spon Regeneron Pharmeceuticals, Inc. Protocol #VGFTe-HD-DME-1934 (1934 PHOTON Study) 10,000 USF Health-Morsani College o Ophthalmology PI: Bhaleeya,Swetangi D Spon Santen Incorporated Protocol #010906IN 37,797 USF Health-Morsani College o Ophthalmology PI: Espana,Edgar M Spon Apellis Pharmaceuticals, Inc. Protocol #APL2-303 99,369

USF Health-Morsani College Ophthalmology PI: Espana,Edgar M , Co-PI(s): Birk,David E Spon National Eye InstituteRegulatory roles for collagen XII in establishment of corneal stromal structure and function and re-establishment after injury 373,750

USF Health-Morsani College o Ophthalmology PI: Glassman,Adam Spon National Eye Institute Diabetic Retinopathy Clinical Research Network 5,839,850 USF Health-Morsani College o Ophthalmology PI: Lockwood,Charles J Conv University of South Florida Foundation Ophthamology Chair 63,500 USF Health-Morsani College o Ophthalmology PI: Miller,Kellee M Spon Juvenile Diabetes Research Foundation JDRF T1D Coordinating Center 527,491

USF Health-Morsani College Ophthalmology PI: Miller,Kellee M Spon Natl Insti of Diabetes (NIDDK)

A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes 560,931

USF Health-Morsani College Ophthalmology PI: Miller,Kellee M Spon Natl Insti of Diabetes (NIDDK)Glycemic Variability and Fluctuations in Cognitive Status in Adults with Type 1 Diabetes 213,858

USF Health-Morsani College o Ophthalmology PI: Pavan,Peter R Spon Genentech Ctr for Clincial Research Protocol #GR40349 234 USF Health-Morsani College o Ophthalmology PI: Pavan,Peter R Spon Regeneron Pharmeceuticals, Inc. Protocol #VGFTe (HD)-AMD-1905 15,310

USF Health-Morsani College of Ophthalmology Total 16,713,572

USF Health-Morsani College Orthopedic Surgery PI: Baker,Christopher Spon ERMIOutcomes of Treatment using the ERMI Shoulder Felxionator: (1) Post-Operative Shoulder Stiffness Study; (2) Adhesive Capsulitis Study 15,785

USF Health-Morsani College Orthopedic Surgery PI: Baker,Christopher Spon Zimmer Biomet

A Randomized Controlled Trial of the Subchondroplasty Procedure with Arthroscopy versus Arthroscopy Alone for Treatment of Bone Marrow Lesions in the Knee 6,442

USF Health-Morsani College o Orthopedic Surgery PI: Baker,Christopher Spon Zimmer Biomet Knee Creations SCP® Observational Cohort Follow-Up Study 200 USF Health-Morsani College o Orthopedic Surgery PI: Bernasek,Thomas L Spon DePuy Orthopaedics, Inc ATTUNE knee system long term outcomes (14006) 6,236

USF Health-Morsani College Orthopedic Surgery PI: Bernasek,Thomas L Spon DePuy Orthopaedics, IncPMA Post-Approval Study for the 36 mm Ceramax Ceramix Hip System (12017) 4,525

150


USF Health-Morsani College o Orthopedic Surgery PI: Bernasek,Thomas L Spon Omega Orthopaedics Adult Reconconstruction Fellowship Grant 70,000 USF Health-Morsani College o Orthopedic Surgery PI: Bernasek,Thomas L Spon Smith & Nephew, Inc Adult Reconconstruction Fellowship Grant 30,000 USF Health-Morsani College o Orthopedic Surgery PI: Frankle,Mark A Spon ASES Foundation Shoulder Fellowship Grant 19,800

USF Health-Morsani College Orthopedic Surgery PI: Frankle,Mark A Spon DJO GlobalClinical and Radiographic Outcomes in Patients Treated with Revision Shoulder Arthroplasty using the AltiVate™ Reverse Shoulder System 49,287

USF Health-Morsani College Orthopedic Surgery PI: Frankle,Mark A Spon DJO Global

Radiographic and Mechanical Stability of Two Subsequent Iteration of Anatomical Glenoid Components: Does Change of Geometry Reduce Loosening? 33,898

USF Health-Morsani College o Orthopedic Surgery PI: Frankle,Mark A Spon Omega Orthopaedics Shoulder Fellowship Grant 55,000 USF Health-Morsani College o Orthopedic Surgery PI: Frankle,Mark A Spon Zimmer Biomet BioWick Surelock 2,250 USF Health-Morsani College o Orthopedic Surgery PI: Gutierrez,Sergio Spon DJO Global Research and Development support 240,000

USF Health-Morsani College Orthopedic Surgery PI: Hess,Alfred Spon Extremity Medical, LLCThe KinematX midcarpal total wrist arthroplasty: a multicenter prospective registry of cilnical and patient reported outcomes 3,311

USF Health-Morsani College Orthopedic Surgery PI: Lyons,Steven T Spon Zimmer Biometmymobility® Clinical Study: A Prospective Multicenter Longitudinal Cohort Study of the mymobility Platform 44,610

USF Health-Morsani College Orthopedic Surgery PI: Mir,Hassan R Spon AO Trauma North AmericaNon-invasive Assessment of Perfusion and the Risk of Wound Complication in High Risk Surigical Incisions 6,662

USF Health-Morsani College Orthopedic Surgery PI: Mir,Hassan R Spon Foundation for Orthopedic Trauma

Does the Use of Broad Spectrum Antibiotic Powder on Intital Presentation of Grade III Open Lower Extremity Fractures Reduce Infection Rates and Need for Return to Operating Room for Revision Surgery within 6 months of Injury 10,394

USF Health-Morsani College Orthopedic Surgery PI: Nydick,Jason Spon Axogen, IncA Multi-Center Registry Study of Avance Nerve Graft Utilization, Evaluation and Outcomes in Peripheral Nerve Injury Repair, or RANGER 52,160

USF Health-Morsani College Orthopedic Surgery PI: Nydick,Jason Spon Axogen, Inc

A Multicenter, Ambispective, Clinical Outcomes Registry Study of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity (ASSIST) 4,360

USF Health-Morsani College Orthopedic Surgery PI: Nydick,Jason Spon Axogen, Inc

A Multicenter, Prospective, Randomized, Subject and Evaluator Blinded Comparative Study of Nerve Cuffs and Avance Nerge Graft Evaluation Recovery Outcomes for the Repair of Nerve Discontinuities (RECON) 13,300

USF Health-Morsani College Orthopedic Surgery PI: Nydick,Jason Spon DJO Global

Prospective, Observational Clinical Investigation of the Exos Reformable Brace for Conservatlively Managed Distal Radius Fractures: An Evaluation of Time to Union, Satisfaction, and Convenience 29,329

USF Health-Morsani College Orthopedic Surgery PI: Nydick,Jason Spon Endo Pharmaceuticals, Inc.Clinical Effectiveness of Splinting after Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture 49,770

USF Health-Morsani College Orthopedic Surgery PI: Nydick,Jason Spon Endo Pharmaceuticals, Inc.

CRSP-05000, A noninterventional, retrospective study to evaluate the effectiveness of collagenase clostridium histolyticum for postsurgical recurrence of dupuytren contracture after surgery 2,750

USF Health-Morsani College o Orthopedic Surgery PI: Nydick,Jason Spon Endo Pharmaceuticals, Inc. Hand Fellowship Training Grant 50,000 USF Health-Morsani College o Orthopedic Surgery PI: Simon,Peter Spon Corelink Cervical Standalone Biomechanical Evaluation 83,890 USF Health-Morsani College o Orthopedic Surgery PI: Simon,Peter Spon DJO Global Research and Development support 180,000 USF Health-Morsani College o Orthopedic Surgery PI: Simon,Peter Spon Pressio Biomechanical Evaluation of UNiTi ACDF Implant System (single-level) 51,034 USF Health-Morsani College o Orthopedic Surgery PI: Simon,Peter Spon Winter Innovation, LLC Usability & Mechanical Evaluation of surgical suture needle EasyWhip™ 41,056

USF Health-Morsani College Orthopedic Surgery PI: Small,John M Spon Centinel Spine, LLC

A Multi-Center, Prospective, Randomized Controlled Trial Comparing the Safety and Effectiveness of prodisc® C SK and prodisc® C Vivo to Mobi-C® Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) 15,994

USF Health-Morsani College Orthopedic Surgery PI: Small,John M Spon Cerapedics, Inc.An assessment ofP-15L bone graft in Transforaminal Lumbar Interbody Fusion with Instrumentation - (ASPIRE) 13,853

USF Health-Morsani College o Orthopedic Surgery PI: Small,John M Spon Medtronic, Inc. The INFUSE Bone Graft with MASTERGRAFT Strip PLF IDE Dosing Study 7,443

USF Health-Morsani College Orthopedic Surgery PI: Tresser,Steve Spon NuVasive, Inc.

A prospective, multicenter study evaluating the clinical and radiographic outcomes of thoracolumbar spine surgery when comprehensive sagittal alignment surgical planning is used (NUVA.IGA1503) 1,125

USF Health-Morsani College o Orthopedic Surgery PI: Tresser,Steve Spon NuVasive, Inc. Spine Fellowship Training Grant 15,000

USF Health-Morsani College Orthopedic Surgery PI: Tresser,Steve Spon Organogenesis

A single-arm, prospective, multi-center study of Nucel in patients receiving interbody fusion for one and two level degenerative disease of the lumbar spine 7,500

USF Health-Morsani College Orthopedic Surgery PI: Watson M.D.,David Spon Corin Group

A Prospective, Comparative, Randomized, Single Blind, Multi-Center Study of the Trinity Biolox Delta Ceramic-on-Ceramic Total Hip Replacement System vs. Trinity Acetabular Hip System 7,565

USF Health-Morsani College o Orthopedic Surgery PI: Watson M.D.,David Spon Smith & Nephew, Inc Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System 1,360 USF Health-Morsani College o Orthopedic Surgery PI: Weinstein,Marc A Spon Corelink FlxFit Post Market Outcome Study 2,000

USF Health-Morsani College Orthopedic Surgery PI: Weinstein,Marc A Spon OrthofixA Multi-Center, Open-Label , Prospective Study of SpinalStim (MOP-SS) as Adjunctive Care following Lumbar Fusion 11,219

USF Health-Morsani College Orthopedic Surgery PI: Weinstein,Marc A Spon OrthofixA Multi-Center, Open-Label Prospective Study of CervicalStim Device as Adjunctive Treatment following Cervical Fusion 15,974

151


USF Health-Morsani College of Orthopedic Surgery Total 1,255,080

USF Health-Morsani College OtolaryngologyPI: Boyev,Kestutis P. , Co-PI(s): Sanchez,Victoria Ann Spon Frequency Therapeutics, Inc. Protocol #FX-322-202 164,700

USF Health-Morsani College o Otolaryngology PI: Padhya,Tapan A Spon Inspire Medical Systems, Inc Protocol #2014-001 21,625 USF Health-Morsani College o Otolaryngology PI: Padhya,Tapan A Spon Inspire Medical Systems, Inc Protocol #ADHERE UAS 6,130

USF Health-Morsani College Otolaryngology PI: Padhya,Tapan A Spon Nyxoah Inc.

¿A Multicenter Study To Assess The Safety And Effectiveness Of The Genio¿ Dual-Sided Hypoglossal Nerve Stimulation System For The Treatment Of Obstructive Sleep Apnea In Adult Subjects¿ short name ¿DREAM 22,000

USF Health-Morsani College o Otolaryngology PI: Sanchez,Victoria Ann Spon Boehringer Ingelheim Pharm., Inc. Consultancy Agreement with Boehringer Inghelheim Pharma 19,000 USF Health-Morsani College o Otolaryngology PI: Sanchez,Victoria Ann Spon Helen of Troy Protocol #CP-C1201-3 233,763 USF Health-Morsani College o Otolaryngology PI: Sanchez,Victoria Ann Spon Otonomy, Inc. Protocol #413-201901 130,975 USF Health-Morsani College o Otolaryngology PI: Sanchez,Victoria Ann Spon Otonomy, Inc. Supporting Pharmaceutical Translation and Audiology Consultancy 5,304

USF Health-Morsani College Otolaryngology PI: Tabor,Mark H Spon Aerin Medical Inc

The Vivaer® Procedure for Treatment of Nasal Airway Obstruction ¿ A ProspecTive, Multicenter Randomized Controlled TriAl Comparing Vivaer to Sham Control (VATRAC) 11,455

USF Health-Morsani College OtolaryngologyPI: Tabor,Mark H , Co-PI(s): Sanchez,Victoria Ann;Toman,Julia Spon Aerin Medical Inc

The RhinAer Procedure for Treatment of CHronic RhInitis ¿ A Prospective, MulticeNter Randomized ConTrolled TRial Comparing RhinAer to Sham Control (RHINTRAC) 49,306

USF Health-Morsani College of Otolaryngology Total 664,257

USF Health-Morsani College Pathology and Cell Biology PI: Sumanas,Saulius Spon Natl Heart Lung and Blood InstThe role of collagen COL22A1 in intracranial aneurysms and vascular stability 345,040

USF Health-Morsani College of Pathology and Cell Biology Total 345,040

USF Health-Morsani College Pediatrics PI: Agazzi,Heather L C Spon Children's Board of Hillsborough CountyHelping Our Toddlers, Developing Our Children's Skills (HOT DOCS) and (DOCS K-5) 246,285

USF Health-Morsani College o Pediatrics PI: Colon Cortes,Yanerys Marie Spon Florida Department of Health CMS Pediatric Pulmonary Disease Management 151,545 USF Health-Morsani College o Pediatrics PI: Couluris,Marisa Spon Cystic Fibrosis Foundation Cystic Fibrosis Center 69,230

USF Health-Morsani College Pediatrics PI: Dishaw,Larry J Spon National Science FoundationInvestigations of an Invertebrate Secreted Immune Effector that Influences Microbial Communities of the Gut 215,371

USF Health-Morsani College Pediatrics PI: Emmanuel,Patricia J Spon Florida State UniversityScale it up: Effectiveness-implementation research to enhance HIV-related self-management among youth 30,735

USF Health-Morsani College Pediatrics PI: Emmanuel,Patricia J Spon University of North Carolina,Chapel HillThe UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum 49,083

USF Health-Morsani College o Pediatrics PI: Emmanuel,Patricia J Spon University of North Carolina,Chapel Hill Tough Talks: A Disclosure Intervention for HIV+ YMSM 40,728

USF Health-Morsani College Pediatrics PI: Espinosa,Claudia Spon MedImmune LLC

A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY) 9,000

USF Health-Morsani College o Pediatrics PI: Flores-Torres,Jaime A Spon Abbott Laboratories Protocol #AL35 35,297

USF Health-Morsani College Pediatrics PI: Flores-Torres,Jaime A Spon Hikma Pharmaceuticals USA IncA Randomized, Double-Blind, Controlled Study to Assess the Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures 10,000

USF Health-Morsani College o Pediatrics PI: Flores-Torres,Jaime A Spon Infant Bacterial Therapeutics Protocol #IBP-9414-020 28,632 USF Health-Morsani College o Pediatrics PI: Flores-Torres,Jaime A Spon ONY Inc. Protocol #Aero 02 6,580 USF Health-Morsani College o Pediatrics PI: Ford,Steven Lee Spon Mallinckrodt Medical Protocol #MNK19050056 (4,820) USF Health-Morsani College o Pediatrics PI: Ford,Steven Lee Spon Shire Pharmaceutical Development, Inc. Protocol #SHP 607-202 115,684 USF Health-Morsani College o Pediatrics PI: Griffith,Christopher B Spon Amicus Therapeutics, Inc. Protocol #AT1001-036 29,637 USF Health-Morsani College o Pediatrics PI: Griffith,Christopher B Spon Amicus Therapeutics, Inc. Protocol #ATB200-03 2,500 USF Health-Morsani College o Pediatrics PI: Griffith,Christopher B Spon Genzyme Corporation Lysosomal Storage Disorders 7,138 USF Health-Morsani College o Pediatrics PI: Hess,Janet S Spon Florida Department of Health FloridaHATS 45,239 USF Health-Morsani College o Pediatrics PI: Ho,Thao Spon Natl Heart Lung and Blood Inst Enteral Iron Supplementation and Intestinal Health in Preterm Infants 195,858 USF Health-Morsani College o Pediatrics PI: Leiding,Jennifer Woodard Spon ADMA Biologics Protocol #994 163,710

USF Health-Morsani College Pediatrics PI: Leiding,Jennifer Woodard Spon Green Cross Corporation

An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects with Primary Humoral Immunodeficiency 10,000

USF Health-Morsani College Pediatrics PI: Leiding,Jennifer Woodard Spon Horizon PharmaUncovering how Interferon gamma is used in the prevention and treatment of infections in Chronic Granulomatous Disease across the United States 149,500

USF Health-Morsani College o Pediatrics PI: Leiding,Jennifer Woodard Spon ProMetic BioTherapeutics Protocol #2004C009G (4,557) USF Health-Morsani College o Pediatrics PI: Leiding,Jennifer Woodard Spon Therapure Biopharma, Inc. Protocol #TBI-001-IGIV 40,631 USF Health-Morsani College o Pediatrics PI: Leiding,Jennifer Woodard Spon University of California, San Francisco Primary Immune Deficiency Treatment Consortium 23,964 USF Health-Morsani College o Pediatrics PI: Lewin,Adam B Spon REAM Foundation Transdiagnostic Treatment for Misophonia 200,000

USF Health-Morsani College Pediatrics PI: Lewin,Adam B Spon Tourette's Syndrome Association

Let's talk Tourette Syndrome and Tic Disorders - An Educational Program for Health Professionals, Educators, and Families 10,000

152


USF Health-Morsani College Pediatrics PI: Lewin,Adam B Spon University of South CarolinaCoordinating Center for Research to Promote The Health of Children with Birth Defects and People with Developmental and other Disabilities 310,000

USF Health-Morsani College o Pediatrics PI: Lilly,Carol M Spon Florida Office of Attorney General Victims of Crime Act (VOCA) 20-21 206,877 USF Health-Morsani College o Pediatrics PI: Lockwood,Charles J Conv University Medical Service Associates House Staff 207,713 USF Health-Morsani College o Pediatrics PI: Nallu,Sagarika Spon GW Pharmaceuticals Protocol #GWEP 18060 19,000 USF Health-Morsani College o Pediatrics PI: Nallu,Sagarika Spon Pulse Infoframe US, LLC TBD 1,000 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University Medical Service Associates UMSA - Rothman Pediatrics Chair 179,628 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University of South Florida Foundation Child Health Policy Chair 46,688 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University of South Florida Foundation Hines Endowed Chair Pediatrics 170,885 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University of South Florida Foundation Interest - Price Endowed Chair 72,206 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University of South Florida Foundation Lewis A. Barness Chair in Pediatrics 206,556 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University of South Florida Foundation Muma Endowed Chair in Neonatology 94,190 USF Health-Morsani College o Pediatrics PI: Nelson Jr.,Robert M Conv University of South Florida Foundation Pediatric Robert Good Endowed Chair in Immunology 240,708 USF Health-Morsani College o Pediatrics PI: Panzarino,Valerie M Spon Advicenne Pharma Protocol #B23CS 8,773 USF Health-Morsani College o Pediatrics PI: Panzarino,Valerie M Spon Advicenne Pharma Protocol #B24CS 17,000 USF Health-Morsani College o Pediatrics PI: Panzarino,Valerie M Spon Florida Department of Health Comprehensive Children's Kidney Failure Center 450,536

USF Health-Morsani College Pediatrics PI: Ranells,Judith D Spon ACADIA Pharmaceuticals, Inc.

A Randomized, Double-Blind, Placebo-Controlled, Study of Oral Trofinetide Versus Placebo in Female Children, Adolescents and Adults with Rett Syndrome 25,000

USF Health-Morsani College o Pediatrics PI: Ranells,Judith D Spon Florida Department of Health CMS Long-Term Genetics Program 612,250 USF Health-Morsani College o Pediatrics PI: Rico,Juan Felipe Spon AstraZeneca Ltd Protocol #D5136C00009 123 USF Health-Morsani College o Pediatrics PI: Rico,Juan Felipe Spon Daiichi Sankyo Pharma Development (DSI) Protocol #DU176b-D-U312 2,992 USF Health-Morsani College o Pediatrics PI: Rico,Juan Felipe Spon Novartis Pharmaceutical Corporation Protocol #SEG101A2202 28,470

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon Florida Department of HealthAll 4 Youth: A Multi-Faceted Approach to HIV Prevention and Treatment in Underserved Youth Populations 250,000

USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A Spon Florida Department of Health Children's Medical Services HIV Program 297,243 USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A Spon Florida Department of Health Family Planning & Reproductive Health 240,000

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon Florida Department of HealthRyan White Part B Medical Case Management and Outpatient Ambulatory Medical Care (PSC38) 90,334

USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A Spon Florida Department of Health Ryan White Part B Medical Case Management Services-Hillsborough 67,500

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon Fred Hutchinson Cancer Research CenterCOVID-19 Prevention Network (CoVPN) Site Preparedness Funding - Tampa, FL Protocol-Specific Site 126,000

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon Gilead Sciences, Inc.

A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734) in Participants from Birth to < 18 Years of Age with COVID-19 28,700

USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A Spon Gilead Sciences, Inc. Protocol #GS-US-216-0128 13,771 USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A Spon Gilead Sciences, Inc. Protocol #GS-US-380-1474 6,665 USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A Spon Gilead Sciences, Inc. Protocol #GS-US-380-5310 15,400

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon Hillsborough County Health Department Pediatric Tuberculosis Contract for Hillsborough County Health Department 8,700

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon Substance Abuse & Mental HealthYouth GPS: A Navigator-Based Program for Substance Abuse Education and HIV/HCV Prevention 200,000

USF Health-Morsani College Pediatrics PI: Rodriguez,Carina A Spon University of Alabama, BirminghamCongenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC) 19,280

USF Health-Morsani College o Pediatrics PI: Rodriguez,Carina A , Co-PI(s): Kim,Kami Spon Fred Hutchinson Cancer Research Center CoVPN 3004 Protocol Funding (PF) - Tampa, FL Protocol-Specific Site 1,922,760

USF Health-Morsani College Pediatrics PI: Rogers,Howard Spon Childrens Home Society of Florida Independent Contractor Agreement (CPT- Bartow Clinical Service Contract) 144,516

USF Health-Morsani College Pediatrics PI: Rogers,Howard Spon Florida Department of Health Children's Medical Services - CPT Medical Director Bartow and Hillsborough 294,966

USF Health-Morsani College PediatricsPI: Rogers,Howard , Co-PI(s): Emmanuel,Patricia J Spon Florida Department of Health CMS Child Protection Team Services FY 2020-2023 957,365

USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Alexion Pharmaceuticlas, Inc. Protocol #ALX-HPP-501 1,110 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Amicus Therapeutics, Inc. Protocol #AT1001-020 10,074 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon BioMarin Pharmaceutical Inc. Protocol #165-304 113,327 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon BioMarin Pharmaceutical Inc. Protocol #307-201 26,000 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon BioMarin Pharmaceutical Inc. Protocol #307-901 57,982 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon BioMarin Pharmaceutical Inc. Protocol #PKUDOS 16,240 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Cerecor Inc. Protocol #Clin800-401 (28,105) USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Florida Department of Health CMS Newborn Screening Program 823,350

USF Health-Morsani College Pediatrics PI: Sanchez-Valle,Amarilis Spon Homology Medicines, Inc.,

A Phase 1/2 Open-Label, Randomized, Concurrently-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of HMI-102 in Adult PKU Subjects with PAH Deficiency 10,000

USF Health-Morsani College Pediatrics PI: Sanchez-Valle,Amarilis Spon Homology Medicines, Inc.,A Prospective Study Investigating the Natural History of Adult with Phenylketonuria (PKU) due to Phenylalanine Hydroxylase Deficiency 20,000

USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Hyperion Therapeutics, Inc. Protocol #HPN 100-014 1,412

153


USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Kaleido Biosciences, Inc. Protocol #K020-218 60,467 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Ultragenyx Pharmaceuticals Inc. Protocol #UX007-CL003 (4,984) USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Ultragenyx Pharmaceuticals Inc. Protocol #UX007-CL202 12,880 USF Health-Morsani College o Pediatrics PI: Sanchez-Valle,Amarilis Spon Ultragenyx Pharmaceuticals Inc. Protocol: DTX301-CL102 5,000 USF Health-Morsani College o Pediatrics PI: Shaffer,Emily J Spon Florida Department of Health Children's Medical Services Bay Area Early Steps (Federal Medicaid) 1,044,305 USF Health-Morsani College o Pediatrics PI: Shaffer,Emily J Spon Florida Department of Health Children's Medical Services Bay Area Early Steps (Federal) 2,009,688 USF Health-Morsani College o Pediatrics PI: Shaffer,Emily J Spon Florida Department of Health Children's Medical Services Bay Area Early Steps (State) 4,550,671 USF Health-Morsani College o Pediatrics PI: Sriaroon,Panida Spon ALK-Abello A/S Protocol #MT-11 9,700 USF Health-Morsani College o Pediatrics PI: Sriaroon,Panida Spon Regeneron Pharmeceuticals, Inc. Protocol #R668-EE-1774 19,450 USF Health-Morsani College o Pediatrics PI: Sriaroon,Panida Spon Regeneron Pharmeceuticals, Inc. Protocol #R668-EE-1877 22,500

USF Health-Morsani College Pediatrics PI: Straub,Diane M Spon Indiana UniversityUse of Public Deliberation in Diverse Communities toImprove Consent Processes for Clinical Research 74,672

USF Health-Morsani College o Pediatrics PI: Straub,Diane M Spon Organon LLC Protocol #MISP #59524 67,319 USF Health-Morsani College o Pediatrics PI: Takagishi,Jennifer C. Spon Florida Department of Health CMS Referral Center 393,120 USF Health-Morsani College o Pediatrics PI: Torres,Benjamin A Spon Florida Department of Health Contract# COQZO- RPICC Statewide Neonatal Consultant 90,000

USF Health-Morsani College Pediatrics PI: Walter,Jolan Spon All Children's HospitalAssessing the Role of T & B Cells and Refractory Cytopenias in Immunocompromised Children (20,015)

USF Health-Morsani College Pediatrics PI: Walter,Jolan Spon All Children's Research InstituteStudies on natural history of and immune response to COVID-19 in the immunocompromised population 67,276

USF Health-Morsani College o Pediatrics PI: Walter,Jolan Spon Baxalta US, Inc. Protocol #161503 50,445 USF Health-Morsani College o Pediatrics PI: Walter,Jolan Spon Children's Hospital of Boston Immune repertoire and function in typical and atypical SCID 44,850

USF Health-Morsani College Pediatrics PI: Walter,Jolan Spon Janssen Research & Development, LLC

Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study with a Long-term Open-label Extension¿ 10,000

USF Health-Morsani College o Pediatrics PI: Walter,Jolan Spon Leadiant Biosciences, Inc. Protocol #LBI-2279-004 27,015 USF Health-Morsani College o Pediatrics PI: Walter,Jolan Spon Momenta Pharmaceuticals, Inc. Protocol #MOM-M254-001 21,000

USF Health-Morsani College Pediatrics PI: Walter,Jolan , Co-PI(s): Murphy,Tanya K Spon All Children's Research Institute

The Microbiome-Gut-Brain Axis in Patients With Pediatric Acute-Onset Neuropsychiatric Syndrome as Affected by Antibiotic Treatment and Native IgA Levels (29,270)

USF Health-Morsani College o Pediatrics PI: Weiss,Amy L Spon Hillsborough County Public Schools Promoting Adolescent Health through School-Based HIV Prevention 34,996 USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Allergan, Inc. Protocol #SCT-MD-60 3,700 USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Emalex Biosciences, Inc. Protocol #EBS-101-CL-001 1,200 USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Emalex Biosciences, Inc. Protocol #EBS-101-OL-001 10,000 USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Genentech Protocol #BP30153 7,977 USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Nuvelution TS Pharma, Inc. Protocol #TV50717-CNS-30046 822 USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Nuvelution TS Pharma, Inc. Protocol #TV50717-CNS-30047 (734) USF Health-Morsani College o Pediatrics PI: Wojas,Justyna S Spon Otsuka America Pharmaceutical Protocol #31-14-204 (7,500)

USF Health-Morsani College of Pediatrics Total 19,088,705

USF Health-Morsani College Personalized Medicine and GenomicsPI: Liggett,Stephen B , Co-PI(s): Kim,Donghwa Spon Natl Heart Lung and Blood Inst

Characterization of biased airway smooth muscle TAS2R agonists for treating asthma 510,843

USF Health-Morsani College Personalized Medicine and GenomicsPI: Liggett,Stephen B , Co-PI(s): Kim,Donghwa Spon Wake Forest University

Effects of Rare Genetic Variants and Ancestry on Beta Agonist Response in Asthma and COPD 232,026

USF Health-Morsani College of Personalized Medicine and Genomics Total 742,869 USF Health-Morsani College o Plastic Surgery PI: Smith JR.,David J Spon MediWound Ltd Protocol #MW2012-01-01 11,424

USF Health-Morsani College Plastic SurgeryPI: Smith JR.,David J , Co-PI(s): Kuykendall,Lauren Spon Avita Medical Americas, LLC

CTP006-2 A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RES (Regenerative Epidermal Suspension) Prepared with the RECELL® Device Compared to Standard of Care Dressings for Treatment of Partia 8,500

USF Health-Morsani College of Plastic Surgery Total 19,924

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Bunnell,Brian Spon National Institutes of HealthA Mobile Health Solution to Improve Between-Session Skills Practice in Youth Mental Health Treatment 160,092

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Currier,Glenn W Spon AbbVie Inc. Protocol #3111-301-001 64,668 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Currier,Glenn W Spon Endpoint Outcomes Protocol #AVA1407 31,268

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Currier,Glenn W Spon Janssen Pharmaceutica Inc

¿A Double-Blind, Randomized, Parallel-Group Study with Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorde 19,750

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Currier,Glenn W Spon Janssen Research & Development, LLC

A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants with Treatment-resistant Depression 58,633

USF Health-Morsani College Psychiatry and Behavioral Medicine

PI: Edwards,Jerri D , Co-PI(s): Krischer,Jeffrey P;Lister,Jennifer J.;O'Brien,Jennifer L;Andel,Ross;Harrison,Aryn;Ji,Ming Spon National Institute on Aging

Cognitive training to reduce incidence of cognitive impairment in older adults 7,399,274

154


USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fallon,Daniel Spon Allergan, Inc. Protocol #LVM-MD-14 (3,600) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fallon,Daniel Spon Otsuka America Pharmaceutical Protocol #31-14-204 (1,580) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fallon,Daniel Spon Supernus Pharmaceuticals, Inc Protocol #810P302 3,160 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fallon,Daniel Spon Supernus Pharmaceuticals, Inc Protocol #810P503 (4,878) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fallon,Daniel Spon Supernus Pharmaceuticals, Inc Protocol #812P310 11,798 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon AbbVie Inc. Protocol #RGH-MD-25 110,572 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon ACADIA Pharmaceuticals, Inc. Protocol #ACP-103-047 (20) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Allergan, Inc. Protocol #2006-308-008 15,000 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Avanir Pharmaceuticals, Inc Protocol: 20-AVP-786-306 34,976

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Eisai Inc.

An Open Label Study to Evaluate the Pharmacodynamic Effects, Efficacy, Safety and Tolerability of E2027 in Subjects with Dementia With Lewy Bodies or Parkinson¿s Disease Dementia With or Without Amyloid Copathology 37,503

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Florida Department of Elder Affairs Alzheimer's disease Initiative/Memory Disorder Clinic 3,727 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Functional Neuromodulation, Ltd Protocol #FNMI-002 203,474 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Genentech Protocol #WN28745 12,416 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Genentech Protocol #WN41874 33,375 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Fils,Jean Marius Spon Mediti Pharma Inc. Protocol #MP-101-01 (2,403) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Jones,Genevra Spon Research Foundation for Mental Hygiene OnTrackNY's Learning Healthcare System 53,174

USF Health-Morsani College Psychiatry and Behavioral MedicinePI: Jones,Genevra , Co-PI(s): Teague,Gregory B;Kosyluk,Kristin Ann Spon National Empowerment Center, Inc. (NEC) Mental Health Treatment Training and Integration Program 5,040

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Lockwood,Charles J Conv University Medical Service Associates House Staff - GME Administration 27,768 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Lockwood,Charles J Conv University of South Florida Foundation Cognitive Training Innovation Research 17,886

USF Health-Morsani College Psychiatry and Behavioral MedicinePI: Philpot,Rex M , Co-PI(s): Bickford,Paula C Spon Florida Department of Health

The Effects of Chemotherapy for Breast Cancer on the Central Nervous System 257,457

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon AbbVie Inc. Protocol #M15-570 146,704 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Biogen Protocol #221AD304 174,493 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Eisai Company Ltd Protocol #BAN2401-G000-301 318,426 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Eli Lilly and Company Foundation Protocol #I5T-MC-AACI 68,214

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Janssen Research & Development, LLC

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer¿s Disease 10,000

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Miro Health Protocol #MIRO_002_2018 (9,000) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Miro Health Protocol #MIRO_003_2018 (9,000) USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Novartis Pharmaceutical Corporation Protocol #API015A2201J 12,564 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Novartis Pharmaceutical Corporation Protocol #CNP520A2202J 4,000

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon Samus Therapeutics, Inc.

A Phase 2A study to evaluate safety, tolerability and pharmacological effects of PU-AD in subjects with mild Alzheimer¿s Disease (AD) dementia (¿Study¿). 10,000

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon University of California, San Diego Protocol #BHV4157-203 28,925 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon University of Southern California Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials 57,186

USF Health-Morsani College Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon University of Southern CaliforniaAnti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study 44,300

USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon University of Southern California Combination of anti-amyloid therapy for preclinical Alzheimer's disease 76,000 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon University of Southern California Protocol #BAN2401-G000-303 262,180 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Smith,Amanda G Spon University of Southern California The A3 Study: Ante-Amyloid prevention of Alzheimer's disease 76,000 USF Health-Morsani College o Psychiatry and Behavioral Medicine PI: Walker,Brendan Spon Natl Insti Alcohol Abuse and Alcoholism The Role of Kappa-Opioid Receptors in Alcohol Use Disorders 339,634

USF Health-Morsani College Psychiatry and Behavioral Medicine

PI: Edwards,Jerri D , Co-PI(s): Andel,Ross;Lister,Jennifer J.;Bugos,Jennifer A.;Ji,Ming Spon National Institute on Aging Interventions to Attenuate Cognitive Decline 482,669

USF Health-Morsani College of Psychiatry and Behavioral Medicine Total 10,641,824 USF Health-Morsani College o Radiology PI: Berk,Lawrence B Spon Galera Therapeutics, Inc. Protocol #GTI-4419-203 20,472

USF Health-Morsani College RadiologyPI: Decker,Summer J , Co-PI(s): Ford,Jonathan Michael Spon US Department of Justice

Human Identification from Computed Tomography Derived 3D Models using Part-to-Part Comparison Analysis 204,677

USF Health-Morsani College o Radiology PI: Hazelton,Todd R Conv University of South Florida Foundation USF Radiology Support Fund Foundation Account 250142 507,291 USF Health-Morsani College o Radiology PI: Hoots,Glenn Allen Spon Inari Medical Protocol #FLASH 18-002 12,550

USF Health-Morsani College of Radiology Total 744,990

USF Health-Morsani College School of Physical Therapy

PI: Haladay,Douglas E , Co-PI(s): Miro,Rebecca M;Russ,David WAnderson,Stephanie Ann Spon Foundation for Physical Therapy Research

Development of a novel Evidence Based Practice-specific Entrustable Professional Activity for Doctor of Physical Therapy Student Clinical Education 15,176

USF Health-Morsani College School of Physical Therapy PI: Highsmith,Michael J Spon Jackson (Henry M) FoundationResolving the Burden of Low Back Pain in Military Service Members and Veteran: A Multi-Site Pragmatic Clinical Trial 218,854

USF Health-Morsani College School of Physical Therapy PI: Highsmith,Michael J Spon Ocean State Research InstituteComparative Effectiveness of Upper Limb Prostheses and Component Effects 1,751

155


USF Health-Morsani College School of Physical TherapyPI: Holloway,Jamie Michelle , Co-PI(s): Hardwick,Dustin Spon APTA Academy of Pediatric Physical Thera

Effects of attentional focus on motor learning in children with autism spectrum disorder 26,172

USF Health-Morsani College School of Physical TherapyPI: Miro,Rebecca M , Co-PI(s): Highsmith,Michael J Spon American Orthotic Prosthetic Assoc

Prosthetic, functional, and clinical outcomes among female amputees. A scoping project to include a systematic review and 10-year retrospective record review of female Veterans with limb loss 14,117

USF Health-Morsani College School of Physical Therapy PI: Russ,David W Spon National Institutes of HealthEnhancement of Aged Skeletal Muscle Contractility and Muscle Quality by Administration of Trimetazidine 93,438

USF Health-Morsani College of School of Physical Therapy Total 369,508 USF Health-Morsani College o SunCoast Gerontology Center PI: Smith,Amanda G Spon AbbVie Inc. Protocol #M15-566 186,832 USF Health-Morsani College o SunCoast Gerontology Center PI: Smith,Amanda G Spon Biogen Protocol #221AD301 199,672

USF Health-Morsani College SunCoast Gerontology Center PI: Smith,Amanda G Spon University of Southern California Anti-Amyloid Treatment in Asympotomatic Alzheimer's Disease (A4 Study) 82,424

USF Health-Morsani College SunCoast Gerontology Center PI: Smith,Amanda G Spon University of Southern CaliforniaGlobal Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease Infrastructure Subaward 40,000

USF Health-Morsani College o SunCoast Gerontology Center PI: Smith,Amanda G Spon University of Southern California Protocol #ADC-051 61,637 USF Health-Morsani College of SunCoast Gerontology Center Total 570,565

USF Health-Morsani College o Surgery PI: Al Salihi,Mazin Adel Ahmed Spon TransMedics Protocol #OCS-LUN-PAS01 1,560

USF Health-Morsani College Surgery PI: Bailey,Charles Spon New England Research Institutes, IncThe Therapeutic Strategies, Outcomes and Costs of Critical Limb Ischemia (BEST-VIVA Registry (vCLI) 9,500

USF Health-Morsani College o Surgery PI: Belli,Erol Vahit Spon CryoLife, Inc. Protocol #ONX1801.000-C PROACT Xa 21,569 USF Health-Morsani College o Surgery PI: Calero,Aurelia T Spon Humacyte, Inc Protocol #CLN-PRO-V005 25,000 USF Health-Morsani College o Surgery PI: Calero,Aurelia T Spon Humacyte, Inc Protocol #CLN-PRO-V006 27,221 USF Health-Morsani College o Surgery PI: Calero,Aurelia T Spon Humacyte, Inc Protocol #CLN-PRO-V007 8,509 USF Health-Morsani College o Surgery PI: Cox,Charles E Spon Agendia, Inc. Protocol #FLEX Registry 1,040 USF Health-Morsani College o Surgery PI: Cox,Charles E Spon Paradigm Diagnostics, Inc. Protocol #Paradigm Registry (4,000) USF Health-Morsani College o Surgery PI: Cox,Charles E Spon PreludeDX Protocol #DCISionRT 17,690 USF Health-Morsani College o Surgery PI: Davis JR.,Donald M Spon IrriMax Corporation Protocol #CLP-01 31,080 USF Health-Morsani College o Surgery PI: Katlaps,Gundars Spon ABIOMED, Inc. SURPASS Study 10,000 USF Health-Morsani College o Surgery PI: Katlaps,Gundars Spon Medtronic, Inc. Protocol #DT PAS 17,500 USF Health-Morsani College o Surgery PI: Lockwood,Charles J Conv University of South Florida Foundation Juan C. Bolivar Surgical Oncology Chair 119,681 USF Health-Morsani College o Surgery PI: Lockwood,Charles J Conv University of South Florida Foundation Richard G. Connar Endowed Chair 144,645 USF Health-Morsani College o Surgery PI: Lockwood,Charles J Conv University of South Florida Foundation The Culverhouse Endowed Professorship 176,968

USF Health-Morsani College Surgery PI: Lominadze,David Spon National Institutes of HealthMechanisms of Neurodegeneration by a Fibrinogen-Containing Protein Complex During Traumatic Brain Injury 373,750

USF Health-Morsani College Surgery PI: Lozonschi,Lucian Spon TransMedics

The Portable Organ Care System (OCS¿) Heart For Resuscitation, Preservation and Assessment of Hearts from Donors after Circulatory Death Continued Access Protocol (OCS DCD Heart CAP) 10,000

USF Health-Morsani College Surgery PI: Majetschak,Matthias Spon Natl Insti of Gen Medical ScienceContributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock 360,381

USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon AbbVie Inc. Protocol #M14-234 12,420 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon AbbVie Inc. Protocol #M14-533 (3,580) USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon AbbVie Inc. Protocol #M14-675 8,023 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-418-3898 (4,963) USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-418-3899 9,936 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-418-4279 4,607 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-419-3895 1,402 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-419-3896 16,613 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-419-4015 8,410 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Gilead Sciences, Inc. Protocol #GS-US-419-4016 19,857 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Hoffmann-La Roche Inc Protocol #GA29144 (9,081) USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Hoffmann-La Roche Inc Protocol #GA29145 (8,300) USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Janssen Biotech, Inc. Protocol #CNTO1959COR1001 23,000 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Janssen Pharmaceutica Inc Protocol #CNT01275UCO3001 (10,200) USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon SafeHeal SAS Protocol #SH-001 27,300 USF Health-Morsani College o Surgery PI: Marcet,Jorge E Spon Theravance Inc Protocol #0173 2,000 USF Health-Morsani College o Surgery PI: Rosemurgy,Alexander S Conv University of South Florida Foundation Reeves / Culverhouse Chair in Digestive Disorders 55,895

USF Health-Morsani College SurgeryPI: Sanchez,Jaime E , Co-PI(s): Rasheid,Sowsan H. Spon TiGenix Protocol #Cx601-0303 143,727

USF Health-Morsani College o Surgery PI: Shames,Murray L Spon Cook Biotech Inc. Protocol #14-09-01 4,435 USF Health-Morsani College o Surgery PI: Shames,Murray L Spon Cook Biotech Inc. Protocol# Zenith TX2 10-001 (1,015) USF Health-Morsani College o Surgery PI: Shames,Murray L Spon Cook Biotech Inc. Protocol#08-005 ZENITH TX2 TAA 496 USF Health-Morsani College o Surgery PI: Shames,Murray L Spon Cook Biotech Inc. Protocol#Zenith TX2 11-007 1,290 USF Health-Morsani College o Surgery PI: Shames,Murray L Spon Medtronic, Inc. Protocol #IP-01-001 3,144 USF Health-Morsani College o Surgery PI: Shames,Murray L Spon Terumo Medical Corporation Protocol #TIS2018-01 16,823 USF Health-Morsani College o Surgery PI: Shames,Murray L Spon W. L. Gore & Associates Protocol #AAA 17-01 27,119

156


USF Health-Morsani College o Surgery PI: Shames,Murray L Spon W. L. Gore & Associates Protocol #SSB-11-02 1,495 USF Health-Morsani College o Surgery PI: Smith JR.,David J Spon Queen's University Protocol #RE-ENERGIZE 10,727 USF Health-Morsani College o Surgery PI: Velanovich,Vic Spon Allergan, Inc. Protocol #RLM-MD-01 (4,230) USF Health-Morsani College o Surgery PI: Velanovich,Vic Spon Allergan, Inc. Protocol #RLM-MD-03 23,380 USF Health-Morsani College o Surgery PI: Velanovich,Vic Spon Allergan, Inc. Protocol #RLM-MD-04 20,380 USF Health-Morsani College o Surgery PI: Velanovich,Vic Spon AngioDynamics Protocol #2019-ONC-02 20,800 USF Health-Morsani College o Surgery PI: Velanovich,Vic Spon AngioDynamics Protocol #28-001-ONC 21,500 USF Health-Morsani College o Surgery PI: Velanovich,Vic Spon EndoStim, Inc Protocol #CS-100 (77,033)

USF Health-Morsani College Surgery PI: Velanovich,Vic Spon H. Lee Moffitt Cancer Center

The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for PancreaticCancer 1,600

USF Health-Morsani College o Surgery PI: Wu,Mack Spon James A. Haley Veteran's Hospital 2020-2021 VA IPA Fang Wang 55,184 USF Health-Morsani College o Surgery PI: Wu,Mack Spon James A. Haley Veteran's Hospital 2020-2021 VA IPA Thomas Ewing 48,042 USF Health-Morsani College o Surgery PI: Wu,Mack Spon James A. Haley Veteran's Hospital 2020-2021 VA IPA Xiaoqi Sun 13,776

USF Health-Morsani College of Surgery Total 1,837,072

USF Health-Morsani College Urology PI: Hernandez,David J Spon Becton, Dickinson and CompanyA Single-Center, Evaluation of Two Adhesive for the PureWick¿ Male One Piece External Catheter in Healthy Volunteers 104,979

USF Health-Morsani College o Urology PI: Lockhart,Jorge L Conv University of South Florida Foundation USFF Prosthetic Urology & Andrology Fellowship 122,010 USF Health-Morsani College o Urology PI: Wiegand,Lucas Ross Spon Endo Pharmaceuticals, Inc. Protocol #CHC 61,500 USF Health-Morsani College o Urology PI: Wiegand,Lucas Ross Spon Provepharm, Inc. Protocol #PVP-19IC01 133,500

USF Health-Morsani College of Urology Total 421,989 USF Health-Morsani College o USF Alzheimer's Institute PI: Lockwood,Charles J Conv Johnnie B Byrd Sr Alzheimers Research Ct Byrd Institute 116,969 USF Health-Morsani College o USF Alzheimer's Institute PI: Morgan,David G Conv University of South Florida Foundation Benjamin Chair Pharmacology Alzheimers 21,899 USF Health-Morsani College o USF Alzheimer's Institute PI: Van Loveren,Harry R Conv University of South Florida Foundation Bagnor Endowmment for Alzheimer's Research 1 USF Health-Morsani College o USF Alzheimer's Institute PI: Van Loveren,Harry R Conv University of South Florida Foundation Eric Pfeiffer Alzheimers Endowed Chair 56,000 USF Health-Morsani College o USF Alzheimer's Institute PI: Van Loveren,Harry R Conv University of South Florida Foundation Fleming Alzheimer's Research Chair 90,000 USF Health-Morsani College o USF Alzheimer's Institute PI: Van Loveren,Harry R Conv University of South Florida Foundation James & Martha Porter Alzheimers Research 14,892 USF Health-Morsani College o USF Alzheimer's Institute PI: Van Loveren,Harry R Conv University of South Florida Foundation Orcutt Family Endowment for Alzheimer's Disease Research 53,904

USF Health-Morsani College of USF Alzheimer's Institute Total 353,664 USF Health-Morsani College o USF Health - IT PI: Lockwood,Charles J Conv University Medical Service Associates House Staff - Graduate Medical Education 1,094

USF Health-Morsani College of USF Health - IT Total 1,094 USF Health-Morsani College o USF Health Womens Health PI: Lockwood,Charles J Conv University of South Florida Foundation Women's Health Collaborative Seed Grants 24,726

USF Health-Morsani College of USF Health Womens Health Total 24,726

USF Health-Morsani College of Medicine Total 386,570,669

USF Health-Taneja College o Pharmaceutical Science PI: Biswal,Manas Ranjan Spon National Eye InstituteDefining Oxidative Stress Induced Changes in RPE That Control RPE and Photoreceptor Degeneration 246,372

USF Health-Taneja College o Pharmaceutical Science PI: Cao,Chuanhai Spon Mega Nano BiotechDeveloping a Multiplex Assay for Alzheimer's and Parkinson's Disease States. 140,000

USF Health-Taneja College of Pharmaceutical Science PI: Cao,Chuanhai Spon Mega Nano Biotech Immature peptide sensitized DC vaccine for prostate cancer 89,500

USF Health-Taneja College o Pharmaceutical Science PI: Cheng,Feng , Co-PI(s): Hill,Angela M Spon National Institute on AgingIdentification of Potential Drug-drug Interactions in Alzheimer's Disease Patients 74,750

USF Health-Taneja College o Pharmaceutical SciencePI: Kindy,Mark Stephen , Co-PI(s): Yu,Jin;Taheri,Saeid Spon American Heart Association Serum, Amyloid, Inflammasome, Activation and Stroke 100,000

USF Health-Taneja College o Pharmaceutical Science PI: Limayem,Alya Chahed Spon Natural Immunogenics Corp.

Integrating Automated Intelligence and Bio-active Silver (Ag) Nanotherapeutics on Both Viruses & Drug Resistant Bacteria for Precise 3D Treatment 70,000

USF Health-Taneja College o Pharmaceutical SciencePI: Mondy,William , Co-PI(s): Haldar,Pradeep Spon National Science Foundation

I-Corps: Extracellular matrix materials for use in creating tissue scaffolding to regenerate organs and tissues 50,000

USF Health-Taneja College of Pharmaceutical Science PI: Panguluri,Siva Kumar Spon National Institute on Aging Hyperoxia exposure in an aging model of type 1 diabetes 74,750

USF Health-Taneja College o Pharmaceutical Science PI: Panguluri,Siva Kumar Spon National Institute on AgingHyperoxia-Induced KV Channel Regulation in an Aging Mouse Model (re-Submission) 430,649

USF Health-Taneja College o Pharmaceutical Science PI: Sutariya,Vijaykumar Spon Param Bhakti Healthcare and Research SerFormulation Development and characterization of Ayurvedic Herb Based Neutraceuticals 50,000

USF Health-Taneja College o Pharmaceutical SciencePI: Taheri,Saeid , Co-PI(s): Kindy,Mark Stephen Spon Florida Department of Health

The Impact of Cerebrovascular Injury Biomarkers on Vascular Dementia and Alzheimer's Disease 78,125

USF Health-Taneja College of Pharmaceutical Science PI: Tipparaju,Srinivas M Spon National Institutes of Health Protecting the diabetic skeletal muscle by Nampt activation 818,932 USF Health-Taneja College of PhPharmaceutical Science Total 2,223,078

USF Health-Taneja College of Pharmacy Practice PI: Perkins,Janelle B Spon Spectrum Pharmaceuticals Protocol #not assigned 10,315 USF Health-Taneja College of PhPharmacy Practice Total 10,315

USF Health-Taneja College of Pharmacy Total 2,233,393

USF Other AreasCenter for Digital Heritage Geospatial Information

PI: Collins,Lori D , Co-PI(s): Doering,Travis Francis Spon Argonne National Laboratory

Three-Dimensional Digital Documentation of the Cape Canaveral Lighthouse (8BR212), Cape Canaveral Air Force Station, Brevard County, Florida 65,868

USF Other Areas Center for Digital Heritage Geospatial Information Total 65,868

157


USF Other Areas Comparative Medicine PI: Engelman,Robert W Spon James A. Haley Veteran's Hospital Oversight & Research Animals Support Services J A Haley VA 388,188 USF Other Areas Comparative Medicine Total 388,188

USF Other Areas Enrollment Planning and Management PI: Cummings,William P Spon The School Board of Hillsborough CountyGaining Early Awareness and Readiness through Undergraduate Program (GEAR UP): Project SCORE - Year 6 20,000

USF Other Areas Enrollment Planning and Management PI: Dosal,Paul J Spon Bill and Melinda Gates FoundationFlorida College Access Network Post-secondary Advocacy and Capacity-Building Grant 666,668

USF Other Areas Enrollment Planning and Management PI: Dosal,Paul J Spon Helios Education Foundation FCAN Capacity and Network Support Grant 596,445

USF Other Areas Enrollment Planning and Management PI: Dosal,Paul J Spon The Kresge Foundation Florida College Access Network: Operating Support for New Strategic Plan 50,000 USF Other Areas Enrollment Planning and Management Total 1,333,113

USF Other Areas Florida Center for Cybersecurity PI: Sanders,Ronald P Conv University of South Florida Foundation Cyber Florida Payroll 22,989 USF Other Areas Florida Center for Cybersecurity PI: Sanders,Ronald P Spon MOHAWK VALLEY COMMUNITY COLLEGE 2020 NSA CAE-C National Competition 240,868

USF Other Areas Florida Center for Cybersecurity PI: Sanders,Ronald P Spon University of West FloridaNCAE-C-003-2020 Cyber Curriculum and Research: University of West Florida 713,707

USF Other Areas Florida Center for Cybersecurity Total 977,564

USF Other Areas Genshaft Honors CollegePI: Young,Benjamin Scott , Co-PI(s): Wilkins,Catherine J. Spon National Endowment for the Humanities Medical Humanities in a Global Context 13,710

USF Other Areas Genshaft Honors College Total 13,710 USF Other Areas Graduate School Administration PI: Bahr,Ruth H Spon EdVision Corp. EdVision: AI-powered academic guidance for PhD programs 71,452 USF Other Areas Graduate School Administration PI: Bahr,Ruth H Spon Florida Education Fund, Inc. McKnight Dissertation Fellowship 2020 26,000 USF Other Areas Graduate School Administration PI: Bahr,Ruth H Spon Florida Education Fund, Inc. McKnight Doctoral Fellowship 2018 26,833 USF Other Areas Graduate School Administration PI: Bahr,Ruth H Spon Florida Education Fund, Inc. McKnight Doctoral Fellowship 2020 248,093 USF Other Areas Graduate School Administration PI: Bahr,Ruth H Spon National Science Foundation Graduate Research Fellowship Program (GRFP) 161,334

USF Other Areas Graduate School Administration PI: Bahr,Ruth H Spon US Department of EducationGender-based Violence Resource Acquisition among Indigenous Guatemalan Women 26,769

USF Other Areas Graduate School Administration Total 560,481

USF Other Areas Information TechnologyPI: Fawcett,Timothy J , Co-PI(s): Kaplan,Howard Spon James A. Haley Veteran's Hospital Patient Safety Center of Inquiry 20,000

USF Other Areas Information Technology PI: Kaplan,Howard Spon James A. Haley Veteran's Hospital VA CINDRR Simulation 2 4,176 USF Other Areas Information Technology PI: Tobias,Adam P Spon US Geological Survey USGS Monthly Internet Service 4,800

USF Other Areas Information Technology Total 28,976

USF Other Areas Library PI: Collins,Lori D Spon National Science FoundationCollaborative Research: Ethical Considerations in Three-Dimensional Digitization of Indigenous Heritage 14,050

USF Other Areas LibraryPI: Collins,Lori D , Co-PI(s): Doering,Travis Francis Spon Argonne National Laboratory

Three- Dimensional Digital Documentation of Historic Structures at CCAFS: Launch Complexes 16, 18, and 20 - Cape Canaveral Air Force Station, Brevard County, Florida 174,771

USF Other Areas LibraryPI: Collins,Lori D , Co-PI(s): Doering,Travis Francis Spon Rhodes & Brito Architects

Cultural Resource Assessment Survey (CRAS), Phase I and Phase II, SLC-46 Shoreline Stabilization, Cape Canaveral Air Force Station (CCAFS), Brevard County, Florida 25,907

USF Other Areas Library Total 214,728 USF Other Areas Office of Research & Innovation PI: Anderson,Keith Spon University of South Florida Foundation USF Foundation Gifts for Research 10,803,501

USF Other Areas Office of Research & Innovation

PI: Limayem,Moez , Co-PI(s): Maradei,Lauren Hunt;Bishop,Robert Harold;Pandolfo,Autumn Spon The National Academy of Inventors, Inc. National Academy of Inventors 150,000

USF Other Areas Office of Research & Innovation PI: Lowry,Judith Heck Spon Florida High Tech Corridor WK 18-30 Florida Inventors Hall of Fame Annual Support 154,956 USF Other Areas Office of Research & Innovation Total 11,108,457

USF Other Areas Project THRUST PI: Nixon,Allyson L Spon St. Petersburg College College Reach-Out Program (CROP) 2,557 USF Other Areas Project THRUST PI: Nixon,Allyson L Spon St. Petersburg College College Reach-Out Program (CROP) 2020-2021 41,661

USF Other Areas Project THRUST Total 44,219 USF Other Areas Public Broadcasting/WUSF-FM PI: Urofsky,Joann Spon Corporation for Public Broadcasting WUSF-FM community Service Grant FY 2021 520,667 USF Other Areas Public Broadcasting/WUSF-FM PI: Urofsky,Joann Spon Florida Department of Education WUSF-FM Radio Grant FL DOE 2020-2021 94,000

USF Other Areas Public Broadcasting/WUSF-FM Total 614,667 USF Other Areas STP - Academic Affairs PI: Tadlock,Martin Kieth Spon Department of State Poetry Out Loud 2021 20,000

USF Other Areas STP - Academic Affairs Total 20,000

USF Other Areas STP - Biology PI: Judkins,Heather Spon Nova Southeastern UniversityTrends and Drivers of Faunal Abundance of the Offshore Gulf of Mexico: Narrowing the Data Gap in the Gulf's Largest Ecosystem 15,817

USF Other Areas STP - Biology Total 15,817

USF Other Areas STP - English PI: McCracken,Jill L Spon Proteus FundComplex Rights and Wrongs: The Stories We Deny in Mainstream Understandings of Prostitution and Trafficking in the Sex Industry 15,000

USF Other Areas STP - English Total 15,000

USF Other Areas STP - Facilities Services PI: Toler,Susan M Spon Florida Department of StateJohn C Williams House Planning Project: Preservation, Protection and Master Plan 17,837

USF Other Areas STP - Facilities Services Total 17,837

158


USF Other Areas STP - History PI: Francis,John Michael Spon Natl Historical PublicationsEuropeans, Indians, and Africans: Lost Voices from America's Oldest Parish archive, 1594-1821. 125,000

USF Other Areas STP - History Total 125,000 USF Other Areas STP - Psychology PI: McHale,James P Spon Florida Office of Early Learning OEL-PDG Reflective Supervision 210,229 USF Other Areas STP - Psychology PI: McHale,James P Spon Foundation for a Healthy St. Pete Trauma-Informed Infant-Family Mental Health 46,907

USF Other Areas STP - Psychology PI: McHale,James P Spon Pinellas Community FoundationAttending to Infant-Family Mental Health during COVID-19 in Pinellas County 178,004

USF Other Areas STP - Psychology PI: Rodriguez,Lindsey Michell Spon University of Nebraska

Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking 6,119

USF Other Areas STP - Psychology Total 441,259 USF Other Areas STP - Public Safety PI: Hendry,David Francis Spon Florida Department of Law Enforcement Coronavirus Emergency Supplemental Funding 26,817

USF Other Areas STP - Public Safety Total 26,817 USF Other Areas STP - Regional Chancellor PI: Tadlock,Martin Kieth Spon Florida Department of State Poetry Out Loud Gets Original 2021 7,300

USF Other Areas STP - Regional ChancellorPI: Tadlock,Martin Kieth , Co-PI(s): Nesmith,Caryn Alexandra Spon Foundation for a Healthy St. Pete Truth, Racial Healing, and Transformation CC Planning Gran 12,616

USF Other Areas STP - Regional Chancellor Total 19,916 USF Other Areas STP - Special Education PI: Dukes III,Lyman L Spon University of Central Florida Preparing Scholars to Lead Inclusion and Transition (LEAD IT) 17,684

USF Other Areas STP - Special Education PI: Dukes III,Lyman L Spon University of Central Florida - FSEC LEAD-PREP: Preparation Through Residencies and Enhanced Partnerships 47,544

USF Other Areas STP - Special Education PI: Knab,Jordan T Spon Florida Department of EducationSEDNET 20-21: Admin (Multiagency Network for Students with Emotional or Behavioral Disabilities) 505,183

USF Other Areas STP - Special Education Total 570,411 USF Other Areas University Police PI: King III,Martin V Spon Florida Department of Law Enforcement Coronavirus Emergency Supplemental Funding (CESF) Program 89,389

USF Other Areas University Police Total 89,389

USF Other Areas Upward BoundPI: Cummings,William P , Co-PI(s): Cabrera,Raymond Spon US Department of Education TRIO Upward Bound Program 824,294

USF Other Areas Upward Bound Total 824,294 USF Other Areas USF World PI: Caruson,Kiki Spon Peace Corps Campus Recruitment Services 23,964

USF Other Areas USF World Total 23,964 USF Other Areas Vice President Administrative Services PI: Montalvo,Gabriel Spon Florida Division of Emergency Management USF 2017 Hurricane IRMA - FEMA 641,856

USF Other Areas Vice President Administrative Services Total 641,856 USF Other Areas Vice President Student Affairs PI: Garth,Reba A Spon US Department of Education Student Support Services Program 344,904

USF Other Areas Vice President Student Affairs Total 344,904

USF Other Areas Total 18,526,433

Grand Total 568,117,432

159


REPORT OF RESEARCH

ACTIVITIES

F I S C A L Y E A R 2 0 2 1

S E C T I O N 4 P R O P O S A L D A T A

160

161

Research and Innovation Summart of Proposals Annual Report FY2021

Section 6College Area and Department Proposals Requested Amount

Academic AffairsCenter for Digital Heritage Geospatial Information 1 $65,869Enrollment Planning and Management 6 $34,978,634Florida Center for Cybersecurity 2 $954,575Florida Institute of Oceanography 1 $47,826,688Library 5 $392,810

Office of Decision Support 1 $448,729

STP - Academic Affairs 1 $20,000STP - Center for Teaching and Learning 1 $10,000STP - Public Safety 1 $26,817STP - Regional Chancellor 2 $19,916STP - Women's and Gender Studies 1 $25,000USF World 1 $5,992

Academic Affairs Total 23 $84,775,030

College of Arts and SciencesAnthropology 25 $2,207,354Cellular, Molecular & Micro-Biology 37 $29,691,736Center Improve Teaching & Research STEM 3 $960,639Chemistry 30 $22,509,592Communication 1 $38,351Economics 2 $838,112Environmental Science Program 2 $849,803Florida Institute of Government 5 $348,733Geosciences 54 $13,151,022History 2 $30,000Integrative Biology 25 $7,307,105Mass Communication 1 $74,978Mathematics & Statistics 18 $8,192,133Physics 29 $19,605,993Psychology 22 $10,050,559Public Affairs 4 $156,500Religious Studies 1 $45,000School of Information 7 $3,189,890School of Interdisciplinary Global Studies 3 $378,997Sociology 1 $653,740STP - Anthropology 3 $246,828STP - Biology 3 $549,308STP - Chemistry 3 $147,670STP - Dean Arts and Sciences 3 $868,774STP - Environmental Science Program 4 $340,366STP - Infant Family Mental Health Center 1 $120,000

162



STP - Integrative Biology 2 $147,017STP - Mass Communications 2 $45,362STP - Psychology 7 $6,218,146World Languages 1 $500

College of Arts and Sciences Total 301 $128,964,208

College of Behavioral and Community SciencesAging and Mental Health Disparities 1 $625,000CFS RIghtpath Research Center 12 $7,524,805Child and Family Behavioral Health 17 $13,238,155Child and Family Studies 23 $30,334,193College of Behavioral and Community Sci 1 $33,599Communication Sciences and Disorders 9 $9,265,841Criminology 2 $244,945Mental Health Law and Policy 22 $11,067,547Rehabilitation Counseling 10 $6,695,145School of Aging Studies 17 $10,106,502School of Social Work 19 $3,642,236STP - Criminology 1 $20,000

College of Behavioral and Community Sciences Total 134 $92,797,968

College of EducationCREAM 8 $1,804,545David Anchin Center 3 $1,694,619Educational and Psychological Studies 36 $25,010,372Institute for School Reform 13 $21,106,996Language,Literature, Exceptional Educ, PE 6 $5,089,989Leadership, Counseling & Adult Education 10 $2,089,481SAR - Educational Leadership and Policy 1 $34,073STP - Dean of Education 5 $1,037,594STP - Education Measures and Research 2 $608,610STP - Secondary Education 2 $699,991STP - Special Education 7 $7,596,591Teaching and Learning 12 $2,131,414

College of Education Total 105 $68,904,275

College of EngineeringCenter for Hearing and Speech Research 1 $11,097,473Center for Urban Transportation Research 67 $16,481,877Chemical & Biomedical Engineering 32 $17,446,872Civil and Environmental Engineering 53 $68,901,468Clean Energy Research Center 1 $47,140

163



College of Engineering Academic Advising 2 $479,967Computer Science and Engineering 48 $52,502,522Electrical Engineering 41 $25,254,283Industrial & Management Sys Engineering 17 $13,410,338Institute of Applied Engineering 15 $1,965,661Mechanical Engineering 36 $13,122,302Medical Engineering 11 $8,330,215

College of Engineering Total 324 $229,040,118

College of Marine ScienceCollege of Marine Science 77 $53,949,965

College of Marine Science Total 77 $53,949,965

College of NursingCollege of Nursing 37 $28,241,776

College of Nursing Total 37 $28,241,776

College of Public HealthCOPH Genetic Counseling 2 $1,193,909COPH MHA Program 7 $1,575,753COPH OSHA Education Center 1 $235,000Florida Prevention Research Center 2 $43,807GHIDR Global Health Center 16 $8,327,008Global Health 6 $1,317,429Lawton & Rhea Chiles Center 13 $2,489,949PH Interdisciplinary Research & Education 48 $75,323,998USF Genomics 6 $8,803,594

College of Public Health Total 101 $99,310,447

College of The ArtsFlorida Ctr for Community Design & Res 6 $254,328School of Music 5 $2,378,732USF Art Museum 8 $473,006Visual Arts 1 $16,800

College of The Arts Total 20 $3,122,866

Graduate SchoolGraduate School Administration 5 $360,611

Graduate School Total 5 $360,611

Morsani College of MedicineArea Health Education Center 1 $17,562

164



Clinical and Translational Science Inst 6 $2,214,998Dermatology 14 $528,854Diabetes Center 3 $29,998Family Medicine 1 $40,475Health Informatics Institute 13 $80,092,766Heart Inst - Cardiology 1 $2,298,446Heart Institute - Internal Medicine 15 $25,694,171Internal Medicine 135 $46,811,535MCOM Medical Engineering 7 $8,495,024Molecular Medicine 66 $58,227,927Molecular Pharmacology and Physiology 67 $83,513,338Morsani College of Medicine 2 $2,265,295Neurology 68 $8,569,557Neurosciences Center for Aging 3 $4,550,174Neurosurgery 30 $20,097,537Obstetrics and Gynecology 19 $8,218,369Ophthalmology 3 $173,021Otolaryngology 10 $1,713,720Pathology and Cell Biology 3 $5,290,845Pediatrics 49 $5,612,309Plastic Surgery 6 $193,579Psychiatry and Behavioral Medicine 18 $28,460,650Radiology 3 $84,999School of Physical Therapy 10 $1,703,726SunCoast Gerontology Center 2 $19,998Surgery 36 $18,707,081Urology 3 $29,628

Morsani College of Medicine Total 594 $413,655,582

Muma College of BusinessDBA Program 1Information Systems & Decision Sciences 9 $2,141,023Marketing 2 $129,985Muma College of Business 4 $33,990Small Business Development Center 6 $2,194,001STP - Information Systems 1 $10,000,000

Muma College of Business Total 23 $14,498,999

Office of Research & InnovationComparative Medicine 1 $373,750

Office of Research & Innovation Total 1 $373,750

165



Patel College of Global SustainabilityPatel Center for Global Understanding 2 $343,811

Patel College of Global Sustainability Total 2 $343,811

Student AffairsSAR - Academic Support 1 $503,585

Student Affairs Total 1 $503,585

Taneja College of PharmacyPharmaceutical Science 28 $28,475,522Pharmacy Practice 3 $153,500

Taneja College of Pharmacy Total 31 $28,629,022

Undergraduate StudiesProject THRUST 1 $11,007

Undergraduate Studies Total 1 $11,007

University AdvancementPublic Broadcasting 2 $114,000STP - Development 1 $135,487

University Advancement Total 3 $249,487

University ServicesInformation Technology 3 $30,000Public Broadcasting/WUSF-FM 1 $520,667Public Safety 1 $89,389Vice President Administrative Services 1 $690,808

University Services Total 6 $1,330,864

Grand Total 1,789 $1,249,063,371

166


REPORT OF RESEARCH

ACTIVITIES

F I S C A L Y E A R 2 0 2 1

S E C T I O N 5 I N T E R N A L A W A R D S P R O G R A M S

O V E R V I E W R E S E A R C H C O U N C I L M E M B E R S

A N N U A L A W A R D L I S T I N G F I V E - Y E A R S U M M A R Y

D E T A I L E D F U N D I N G

167

168

INTERNAL AWARDS PROGRAM (FY 2020-2021)

Established in 1980, the Internal Awards Program is funded from Facilities and Administrative (F&A) cost revenue generated by externally funded grants and made available by USF Research & Innovation (USFRI). The USF Senate Research Council advises on policies and procedures, and recommends funding grants to USF System faculty from the Internal Awards Program funds. The program is administered through USFRI and Sponsored Research. The USF Internal Awards program web site is https://www.usf.edu/research-innovation/sr/internal-awards-program.aspx

The submission deadlines were divided between fall 2020 and spring 2021 semesters. Applications for the Faculty International Travel Grants (FITG) and Conference Support Grants (CONF) had two submission deadlines. Applications for the Creative Scholarship Grants (CSG), New Researcher Grants (NRG), and Proposal Enhancement Grants (PEG) had one submission deadline.

The Research Council uses a peer review process to evaluate and select awardees. During FY 2020-2021, designated USF System faculty across multiple disciplines served as proposal reviewers for the applications received for consideration.

OVERVIEW

USF tenured/tenure-earning faculty and non-tenure track faculty, whose position description includes responsibility for conducting independent research, were eligible to apply (subject to certain restrictions) for grants offered in the Internal Awards Program. A total of $334,877 was awarded in FY2020-2021.

CONFERENCE SUPPORT GRANTS (CONF)

The Conference Support Grants provide a maximum of $5,000 supplemental funding to assist faculty in the planning and implementation of national and international conferences. Conferences are an important part of the research environment at the university. They provide a venue for the dissemination of new information, a forum for the exchange of ideas, and bring prestige (recognition) to the USF System and the State of Florida.

In the grant application, faculty describes the objectives of their conference and includes available and pending funding in the budget. Award recipients are required to submit a final report at the conclusion of the conference.

• 7 applications were received and 7 applications were awarded for a 100% success rate. • 7 grants were funded totaling $35,000 with an average award of $5,000.

169

https://www.usf.edu/research-innovation/sr/internal-awards-program.aspx

CREATIVE SCHOLARSHIP GRANTS (CSG)

The Creative Scholarship Grants offer a maximum of $10,000 for a one-year grant period and are intended for faculty working in disciplines, e.g., Fine Arts and Humanities, where significant external funding is scarce.

The Humanities include: “language (both modern and classical), linguistics, literature, history, jurisprudence, philosophy, archaeology, comparative religion, ethics, the history (criticism and theory of the arts), those aspects of social sciences which have humanistic content and employ humanistic methods, and the study and application of the humanities to the human environment with particular attention to reflecting our diverse heritage, traditions, and history and to the relevance of the humanities to the current conditions of national life.” – National Endowment for the Humanities

The Arts include: “dance, design, folk & traditional arts, literature, media arts (film, television, radio, and audio art), music, musical theater, opera, theater, visual art (including painting, photography, sculpture, crafts, works on paper, other genres) and multidisciplinary works.” – National Endowment for the Arts

Applicants are required to describe how they will publish/disseminate the results of their projects, identify potential funding sources, and outline plans for applying the results of the projects to an external grant proposal. A final report is required from all award recipients.


FACULTY INTERNATIONAL TRAVEL GRANTS (FITG)

The Faculty International Travel Grants provide up to $2,500 per trip of financial support for scholarly/artistic presentations by USF System faculty at major professional meetings or conferences outside the USA. The primary goal is to enhance the international visibility and prestige of the USF System; therefore, the prestige and scope of the presentation and conference are considered.

Faculty must include with the application the invitation/acceptance to give keynote speeches, plenary presentations or other major addresses, presentations, or performances. A travel impact report is required from all award recipients.


170

NEW RESEARCHER GRANTS (NRG)

The New Researcher Grants are for Assistant Professors (or the equivalent rank) who are new to the USF System (four years or less) and do not have established funding sources for their programs of research, scholarship, exhibition or performance. The goal of the grant is to fund activities that will provide the experience, data, or work necessary to successfully compete for grants from external agencies or foundations. The maximum funding is $10,000 for a one-year grant period.

Applicants are required to describe how they will publish/disseminate the results of their projects, identify potential funding sources, and outline plans for applying the results of the projects to external grant proposals. A final report is required from all award recipients.


PROPOSAL ENHANCEMENT GRANTS (PEG)

The Proposal Enhancement Grants are designed to help faculty develop competitive proposals for resubmission to an external funding agency. These funds can lead to an enhanced proposal for resubmission by addressing limitations or problems enumerated by the external agency. The program is a valuable resource for aiding faculty who have received positive reviews from a grant application but are not yet in the agency’s “fundable” range. The maximum funding is $25,000 for a one-year grant period.

As part of the application for these grants, faculty are required to submit a proposal plan which includes the name of the external funding agency, the next application deadline, the full reviews provided by the external funding agency, and an explanation of how the PEG will address the concerns raised by the reviewers in the previous external review. A final report is required from all award recipients.


171

UNIVERSITY OF SOUTH FLORIDA SENATE RESEARCH COUNCIL ROSTER (2021 - 2022)

Terms begin and end at the beginning of Fall (i.e., the beginning of Fall 2021 to the beginning of Fall 2024)

Meetings held via Microsoft Teams or at USF Research & Innovation, Multi-Purpose Room 3702 Spectrum Blvd., Suite 165, Front Office: 813-974-5570

Contact information for Sponsored Research, Research Council Coordinator: Melody Spencer, 813-974-2897, [email protected]

Alphabetical Order by College

Member College Represented Term Department Phone E-mail Address Research/Specialization 1 Janelle Applequist, PhD

Assistant Professor College of Arts

and Sciences (1) 2019-2022 The Zimmerman

School of Advertising & Mass Communications

974-4662 [email protected]

Dr. Applequist's research is focused on health communication and advertising in the pharmaceutical industry, especially in regards to developing more normative frameworks to encourage proper patient education. Applequist's research explores the content of pharmaceutical advertisements, legal compliance with Food and Drug Administration (FDA) requirements, and issues of representation related to patients and health care in these advertisements. Other research interests include qualitative research methods, advertising, and patient representations via advertising.

2 Zachary Atlas, PhD Research Assistant Professor & Manager, USF Center for Geochemical Analysis

College of Arts and Sciences (2)

2019-2022 Geosciences 974-6419 [email protected] Volcanic geochemistry applied to pre- eruptive magma dynamics, the nature of subsurface storage of magma and subduction recycling of elements in volcanic systems. Plasma spectroscopy, which involves but not limited to forensic geochemistry and the trace element chemistry of the human body.

172




Member College Represented Term Department Phone E-mail Address Research/Specialization 3 Robert Tykot, PhD

Professor College of Arts and

Sciences (3) 2019-2022 Anthropology 974-7279 [email protected]

Research focuses on applying a range of scientific methods of analysis to archaeological materials, in prehistoric Europe an many other parts of the world. This includes including isotopic analyses of human remains to address dietary life history and mobility: trace element patterns in obsidian and ceramics to reconstruct long-distance trade networks; and major element composition of copper- based metals to examine the use of different alloys.

4 Marilyn Stern, PhD, CRC Professor

College of Behavioral & Community

Sciences

2019-2022 Child and Family Studies

974-0966 [email protected] Primary research focus in pediatric, adolescent and young adult (AYA) psychosocial oncology, communication, and transition to survivorship; developing interventions to reduce childhood and adolescent obesity, and the vulnerable child syndrome.

5 Nathaniel von der Embse, PhD, NCSP Associate Professor

College of Education 2018-2021 2021-2022

School Psychology 974-5247 [email protected]

Examination of teacher stress and student test anxiety surrounding high- stakes exams; The creation and validation of internalizing behavior and socio-emotional wellness screening assessments; and training of teachers and schools in population- based assessment methods to inform tiered and targeted intervention.

6 Yu Zhang, PhD Associate Professor

College of Engineering 2018-2021 2021-2022

Civil and Environmental Engineering

974-5846 [email protected] Transportation network modeling and optimization, emerging technologies and services in transportation, sustainable transportation, resilient infrastructure and emergency management.

7 Alastair Graham, PhD Associate Professor


2021-2024 Geological Oceanography

727-553- 3415

[email protected] Past changes in Earth’s cryosphere, Geomorphological Processes in Sub- Ice and Open-Ocean Sea-Floor Environments, Antarctic Continental Margin Evolution, Sub-Antarctic Climate History.

173






Member College Represented Term Department Phone E-mail Address Research/Specialization 8 Richard Heller, PhD,

Professor Member-At-Large (1) 2021-2024 Medical

Engineering, Medical

Microbiology and Immunology

974-3780 [email protected]

Developing and testing novel procedures using pulse electric fields for the delivery of plasmid DNA and cancer chemotherapeutics. The research has led to the development of new protocols or devices that are being tested for potential therapies for cancer, wound healing and vascular diseases (peripheral and coronary ischemia) as well as vaccine and immunotherapy protocols. Utilizing a long-term effort and multi-disciplinary approach, critical breakthroughs have been made that enhanced the progress of pulse electric fields for biomedical applications including First- in-Human clinical trials.

9 Vacant Member-At-Large (2)

10 Ganesh Halade, PhD Associate Professor

Morsani College of Medicine (1) USF Health

Feb-May 2022

Internal Medicine and Cardiovascular

Research

813-396- 0104

[email protected] Primary research focus is to understand how inflammation and immune responsive metabolic dysregulation contributes to ischemic and non-ischemic heart failure: 1) study of heart failure etiology with an integrative approach focusing on splenic leukocytes and heart; 2) measurement of inflammatory mediators that impair cardiac repair and resolving lipid mediators that facilitate cardiac repair after heart attack; 3) role of resolution receptor in inflammation-resolution processes in heart failure; and 4) translate our findings for use in human therapy, considering risk factors such as obesity, diabetes, aging, and cardiotoxic co-medications (oncological drugs).

174



Member College Represented Term Department Phone E-mail Address Research/Specialization 11 Kristian Lynch, PhD, MSc

Associate Professor Morsani College of

Medicine (2) USF Health

2021-2024 Health Informatics Institute

972-3854 [email protected] Primary research focus is in identifying environmental triggers of autoimmunity leading to celiac disease and type 1 diabetes among genetically at-risk children. Expertise in biostatistics and epidemiology with interest in study design of observational studies, disease heterogeneity, gene-environment interactions, causal inference and data integration.

12 Emily Shaffer-Hudkins, PhD NCSP Associate Professor

Morsani College of Medicine (3) USF Health

2021-2024 Pediatrics 974-7588 [email protected] Dr. Shaffer-Hudkins' areas of research interest include parent-child interaction and attachment, supporting those with developmental disabilities and their families, particularly those with autism spectrum disorder, positive psychology and resilience, and training experiences for future professionals serving young children.

13 Ehsan Sheybani, MS, PhD Associate Professor

Muma College of Business

2019-2022 Information Systems and

Decision Science, Sarasota-Manatee

Campus

941-359- 4200

[email protected] Applications of communication systems, signal processing, and artificial intelligence to big data, cybersecurity, biomedicine/bioengineering, space communications, oceanography, wireless communications, internet of things, and other physical sciences.

14 Ponrathi Athilingam, PhD Associate Professor

College of Nursing 2021-2024 College of Nursing 974-7526 [email protected] Dr. Athilingam’s research is focused on interventions for patients with heart failure and Chronic Obstructive Pulmonary Disease (COPD) to improve self-care practices, quality of life, and reduce admission rates.

15 John H Adams, PhD, FAAAS, FASTMH, Distinguished University Professor Chair-Elect

College of Public Health USF Health

2020-2022 USF Genomics Program and

Center for Global Health Infectious Disease Research

974-9916 [email protected] My main research interests are in malaria parasite biology and translational studies. Broadly, this research focuses on host-parasite interactions and processes critical for infection and pathogenesis to support discovery of new vaccines and drug treatments. The research is funded by competitive grants from NIH, BMGF and other NGOs. 175






Member College Represented Term Department Phone E-mail Address Research/Specialization 16 Jennifer A. Bugos, PhD

Associate Professor College of The Arts 2018-2021

2021-2022 Center for Music

Education Research

974-2311 [email protected] The neurological basis for music perception and cognition with regard to human development, lifespan learning, and cognitive transfer. Research includes examining the impact of music training on cognition in healthy and clinical populations.

17 Karen Atwood, M.S. Biology Instructor

Sarasota-Manatee Campus

2019-2022 Biology 813-463- 0989

[email protected] Research Focuses on Harmful Algal Blooms (HABs) and includes the production of algal toxins by multiple species of phytoplankton found in Florida waters, specifically brevetoxins produced by Karen Brevis, the Florida Red Tide organism. Research Interests also includes the persistence of algal toxins in the environment and the impacts on fish, wildlife, and humans.

18 Diane Allen-Gipson, MS, PhD Associate Professor Chair

Taneja College of Pharmacy USF Health

2019-2022 Pharmaceutical Sciences

974-5699 [email protected] Mechanisms controlling repair of bronchial epithelium particularly, adenosine signal pathway and its role of epithelial injury in airway diseases associated with cigarette smoke and/or in combination with alcohol exposure. In addition to understanding the mechanisms involved in adenosine-mediated wound repair our lab has a growing interest in targeting efforts to reduce existing disparities in mortality rates particularly associated with smoke-related lung diseases and lung cancer for minorities including but not limited to Black and Hispanic population.

EX-OFFICIO, NON-VOTING MEMBERS 3/22/2022 1 Keith Anderson, MS, CRA, Assistant Vice President

Research & Innovation, 30338 USF Holly Drive, 974-5570

2 Sylvia Thomas, PhD, Interim Vice President Research & Innovation, 30338 USF Holly Drive, 974-5570

176




Internal Awards Summary By College Fiscal Year 2021

College/AreaConference

Support Grant

Creative Scholarship

Grant

Faculty International Travel Grant

New Researcher

Grant

Proposal Enhancement

Grant Grand TotalCOLLEGE OF ARTS AND SCIENCES $10,000 $34,080 $3,237 $29,664 $76,981COLLEGE OF BEHAVIORAL AND COMMUNITY SCIENCES $9,975 $10,000 $19,975COLLEGE OF EDUCATION $5,000 $10,000 $15,000COLLEGE OF ENGINEERING $5,000 $19,910 $24,959 $49,869COLLEGE OF MARINE SCIENCE $9,640 $25,000 $34,640COLLEGE OF PUBLIC HEALTH $5,000 $5,000COLLEGE OF THE ARTS $29,278 $29,278MORSANI COLLEGE OF MEDICINE $5,000 $9,948 $10,000 $49,786 $74,734MUMA COLLEGE OF BUSINESS $10,000 $10,000 $20,000TANEJA COLLEGE OF PHARMACY $9,400 $9,400Grand Total $35,000 $97,921 $3,237 $98,974 $99,745 $334,877

177

Internal Awards Summary By College Five Year History

Sum of AWARDED_AMOUNT Column Labels

College/Area 2017 2018 2019 2020 2021 Grand TotalCOLLEGE OF ARTS AND SCIENCES

Conference Support Grant $24,992 $31,050 $39,769 $33,913 $10,000 $139,724Creative Scholarship Grant $37,806 $49,500 $49,754 $39,359 $34,080 $210,499Faculty International Travel Grant $34,080 $33,733 $42,880 $50,208 $3,237 $164,138New Researcher Grant $49,837 $9,664 $19,974 $40,135 $29,664 $149,274Proposal Enhancement Grant $24,153 $43,341 $44,812 $24,675 $136,981

COLLEGE OF ARTS AND SCIENCES Total $170,868 $167,288 $197,189 $188,290 $76,981 $800,616COLLEGE OF BEHAVIORAL AND COMMUNITY SCIENCES

Creative Scholarship Grant $9,974 $10,000 $10,000 $9,975 $39,949Faculty International Travel Grant $5,000 $5,000 $10,000New Researcher Grant $19,888 $10,000 $9,988 $9,998 $10,000 $59,874Proposal Enhancement Grant $15,303 $15,303

COLLEGE OF BEHAVIORAL AND COMMUNITY SCIENCES Total $34,862 $35,303 $14,988 $19,998 $19,975 $125,126COLLEGE OF EDUCATION

Conference Support Grant $5,000 $5,000Creative Scholarship Grant $10,000 $10,000 $5,000 $25,000Faculty International Travel Grant $2,218 $5,000 $4,359 $3,101 $14,678New Researcher Grant $20,000 $20,000 $10,000 $50,000

COLLEGE OF EDUCATION Total $32,218 $25,000 $4,359 $18,101 $15,000 $94,678COLLEGE OF ENGINEERING

Conference Support Grant $5,000 $5,000 $5,000 $5,000 $20,000Creative Scholarship Grant $10,000 $10,000 $20,000Faculty International Travel Grant $5,000 $12,497 $9,905 $7,498 $34,900New Researcher Grant $17,658 $29,976 $20,000 $20,000 $19,910 $107,544Proposal Enhancement Grant $22,290 $25,000 $47,500 $25,000 $24,959 $144,749

COLLEGE OF ENGINEERING Total $59,948 $67,473 $82,405 $67,498 $49,869 $327,193COLLEGE OF MARINE SCIENCE

Creative Scholarship Grant $9,640 $9,640Faculty International Travel Grant $2,500 $2,500 $5,000New Researcher Grant $9,975 $9,975Proposal Enhancement Grant $8,445 $25,000 $33,445

COLLEGE OF MARINE SCIENCE Total $12,475 $10,945 $34,640 $58,060COLLEGE OF NURSING

Conference Support Grant $4,937 $4,937Faculty International Travel Grant $7,500 $7,500

COLLEGE OF NURSING Total $4,937 $7,500 $12,437COLLEGE OF PUBLIC HEALTH

Conference Support Grant $9,887 $5,000 $14,887Faculty International Travel Grant $7,500 $4,101 $5,000 $5,000 $21,601New Researcher Grant $19,983 $10,000 $29,983

COLLEGE OF PUBLIC HEALTH Total $27,483 $14,101 $5,000 $14,887 $5,000 $66,471COLLEGE OF THE ARTS

Conference Support Grant $10,000 $5,000 $5,000 $5,000 $25,000Creative Scholarship Grant $37,596 $20,000 $10,000 $49,500 $29,278 $146,374Faculty International Travel Grant $13,000 $2,006 $14,157 $2,500 $31,663New Researcher Grant $6,000 $19,164 $25,164Proposal Enhancement Grant $19,616 $19,616

COLLEGE OF THE ARTS Total $66,596 $46,170 $29,157 $76,616 $29,278 $247,817MORSANI COLLEGE OF MEDICINE

Conference Support Grant $5,000 $5,000 $10,000Creative Scholarship Grant $20,000 $9,948 $29,948Faculty International Travel Grant $2,500 $7,500 $2,500 $5,000 $17,500New Researcher Grant $9,300 $9,709 $17,297 $29,575 $10,000 $75,881Proposal Enhancement Grant $25,000 $18,431 $25,000 $25,000 $49,786 $143,217

MORSANI COLLEGE OF MEDICINE Total $36,800 $35,640 $69,797 $59,575 $74,734 $276,546MUMA COLLEGE OF BUSINESS

Conference Support Grant $5,000 $5,000 $8,500 $5,000 $10,000 $33,500Creative Scholarship Grant $20,000 $20,000Faculty International Travel Grant $5,000 $2,500 $7,500New Researcher Grant $10,000 $10,000

MUMA COLLEGE OF BUSINESS Total $5,000 $5,000 $33,500 $7,500 $20,000 $71,000TANEJA COLLEGE OF PHARMACY

Conference Support Grant $10,000 $10,000 $20,000Faculty International Travel Grant $3,496 $1,710 $1,460 $6,666New Researcher Grant $20,000 $9,400 $29,400Proposal Enhancement Grant $25,000 $25,000

TANEJA COLLEGE OF PHARMACY Total $25,000 $13,496 $21,710 $11,460 $9,400 $81,066USF SARASOTA/MANATEE

Conference Support Grant $5,000 $5,000Faculty International Travel Grant $2,500 $9,937 $7,220 $5,000 $24,657New Researcher Grant $18,393 $30,000 $20,000 $68,393

USF SARASOTA/MANATEE Total $20,893 $44,937 $27,220 $5,000 $98,050USF ST. PETERSBURG

Conference Support Grant $5,000 $10,000 $5,000 $8,255 $28,255Faculty International Travel Grant $4,091 $9,710 $7,100 $20,901New Researcher Grant $10,000 $10,000 $20,000

USF ST. PETERSBURG Total $9,091 $29,710 $5,000 $25,355 $69,156Grand Total $501,233 $500,000 $497,825 $494,280 $334,877 $2,328,216

178

Research and Innovation Internal Awards Programs Detailed Annual Report 7/1/2020-6/30/2021

Program PI name Department Title AmountConference Support Grant Hevner,Alan Systems and Management 17th International Conference on Design Science Research in Information Systems and 5,000

Mondello,MichaelSchool of Marketing and Innovation Sport and Entertainment Analytics Conference 5,000

Vasquez,Camilla World Languages Approaches to Digital Discourse Analysis (ADDA3) 5,000Jiang,Hong Yuan Global and Planetary Health March Malaria Madness meeting 5,000Obican,Sarah Obstetrics and Gynecology Human Teratogens Virtual Course 5,000Kwon,Changhyun Industrial Engineering The 17th INFORMS Computing society Conference 5,000Schotter,Elizabeth R Psychology Neural underpinnings of attention in the real world: Insights from co-registration of eye 5,000

Conference Support Grant Total 35,000Creative Scholarship Grant Akin-Kivanc,Esra School of Art and Art History Research for new book manuscript titled, In the Mirror of the Other: Imprints of Muslim 9,328

La Mattina,Giulia Economics Housing Affordability and Domestic Violence 9,080Ngo,Fawn Criminology Cyber Safety and Awareness Educational Program for Hispanic and Vietnamese Americ 9,975Runge,Laura English Mary Delany Digital Archive 10,000Travers,Jeanne Dance Murmurs of the River-Race, Identify and Memory: An Interdisciplinary, collaborative, C 9,950Tykot,Robert Anthropology Plague in Venice Project: A Pilot Study Using Isotope Analyses and Proteomics 10,000

Samnotra,ManuSchool of Interdisciplinary Global Studies "Duty Bound": A Gandhian Defense of Dignity 5,000

Sherry,Michael B Comm., Instruction and Learning Cultivating Anti-racist Writing Teachers through the Tampa Bay Area Writing Project 5,000Fernandez,Joel Internal Medicine Health Outcomes in an Academic Center's Multidisciplinary Congestive Heart Failure Cl 9,948Greely,Teresa M Marine Science The Story of Coastal Resiliency: A Guardians of the Gulf Augmented Reality (AR) Experie 9,640Bundrick,Sheramy D School of Art and Art History The Family of Citizens in Classical Athenian Art 10,000

Creative Scholarship Grant Total 97,921Faculty International Travel Grant Turner,Stephen Philosophy Faculty International Travel to Kolymari, Crete, Greece 2,375

Morris,Delores G Philosophy Faculty International Travel to Amsterdam, Netherlands 862Faculty International Travel Grant Total 3,237

New Researcher Grant Abella,Anna L D Child and Family Studies Assessment of Mental Health Unit Officers' Confidence and Skill in Addressing Mental H 10,000Naeini,Mia Electrical Engineering Graph Signal Processing for Security and Reliability Enhancement of Power Grids 9,910Doody,Jeremiah Sean Inegrative Biology Spatial Ecology of the Invasive Nile Monitor Lizard 9,670Zalamea Zamora,Paul Cam Inegrative Biology New Insights into Microbial Drivers of Plant Diversity: Characterization of Seed-Associat 10,000

Persohn,Lindsay ELang., Literacy, Ed., Exceptional Ed. And Physical Ed. Evaluating Public Scholarship for Impact: Podcasting to Expand the Reach of Research 10,000

Ding,Bo Medical Engineering Novel Imaging of Key Aspects of Inner Ear Function for Understanding Hearing Loss 10,000Khalaf,Racha T. Pediatrics Impact of CFTR Modulators on Aerodigestive Microbiota and Inflammation in Pediatric 10,000

Cowart,Kevin MichaelPharmacotherapeutics and Clinical Research Investigating the Impact of Pharmacist-led Flash Continuous Glucose Monitoring on Clin 9,400

Trinh,Minh Tuan Physics Transition Metal Dichalogenide Monolayers with Controllable Magnectic Doopants for 9,994

Hartmann,NathanielSchool of Marketing and Innovation Understand Salesperson-Buyer Interactin Through Text 10,000

New Researcher Grant Total 98,974Proposal Enhancement Grant Blanck,George Molecular Medicine Development of a Repository of Immune Receptor Data Obtained From Genomics Files 24,786

Breitbart,Mya Marine Science Ecology and Evolution of Seagrass Viruses 25,000Mohapatra,Subhra Molecular Medicine Leriglitazone as an Adjunct to Stem Cell Therapy Targeting COVID-19 Neurotropism 25,000Wang,Cai Mike Mechanical Engineering Emergent Deformation-Activated Basal Plane Catalytic Domains in Transition Metal Cha 24,959

Proposal Enhancement Grant Total 99,745Grand Total 334,877

179

USF Research & Innovation University of South Florida

3702 Spectrum Blvd, Suite 165 Tampa, Florida 33612-9445

Phone: 813-974-5570 Fax: 813-974-4962

Email: [email protected]

This document is also available on the USF Office of Research Web site at www.research.usf.edu

180

FY 2021 Annual Report

Documents